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The University of Manchester               Chloe Holloway
  
Stereoselective construction of quaternary centres under Brønsted acid 
catalysis 
 
For the degree of ‗Doctor of Philosophy‘ 2010 
 
A methodology featuring the diastereoselective addition of tryptamine derivatives 
to a proline derived diketopiperazine in the presence of an achiral Brønsted acid 
catalyst was used in the synthetic studies towards Subincanadine B, an indole 
alkaloid natural product.  The synthesis began with the formation of a fused 
pentacyclic intermediate containing a diketopiperazine moiety.  Cleavage of the 
diketopiperazine was required to proceed with the synthesis but this did not prove 
facile.  It was possible to cleave the least hindered amide bond of the 
diketopiperazine, but attempts to cleave both amide bonds were unsuccessful. 
 
 
 
A new methodology to access subincanadine B was developed.  This featured an 
asymmetric Pictet-Spengler reaction catalysed by a BINOL-derived phosphoric 
acid catalyst.  Differently substituted tryptamines were reacted with various 1,4-
dicarbonyl compounds bearing a variety of functional groups α-to the ketone in the 
presence of a chiral phosphoric acid catalyst.  A range of products were obtained 
in excellent yield and diastereoselectivity, and in moderate to high enantiomeric 
excess.   
 
 
This methodology was used in a further attempt to access subincanadine B.  The 
Pictet-Spengler cyclisation product with a methyl ester adjacent to the chiral 
quaternary centre was used as the starting material in the synthesis.  Using this 
methodology, an advanced tetracyclic intermediate was successfully synthesised.  
Further studies are currently being aimed at completing the synthesis. 
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M.P.  melting point 
MS  molecular sieves 
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NMR  nuclear magnetic resonance 
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Chapter 1: Overview 
 
1.1 Organocatalysis 
 
The field of organocatalysis
1
 has grown exponentially in the last decade since David Macmillan 
coined the term in 2000
2
 (Figure 1.1).  The interest of numerous research groups in the field and 
their development of a wide range of organocatalysts suggests that organocatalysis has become 
favoured over traditional transition metal catalysis in a number of transformations.  The main 
advantages of organocatalysts over transition metal catalysts are the fewer toxicity issues 
associated with their use, the decreased cost and effort required to prepare them and the greater 
tolerance of the catalysts to air and water.  The first organocatalysts were amino acid derived and 
were used in aldol, Mannich and Diels Alder reactions. Since then a vast selection of catalysts have 
been developed which operate through various modes of activation.
3
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Figure 1.1: SciFinder hits for ―Organocatalysis‖ from 2000 to 2009 
 
1.2 The use of Brønsted acid organocatalysis in chiral quaternary centre formation 
 
The formation of a chiral quaternary centre with high stereocontrol represents a major challenge to 
chemists.  The issues of steric hindrance associated with the creation of a quaternary centre mean 
that harsh reaction conditions are often required and the scope of nucleophiles and electrophiles 
employed is limited.  The growth in the field of organocatalysis over the last few years has led to 
the development of numerous methodologies where organocatalysts have been employed to 
promote the formation of quaternary stereocentres with excellent stereocontrol and under relatively 
mild reaction conditions.  The use of Brønsted acid catalysis in the formation of quaternary centres 
has been demonstrated recently.  Maruoka et al. exploited the use of triflic acid as a Brønsted acid 
catalyst in the stereoselective insertion of (-)-phenylmenthyl aryldiazoacetates to aldehydes
4
  
(Scheme 1.1 (1)).  By using a phenylmenthyl moiety as a chiral auxiliary, products were formed in 
excellent diastereomeric excesses and in good yields.  Later in 2008, Tsogoeva and co-workers 
published an asymmetric self coupling reaction of enamides in the presence of a BINOL-derived 
phosphoric acid catalyst.
5
  The quaternary stereocentres in the products were formed in excellent 
enantioselectivity (Scheme 1.1 (2)).  Zhou and co-workers also used a BINOL-derived phosphoric 
acid catalyst in their asymmetric Friedel-Crafts reaction of indole with variously substituted 
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enamides.
6
  The chiral amines possessing a quaternary stereocentre were formed in high 
enantioselectivity and in high yield (Scheme 1.1 (3)).   
 
 
Scheme 1.1: Examples of Brønsted acid catalysed quaternary centre formation 
 
1.3 Thesis aims 
 
The use of Brønsted acid catalysis to form chiral quaternary centres has only recently been 
addressed and only a few examples of this mode of catalysis exist in the literature.
7
  The aim of this 
thesis is to explore the use of chiral and achiral Brønsted acid catalysts in the construction of chiral 
quaternary centres with high stereocontrol formed from reactive N-acyl iminium electrophiles.
8
  New 
powerful methodologies will be developed and applied to the synthesis of a complex natural product 
bearing a chiral quaternary centre. 
 
 
 
 Chapter 2 
15 
Chapter 2: Proline as a chiral template for quaternary 
centre formation 
 
2.1 Introduction 
 
2.1.1 Introduction to chiral auxiliaries and chiral templates 
 
Chiral auxiliaries are enantiomerically pure compounds which are covalently bonded to a substrate 
and influence the stereochemical outcome of a reaction by their presence.
9
  They are typically 
small molecules bearing a functional group which will undergo a stoichiometric reaction with a 
reagent to yield the substrate for the diastereomeric selective reaction. Using steric hindrance or 
directing groups during the stereoselective reaction, they are able to influence the stereochemical 
formation of a new chiral centre.  Physical separation of diastereomeric products followed by 
removal of the chiral auxiliary, which can be recycled, results in the formation of products in high 
enantio- or diastereomeric excess.  Chiral templates only differ from chiral auxiliaries in that the 
chiral templates cannot be recycled and are used up in stoichiometric quantities during an 
asymmetric reaction. 
  
The extensive accumulated knowledge regarding chiral auxiliaries and chiral templates means their 
reactivity and stereoselectivity is generally predictable.  They provide a reliable means of 
synthesising enantiomerically enriched compounds which would otherwise not always be readily 
obtainable, and they have been used widely as a tool in the synthesis of therapeutics.  
 
2.1.2 The use of amino acid derived chiral auxiliaries and chiral templates 
 
2.1.2.1 SAMP as a chiral auxiliary and as a chiral template 
 
(S)-1-Amino-2-methoxymethylpyrrolidine (SAMP) is a chiral hydrazine auxiliary derived from (S)-
proline (Figure 2.1).  It was first developed by Enders and Eichenauer
10
 in 1976 and has been used 
extensively in many organic reactions such as in alkylation reactions,
11
 Michael additions,
12
 Diels-
Alder reactions
13
 and in nucleophilic addition reactions to the hydrazone C=N bond formed on 
addition of SAMP to a carbonyl.
14,15
 
 
 
Figure 2.1: SAMP 
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1) Applications 
 
Alkylations: 
 
SAMP is most frequently used as a chiral auxiliary in alkylation reactions.  One of the first 
applications of SAMP was in the synthesis of the alarm pheromone from the ant Atta texana.
16
  
This began with the preparation of hydrazone (2.1) by heating SAMP and ethyl ketone to 60 ºC for 
20 hours.  With the chiral auxiliary in place, the lithium aza enolate was generated using LDA which 
was able to undergo a diastereoselective nucleophilic substitution reaction with iodopropane to 
yield hydrazone (2.2).  Subsequent hydrolytic cleavage of the auxiliary afforded the product (2.3) in 
99.5% ee with an overall yield of 60% from (2.1) (Scheme 2.1). 
 
 
 
 
 
 
Scheme 2.1: Preparation of (2.3) by diastereoselectively controlled alkylation 
 
To explain the stereochemical preference of the alkylation reaction, a transition state was proposed 
which featured chelation of the methoxy-group and hydrazine with lithium of the aza enolate to form 
a six-membered ring (Scheme 2.2). This chelation effect caused the SAMP auxiliary to shield the 
Re-face of the aza enolate and resulted in the preferential attack of the electrophile from the Si-
face. Evidence for the proposed transition state comes from trapping experiments
17
, spectroscopy
18
 
and X-ray analysis.
19
 
 
Scheme 2.2: Transition state model proposed for SAMP assisted alkylation reactions 
 
Michael additions: 
The use of SAMP as a chiral auxiliary was extended to the formation of chiral Michael addition 
products starting from a dioxanone derivative (2.6).  Formation of the aza enolate from hydrazone 
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(2.7) with 
t
BuLi and subsequent Michael addition to an (E)-α,β-unsaturated ester gave the desired 
Michael adducts (2.8).
20
  Ozonolysis of the crude reaction product furnished Michael adducts (2.9) 
in moderate to good yields and in high diastereoselectivies and enantioselectivities (Scheme 2.3).  
 
Scheme 2.3: Diastereoselective Michael addition using SAMP  
 
Addition to the SAMP hydrazone: 
 
When reacted with an aldehyde SAMP forms a hydrazone which can be attacked by an 
organometallic reagent via a nucleophilic addition reaction.  The organometallic reagents will react 
with the SAMP hydrazone in a stereoselective fashion to form products in high enantiomeric and 
diastereomeric excess.  The best results are obtained with organolithium, organocerium, 
organoytterbium and Grignard reagents.  This reaction has been applied to the synthesis of D-
phenylalaninol derivatives (Scheme 2.4).  The synthesis began with the formation of hydrazone 
(2.11) from the addition of SAMP to protected D-glyceric aldehyde.  Benzyl lithium addition was 
followed by carbamate formation, giving adduct (2.12) in 62% yield and in excellent de.  Cleavage 
of the hydrazine bond with lithium and ammonia, and hydrolysis of the carbamate with NaOH 
afforded amine (2.13), which was converted to Boc protected D -phenylalaninol (2.14).
21
 
 
 
Scheme 2.4: The stereoselective addition of benzyl lithium to the SAMP hydrazone 
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Hetero-Diels-Alder reactions: 
 
The use of SAMP in hetero-Diels-Alder reactions is illustrated below in the preparation of piperidine 
derivatives (2.20) and (2.21)
22
 (Scheme 2.5).   
 
 
Scheme 2.5: The use of SAMP in hetero-Diels-Alder reactions 
 
Formation of hetero-Diels-Alder adduct (2.18) in a high diastereomeric excess was achieved by 
reaction of dienophile (2.17) with diene (2.16) at room temperature in acetonitrile.  Ring opening of 
the anhydride with methanol and esterification yielded adduct (2.19) which, after cleavage of the N-
N bond with zinc and acetic acid gave the corresponding piperidine derivatives without 
epimerisation or racemisation of the preformed stereocentres.  The double bond was reduced 
unselectively in the auxiliary cleavage reaction and gave epimers (2.21) and (2.20) in a 7 : 3 ratio 
respectively. 
 
2) Cleavage 
 
The SAMP auxiliary can be removed by various methods such as oxidative cleavage with ozone or 
mCPBA; hydrolytic cleavage with CuCl2 or MeI/HCl; and reductive cleavage with SnCl2.  Besides 
regenerating the parent aldehyde by auxiliary cleavage, new functionalities such as dithian (2.25),
23
 
nitrile (2.23)
24
, and amino groups (2.24)
25
 can be incorporated (Scheme 2.6).  
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Scheme 2.6: Methods of auxiliary cleavage and incorporation of new functionality 
 
Since the mid 1970‘s, SAMP has been used as the chiral auxiliary and chiral template of choice in 
many carbon-carbon bond forming reactions to generate enantiomeric and diastereomeric 
products.  The success of SAMP as a chiral auxiliary and chiral template has promoted the 
development of other amino acid derived chiral auxiliaries.    
 
2.1.2.2 (R)-Phenylglycine amide as a chiral template 
 
(R)-Phenylglycine amide became readily accessible when used as an important intermediate in the 
enzymatic synthesis of β-lactam antibodies on an industrial scale.
26
  It is possible to resolve (R)-
phenylglycine amide from racemic phenylglycine amide by hydrolysis catalysed by aminopeptidase 
or by using (S)-mandelic acid as a resolving agent.
27
   
 
1) Application 
 
Nucleophilic addition reactions: 
 
(R)-Phenylglycine amide has been used as a chiral template to promote the diastereoselective 
addition of allylzinc bromide to imines by Kellogg and co-workers
28
  (Scheme 2.7).  The resulting 
homoallylamines (2.27) were formed in good yield and in excellent diastereoselectivity and allyl 
zinc bromide proved to be an excellent choice of nucleophile even in the presence of a phenolic 
hydroxyl group.  A transition state was proposed to rationalise the observed stereochemical 
outcome.  This featured the chelation of zinc by the two heteroatoms in the phenylglycine moiety 
and the arrangement of the allyl chain in a six-membered Zimmerman Traxler
29
 like transition state 
with the imine.  
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Scheme 2.7: (R)-Phenylglycine amide as a chiral template in addition of zinc bromide to imines 
 
Hydrogenation reactions: 
 
In 2003 Ikemoto, Tellers, and Rivera reported an asymmetric hydrogenation reaction of an 
enamine, employing (S)-phenylglycine amide as a chiral template.
30
  The high diastereoselectivities 
observed were thought to result from a hydrogen bonding interaction between the secondary amine 
proton and the sp
2
 oxygen atoms.  This arrangement resulted in a planar structure with the phenyl 
group of the glycine template shielding one of the diastereotopic faces.  As shown below, the 
phenyl moiety occupies the Re-face of enamine (2.28) and as consequence diastereoselective 
hydrogenation will occur from the Si-face to yield products (2.29) (Scheme 2.8).  
 
 
Scheme 2.8: Diastereoselective hydrogenation employing (S)-phenylglycine amide as a chiral 
template 
 
2) Cleavage 
 
The removal of the phenylglycine amide moiety has been achieved using hydrogenation although 
unsurprisingly this has only been successful in the absence of functional groups which are 
sensitive to hydrogenation.  For example, in the work described above by Kellog et al. (Scheme 
2.7) the removal of the (R)-phenylglycine amide chiral template of homoallylamines (2.27) by 
hydrogenation resulted in the loss of the allylic functionality.  In order to address this problem, a 
new approach to the cleavage of phenylglycine amide was developed by Kellog and co-workers 
which avoided hydrogenolysis
28
 (Scheme 2.9). 
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Scheme 2.9: Removal of (R)-phenylglycine amide 
 
The removal of (R)-phenylglycine amide began with the dehydration of the amide using DMF and 
oxalylchloride to furnish the nitrile (2.31).  This was followed by treatment with potassium 
carbonate.  The benzilidine group was removed on treatment with hydroxylamine hydrochloride to 
yield amine (2.33) in 78% overall yield from (2.30).   
 
2.1.3 Formation of quaternary centres using amino acid derived chiral auxiliaries          
         and chiral templates 
 
2.1.3.1 L-valine as a chiral auxiliary in an enantioselective Michael addition 
           reaction 
 
Christoffers and Mann developed a highly enantioselective copper catalysed Michael addition to 
access 1,3-dicarbonyls bearing a quaternary centre by employing L-valine diethylamide as a chiral 
auxiliary
31
 (Scheme 2.10).  Under mild reaction conditions, a quaternary centre α to the carbonyl 
was formed in high enantiomeric excess and a series of 1,3-dicarbonyl derivatives (2.36) were 
afforded.  The reaction sequence began with the formation of enamine (2.35), which under Cu (II) 
catalysis underwent a Michael addition reaction to methyl vinyl ketone to give Michael adducts 
(2.36).  The L-valine chiral auxiliary was hydrolytically cleaved in the reaction conditions and was 
isolated almost quantitatively from the reaction mixture on extraction.  A transition state model was 
proposed in order to rationalise the stereochemical outcome of the reaction.  Enamine (2.35) was 
thought to act as a tridentate ligand and chelate to the Cu (II) species to form a planar Michael 
donor with the isopropyl group of the auxiliary shielding the Re-face.  The blocking of the Re-face 
by the isopropyl group resulted in the Michael acceptor coordinating and being activated from the 
Si-face of the complex to give the (R)-configuration in the product (Scheme 2.10). 
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Scheme 2.10: L-valine as the chiral auxiliary in enantioselective Michael addition 
 
2.1.3.2 Proline derived diketopiperazines (DKPs) as chiral templates in quaternary 
            centre formation  
     
Liebscher et al.
32
 developed a method for the addition of N-heteroaromatics to 3-alkylidine or 3-
benzylidine-2,4-diketopiperazines in the presence of a catalytic amount of HBr to access 3-alkyl-
2,5-diketopiperazines in high diastereomeric ratios as precursors to quaternary α-amino acids.  3-
alkylidine-2,4-diketopiperazines were readily accessed from proline and were used as chiral 
templates (Scheme 2.11).  Under HBr catalysis DKP (2.37) formed an iminium ion (2.38) which 
could undergo a Mannich type reaction with pyrrole or indole to create a new quaternary centre in 
high diastereoselectivity.  Attack of the N-heteroaromatic occurred from the less hindered convex 
side of the fused ring system.   
 
 
Scheme 2.11: Acid catalysed addition of N-heteroaromatics to diketopiperazines 
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This methodology led to the formation of products with differently substituted quaternary centres in 
good yields and in high diastereomeric ratios (Scheme 2.11).  When indole was employed in the 
addition to DKPs bearing bulky R substituents such as phenyl, a constitutional isomeric product 
was formed (2.43)
33
 (Scheme 2.12).  Under acidic conditions the C-C double bond was able to 
migrate via a series of protonation and deprotonation steps.  The equilibrium was found to lie 
towards the product which offered the greatest degree of conformational flexibility to the 
substituents attached to the N-atoms and adjacent C-atoms.  Compound (2.43) was afforded in 
93% yield and was thought to have been formed via iminium ion (2.41).   
 
 
Scheme 2.12: Acid catalysed isomerisation of double bonds leading to one of two regioisomers 
 
Further investigation of the C-C double bond migration showed that in the absence of steric 
interactions, i.e. when N-unsubstituted DKPs were used, no migration of the double bond occurred, 
only E/Z isomerisation.     
 
2.2 Concept and Aims 
 
Liebscher et al. have developed an approach to access quaternary centres using a 
diketopiperazine derived from proline.  They demonstrated that both pyrrole and indole can be 
used as nucleophiles in the Mannich type addition reaction to give quaternary centres in high 
diastereomeric ratios.  However, they did not explore the use of 3-substituted indoles in order to 
probe the methodology further, and give rise to compounds which could be used as intermediates 
in natural product synthesis. 
 
Specifically, the aims of this study were: 
 
1) To develop and optimise the synthesis of an N-unsubstituted DKP. 
2) To explore the reactions of DKPs with various 3-substituted indole nucleophiles.  
3) To identify a natural product with the same quaternary centre motif and apply the methodology 
to its synthesis. 
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2.3 Results and Discussion 
 
2.3.1 Initial construction of the diketopiperazine (DKP) chiral building block  
 
α,β-Unsaturated amide (2.51) could be synthesised from diketopiperazine (2.49), which had been 
previously synthesised by Falorni et al.
34
  The synthesis began with the amide coupling of L-serine 
methyl ester hydrochloride (2.45) with Cbz-protected L-proline (2.46), followed by hydrogenation of 
the Cbz group to afford dipeptide (2.48) and subsequent heat induced cyclisation to yield (2.49) 
(Scheme 2.13).  
 
 
Scheme 2.13: Synthesis of α,β-unsaturated amide (2.51) 
 
Falorni et al used 4-methyl morpholine and ethylchloroformate to facilitate the amide coupling, but 
when these conditions were tried only a 20% yield was obtained.  More conventional coupling 
conditions using DCC, HOBt and NEt3 in dichloromethane were investigated and resulted in an 
improved yield of 64%.  Dipeptide (2.47) was deprotected to give adduct (2.48) using typical 
hydrogenation conditions with no need for further purification before being refluxed in MeOH in 
order to effect cyclisation.  Falorni et al. obtained diketopiperazine (2.49) in poor 36% yield, 
probably due to the concentrated conditions (1.6 M) in which they conducted the intramolecular 
cyclisation of dipeptide (2.48) as this could have promoted intermolecular side reactions.  Using a 
reduced concentration of 0.05 M diketopiperazine (2.49) was afforded in a respectable 59% yield, 
although the reaction required an extra two days to reach completion.   
 
Having successfully synthesised diketopiperazine (2.49), the formation of α,β-unsaturated amide 
(2.51) was achieved by mesylation of the primary alcohol followed by elimination with NaH in DMF.  
This was confirmed by the presence of the two methylene protons as singlets in the 
1
H NMR 
spectrum at δ 4.82 and δ 5.53 ppm.   
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2.3.2 Improved synthesis of the DKP 
 
Due to the lengthy and relatively poor yielding synthesis of α,β-unsaturated amide (2.51) via DKP 
(2.49), an alternative route that did not involve the loss of a chiral centre was investigated, and a 
more efficient synthesis via formation of tertiary alcohol (2.53) was found (Scheme 2.14).  This 
synthesis of tertiary alcohol (2.53) had been employed by Bycroft and Lee in 1975 in their synthesis 
of α-amino acids from α-keto acids
35
 and was subsequently used by Sanz-Cervera et al.
36
 however, 
experimental procedures were absent from both publications.  
 
 
Scheme 2.14: Synthesis of α,β-unsaturated amide (2.51) via tertiary alcohol (2.53) 
 
The first step was the coupling of pyruvic acid with commercially available L-proline methyl ester 
hydrochloride to give amide (2.52).  Standard coupling conditions using DCC, HOBt and NEt3 in 
dichloromethane afforded (2.52) in poor yield (13%), after purification by column chromatography, 
despite the 70-80% yields reported.  A procedure
37
 was found for the generation of pyruvyl chloride 
in situ, prior to the addition of L-proline methyl ester hydrochloride, this resulted in an impressive 
yield, 98% of adduct (2.52) which did not require further purification.  Compound (2.52) was found 
to exist as a pair of rotamers which after reaction with anhydrous ammonia in methanol 
spontaneously cyclised to afford tertiary alcohol (2.53) in 84 % yield (Scheme 2.14).  
 
Bycroft and Lee dehydrated the tertiary alcohol of (2.53) with trifluoroacetic acid
35
 but no procedure 
or yield was available to follow; stirring tertiary alcohol (2.53) in neat TFA for three days at room 
temperature gave 43% of a product which could not be satisfactorily purified.  However on 
optimisation it was found that the use of phosphorous pentoxide in refluxing toluene with a Dean-
Stark apparatus, furnished adduct (2.51) in an impressive 96% yield. 
 
 
2.3.3 Nucleophilic additions to iminium ions generated in situ  
 
After having successfully optimised a route to α,β-unsaturated amide (2.51), it was proposed that 
instead of dehydrating tertiary alcohol (2.53) prior to the reaction, it could be dehydrated in situ 
using catalytic acid and thus generate an iminium ion.  This would be able to undergo a 
nucleophilic addition reaction with an N-heteroaromatic nucleophile to generate a chiral quaternary 
centre and furnish the product.  This proposal proved successful, and when tertiary alcohol (2.53) 
was subjected to catalytic p-toluenesulphonic acid in dichloromethane at room temperature in the 
presence of indole or pyrrole, a diastereoselective nucleophilic addition reaction occurred.  Single 
regioisomers of indole addition product (2.54) and pyrrole addition product (2.55) were obtained in 
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95% and 98% yields respectively and in diastereomeric ratios of 4.5 : 1 and 3.2 : 1 respectively.  
These diastereomeric ratios are significantly lower than those obtained by Liebscher et al.
32
 where 
an N-alkylated DKP was employed in the reaction.  N-alkylation of the DKP obviously results in 
enhanced diastereoselectivity.  Single crystal X-ray crystallography of the major diastereomers of 
both products proved the relative stereochemistry.  The absolute stereochemistry could be 
assigned from the fixed stereocentre of L-proline and showed that the addition of indole and pyrrole 
to DKP (2.53) had occurred from the Re convex face (Scheme 2.15). 
 
 
Scheme 2.15: Diastereoselective addition reactions of N-heteroaromatics to DKP (2.53) and x-ray 
crystal structures showing the relative stereochemistry of the major diastereomers for the 
corresponding products 
 
2.3.4 The use of 3-substituted indoles as nucleophiles 
 
After obtaining pleasing results from the use of tertiary alcohol (2.53) to generate iminium ions in 
situ, attention was turned to the extension of the methodology by employing 3-substituted indoles.  
Addition reactions of 3-substitued indoles to Michael acceptor 2-cyclohexenone was reported in 
2005 by McClusky et al.
38
  The 3-substituted indoles were found not only to react at the 2-position 
of indole, but also on the indole nitrogen atom to form N-alkylated indoles under Bi (III) Lewis acidic 
conditions.  Using the conditions established for the addition of pyrrole and indole to DKP (2.53), a 
range of 3-substituted indoles were screened.  Fortunately none of the undesired N-alkylated 
products were observed and only C-2 addition had occurred.  The mechanism by which the 
addition reaction took place was unknown but it seemed likely that direct attack from the 2-position 
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of indole occurred rather than attack from the 3-position and subsequent rearrangement, due to 
steric hindrance at the 3-position (Scheme 2.16).  
 
Scheme 2.16: Proposed reaction pathways to explain observed products 
 
Had attack occurred from the 3-position, then intramolecular cyclisation of the tryptamine derivative 
onto the 2-position of indole could have afforded cyclised products.
39,40
  However, these were not 
observed in the crude 
1
H NMR.  Instead, chiral quaternary centres were formed to give a range of 
compounds possessing different side chains at the C-3 indole position in good to high 
diastereomeric ratios and in good yield (Scheme 2.17).  Tryptamine derivatives, (2.57), (2.58), 
(2.59) and (2.62), and tryptophan derivatives (2.60) and (2.61) were obtained in high yields and 
tryptophol addition to tertiary alcohol (2.53) furnished product (2.63) in an excellent 96% yield.  
Tertiary alcohol (2.56) was developed with a propyl chain at R
1
, and was also found to undergo 
addition reactions with 3-substituted indoles.  The products (2.64), (2.65) and (2.66) were obtained 
in lower yield and required longer reaction times than the corresponding adducts where R
1
 was a 
methyl group.  This was probably due to the increased steric hindrance caused by the propyl chain 
in the formation of the quaternary centre by nucleophilic addition to the iminium ion. 
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Scheme 2.17: Methodology scope 
 
The relative stereochemistry of (2.62) was confirmed by single crystal x-ray diffraction and the 
absolute stereochemistry was assigned from the fixed stereocentre of L-proline.  This assignment 
was consistent with attack from the Re, convex face of DKP (2.53) (Figure 2.2). 
 
 Figure 2.2: X-ray crystal structure of (2.62)  
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2.3.5 The identification of a natural product featuring the quaternary centre motif 
 
With the methodology in place, attention was turned to its application in the synthesis of natural 
products featuring a quaternary centre adjacent to an amide and an indole moiety.  The natural 
product subincanadine B
41
 was found to contain the exact motif constructed in the methodology 
and could be envisaged as being accessed from tryptophol derivative (2.63) (Scheme 2.18). 
 
 
Scheme 2.18: The quaternary centre motif present in subincanadine B 
 
2.4 Summary 
 
A new methodology resulting in the formation of a chiral quaternary centre by the addition of 3-
substituted indoles to L-proline derived DKPs was developed.  Products were afforded in excellent 
yield and in high regio- and diastereoselectivity.  The quaternary stereocentre motif was found to 
resemble the quaternary centre found in the natural product subincanadine B.  The application of 
this methodology to the synthesis of subincanadine B will be reported in the following chapter. 
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Chapter 3: Synthetic studies towards Subincanadine B – 
Chiral template approach 
 
3.1 Introduction 
 
3.1.1 Isolation and structural assignment of subincanadine B 
 
Subincanadine B, an indole alkaloid, was first isolated from the Brazilian medicinal plant 
Aspidosperma subincanum in 2002 by Kobayashi et al.
41
 together with subincanadine A and 
subincanadines C-F.  Subincanadines A-C feature a 1-azoniatricyclo[4.3.3.0
1,5
]-undecane moiety 
and differ from each other by the stereochemistry at C-17 and by the R group adjacent to the 
quaternary centre (Figure 3.1). 
 
 
Figure 3.1: Subincanadines A-C 
 
In order to structurally assign the subincanadines a number of spectroscopic techniques were 
used.  A mass spectrum showed a molecular peak at m/z 295 corresponding to subincanadine B.  
The same peak was also seen for subincanadine A.  NOE correlation experiments were conducted 
and showed that in subincanadine B the methyl group at C-16 had an α-orientation, proving that 
subincanadine B was the C-16 epimer of subincanadine A.  The Z-configuration of the double bond 
was assigned from the NOE correlation between H-19 and HA-21.   
 
 
3.1.2 Biological activity of subincanadine B 
 
Although subincanadines E and F were shown to exhibit cytotoxic activity towards murine 
lymphoma L1210 cells (IC50 0.3 μg/ml and 2.4 μg/ml respectively) and towards human epidermoid 
carcinoma KB cells (IC50 4.4 μg/ml and 4.8 μg/ml respectively) in vitro, subincanadines A-D failed 
to display any cytotoxic activity. 
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3.1.3 Previous syntheses of subincanadine B 
The synthesis of subincanadine B was first attempted by Zhai et al.
42
 in 2006 where two analogues 
of the target were made in eleven steps (Scheme 3.1).  The key steps in the synthesis were a 
Pictet-Spengler cyclisation followed by a Dieckmann condensation.  The synthesis began with the 
protection of the primary amine of tryptamine as a phthalamide derivative followed by the 
benzylation
43
 of the indole nitrogen and subsequent transamidation to yield protected tryptamine 
(3.3).  Michael addition of tryptamine (3.3) with methyl acrylate gave the precursor to the Pictet-
Spengler product.  In order to affect Pictet-Spengler cyclisation of (3.4) it was necessary to use 
TFA in benzene at reflux for two days.  Having obtained the Pictet-Spengler product in 84% yield, 
the second key step – a Dieckmann condensation, was successfully achieved by reaction of (3.5) 
with potassium tert-butoxide followed by decarboxylative hydrolysis with acetic acid and 
hydrochloric acid.  This yielded tetracyclic ketone (3.6) as a key intermediate in the synthesis in 
81% yield over two steps.  With N-protected tetracyclic ketone (3.6) in hand, their attention was 
turned to the construction of the azoniacycle of subincanadine B.  Many attempts to attach a side 
chain onto ring D were tried but ketone (3.6) proved to be too sterically hindered to allow addition.  
Thus attention was turned to producing analogues of subincanadine B by employing nucleophiles 
with less steric bulk, able to undergo nucleophilic addition to ketone (3.6).  Lithium enolates of ethyl 
acetate and ethyl butyrate were used to obtain aldol products (3.7) and (3.9), and (3.8) and (3.10) 
respectively as mixtures of separable diastereomers in the ratios 14:1 and 1.73:1 respectively.  The 
relative stereochemistry of the diastereomers was assigned by NOE analysis and the 
stereoselectivity of nucleophilic addition was explained by nucleophilic addition to the less hindered 
face of the ketone, i.e. from the opposite face to that occupied by the methyl group at the 
quaternary centre.  Complete reduction of esters (3.7) and (3.8) with LiAlH4 gave the corresponding 
diols which were subsequently debenzylated to form N-deprotected diols (3.11) and (3.12) in 74% 
and 70% respectively over two steps.  Spontaneous intramolecular SN2 reactions took place after 
tosylation of primary alcohols (3.11) and (3.12) to form subincanadine B analogues: 20-
deethylenylated subincanadine B and dihydrosubincanadine B respectively (Scheme 3.1). 
Although Zhai et al. had failed to synthesise subincanadine B, they had developed a method for 
constructing the pentacyclic framework of subincanadine B and outlined the difficulty of successful 
nucleophilic addition to ketone (3.6).   
 Chapter 3 
32 
 
Scheme 3.1: The total synthesis of 20-deethylenylated subincanadine B and  
dihydrosubincanadine B 
 
In 2006 Takayama et al.
44
 published the first asymmetric synthesis of (-)-subincanadine B and (-)-
subincanadine A, both in sixteen steps with an overall yield of 2.7%. These syntheses involved an 
intramolecular diastereoselective Pictet-Spengler cyclisation and an intramolecular Nozaki-Hiyama-
Kishi reaction.
45
  The syntheses began with the protection of the 1,2-carboxylic acid – alcohol 
residue of (S)-malic acid,
46
 followed by the reduction of the free carboxylic acid moiety and 
formation of γ-lactone (3.14)
47
 (Scheme 3.2).  Protection of the secondary hydroxyl group with a 
tert-butyldimethylsilyl protecting group afforded lactone (3.15) which was treated with methyl lithium 
in THF to form the corresponding methyl ketone.  The resulting primary alcohol was protected with 
a pivaloyl group and the TBS protecting group was removed to give (3.17).   
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Scheme 3.2: Synthetic route towards (-)-subincanadines A and B 
 
On reacting methyl ketone (3.17) with tryptamine in the presence of CDI, carbonate (3.19) was 
formed which was found to exist in the form of a hemi-aminoacetal in solution.  This was able to 
undergo a diastereoselective Pictet-Spengler reaction in the presence of TMSCl as a Lewis acid to 
afford Pictet-Spengler product (3.20) as a 9:1 mixture of diastereomers.  The mixture was 
recrystallised to give a single diastereomer with an ee of 99% which was used in the remaining 
steps of the synthesis.  The relative stereochemistry was assigned by NOE analysis and it was 
found that the methyl group and adjacent alkyl chain of the major diastereomer adopted a cis 
arrangement.  This pointed to indole attack of the in situ formed iminium ion from the less hindered 
side, anti to the side chain. The synthesis was continued with the removal of the pivaloyl group of 
the primary alcohol and protection with a MEM ether which would be stable to the strong basic 
conditions used in the next step.  Base hydrolysis of the carbamate and subsequent alkylation of 
the secondary amine with allylic bromide (3.23) afforded iodide (3.24).  In order to construct the 
third ring, the primary alcohol was oxidised to ketone (3.25) using IBX which was able to undergo 
the second key step in the synthesis – an intramolecular Nozaki-Hiyama-Kishi reaction (Scheme 
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3.3).  This furnished tetracyclic diastereomers (3.26) and (3.27) in 53% and 35% yield respectively; 
the relative stereochemistry of which was assigned by NOE analysis.  The synthesis was 
completed by deprotection of the MEM ether
48
 followed by reprotection with MsCl under standard 
conditions and cyclisation to give the ent form of natural subincanadine B and (-)-subincanadine A.  
 
 
Scheme 3.3: Completion of synthesis of (-)-subincanadines A and B  
 
In the synthesis of subincanadine B by Takayama et al. five different alcohol protecting groups 
were used and 16 synthetic steps were required to furnish the natural product.  The chiral 
quaternary centre was formed in a good diastereomeric ratio of 9:1 but recrystallisation was 
needed to obtain an enantiomerically pure compound resulting in a poor 47% yield of the key step.  
 
3.2 Concept and Aims 
 
Although subincanadine B had not displayed cyctotoxic activity when tested, its interesting 
structure rendered it an attractive target for synthesis.  It was thought that by using the 
methodology described in the previous chapter, the quaternary centre of subincanadine B could be 
constructed by the addition of tryptophol to DKP (2.53) to give intermediate (2.63) as a single 
diastereomers (Scheme 3.4).  With adduct (2.63) in hand, cyclisation of the amide to form fused 
pentacyclic system (3.30) could be achieved.  Cleavage of the DKP would regenerate the proline 
chiral auxiliary and yield amine (3.31) which could undergo an alkylation addition with bromide 
(3.32) to provide the required tetracyclic system. Further alkylation would yield subincanadine B.  
 
 Chapter 3 
35 
 
Scheme 3.4: Retrosynthetic analysis of subincanadine B employing L-proline as a chiral auxiliary 
 
Cyclisation product (3.30) had been synthesised previously by Czarnoki et al.
49
 via a Pictet-
Spengler reaction of aminol (3.34) to yield product (3.30) in a 75% yield and in 75% de (Scheme 
3.5).     
 
 
Scheme 3.5: Pictet-Spengler reaction developed by Czarnoki et al. 
 
By employing the methodology outlined in chapter 2 in the synthesis of pentacyclic product (3.30), 
the dr of the cyclised product would be higher than that obtained by Czarnoki et al. in their Pictet-
Spengler reaction. 
 
Specifically, the aim of this study was: 
 
1) To apply the methodology developed for the addition of 3-substituted indoles to L-proline derived 
DKPs to the synthesis of subincanadine B. 
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3.3 Results and Discussion 
 
3.3.1 Synthesis of the pentacyclic ring system 
 
The synthesis of the fused pentacyclic ring system from primary alcohol (2.63) was thought to be 
achieved by first creating a leaving group from the primary alcohol, followed by its displacement via 
an SN2 reaction with the amide of the DKP (Scheme 3.6).  
 
 
Scheme 3.6: Synthetic plan towards pentacyclic intermediate (3.30) 
 
Initially, tosyl chloride was used to form tosylate (3.36) and the desired tosylated product was 
obtained in a 59% yield.  By using tosic anhydride as an alternative tosylating agent, the yield was 
improved to 82% (Scheme 3.7).  With tosylate (3.36) in hand, attention was turned to the formation 
of the fifth cycle by displacement of the newly formed leaving group with the free amide of the DKP.  
However under basic conditions (NaH), chloride (3.37) was afforded in 72% yield as the sole 
reaction product.   It was thought that formation of chloride (3.37) was a consequence of using 1M 
HCl during the aqueous workup (vide infra).  Attempts were made to use chloride (3.37) in the 
cyclisation reaction with sodium hydride, but chloride proved to be an insufficient leaving group in 
the intramolecular SN2 reaction, and only starting material was isolated.   
 
 
Scheme 3.7: Formation of chloride (3.37) 
 
Proof for the absolute stereochemistry for chloride (3.37) came from single crystal x-ray diffraction 
(Figure 3.2).  The crystal structure showed, as expected, that the indole moiety was positioned 
underneath the convex ring system.    
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Figure 3.2: X-Ray crystal structure of (3.37) 
 
A new approach to prevent chloride formation was to avoid aqueous workup with hydrochloric acid.  
Pleasingly, under 45% aq KOH conditions, cyclised product (3.38) was isolated in 29% yield 
together with cyclopropane (3.39) in 50% yield (Scheme 3.8).  It is assumed that cyclopropane 
(3.39) must have been the predominant product in the cyclisation reaction with NaH, (Scheme 3.7) 
and on workup with hydrochloric acid, the cyclopropane was opened by chloride ions in solution to 
yield chloride (3.37).  Cyclisation product (3.38) appeared to have epimerised at C-3 under strongly 
basic conditions.  Epimerisation at C-3 of (3.38) was previously reported by Czarnocki et al.
50
 in the 
presence of sodium methoxide in methanol at room temperature. 
 
 
Scheme 3.8: Cyclisation reaction 
 
The reaction was thought to proceed through two competing pathways (Scheme 3.9).  The first was 
deprotonation of the indole N-H and subsequent formation of cyclopropane (3.39).  The second 
was deprotonation of the less acidic amide and intramolecular SN2 displacement of the tosylate to 
form cyclised product (3.30).  The change in stereochemistry at position 3 of the DKP is consistent 
with formation of an enolate under basic conditions followed by reprotonation to form pentacycle 
(3.38) as the thermodynamic product.  The larger quantity of cyclopropane (3.39) formed compared 
to cyclised product (3.38) suggests that reaction pathway (1) proceeds more rapidly than reaction 
pathway (2). 
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Scheme 3.9: Proposed reaction pathways 
 
In order to investigate the cyclopropane side product further, it was synthesised directly from 
primary alcohol (2.63) via a Mitsonobu
51
 reaction in 58% yield (Scheme 3.10).  When cyclopropane 
(3.39) was subjected to the same conditions it was formed under (45% aq KOH in THF) no reaction 
took place as expected.  It was proposed that in order to convert cyclopropane (3.39) into cyclised 
product (3.30), the cyclopropane ring would have to be attacked by a nucleophile that would open 
the ring and create a leaving group that could be subsequently displaced by the free amide of the 
DKP in an intramolecular SN2 reaction.   As chloride had failed to act as a leaving group in the 
cyclisation reaction, formation of an iodide was attempted as iodide is a better leaving group than 
chloride.  Cyclopropane (3.39) was reacted with two equivalents of sodium iodide in THF and after 
two days at room temperature, cyclised product (3.30) was isolated in a quantitative yield.  In the 
absence of base, enolate formation at position 3 was not possible so only the less stable cyclised 
product (3.30) could be formed (Scheme 3.10). 
 
 
Scheme 3.10: Ring opening of cyclopropane (3.39) to form cyclised product (3.30) 
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The discovery that sodium iodide could react with cyclopropane (3.39) to generate cyclised product 
(3.30) was used in order to increase the yield of cyclised product in the reaction of tosylate (3.36) 
with aqueous potassium hydroxide.  After the initial reaction of tosylate (3.36) under basic 
conditions to form a mixture of cyclised material (3.38) and cyclopropane (3.39), the reaction was 
worked up and the crude redissolved in THF and sodium iodide added (Scheme 3.11).  Cyclised 
product (3.38) present in the crude starting material remained untouched by the sodium iodide and 
cyclopropane (3.39) was completely converted to cyclised product (3.30).  The two cyclised 
products were isolated as a mixture of diastereomers in a 1.4:1 ratio in 75% yield over two steps.  
The epimerisation at C-3 to give rise to two diastereomers was not problematic for the synthesis as 
the L-proline chiral auxiliary had already been used to form the quaternary centre and would be 
removed in the following step. Having successfully synthesised cyclised products (3.38) and (3.30), 
attention was turned to the cleavage of the DKP. 
 
 
Scheme 3.11: Formation of diastereomers (3.38) and (3.30) 
 
3.3.2 Attempted cleavage of the DKP 
 
DKP‘s such as the one used in the methodology project described in chapter 2, are routinely 
cleaved under strong aqueous hydrochloric acid conditions.  For example, in the final step of the 
enantioselective synthesis of (+)-(1R,2S)-Allocoronamic acid, Bernabé et al.
52
 cleaved DKP (3.41) 
by refluxing in a mixture of 6 M HCl and acetic acid (Scheme 3.12 (1)).  Davies et al.
53
 used similar 
conditions (6 M HCl, reflux) in the cleavage of DKP (3.43) to afford (S)-γ-methylleucine in 94% yield 
(Scheme 3.12 (2)). 
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 Scheme 3.12: Cleavage of diketopiperazine units using aq. HCl  
 
Following these literature precedents different concentrations of aqueous hydrochloric acid were 
used in an attempt to hydrolyse the DKP moiety.  Refluxing cyclised product (3.47) in 0.25 M HCl 
for five days resulted in no reaction and only starting material was isolated (Table 3.1 (entry 1)).  
When the acid concentration was increased to 1 M and refluxed for five days, only decomposed 
starting material was observed in the crude 
1
H NMR (entry 2).  Milder conditions of 3 M HCl at 
room temperature were used but no reaction took place. Refluxing 6M HCl conditions (entry 4), as 
employed by both Bernabé and Davies in their DKP hydrolysis was tried but as expected only 
decomposition products were observed in the 
1
H NMR.  A variety of other acids were tried (entries 
5-9) but each resulted in the recovery of starting material and not the desired hydrolysis products.  
Even under strong basic conditions (entries 10-12) cleavage did not occur. 
 
 
Entry Reagents Solvent Time/days Temperature 
Reaction 
outcome 
1 0.25 M HCl - 5 reflux 
starting material 
(s.m) 
2 1 M HCl - 5 reflux no s.m 
3 3 M HCl - 7 rt s.m 
4 6 M HCl - 2 reflux - 
5 
Tf2O, 5eq 
DMAP, 3 eq 
CH2Cl2 4 rt s.m 
6 pTsOH, 5 eq dioxane 7 rt s.m 
7 Amberlyst-15, 5 eq dioxane 7 rt s.m 
8 TfOH, 5 eq dioxane 7 rt s.m 
 Chapter 3 
41 
9 
Mg, 8 eq 
TiCl4, 1.5 eq 
CH2Cl2/THF 2 0 ºC to rt s.m 
10 45% KOH dioxane 7 rt s.m 
11 45% KOH dioxane 3 reflux s.m 
12 NaOMe, 10 eq MeOH 3 rt s.m 
Table 3.1: Conditions screened in an attempt to cleave DKP (3.47) 
 
A different approach was tried which involved the manipulation of cyclised product (3.47) prior to 
hydrolysis.  Cyclised product (3.47), as a 1.4:1 mixture of diastereomers, was converted to 
thioamide derivative (3.48) using Lawesson‘s reagent as thioamides are better electrophiles than 
amides.  This would increase the susceptibility of the DKP to nucleophilic attack (Scheme 3.13).  
Organometallic reagents nBuLi and MeMgBr were reacted with thioamide (3.48) in an attempt to 
cleave thioamide (3.48), but only starting material was recovered. 
 
 
Scheme 3.13: Synthesis of thioamide (3.48) and reaction with organometallic reagents 
 
A diastereomer of thioamide (3.48) was crystallised and the absolute stereochemistry of the 
isolated diastereomer was proved by single crystal x-ray diffraction (Figure 3.3).  The epimeric 
proton α to the thioamide and the methyl group at the quaternary centre were both on the top face 
of the convex penta-fused ring system. 
 
Figure 3.3: X-Ray structure of (3.48) 
 
Finally success in the manipulation of pentacycle (3.47) was achieved by using DIBAl to reduce the 
amide adjacent to tertiary stereocentre and form an enamine.  The DKP six-membered ring could 
subsequently be opened by dihydroxylation followed by oxidative cleavage.  In the initial reaction 
with DIBAl, four equivalents were used and the reaction was conducted at -78 ºC in THF for four 
hours.  Only 18% of enamine (3.51) was isolated (Table 3.2 (entry 1)).  Interestingly, despite the 
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excess of DIBAl used in the reaction, the amide adjacent to the quaternary stereocentre remained 
untouched, indicative of its sterically hindered nature.  To improve the yield of enamine (3.51) the 
reaction time was reduced to thirty minutes and the yield increased to 56% (entry 2).  Changing the 
solvent to dichloromethane (entry 3) or toluene (entry 4) resulted in a reduced yield of the desired 
product so THF was employed in the remaining optimisation reactions.  Finally by reducing the 
temperature to -100 ºC and by using 1M HCl in the aqueous workup instead of sodium sulphate 
decahydrate a clean crude 
1
H NMR was produced and showed only the presence of product and 
starting material (entry 5).  The reaction time was increased to seven hours at -100 ºC and 
pleasingly enamine (3.51) was isolated in an impressive 93% yield (entry 6). 
 
 
Entry Solvent Temperature/ºC Time/hr Workup Yield/% 
1 THF -78 4  Na2SO4.10H2O 18 
2 THF -78 0.5 Na2SO4.10H2O 56 
3 CH2Cl2 -78 0.5 Na2SO4.10H2O 15 
4 toluene -78 0.5 Na2SO4.10H2O 11 
5 THF -100 3 1 M HCl 54 
6 THF -100 7  1 M HCl 93 
Table 3.2: Optimisation of enamine (3.51) synthesis 
 
With enamine (3.51) in hand, conditions were screened to cleave the double bond.   Initially 
mCPBA was used to epoxidise the enamine before oxidative cleavage with sodium periodate to 
give formamide (3.52) in 26 % yield (Table 3.3 (entry 1)).  Davis oxaziridine was used as an 
alternative epoxidising agent but after oxidative cleavage with sodium periodate the desired 
product was produced in a similarly low yield of 27% (entry 2).  Finally, using a procedure 
developed by Jin and co-workers
54
 to cleave olefins with osmium tetroxide and sodium periodate, 
formamide (3.52) was produced in a 76% yield after just two hours at room temperature (entry 3).   
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Entry Reagents Solvent Temperature Time/hr Yield 
1 
1) mCPBA, 1.1 eq 
2) NaIO4, 1 eq 
CH2Cl2 
THF 
rt 
rt 
12  
12  
26% 
2 
1) Davis oxaziridine 1 eq 
2) NaIO4, 1 eq 
THF 
THF 
-78 ºC to rt 
rt 
12  
12  
27% 
3 
OsO4, 2.5% 
Lutidine, 2 eq 
NaIO4, 4 eq 
dioxane:water 
3:1 
rt 2  76% 
Table 3.3: Optimisation of enamine (3.51) cleavage 
 
 
3.3.3 Attempts to form secondary amine (3.54) 
 
The remaining task to access key intermediate (3.54) in the synthesis of subincanadine B was the 
hydrolysis of the formamide and removal of the lactam of (3.52).  Unfortunately, cleavage of the 
amide to release the lactam was not trivial and hydrolysis attempts employing various 
concentrations of hydrochloric acid resulted in the ring opening of the lactam to yield amine (3.53) 
instead.  As the strength of the acid used was increased, the yield of amine (3.53) was found to 
decrease (Table 3.4 (entries 1-3)).   Base hydrolysis was found to be ineffective and only starting 
material was recovered after reaction with sodium methoxide (entry 4) and potassium hydroxide 
(entry 5).  Attempts to further manipulate amine (3.53) were unsuccessful and it appeared that 
cleavage of the amide bond was not possible due to the poor methyl 5-amino-2-oxopentanoate 
leaving group. 
 
 
Entry Regents Solvent Temperature Time Yield of (3.53) 
1 1 M HCl MeOH reflux 12 hrs 90% 
2 3 M HCl MeOH reflux 12 hrs 84% 
3 6 M HCl MeOH reflux 12 hrs 59% 
4 NaOMe MeOH rt 12 hrs s.m 
5 45% KOH dioxane reflux 12 hrs s.m 
Table 3.4: Attempts at formation of (3.54) 
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At this stage in the synthesis the route via DKP (2.63) was abandoned and an alternative approach 
to access subincanadine B was investigated (chapter 5). 
 
 
3.4 Summary 
 
A new route towards the synthesis of subincanadine B utilising the methodology described in 
chapter 2 was developed (Scheme 3.14).  The synthesis began with iminium ion addition of 
tryptophol to DKP (2.53) to give adduct (2.63) in 96% yield as a single diastereomer.  The primary 
alcohol of (2.63) was protected as a tosylate to act as a leaving group in the SN2 reaction with the 
free amide to form a fused pentacyclic ring system.  Cyclised product (3.38) was formed in the 
reaction, together with a cyclopropane by-product (3.39).  Cyclopropane (3.39) was successfully 
converted to cyclised product (3.30) on reaction of the crude reaction mixture with sodium iodide to 
give a 1.4:1 mixture of diastereomers.  These diastereomers were transformed to enamine (3.51) in 
a 93% yield using DIBAl as a reducing agent.  Subsequent dihydroxylation with osmium tetroxide 
and oxidative cleavage with sodium periodate afforded formamide (3.52) in 76% yield.  On reaction 
of formamide (3.52) with 1 M HCl, amine (3.53) was formed which despite attempts could not be 
transformed to amine (3.54).  
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Scheme 3.14: Attempted synthetic route to subincanadine B 
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Chapter 4: Phosphoric acid catalysed asymmetric Pictet-
Spengler cyclisation 
4.1 Introduction 
 
4.1.1 Chiral phosphoric acid catalysis 
 
4.1.1.1 Introduction to phosphoric acids as chiral catalysts 
 
BINOL derived phosphoric acid catalysts were first used by Takahiko Akiyama et al. in 2004 in a 
Mannich type reaction of a ketene silyl acetal with various aldimines.
55
  By using (R)- or (S)- BINOL 
as a chirality source, and varying the functionalities at the 3 and 3‘ sites, these bifunctional 
catalysts possessing both a Lewis basic site and a Brønsted acidic site could be used in reactions 
to obtain high enantioselectivities
56
 (Figure 4.1).  The acidity of phosphonates, for example 
(OEt)2P(O)OH (pKa 1.3) are comparable to that of HBF3 (pKa -0.44) and are therefore sufficiently 
acidic to promote acid catalysed reactions. 
 
 
Figure 4.1: Features of chiral phosphoric acid catalysts 
 
Initial studies by Akiyama and co-workers
55
 showed that by varying the R group of the phosphoric 
acid catalyst, the enantioselective outcome of the reaction was greatly affected.  For example in the  
Mannich type reaction of silyl ketene (4.2) with aldimine (4.1) in the presence of catalyst (4.4) (R = 
H), β-amino ester (4.3) was produced as a racemate.  By changing the R group to a bulky phenyl 
substituent the enantioselectivity was improved to 27% which was further increased to an 
impressive 87% when 4-NO2C6H4 was replaced as the R group (Scheme 4.1).  These preliminary 
results suggested that a π-stacking interaction was present in the transition state between the 
catalyst and the substrates and therefore it was not surprising that the use of catalyst (4.4) (an 
unsubstituted BINOL phosphoric acid) gave β-amino ester (4.3) as a racemate.   
 Chapter 4 
47 
 
Scheme 4.1: Enantioselective Mannich-type reaction 
 
A transition structure using a biphenol-derived phosphoric acid catalyst to explain the selectivity 
was proposed based on experimental results and density functional theory calculations.  The 
transition structure consisted of a cyclic 9-membered zwitterion which only favoured attack from the 
Re-face of the complex due to the steric hindrance associated with the π-stacking interaction of the 
catalyst R groups and aromatic ring of the aldimine (Figure 4.2).    
 
 
Figure 4.2: Cyclic transition structure to rationalise the observed stereochemistry of the product 
amine 
 
4.1.1.2 Asymmetric reactions employing chiral phosphoric acid catalysts 
 
1) Mannich reaction 
 
Terada et al. found that chiral phosphoric acids effectively catalysed the addition of acetyl acetone 
to N-Boc imine (4.7)
57
 (Scheme 4.2).  After 1 hour at room temperature β-amino ketone (4.8) was 
produced in a high yield with each of the phosphoric acid catalysts screened.  It was found that by 
increasing the steric bulk at the R position of the catalyst, the enantiomeric excess rose 
significantly.  An ee of 95% was produced when catalyst (4.10), possessing an extended π-system, 
was employed.   
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Scheme 4.2: Terada‘s direct asymmetric Mannich reaction 
 
In 2007 this concept was developed further by Gong et al. whom reported a phosphoric acid 
catalysed three-component Mannich reaction.
58
  Cyclic derivatives (4.12) proved to be successful 
nucleophiles in their enol form, and by varying the heteroatom in the ring, a variety of β-amino 
ketones were afforded in excellent yield, dr and ee (Scheme 4.3).  Catalyst (4.14) was found to 
give greater enantioselectivities for tetrahydropyran-4-one and piperidin-4-one whereas (R)-
H8BINOL derivative (4.15) was employed when tetrahydrothiopyran-4-one was used in the 
reaction.  Gong and co-workers proposed that their Mannich reaction proceeded via attack of the 
aldimine (formed in situ from the aldehyde and amine in the presence of the acid), by the enolised 
cyclohexanone derivative.  
 
 
Scheme 4.3: 3-Component Mannich reaction 
 
2) Strecker reaction 
 
Rueping and co-workers developed an asymmetric Strecker reaction using (R)-BINOL-derived 
phosphoric acid catalysts and found, as Terada had found in the asymmetric Mannich reaction, that 
the use of a bulky catalyst afforded products in the highest enantioselectivities.
59
  Catalyst (4.18) 
was found to give impressive ee‘s when a variety of imines (4.16) were reacted with hydrogen 
cyanide to afford amino nitriles (4.17) (Scheme 4.4).  A transition structure to explain selectivity 
was proposed using a crystal structure of cat (4.18) and optimisation calculations.  This featured 
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the attack of an iminium ion formed from imine (4.16) by the cyanide nucleophile from the less 
hindered Re-face rather than the Si-face which was shielded by the phenanthryl group of the 
catalyst.  
 
 
Scheme 4.4: Asymmetric Strecker reaction of imine (4.16) and transition structure proposed by 
Rueping and co-workers 
 
3) Transfer hydrogenations 
 
The creation of chiral amines from achrial pronucleophiles utilising asymmetric phosphoric acid 
catalysts, as seen in the Strecker reaction, had also been achieved by transfer hydrogenation. 
MacMillan et al. were the first to develop an asymmetric organocatalytic reductive amination 
reaction involving the use of Hantzsch ester (4.21)
60
 (Scheme 4.5).  Several hydrogen bonding 
catalysts such as a Jacobsen thiourea and Rawal‘s taddol were screened but failed to promote the 
reaction.  However, BINOL derived phosphoric acid catalysts proved to be successful catalysts in 
the transfer hydrogenation reaction and catalyst (4.23), developed by MacMillan, facilitated the 
desired coupling reaction to afford a range of chiral amine products in excellent yield and with 
impressive enantiomeric excesses.    
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Scheme 4.5: Organocatalytic reductive amination of aromatic ketones 
 
Rueping and co-workers, having previously reported the reduction of imines in the presence of 
chiral phosphoric acid catalysts using a Hantzsch ester, extended this concept to the reduction of 
quinolines
61
 (Scheme 4.6).  By employing bulky catalyst (4.18) in the reaction, a series of 
substituted tetrahydroquinolines (4.25) were afforded in high yield and enantiomeric excess.   
 
 
Scheme 4.6: Transfer hydrogenation of quinolines 
 
4) Aza Friedel Crafts 
 
Terada and co-workers reported a highly enantioselective aza Friedel Crafts alkylation with N-Boc 
imine (4.26) and furan (4.27) under asymmetric phosphoric acid catalysis
62
 (Scheme 4.7).  The 
nature and positions of the substituents on the aldimine aromatic ring did not greatly influence the 
enantioselectivity and imines (4.28) were produced in high yield and enantiomeric excess.  
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Scheme 4.7: Aza-Friedel Crafts alkylation using cat (4.29) 
 
Akiyama applied the concept of an enantioselective Friedel Crafts reaction to the preparation of 3-
substituted indoles from indole and various nitroalkenes (4.30).
63
  In the presence of phosphoric 
acid catalyst (4.23), Friedel Crafts alkylation products (4.31) were afforded in good yield and in 
excellent enantioselectivity (Scheme 4.8).  Interestingly when N-Me indole was used in place of 
indole, the reaction yield decreased significantly and 0% ee was obtained.  These observations 
suggested that a hydrogen bonding interaction between the phosphoryl oxygen atom of the catalyst 
and the hydrogen atom of the indole N-H was essential for reactivity and to induce 
enantioselectivity in the product.  Based on these findings a nine-membered transition structure 
was proposed with the phosphoric acid catalyst acting as a bifunctional catalyst. 
 
 
Scheme 4.8: Friedel-Crafts alkylation of indole with nitroalkenes 
 
5) Aza-ene 
 
The activation of carbonyl compounds using chiral phosphoric acids catalysis had been seen 
previously in a Friedel Crafts reaction developed by Rueping and co-workers.  However, examples 
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using phosphoric acid catalysts to activate aldehydes were unknown.  A novel aza-ene reaction 
with glyoxylate (4.32) and enecarbamates (4.33) was investigated by Terada and co-workers and 
was found to proceed readily in the presence of catalyst (4.5)
64
 (Scheme 4.9).  Hydrolysis of imines 
(4.34) furnished β-hydroxy ketones (4.35) in excellent yields and enantioselectivities.  A variety of 
catalysts were screened and it was found that those possessing substituents at the 2‘, 3‘, 5‘ and 6‘ 
positions of the phenyl ring were unfavourable in promoting the reaction and governing the 
stereochemical outcome.  In order to rationalise these observations, computational studies were 
conducted and a transition structure was proposed which showed hydrogen bonding interactions 
between the aldehyde hydrogen atom and the phosphoryl oxygen atom of the catalyst.  From this 
postulated transition structure it was clear that if the phenyl ring was substituted at the 2‘, 3‘, 5‘ or 6 
positions these hydrogen bonding interactions would be prevented.  Addition of enecarbamate 
(4.33) to aldehyde (4.32) was thought to occur from the Si-face of the aldehyde due to the blocking 
of the Re-face by the catalyst phenyl ring.  
 
 
Scheme 4.9: Aza-ene reaction employing phosphoric acid catalyst (4.5) 
 
6) Aza Diels Alder 
 
Akiyama
65
 developed the first asymmetric Diels Alder reaction of aldimines (4.36) with Brassard‘s 
diene.
66
  Phosphoric acid catalyst (4.39) was chosen to promote the reaction and deliver the 
observed stereochemistry (Scheme 4.10).  Initially the reaction was low yielding due to the 
decomposition of Brassard‘s diene in the reaction medium.  In an attempt to increase the reaction 
yield, pyridine was used in conjunction with the catalyst to reduce its acidity.   This suppressed 
diene decomposition and resulted in the production of Diels Alder adducts (4.38) in high yields and 
enantioselectivities. 
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Scheme 4.10: Akiyama‘s Aza-Diels Alder reaction employing catalyst (4.39) 
 
The first direct aza hetero-Diels-Alder reaction using phosphoric acid catalysis was reported by 
Gong et al.
67
 shortly after Akiyama‘s Diels Alder reaction (Scheme 4.10) appeared in the literature.  
It involved the direct use aldimines (4.41) with cyclohexenone (4.40) in the presence of chiral 
phosphoric acid catalyst (4.48) to form a range of Diels Alder adducts (4.46) and (4.47) (Scheme 
4.11).  It was thought that cyclohexenone (4.40) would enolise under the acidic conditions to enol 
(4.42) and undergo a Mannich reaction with the activated aldimine (4.43).  Newly formed amines 
(4.44) and (4.45) would react with the cyclohexenone moiety via an intramolecular 1,4-addition to 
furnish cyclised adducts (4.46) and (4.47).  A range of differently substituted aromatic aldimines 
were employed and gave products in good diastereomeric ratios, and in excellent yields and 
enantioselectivities. 
 
 
Scheme 4.11: Aza hetero-Diels Alder reaction of cyclohexenone with aldimines (4.41) 
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7) Nazarov cyclisation 
 
A subsequent use of phosphoric acid catalysis in electrocyclic reactions was reported by Reuping 
et al. in their phosphoric acid catalysed Nazarov cyclisation
68
 (Scheme 4.12).  The reaction could 
be applied to dienones with alkyl and aryl substituent‘s to give cyclised products (4.50) in moderate 
selectivity and in excellent yield and enantiomeric excess.  N-triflyl phosphoramide catalyst (4.51)
69
 
was found to give higher enantiomeric excesses and faster reaction times that the corresponding 
BINOL phosphoric acid derivative.  Replacing the hydroxyl group in the catalyst with a strong 
electron acceptor group such as NTf, would result in a lowering of the catalyst pKa, and hence a 
reduction in reaction time.  Indeed the pKa of N-triflyl benzamide (pKa 11.06) in acetonitrile was 
found to be much lower than that of benzoic acid (pKa 20.7).  
 
 
Scheme 4.12: Reuping‘s Nazarov cyclisation with catalyst (4.51) 
  
4.1.2 Enantioselective Pictet-Spengler cyclisation reactions 
 
4.1.2.1 Employment of chiral phosphoric acid catalysis 
 
List and co-workers
70
 were the first to use BINOL derived phosphoric acid catalysts in an 
asymmetric Pictet-Spengler
71
 reaction.  Initially, to probe reactivity, a Pictet-Spengler reaction with 
tryptamine and propionaldehyde was carried out in the presence of TFA (Scheme 4.13 (1)).  
However, imine (4.52) was the major product of the reaction resulting from homo aldol 
condensation and imine formation.  It was postulated that by using geminally disubstituted 
tryptamine (4.53), reactivity would be increased, suppressing homo aldol condensation, and 
cyclisation would be favoured due to the Thorpe-Ingold effect
72
.  Indeed geminally disubstituted 
tryptamine (4.53), when reacted under the previously tried reaction conditions afforded the desired 
Pictet-Spengler product as the dominant reaction product (Scheme 4.13 (2)). 
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Scheme 4.13: Pictet-Spengler reaction with disubstituted tryptamine 
 
After optimisation of the reaction conditions a variety of aldehydes were screened to expand the 
reaction scope.  It was found that aromatic aldehydes and both branched and unbranched aliphatic 
aldehydes yielded Pictet-Spengler products in impressive enantioselectivities and yields in the 
presence of bulky phosphoric acid catalyst ((S)-4.57) (Scheme 4.14). 
 
 
Scheme 4.14: The scope of List‘s enantioselective Pictet-Spengler reaction 
 
To address the limitation associated with the requirement of using geminally disubstituted 
tryptamine (4.53) to effect a Pictet-Spengler reaction, Hiemstra et al.
73
 developed a methodology 
for the preparation of tetrahydro-β-carbolines (4.59) from N-sulfenyltryptamines (4.58) (Scheme 
4.15).  The role of the sulfenyl substituent was to stabilise the intermediate iminium ion formed and 
thus promote the Pictet-Spengler reaction.  The sulfenyl substituent could be removed at the end of 
the reaction by stirring with thiophenol in aqueous acid.  The reaction was successful and after 
optimisation of the reaction conditions, the scope of the reaction was explored by employing 
different aldehydes to generate a series of differently substituted tetrahydro-β-carbolines in 
excellent yields and enantioselectivities. 
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Scheme 4.15: Asymmetric Pictet-Spengler reaction using sulfenyl tryptamine (4.58) 
 
4.1.2.2 Employment of thiourea derived asymmetric organocatalysts 
 
Jacobsen and co-workers
74
 found an alternative means of catalysing the reaction between 6-
methoxy tryptamine and an aldehyde to yield tetrahydro-β-carbolines.  This involved the use of 
thiourea derived catalyst (4.62) (Scheme 4.16).  The catalyst was thought to assist in the reaction 
by forming a hydrogen bond between the thiourea moiety and the conjugate base of a weak 
Brønsted acid additive, which would allow the free proton to activate the iminium ion towards 
Pictet-Spengler cyclisation.  The acid additive (benzoic acid) proved essential for reactivity when 
aromatic aldehydes were employed.  Aliphatic aldehydes, however, did not require the presence of 
an acid additive for the reaction to proceed but reaction rate was found to decrease appreciably in 
its absence.  Under optimised reaction conditions a range of aliphatic and aromatic aldehydes were 
used and yields and ee‘s were consistently high.   
 
 
Scheme 4.16: Thiourea catalysed Pictet-Spengler reaction and proposed mode of catalyst 
activation 
 
Jacobsen and co-workers had previously investigated the Pictet-Spengler cyclisation of 
hydroxylactams (4.63) using chiral thiourea derived catalyst (4.65), in the presence of an acid 
additive
75
 (Scheme 4.17).  A thorough screen of acid additives had shown that when 
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chlorotrimethylsilane was employed, products were formed in high conversion and enantiomeric 
excess.  A selection of hydroxylactams derived from succinimide and glutarimide precursors were 
cyclised under optimised conditions to furnish a range of Pictet-Spengler products bearing a chiral 
quaternary centre.  The products were obtained in high enantiomeric excess and in excellent 
yields.   
 
 
Scheme 4.17: Pictet-Spengler cyclisations of hydroxylactams 
 
In an effort to understand the reaction mechanism, Jacobsen et al. conducted variable temperature 
1
H NMR experiments and found that chlorolactam (4.67)
76
 was formed rapidly and reversibly in 
solution (Scheme 4.18).  Cyclisation was thought to occur via an SN1-type mechanism rather than 
by an SN2-type displacement as when R=H, the reaction rate was considerably reduced.
77
  The 
enantio determining step was thought to be either addition of the indole to the lactam to form (4.70) 
or (4.71), or collapse of spirocyclic intermediate (4.70) to form cyclised product (4.71).  As (4.69) or 
(4.70) did not possess any Lewis basic sites for catalyst association, the catalyst was thought to 
bind through hydrogen-bonding with the chloride counter ion of iminium (4.69).  Indeed, 
pronounced halide counterion effects and solvent effects on enantioselectivity were observed, 
consistent with the proposed mode of catalyst action.    
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Scheme 4.18: Proposed reaction mechanism 
 
4.2 Concept and Aims 
Previous work in the Dixon group by Michael Muratore
78
 applied BINOL-derived phosphoric acid 
catalysis to the Pictet-Spengler cyclisation of hydroxylactams, first introduced by Jacobsen and co-
workers.
75
  It was found that at elevated temperatures, and in the presence of a BINOL-derived 
phosphoric acid, tetracyclic products (4.73) were afforded in high enantioselectivity and in high 
yield (Scheme 4.19).  The absolute stereochemistry of the cyclised products was determined by 
single X-ray crystal analysis of 5-bromo product (4.80). 
 
Scheme 4.19: Scope of the cyclisation cascade 
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It was thought that the methodology developed by Michael Muratore could be applied to the 
synthesis of subincanadine B, providing functionalisation α to the quaternary centre of the Pictet-
Spengler product could be introduced prior to, or after cyclisation.  If intermediate (4.84) could be 
accessed efficiently using this methodology then further chemical manipulations
79
 could furnish (-)-
subincanadine B (Scheme 4.20). 
 
 
Scheme 4.20: Plan to apply methodology to the synthesis of (-)-subincanadine B 
 
Specifically the aims of this study were: 
 
1) To develop a method to functionalise adjacent to the quaternary centre of the Pictet-Spengler     
product 
2) To discover new methodologies  
3) To investigate the reaction mechanism 
4) To provide an intermediate that could be used in the synthesis of subincanadine B  
 
 
4.3 Results and Discussion 
 
4.3.1 Strategy to functionalise α-to the quaternary centre of a cyclised product 
 
It was necessary to functionalise α-to the quaternary centre of the Pictet-Spengler product in order 
to provide a substrate which could be manipulated further to give the target, subincanadine B.  
Investigations began to find a substrate which could undergo an enantioselective Pictet-Spengler 
cyclisation to afford a cyclised product with functionality adjacent to the quaternary centre.  In order 
for the cyclised product to be used in the synthesis of the target, the ee at the quaternary centre 
would have to be significant and ideally between 80-90% to allow simple recrystallisation to 
upgrade the ee.  Initial studies focused on the synthesis of oxazolidinone (4.85) which could be 
hydrolysed to give β-amino alcohol (4.86), an important intermediate in the synthesis of 
subincanadine B.  
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Scheme 4.21: Target structures 
 
4.3.1.1 Enantioselective oxazolidinone (4.85) formation  
 
To access the precursor to cyclised product (4.85), tryptamine was reacted with hydroxyacetone 
and CDI to give aminol (4.87) in 62% yield.  With aminol (4.87) in hand, investigations began to 
obtain cyclised product (4.85) in good yield and in high enantiomeric excess (Table 4.1). 
 
 
Entry Catalyst Temperature Time/mins ee/% 
1 (4.23) warmed  to reflux 60 34 
2 (4.23) reflux 15 37 
3 (4.23) rt 100 13 
4 (4.23) 50 ºC 100 18 
5 (4.23) 70 ºC 15 22 
6 (4.23)
* 
reflux 15 33 
7 (4.39) reflux 120  10 
8 (4.57) reflux 30  30 
9 (4.88) reflux 30  36 
                                 
*
 4 Å molecular sieves added 
Table 4.1: Catalyst and temperature screen in the enantiomeric excess optimisation of 
oxazolidinone (4.85) 
Initially, reaction conditions that had been established in the group for Pictet-Spengler cyclisations 
of hydroxylactams under phosphoric acid catalysis were tried (Table 4.1, entry 1).  However, 
despite the structural similarities between cyclised product (4.74) from the previous methodology 
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and oxazolidinone (4.85), the ee of oxazolidinone (4.85) was considerably lower (34%), although 
the reaction yield was comparable (89%). The rate of cyclisation of aminol (4.87) was much faster 
than the rate of reaction between Angelica lactone and tryptamine under the same conditions, so in 
an effort to improve the enantiomeric excess, which was thought to be affected by temperature, 
aminol (4.87) was added to the reaction mixture only when the solution had reached reflux (entry 
2). However, there was not an appreciable increase in enantiomeric excess.  A temperature screen 
was conducted which showed that the lower the reaction temperature, the lower the ee (entries 3-
5).  It was thought that the reason for the observed decrease in ee with temperature was the 
reduced ability for water to be driven off in the reaction.  In order to test whether water was 
influencing the enantioselectivity, 4 Å molecular sieves were added to the solution but were found 
to lower the ee (entry 6). Next a selection of phosphoric acid catalysts bearing different groups at 
positions 3 and 3‘ were screened and showed that bulky catalysts (4.57) and (4.88) (entries 8 & 9) 
afforded the product in a higher ee than catalyst (4.39).  However, enantioselectivities still 
remained low. 
 
 
Entry Catalyst Solvent Temperature Time/mins ee/% 
1 (4.23) heptane reflux 50  20 
2 (4.23) cyclohexane reflux 50  27 
3 (4.23) CH2Cl2 reflux 15 9 
4 (4.23) THF reflux 15 8 
5 (4.23) mesitylene reflux 15  44 
6 (4.23) xylene reflux  15  41 
7 (4.23) toluene mw, 200 ºC 15  42 
8 (4.23) acetonitrile mw, 166 ºC 15  18 
9 (4.23) DMSO mw, 200 ºC 15  22 
10 (4.23) DME mw, 200 ºC 15  38 
11 (4.23) THF mw, 200 ºC 15  40 
Table 4.2: Solvent screen in the enantiomeric excess optimisation of oxazolidinone (4.85) 
 
A screen of different solvents showed that solvents such as heptane and cyclohexane were 
ineffective at promoting high enantiomeric excesses (Table 4.2, entries 1 & 2).  Likewise, 
dichloromethane and THF gave very low ee‘s (entries 3 & 4).  Aromatic solvents such as toluene, 
mesitylene and xylene gave the highest enantiomeric excesses (37%, 44% & 41% respectively). 
The solvent screen demonstrated that those solvents which refluxed at a high temperature gave 
oxazolidinone (4.85) in the greatest enantiomeric excess, therefore a series of microwave 
experiments where it was possible to conduct the cyclisation at elevated temperatures for solvents 
with low boiling points were carried out (entries 7-11).  Interestingly, when THF was heated to 200 
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ºC the ee increased from 8% (at reflux) to 40%.  Toluene and DME also gave reasonable ee‘s 
(42% and 38% respectively), however, these ee‘s were still not high enough to enable 
recrystallisation of the product to enantiomeric purity, and consequently an alternative approach for 
generating a cyclisation product which could be used in the synthesis of subincanadine B was 
explored. 
 
4.3.1.2 Enantioselective oxazolidinethione (4.90) formation 
 
From the enantioselectivity optimisation studies conducted on oxazolidinone (4.85) formation it 
seemed that the presence of an oxygen atom in the lactam ring had a detrimental effect on 
enantioselectivity.  An increase in electronegativity around the amide bond of β-carboline (4.74) 
(Scheme 4.19) was obviously not favourable.  To address this, the carbamate functionality was 
replaced by a less electronegative O-thiocarbamate.  Aminol (4.89) was synthesised in a 70% yield 
from tryptamine, CSI and hydroxyacetone.  
 
 
Entry Catalyst Solvent Time/days ee/% 
1 (4.23) toluene 1 3 
2 (4.57) toluene 1 18 
3 (4.88) toluene 4  11 
4 (4.57) CH2Cl2 1 12 
5 (4.57) THF 7 9 
6 (4.57) acetonitrile 1 1 
7 (4.57) diethyl ether 1 12 
Table 4.3: Enantiomeric excess optimisation of oxazolidinethione (4.90) 
 
Initial findings were not as promising as under the standard conditions used in the Pictet-Spengler 
cyclisations of hydroxylactams, oxazolidinethione (4.90) was isolated with an ee of 3% (Table 4.3, 
entry 1).  The employment of bulky catalyst (4.57) improved the ee to 18% (entry 2), but even after 
a solvent screen (entries 4-7) the ee could not be further improved.  Having failed to obtain an ee of 
80% or greater with oxazolidinone (4.85) and oxazolidinethione (4.90), a new means of 
functionalising α-to the quaternary centre of the Pictet-Spengler product was explored. 
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4.3.1.3 Attempted formation of 3-methylene amide (4.96) 
 
Instead of introducing functionality α-to the quaternary centre that was contained within the lactam 
ring, a direct method for functionalising adjacent to the chiral quaternary centre was explored.  This 
method would prove advantageous to that described in sections 4.3.1.1 and 4.3.1.2 as the 5-
membered lactam ring, which is a feature of subincanadine B, would remain intact.  In order to 
synthesise subincanadine B using an enantioselective Pictet-Spengler cyclisation it seemed 
necessary to access intermediate (4.84), which had been prepared by Zhai et al. in their synthesis 
of subincanadine B.
42
  An obvious first approach would be to synthesise terminal alkene (4.91), 
reduce the amide functionality and introduce the desired ketone through an oxidative cleavage 
(Scheme 4.22).     
  
 
Scheme 4.22: Retrosynthetic plan to ketone (4.84) 
 
The synthetic route towards the desired Pictet-Spengler precursor (4.96a) is outlined below 
(Scheme 4.23).  It began with the alkylation of phosphonate (4.92) with ethyl bromoacetate to 
afford ethyl ester (4.93) in 66% yield.
80
  A high yielding Horner-Wadsworth-Emmons
81
 reaction 
provided α,β-unsaturated ketone (4.94) which was reacted with tryptamine in the presence of Lewis 
acid AlMe3 in an attempt to form amide (4.96a).  However, tryptamine underwent a 1,4-addition 
reaction with the α,β-unsaturated ketone, instead of directly attacking the ketone, and lactam (4.95) 
was isolated in 77% yield. 
 
 
Scheme 4.23: Synthetic strategy to 3-methylene amide (4.96a) 
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In order to control the reactivity of tryptamine, a new synthesis of the desired product (4.96) was 
tried and tryptamine was incorporated at the beginning of the synthesis.  Tryptamine was reacted 
with chloroacetyl chloride to give chloride (4.97a)
82
 in a quantitative yield (Scheme 4.24).  However, 
this proved to be unreactive when exposed to phosphonate (4.92) under basic conditions.  It 
seemed that a chloride ion was not a good leaving group and so it was substituted for iodide by 
means of a Finkelstein reaction.
83
  Iodide (4.99a) was reacted with phosphonate (4.92) to give 
aminol (4.100) in 60% yield.  Unfortunately attempts to convert the phosphonate group in aminol 
(4.100) to a terminal alkene via a Horner-Wadsworth-Emmons reaction failed. 
 
 
Scheme 4.24: Synthesis of phosphonate aminol (4.100) 
 
4.3.2 The development of a diastereoselective Pictet-Spengler cyclisation 
 
Instead of introducing an exo methylene onto the lactam ring prior to cyclisation, it was thought that 
a Horner-Wadsworth-Emmons reaction could be tried after cyclisation.  A cyclisation reaction of 
this type had not been tried previously and it was hoped that in the presence of a chiral phosphoric 
acid catalyst, the two adjacent stereogenic centres would be formed with high enantio- and 
diastereomeric control.  Pleasingly, when aminol (4.100) was subjected to standard Pictet-Spengler 
cyclisation conditions, it cyclised to give phosphonate (4.101) in an impressive 83% ee, as a single 
diastereomers (Table 4.4 entry 1).  To be able to control the formation of two stereocentres in a 
Pictet-Spengler cyclisation, one of which was a quaternary centre, was worthy of further 
investigation.   
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Entry Catalyst Catalyst conc/mM Temperature Time/days ee/% 
1 (4.57) 7.2 reflux 1 83 
2 (4.39) 7.2 reflux 1 42 
3 (4.88) 7.2 reflux 7 18 
4 (4.60) 7.2 reflux 1 67 
5 (4.23) 7.2 reflux 1 16 
6 (4.102) 7.2 reflux 1 7 
7 (4.57) 7.2 20 ºC 7 - 
8 (4.57) 7.2 50 ºC 7 88 
9 (4.57) 7.2 70 ºC 2 86 
10 (4.57) 13.6 reflux 1 82 
11 (4.57) 4.8 reflux 1 86 
12 (4.57) 3.4 reflux 1 83 
13 (4.57) 2.7 reflux 1 83 
Table 4.4: Enantiomeric excess optimisation of phosphonate (4.101)   
 
A series of optimisation experiments were conducted, starting with a catalyst screen.  However, 
despite testing a further five catalysts possessing different electronic and steric properties, a higher 
enantiomeric excess was not achieved (entries 1-6).  A screen of temperature showed that a lower 
temperature than 110 ºC was favourable for ee but resulted in an increased reaction time (entries 
7-9).  At 20 ºC, however, the reaction did not proceed due to lack of catalyst and substrate 
solubility.  A concentration screen was conducted subsequently (entries 10-13) and ee was found 
to rise as the concentration of the catalyst decreased, until an optimal concentration of 4.8 mM 
(86% ee).  Below this concentration the ee decreased to 83% and became independent of catalyst 
concentration.   
 
Having obtained phosphonate (4.101) in good enantioselectivity, the removal of the phosphonate 
group and replacement with a terminal alkene was attempted using LDA to deprotonate α-to the 
chiral quaternary centre, followed by the addition of paraformaldehyde in a Horner-Wadsworth-
Emmons reaction.  However, only starting material was isolated.  It was thought that a different 
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functional group in place of the phosphonate could be manipulated to provide a suitable substrate 
to use in the synthesis of subincanadine B. 
 
4.3.2.1 Exploring the scope of the methodology 
 
To probe the reaction scope a series of aminols bearing electron withdrawing groups α-to the 
quaternary centre were prepared from iodide (4.103) and variously substituted ketones (4.104)
84
 
under basic conditions (Table 4.5).  Those aminols with longer alkyl chains at R2 (entries 5 & 6) 
gave lower yields than those with methyl groups at R2, for example phosphonate (4.100) (entry 1) 
was obtained in a 60% yield compared to phosphonate (4.110) with a pentyl chain at R2 which was 
afforded in a 34% yield.   Likewise, those aminols with longer alkyl chains attached to the EWG 
such as aminol (4.108) (entry 4) were obtained in a lower yield than the corresponding aminol with 
shorter alkyl chains (aminol (4.107) entry 3).  This was probably due to the steric hindrance 
associated with the formation of a lactam with bulky groups adjacent to each other. 
 
 
Entry 
Compound 
no. 
R1 R2 EWG dr Yield 
1 
(4.100) 
H 
Me 
P(O)(OMe)2 single 
diastereomer* 
60% 
2 (4.106) H Me P(O)(OEt)2 9.5:1 40% 
3 (4.107) H Me CO2Me 3:1 56% 
4 (4.108) H Me CO2Et 1:7 38% 
5 (4.109) H Et CO2Me 1:2 43% 
6 (4.110) H n-pentyl P(O)(OMe)2 -** 34% 
7 
(4.111) 
H 
Me 
SO2Me single 
diastereomer* 
62% 
8 (4.112) 7-Me Me SO2Ph 3:1 89% 
* Purification by trituration only afforded one diastereomer.   ** Compound isolated in open chain form, not as an aminol. 
Table 4.5: Prepared aminols 
 
With aminols (4.105) in hand, a series of Pictet-Spengler reactions were carried out using the 
optimised reaction conditions for phosphonate (4.101). Products were obtained as single 
diastereomers and in good yield.  However, not all substrates were found to give good ee‘s in the 
presence of TIPS catalyst (4.57), which gave the highest ee for phosphonate (4.101), so catalysts 
were screened for each aminol. The catalysts which gave the greatest enantiomeric excesses were 
triphenyl silyl catalyst (4.23) and TIPS catalyst (4.57).  The best enantiomeric excess obtained for 
each substrate is given below (Scheme 4.25).  Enantiomeric excesses tended to be influenced by 
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the size of the substituent α to the quaternary centre which can be seen by comparing the ee of 
ethyl phosphonate (4.115) (ee= 69%) with that of the methyl analogue (4.101) (ee = 85%).  This 
observation is consistent with the enantiomeric excesses observed for ethyl ester (4.117) (ee = 
64%) and methyl ester (4.116) (ee = 92%).  It appeared from the enantiomeric excesses obtained 
for cyclised methyl esters (4.116) and (4.118) that a large alkyl group at the quaternary centre lead 
to a reduction in ee.  However, this was not the case for phosphonate products (4.119) and (4.101), 
where a pentyl chain at the quaternary centre resulted in a larger ee than a methyl group at the 
quaternary centre (91% ee c.f 85% ee, respectively).  In the work conducted by Michael Muratore 
on the Pictet-Spengler cyclisations of hydroxylactams, it was observed that by using 7-methyl 
tryptamine in the cyclisation, higher enantiomeric excess could be obtained (Scheme 4.19).  This 
could explain the larger ee observed for phenylsulfone (4.121) with a methyl group at position 7 on 
the indole ring, compared to methylsulfone (4.120) despite the smaller size of the methylsulfone 
functionality.   
 
Scheme 4.25: Methodology scope 
 
In order to determine the relative stereochemistry of the cyclised products, NOE experiments were 
conducted on phenylsulfone (4.121) and showed that H-4a, H-9 (Me) and H-6b were on the same 
face of the molecule while H-7 and H-6a were on the opposite face (see appendix 8). From this it 
was deduced that the methyl group and the phenylsulfone were syn (Figure 4.3). 
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Figure 4.3: Results of NOE experiments on phenyl sulphone (4.121) 
 
In order to prove the absolute stereochemistry of phenyl sulphone (4.121), the phenyl sulfone 
moiety was removed in the presence of magnesium to afford the corresponding product (4.83) in 
48% yield (Scheme 4.26).  The optical rotation of product (4.83) ([α]D
21 
= + 176.7 (c = 1.25 in 
CHCl3), 72% ee) was found to be positive and comparable in magnitude to the optical rotation of 
cyclised product (4.83) (([α]D
21 
= +215.6 (c = 1.25 in CHCl3), 92% ee)) synthesised by Michael 
Muratore (Scheme 4.19).   
 
 
Scheme 4.26: Removal of the phenyl sulphone moiety 
 
An impressive collection of cyclised products (4.114) as single diastereomers, were obtained from 
the Pictet-Spengler cyclisation of aminols (4.113) in the presence of a BINOL-derived phosphoric 
acid catalyst.  However, a more direct, higher yielding route to Pictet-Spengler products (4.114) 
was investigated, beginning with the construction of enol lactones.
85
 
 
 
4.3.3 Extension of the methodology to the use of enol lactones 
 
Enol lactones were prepared for those compounds which gave the highest ees in the Pictet-
Spengler reaction of aminols (4.113) (Table 4.6).  Firstly in the synthesis of enol lactones (4.126a), 
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oxoesters (4.124) were prepared from the alkylation of alkyl ketones (4.123) with tert-butyl 
bromoacetate under basic conditions.  The crude reaction mixtures were hydrolysed with trifluoro 
acetic acid and purified to yield oxoacids (4.125).  Oxoacids (4.125) proved to be unstable to silica 
so were afforded in relatively low yields after purification.  Phenyl sulphone oxoester (4.130) was 
isolated prior to ester hydrolysis.  Exposure of oxoester (4.130) to TFA furnished the oxoacid, 
which due to its instability on silica was not isolated but used crude in the lactonisation reaction.  
With the exception of methyl ester enol lactone (4.131), the enol lactones were obtained in poor 
yield due to the tautomerisation of the double bond to form α,β-unsaturated lactone (4.126b).  It 
was necessary to monitor the reaction to form enol lactones (4.126a) very carefully as α,β-
unsaturated lactone (4.126b) proved to be the thermodynamic product of the reaction and the 
desired enol lactone would not be isolated if the reaction was left for too long.  When crude phenyl 
sulphone oxoacid was heated to 60 ºC for two hours in the presence of p-TsOH, acetic anhydride 
and acetic acid, enol lactone (4.134) was isolated in a poor 15% yield.  Decreased reaction times 
and reaction temperatures failed to improve the yield of enol lactone (4.134), which was only ever 
obtained in a 12-15% yield.   
 
 
Entry 
Enol 
lactone 
R1 R2 
Yield of 
oxoacid 
(4.125) 
Yield of enol 
lactone 
(4.126a) 
1 (4.131) Me  CO2Me 40% 74% 
2 (4.132) Me  P(O)(OMe)2 46% 64% 
3 (4.133) n-pentyl P(O)(OMe)2 65% 41% 
4 (4.134) Me SO2Ph 57%* 15%
Ψ
 
        * Yield of isolated t-butyl oxoester.  
Ψ 
Yield of enol lactone from t-butyl oxoester. 
Table 4.6: Yields of oxoacids (4.125) and enol lactones (4.126a) 
 
With enol latones (4.126a) in hand, Pictet-Spengler reactions with tryptamine or 7-methyl 
tryptamine in the presence of a BINOL-derived phosphoric acid derived catalyst were conducted 
using optimal reaction conditions
78
 (Scheme 4.27).  Reaction yields were slightly improved by using 
enol lactones in the Pictet-Spengler reaction rather than aminols but enantioselectivities remained 
the same with the exception of methyl ester (4.116) where the ee decreased from 92% to 72%.  
Reaction times were at least doubled by using enol lactones (4.126a) in an intermolecular reaction 
rather than aminols (4.113) in an intramolecular reaction even when catalyst loadings were 
increased to 20%.  This was to be expected due to the reaction rate of intermolecular reactions 
compared with intramolecular reactions especially at high dilution (4.8 mM).   
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At this point, it was decided that an investigation into the mechanistic pathway of the reaction by 
identifying key reaction intermediates would be useful to gain an insight into the strong preference 
for syn cyclised products.  
 
 
Scheme 4.27: The employment of enol lactones (4.126a) 
 
4.3.4 Mechanistic studies  
 
When following the progress of a Pictet-Spengler cyclisation of an enol lactone and tryptamine in 
the presence of a chiral phosphoric acid catalyst, two different intermediates could be seen by TLC.  
The first intermediate to appear had a lower Rf value than the product, and the second had a very 
similar Rf value to the product.  In an attempt to isolate the first intermediate a cyclisation reaction 
of enol lactone (4.131) with tryptamine was conducted under standard reaction conditions but 
stopped after 10 minutes by cooling to room temperature.  The first intermediate was isolated in a 
65% yield and was found to be oxoamide (4.135) (Scheme 4.28).   The reaction was repeated 
following the same protocol but was allowed to proceed for 50 minutes before being quenched by 
triethylamine.  The second intermediate was isolated in a 43% yield and identified as pro-chiral 
enamide (4.136).  In boiling toluene, in the presence of a catalytic amount of para-toluenesulfonic 
acid, enamide (4.136) readily cyclised to form a single diastereomer of (±)-(4.116).  The 
observation that a single diastereomer of methyl ester (4.116) was obtained even under racemic 
conditions suggested that the preference for the group at the quaternary centre and the group α-to 
the quaternary centre to be on the same side of the lactam ring was under substrate control rather 
than catalyst control.  The observed enantiocontrol in the reaction was consistent with the rapid 
and reversible formation of iminium-catalyst complexes (4.137) and (4.138), and the faster rate of 
formation of major product (4.137) compared to minor product (4.138) due to matched substrate 
and catalyst control.  This proposed reaction pathway was consistent with a type I DYKAT 
(dynamic kinetic asymmetric  transformation) mechanism, first introduced by Trost et al.
86
  DYKAT 
was defined as: ―The de-symmetrization of racemic or diastereomeric mixtures involving 
interconverting diastereomeric intermediates-implying different equilibrium rates of the 
stereoisomers‖.
87
  A type I DYKAT mechanism features the interconversion of a chiral catalyst 
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chelated to an achiral intermediate into two different diastereomeric substrate-catalyst complexes 
before the formation of two diastereomeric products. 
    
 
Scheme 4.28: Proposed reaction mechanism 
 
With an insight into the reaction pathway, it was decided that further exploration of the reaction 
scope was needed.  Specifically, to ascertain whether it was necessary for the group adjacent to 
the quaternary centre to have an electron withdrawing character or whether an alkyl chain at this 
position would also result in a cyclisation reaction via an enamide intermediate such as (4.136).  It 
was also deemed necessary to improve the syntheses of enol lactones (4.126a) or to find an 
alternative starting material which could react with tryptamine and undergo a Pictet-Spengler 
reaction.   
 
 
4.3.5 A new approach: The cascade reaction with oxo-acids and esters 
 
Enol lactones are very reactive species.
88
  This was proved by closely monitoring the Pictet-
Spengler reaction and observing the disappearance of enol lactone (4.131) after 10 minutes of 
refluxing in toluene with tryptamine and an acid catalyst.  During the reaction, tryptamine attacks 
the enol functionality and causes the lactone ring to be opened to form an oxoamide such as 
(4.135).  It was postulated that under the established Pictet-Spengler cyclisation conditions, 
tryptamine may react with a straight chain ester to give the same intermediate oxoamide, and 
therefore straight chain esters could be used directly in the Pictet-Spengler reaction with 
tryptamine.   
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Reactions employing ester (4.139) and phenyl sulphone (4.130) as straight chain esters in the 
Pictet-Spengler reaction with tryptamine were conducted and found to yield cyclised products 
(4.116) and (4.121) respectively (Scheme 4.29).  The reaction times were considerably longer and 
starting materials were still observed by TLC after days of refluxing in toluene, however reaction 
yields remained high and were comparable with those previously obtained.  The enantiomeric 
excess only decreased slightly for Pictet-Spengler products (4.116) and (4.121) compared to those 
obtained when enol lactones were employed as starting materials.  However, this presented an 
attractive method to access Pictet-Spengler products as it avoided the preparation of enol lactones 
which could only be synthesised in low yields. 
 
 
Scheme 4.29: Formation of Pictet-Spengler products (4.116) and (4.121) from esters (4.139) and 
(4.130) respectively 
 
With the development of an attractive method for the formation of Pictet-Spengler products, an 
investigation into the reaction scope employing the new methodology began. Various electron 
withdrawing groups were tried as the group adjacent to the quaternary centre but alkyl chains and 
rings had not been employed.  To address this, a preliminary study was conducted using 
commercially available ethyl 2-(2-oxocyclohexyl)acetate (Table 4.7, entry 1).  Pleasingly after 24 
hours of refluxing in toluene in the presence of triphenyl silyl phosphoric acid catalyst (4.23) the 
Pictet-Spengler product was isolated in a 77% yield, in 82% ee and in >98:2 dr.  Encouraged by 
these results, the dependence of the reaction time and ee on leaving group R was investigated.  
The methyl ester and carboxylic acid derivative of (4.140) were prepared and used in the Pictet-
Spengler cyclisation with tryptamine.  Interestingly there was not a large difference in the ee‘s or 
dr‘s obtained, and it was concluded that carboxylic acids and different esters could be used in the 
reaction without influencing the reaction time or the ee and yield of the final Pictet-Spengler 
product. 
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Entry R Time/hrs Yield dr ee 
1 Et 24 77% >98:2 82 
2 Me 24 80% >98:2 83 
3 H 24 77% >98:2 81 
Table 4.7: A screen of starting materials used to access Pictet-Spengler adduct (4.141) 
 
With these pleasing results in hand, the reaction scope was explored by first synthesising a 
selection of carboxylic acids bearing alkyl chains and rings (Table 4.8).  Carboxylic acids (4.146) 
were prepared by the alkylation of 1,3-dicarbonyls (4.144) with methyl bromoacetate followed by 
Krapcho decarboxylation and concomitant hydrolysis of the terminal ester in the presence of 6M 
HCl and acetic acid.  They were obtained in moderate yields and it was possible to prepare them 
on a multigram scale.   
 
 
Entry Compound no. R1 R2 R3 
Yield of 
(4.146) 
1 (4.147)
89
 Me  Me Et 37% 
2 (4.148) Me Et Me 52% 
3 (4.149) Me Bu Et 47% 
4 (4.150)
90
 Me Bn Et 23% 
5 (4.151)
91
 -CH2CH2- -CH2- Et 49% 
6 (4.152) -CH2CH2CH2- -CH2CH2- Me 57% 
Table 4.8: Preparation of oxoacids (4.146) 
 
Oxoacids (4.146) were screened against a range of phosphoric catalysts in the hope of obtaining 
Pictet-Spengler adducts (4.153) in high yield and in high enantioselectivity and diastereoselectivity 
(Table 4.9).  It became apparent that the employment of different catalysts caused a large variation 
in enantiomeric excess for a particular substrate.  Generally, those catalysts which possessed large 
bulky R groups such as triphenyl silyl catalysts (4.23) and (4.102) and triisopropyl phenyl catalyst 
(4.57) afforded Pictet-Spengler products in greater ee.  An overall decrease in ee was observed as 
the length of the alkyl chain at position R2 increased from 1 to 2 to 4 carbons which suggested that 
a bulkier group at R2 interacted less favourably with the catalyst.  This observation was confirmed 
when a bulky benzyl group was introduced at R2 and consistently gave poor ee‘s when a range of 
catalysts were screened.  Interestingly the use of oxoacids (4.151), (4.143) and (4.152) with 
different sized rings afforded Pictet-Spengler products in high ee‘s when matched with the best 
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catalysts.  In general it was found that the larger the ring size the higher the ee obtained which 
could be explained by the higher degree of conformational flexibility associated with larger rings 
which would enable the substrate to orient the ring in such a way as to form a favourable catalyst-
substrate interaction.   
 
 
Product 
no. 
(4.154) (4.155) (4.156) (4.157) (4.158) (4.141) (4.159) 
 
 
 
    Cat 
 
 
  
 
 
 
 
 
 
 
 
 
(4.23) 
y = 99% 
ee = 76% 
y = 42% 
ee = 44% 
y = 47% 
ee = 54% 
y = 99% 
ee = 8% 
y = 54% 
ee = 60% 
y = 77% 
ee = 81% 
y = 83% 
ee = 73% 
(4.60) 
y = 51% 
ee = 61% 
 
y = 69% 
ee = 38% 
No reaction 
y = 57% 
ee = 68% 
y = 95% 
ee = 63% 
y = 72% 
ee = 74% 
(4.57) 
y = quant 
ee = 14% 
 
y = 70% 
ee = 50% 
y = 46% 
ee = 32% 
y = 53% 
ee = 18% 
y = 87% 
ee = 14% 
 
(4.39) 
y = 80% 
ee = 2% 
 
y = 98% 
ee = 40% 
y = 54% 
ee = 21% 
y = 32% 
ee = 8% 
y = 95% 
ee = 43% 
 
(4.18) 
y = 79% 
ee = 14% 
 
y = 82% 
ee = 32% 
y = 82% 
ee = 9% 
y = 66% 
ee = 25% 
y = quant 
ee = 53% 
 
(4.6) 
y = 93% 
ee = 30% 
 
y = 75% 
ee = 7% 
y = 75% 
ee = 7% 
y = 26% 
ee = 50% 
y = 86% 
ee = 57% 
 
(4.161) 
y = quant 
ee = 43% 
 
y = 55% 
ee = 43% 
y = 62% 
ee = 27% 
y = 90% 
ee = 35% 
y = 89% 
ee = 74% 
 
(4.102) 
y = 55% 
ee = 74% 
y = 34% 
ee = 61% 
y = quant 
ee = 59% 
y = quant 
ee = 12% 
y = 76% 
ee = 22% 
y = 63% 
ee = 82% 
y = 90% 
ee = 86% 
N.B. A blank box in the table indicates that a reaction has not been conducted 
Table 4.9: Screening different catalysts with different carboxylic acids 
 
With the results of the catalyst screen in hand and an optimised ee for each Pictet-Spengler 
adduct, attention was turned to using variously substituted tryptamines and observing the effect on 
enantiomeric excess.  As seen previously in the preliminary work on phosphoric acid catalysed 
Pictet-Spengler reactions by Michael Muratore, the presence of a halogen at position 4 or 5 in the 
indole ring increased the ee by 3-7% typically.
78
  When 7-methyl tryptamine was employed in the 
reaction the ee rose by 12% in two cases (Scheme 4.19).  In view of these findings, 5-bromo 
tryptamine, 7-methyl tryptamine and 5-methoxy tryptamine were screened with cyclohexanone 
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oxoacid (4.143) (Table 4.10).  As expected, the presence of a bromine atom at position 5 on the 
indole ring (entry 3) gave an increase in ee of 5% when compared with the non-substituted 
analogue (entry 1).  The 7-methyl tryptamine (entry 4) gave an excellent ee of 98%, which 
amounted to a 15% increase compared to the non-substituted analogue, inline with Michael 
Muratore‘s findings.  Surprisingly, the presence of the mesomerically donating methoxy substituent 
on the indole ring (entry 2) caused a slight decrease in enantiomeric excess when compared to the 
non-substituted derivative.  In order to increase the enantiomeric excesses of the Pictet-Spengler 
products obtained using different oxoacids, 7-methyl tryptamine was used in place of tryptamine as 
from the substituted tryptamines tried, it had caused the greatest increase in ee. 
   
 
Entry Compound no. R Time/days Yield dr ee 
1 (4.141) H 1 63% >98:2 83% 
2 (4.163) 5-OMe 1 90% >98:2 79% 
3 (4.164) 5-Br 2 88% >98:2 88% 
4 (4.165) 7-Me 2 89% >98:2 98% 
Table 4.10: Investigating the use of differently substituted tryptamines 
 
The absolute and relative stereochemistry of 5-bromo cyclised adduct (4.163) was confirmed by 
single crystal X-ray crystallography.  The configuration (4aR,14bR) was in agreement with the 
previously observed stereochemistry when the (R) enantiomer of the catalyst was used to induce 
enantioselectivity.  The relative stereochemistry was confirmed to be syn, agreeing with the relative 
stereochemistry observed for β-carbolines bearing an electron-withdrawing group adjacent to the 
quaternary stereogenic centre (Figure 4.4). 
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Figure 4.4: Single crystal X-ray structure of 5-bromo adduct (4.164) 
 
 
The results of the reaction of 7-methyl tryptamine with four different oxoacids are summarised 
below (Scheme 4.30).  For those oxoacids which gave moderate enantioselectivities when reacted 
with tryptamine to give cyclised products (4.155) and (4.156), a large increase in ee (33% and 39% 
respectively) was found when 7-methyl tryptamine was used instead.  For those oxoacids which 
had given good ee‘s when reacted with tryptamine, the employment of 7-methyl tryptamine gave 
ee‘s in excess of 90% (Pictet-Spengler products (4.167) and (4.170)).   
 
 
Scheme 4.30: Exploring the scope using 7-Me tryptamine 
 
The relative stereochemistry of 7-methyl tryptamine adduct (4.167) was determined by single X-ray 
crystallography, and as expected the adjacent stereocentres on the lactam ring were found to 
occupy a syn arrangement (Figure 4.5). 
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Figure 4.5: Single X-ray crystal structure of 7-methyl tryptamine adduct (4.167)Ψ 
                                   Ψ Crystal grown by Michael Muratore 
 
In a final attempt to increase the scope of the methodology a reaction with commercially available 
ethyl 4-acetyl-5-oxohexanoate and tryptamine was tried under standard cyclisation conditions (10 
mol% catalyst in toluene at reflux).  It was hoped that by employing ethyl ester (4.171) in the 
reaction δ-lactam (4.173) would be dominant reaction product.  However standard reaction 
conditions failed to promote any reaction so harsher conditions were tried.  The solution was 
refluxed for 5 days in xylene, after which a polar product appeared by TLC analysis.  Amine (4.172) 
was isolated in a 37% yield which led to the conclusion that the formation of a δ-lactam bearing an 
electron withdrawing group was unflavoured (Scheme 4.31). 
 
 
Scheme 4.31: Attempt at forming δ-lactam (4.173) 
 
4.4 Summary 
 
A series of BINOL-derived phosphoric acid catalysed cascades have been developed, all featuring 
an asymmetric Pictet-Spengler reaction.  Through careful optimisation and planning, each 
methodology has been improved upon to provide subsequent methodologies leading to more 
complex products with greater enantioselectivities, and the use of structurally simpler starting 
materials to achieve this.  Furthermore, an investigation into the reaction mechanism by which 
these products are constructed has been conducted and has revealed the set of intermediates 
formed and has provided a rationale for the impressive diastereoselectivity observed.  NOE 
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experiments and x-ray crystallography have proved the relative and absolute stereochemistry of 
the Pictet-Spengler cyclisation products respectively.   Details of how these methodologies were 
applied in the studies towards the synthesis of subincanadine B are discussed in the following 
chapter.       
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Chapter 5: Synthetic studies towards Subincanadine B – 
asymmetric Pictet-Spengler cyclisation approach 
 
 
5.1 Concept and Aims 
 
After the successful development of a versatile, reliable methodology employing BINOL-derived 
phosphoric acid catalysts, the task which remained was the application of the methodology to the 
synthesis of subincanadine B.   
 
Specifically the aims of this study were: 
 
1) To synthesise a series of substrates which could be used in the Pictet-Spengler reaction and 
provide products from which subincanadine B could be accessed.   
2) With the chosen intermediate, explore possible synthetic transformations towards the synthesis 
of subincanadine B. 
 
 
5.2 Results and Discussion 
 
5.2.1 Studies towards the synthesis of ketone (4.84) 
 
In order to access subincanadine B using the methodology developed in chapter 4, it was 
necessary to first obtain ketone (4.84) (Scheme 5.1).  This could be achieved by the synthesis of 
alkene (5.1) followed by amide reduction and subsequent dihydroxylation of the alkene and 
oxidative cleavage.
54
  A more direct approach to ketone (4.84) would be to synthesise β-hydroxy 
amide (5.2) followed by amide reduction and oxidation of the secondary hydroxyl group to a 
ketone.  An alternative method to access ketone (4.84) would be to synthesise β-nitro amide (5.3, 
reduce the amide and convert the nitro group to a ketone via a Nef reaction.
92
  If these synthetic 
routes to access ketone (4.84) failed then methyl ester (4.116) which had been synthesised in 78% 
yield with an ee of 72% could be manipulated to access ketone (4.84), via reduction of the ester 
and amide functionalities to give a primary alcohol.  This could be eliminated to give terminal 
alkene (5.1) which could undergo dihydroxylation and oxidative cleavage to yield the desired 
ketone (4.84). 
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Scheme 5.1: Retrosynthetic analysis of ketone (4.84) 
 
5.2.1.1 Attempts to form alkene (5.1) 
 
α,β-Unsaturated ketone (4.94) had been synthesised previously as mentioned in chapter 4 
(Scheme 4.23).  It had been reacted with tryptamine in the presence of Lewis acid AlMe3 and the 
amine had undergone a Michael addition with the alkene to form an undesired product. It was 
hoped that using a milder acid catalyst, a Pictet-Spengler reaction would occur instead.  However, 
under standard Pictet-Spengler cyclisation conditions product (4.74) was obtained unexpectedly in 
a 24% yield (Scheme 5.2).  A rationale for the formation of product (4.74), which was previously 
synthesised by Jacobsen et al.,
75
 is outlined below.   
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Scheme 5.2: Proposed rationale for the formation of unexpected product (4.74) 
 
Following the formation of iminium ion (5.4), the addition of water to the terminal alkene was 
thought to occur and give rise to enamide (5.5) which would equilibrate in solution to iminium ion 
(5.6).  Formaldehyde would be eliminated and enamide (5.7) would be the resulting product which 
could subsequently undergo a Pictet-Spengler cyclisation to yield adduct (4.74).     
 
In an attempt to avoid the formation of cyclic adduct (4.74), the terminal alkene was protected as a 
phenyl sulfane to prevent the addition of water
93
 (Scheme 5.3).  Unfortunately when this was 
subjected to Pictet-Spengler cyclisation conditions in the presence of a phosphoric acid catalyst, 
undesired product (4.74) was isolated in a 51% yield. No further attempts to avoid water addition 
and prevent elimination were made, and attention was turned to the preparation and use of β-
hydroxyester (5.14) to access β-oxyamide (5.2).   
 
 
Scheme 5.3: Pictet-Spengler reaction with thiol (5.10) 
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5.2.1.2 Attempts to form β-oxyamide (5.2) 
 
β-Oxyester (5.14) was prepared in two facile steps from commercially available (E)-2-methylpent-2-
enal in an overall yield of 94%
94
 (Scheme 5.4).  When subjected to Pictet-Spengler cyclisation 
conditions in the presence of phosphoric acid catalyst (4.23), pyrrolidine dione (5.15) was isolated 
in 43% yield.  Presumably, once the enamide intermediate had formed, tautomerisation had 
occurred to form pyrrolidine dione (5.15), the thermodynamic product of the reaction.   
 
 
Scheme 5.4: Pictet-Spengler reaction of β-hydroxy ester (5.14) 
 
In an attempt to suppress the formation of pyrrolidine dione (5.15), the hydroxyl group of β-oxyester 
(5.14) was protected as an acetyl (Scheme 5.5).  This would prevent tautomerisation occurring and 
by using a small protecting group it was hoped that the enantiomeric excess of the desired cyclised 
product would be high.  However, under Pictet-Spengler cyclisation conditions, tryptamine 
underwent a nucleophilic addition reaction with the acetyl protecting group on the ester rather than 
reacting with the ketone and tert-butyl-ester functionalities.  Amide (5.17)
95
 was isolated in a 43% 
yield, and there was no trace of the Pictet-Spengler product by 
1
H NMR or TLC analysis. 
 
 
Scheme 5.5: Reaction of acetate (5.16) with tryptamine under Pictet-Spengler cyclisation 
conditions 
 
5.2.1.3 Attempts to form β-nitroamide (5.3) 
 
An alternative approach to desired ketone (4.84) was explored involving the use of β-nitroester 
(5.18).  This was prepared in the group and was used in the Pictet-Spengler reaction with 
tryptamine in the presence of a phosphoric acid catalyst (Scheme 5.6). Unfortunately, the β-
nitroester moiety proved to be a good leaving group when the adjacent ketone was attacked by 
tryptamine.  The result was the formation of previously isolated amide (5.17) in 58% yield after two 
days at reflux.     
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Scheme 5.6: Reaction of β-nitroester (5.18) with tryptamine under Pictet-Spengler cyclisation 
conditions 
 
 
5.2.1.4 Attempts to access β-ketoester (5.19) directly  
 
After the disappointing results obtained in the attempts to synthesise ketone (4.84), a more direct 
approach was tried involving the preparation of β-ketoester (5.19) (Scheme 5.7).  Firstly ozonolysis 
of α,β-unsaturated ketone (4.94) was attempted but only starting material was recovered.  
Secondly, oxidation of β-hydroxy ester (5.14) was tried using Jones reagent but resulted in a 
complex mixture of products.  Oxidation with Dess Martin periodinane
96
 also produced a variety of 
unstable products as seen in the 
1
H NMR.  Further attempts to synthesise β-ketoester (5.19) were 
abandoned and attention was turned finally to the manipulation of methyl ester (4.116) into ketone 
(4.84). 
 
 
Scheme 5.7: Attempts at formation of β-ketoester (5.19) 
 
5.2.2 Synthetic studies towards subincanadine B via methyl ester (4.116) 
 
Methyl ester (4.116) had previously been synthesised in good yield and enantiomeric excess and it 
was thought that modification to desired ketone (4.84) could be achieved by three transformations 
(Scheme 5.8).  Firstly, the amide and ester functionalities could be simultaneously reduced to give 
alcohol (5.20), secondly, the primary alcohol could be eliminated to provide alkene (5.1), which 
could undergo dihydroxylation and oxidative cleavage in the final transformation to yield ketone 
(4.84).  
 
 
Scheme 5.8: Retrosynthetic analysis of ketone (4.84) from methyl ester (4.116) 
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A variety of reducing agents were screened including a borane-tetrahydofuran complex, a borane-
dimethylsulfide complex and lithium aluminium hydride
97
 (Table 5.1).  When a borane-
tetrahydrofuran complex was employed in the reaction only the amide was reduced and the methyl 
ester remained intact.  In order to achieve complete reduction of the amide and ester functionalities 
six equivalents of borane-dimethylsulfide were employed in the reaction (entry 1).  Two different 
reaction products could be seen by TLC after a short reaction time together with starting material.  
The apolar spot corresponded to the product where the amide had been reduced but the methyl 
ester was still intact.  The more polar product was desired alcohol (±)-(5.20), which was isolated in 
a 34% yield after 24 hours (entry 2).  Finally LiAlH4 was employed and alcohol (±)-(5.20) was 
obtained quantitatively.
98, 99
   
  
 
Entry Reagents Solvent Temperature Time/hrs Yield 
1 BH3.SMe2, 6 eq THF reflux 24 34% 
2 LiAlH4, 4 eq THF rt 7 quant. 
          
 
Table 5.1: Amide and ester reduction optimisation 
      
With alcohol (±)-(5.20) in hand, reagents were screened which had been shown in the literature to 
assist with the elimination of a primary hydroxyl group to form an alkene (Table 5.2).  Firstly, 
potassium tert-butoxide was tried using a procedure by Mazitscheck and Giannis
100
 for the 
elimination of a primary alcohol in their synthesis of ovalicin analogues.  However, no alkene 
signals were observed in the crude 
1
H NMR so an alternative method of alcohol elimination was 
tried.  DCC/CuCl had been used by Qin et al.
101
 in the dehydration of a secondary alcohol in the 
presence of an indole moiety, however under these conditions the 
1
H NMR spectrum of the crude 
reaction mixture was complicated and no alkene peaks were visible.  In a final attempt to form 
alkene (±)-(5.1), P2O5 was employed as a dehydrating agent after demonstrating the ability to 
effectively eliminate a tertiary alcohol in the synthesis of diketopiperazine (2.51) (Scheme 2.14).  
Unfortunately no product was seen in the crude 
1
H NMR or in the mass spectrum so this approach 
was abandoned.    
 
 
Entry Reagents Solvent Temperature Time/hrs 
1 
t
BuOK, 3 eq DMF 100 ºC 3  
2 DCC, 5eq, CuCl, 10 eq toluene reflux 48 
3 P2O5, 2 eq toluene reflux 4  
Table 5.2: Conditions tried to form alkene (±)-(5.1) from primary alcohol (±)-(5.20) 
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An alternative strategy to eliminate the primary alcohol was to convert it into a good leaving group 
and then attempt elimination.  This was the approach adopted by Amat and Bosch
102
 in their 
syntheses of uleine alkaloids.  They firstly mesylated alcohol (5.21) and then effected elimination 
with DBU
103
 to furnish desired alkene (5.22) in 53% yield over two steps (Scheme 5.9 (1)).  The 
fact that their substrate was structurally similar to alcohol (±)-(5.20) suggested that success in the 
elimination of the primary alcohol could be achieved using their method.  Following their procedure, 
alcohol (±)-(5.20) was mesylated quantitatively and then DBU employed to effect elimination 
(Scheme 5.9 (2)).  However although alkene peaks were observed in the crude 
1
H NMR, isolation 
of the product was problematic and the reaction did not prove to be easily reproducible. 
 
 
Scheme 5.9: 1) Elimination of a primary hydroxyl group from product (5.21) reported by Amat and 
Bosch.  2) The attempted formation of alkene (±)-(5.1) from mesylate (±)-(5.23) 
 
An alternative approach to access ketone (4.84) via methyl ester (4.116) was to first hydroxylate α 
to the methyl ester functionality with an electrophilic oxygen source.  A precedent was found in the 
literature featuring the α-hydroxylation of β-dicarbonyl compounds with para-chloro nitrosobenzene 
in the presence of a BINOL derived phosphoric acid catalyst
104
 (Scheme 5.10 (1)).  It was thought 
that this methodology, developed by Zhong et al., could be used to form desired α-hydroxylated 
product (5.26).  Reduction of the ester and amide moieties with lithium aluminium hydride would 
provide diol (5.27) which could be converted to ketone (4.84) with sodium periodate (Scheme 5.10 
(2)). 
 
 
Scheme 5.10: 1) α-Hydroxylation of indanone (5.24) developed by Zhong et al. 2) Synthetic plan to 
ketone (4.84) via α-hydroxylation of the methyl ester 
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Cyclised methyl ester (±)-(4.116) proved to be unreactive when used as the substrate in a reaction 
with nitrosobenzene in refluxing toluene in the presence of phosphoric acid catalyst (4.60).  It was 
suggested that in order for a reaction to take place the reactive enamide would need to be present 
in solution to react as a nucleophile.  In view of this a reaction was tried using aminol (4.107) in 
place of cyclised methyl ester (±)-(4.116).  Under the previously described conditions, unexpected 
product (5.33) was afforded in a 37% yield and 44% ee.  Cyclised product (5.33) was found to be 
the dominant product of the reaction (Scheme 5.11).  In order to rationalise the formation of amine 
(5.33), a mechanism was proposed which began with the formation of iminium ion (5.28).  
Tautomerisation to hydroxy pyrrole species (5.29) would enable nucleophilic attack by the pyrrole 
species onto nitrosobenzene to furnish enamide (5.30).  Loss of water and further tautomerisation 
would give iminium ion (5.32) which could undergo a Pictet-Spengler reaction to afford the 
observed product.   
 
 
Scheme 5.11: Reaction of methyl ester aminol (4.107) with nitrosobenzene 
 
The observed reactivity showed that the carbon α to the amide on the lactam ring would act as a 
nucleophile in preference to the carbon α to the methyl ester.  Despite the failed attempt to 
hydroxylate α to the ester, an interesting product had been obtained which could be used in the 
development of a future methodology. 
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5.3 Summary 
Despite trying different approaches to access ketone (4.84), a viable synthesis was not achieved.  
Further investigation into the application of the methodology developed in chapter 4 to the synthesis 
of subincanadine B is required.  An insight has been gained into the reactivity of methyl ester 
enamide (4.136) in the presence of an electrophilic species and has led to the discovery of a new 
methodology exploiting the reactivity of the enamide intermediate at the position adjacent to the 
amide functionality. 
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Chapter 6: Conclusions and future work 
 
6.1 Conclusions 
 
In conclusion, this thesis describes the development of two methodologies which were both used in 
the synthetic studies towards subincanadine B.  Both methodologies featured the use of a Brønsted 
acid catalyst in the formation of a chiral quaternary centre in excellent diastereoselectivity and 
enantiomeric excess.   
 
In the first methodology, the addition of various tryptamine nucleophiles to a proline derived 
diketopiperazine under Brønsted acidic conditions was developed.  The diketopiperazine was found 
to act as a chiral indicator and induced excellent diastereoselectivity in the products obtained.  A 
range of adducts were afforded bearing different groups at the 3-position of indole (75% average 
yield over 10 examples).  This methodology was used in the synthetic studies towards the synthesis 
of subincanadine B.  The synthesis featured the construction of a fused pentacyclic product (dr = 
1.4:1) containing a proline derived diketopiperazine moiety.  It was necessary to cleave the 
diketopiperazine moiety in order to proceed with the synthesis but this did not prove facile and only 
the least sterically hindered amide bond was susceptible to further reaction.  A new methodology to 
access subincanadine B was investigated. 
 
The new methodology built on the work by Michael Muratore in the enantioselective Pictet-Spengler 
cyclisation of enol lactones with tryptamine in the presence of a BINOL derived phosphoric acid 
catalyst.  The previous work had focused on obtaining cyclised products in high enantiomeric 
excesses with different alkyl and aryl groups at the chiral quaternary centre.  In this thesis the 
concept was extended to the formation of Pictet-Spengler products with different groups adjacent to 
the quaternary stereocentre.  The initial methodology explored the intramolecular Pictet-Spengler 
cyclisation of aminols bearing electron withdrawing groups adjacent to the quaternary stereocentre.  
Conditions were optimised and eight products were obtained, each bearing a different electron 
withdrawing group, as single diastereomers in good to excellent enantiomeric excess (64%-91%) 
and in good yields (64%-94%).   
 
The second development of the methodology was to use substituted enol lactones in an 
intermolecular Pictet-Spengler reaction with tryptamine which afforded the same Pictet-Spengler 
products in comparable enantioselectivities and yields.   
 
An investigation into the reaction mechanism of the Pictet-Spengler cyclisation with tryptamine and 
an enol lactone revealed that a dynamic kinetic equilibrium was operative and that the reaction was 
proceeding through an achiral enamide intermediate.  The observed enantiocontrol in the reaction 
was consistent with the rapid and reversible formation of two acyl iminium-catalyst complexes, and 
the faster rate of formation of one of these complexes compared to the other due to matched 
substrate and catalyst control.   
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In the final development of the methodology, alkyl groups were introduced adjacent to the 
quaternary stereocentre and different sized carbon rings were fused to the lactam ring linking the 
quaternary stereocentre and the adjacent tertiary centre.  Instead of employing enol lactones, 
straight chain esters and carboxylic acids were reacted directly with differently substituted 
tryptamines.  A series of Pictet-Spengler products were afforded in excellent diastereoselectivities, 
enantioselectivities and yields.   
 
The enantioselective Pictet-Spengler methodology was applied in the synthetic studies towards 
subincanadine B and although some progress was made, further work is needed to complete the 
synthesis. 
 
6.2 Future work 
 
Further investigation into the application of the Pictet-Spengler cyclisation cascade to the synthesis 
of subincanadine B is needed.  Initial studies outlined in chapter 5 have shown the difficulties in 
introducing a methylene unit adjacent to the quaternary stereocentre, but there are other methods 
which have not been explored and in which an investigation could prove worthwhile.  For example, 
alternative procedures for inserting a hydroxyl group α-to a methyl ester exist in the literature and 
could be tried.
105,106,107
   
 
The scope of the enantioselective Pictet-Spengler methodology could be broadened by the use of 
other heterocycles in place of indole to affect cyclisation.  Pyrrole,
108
 furan or thiophene could be 
employed in the reaction to generate a wide range of Pictet-Spengler products.   
 
A new methodology could be explored and developed from the new reactivity displayed by the 
enamide intermediate in the presence of an electrophilic species as detailed in chapter 5.  
Optimisation of the reaction conditions would be needed before trying reactions with a range of 
small electrophiles. 
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Chapter 7: Experimental 
 
7.1 General Procedures 
 
All reactions were performed under an atmosphere of dry nitrogen unless otherwise stated.  All 
glass apparatus was oven dried and cooled under vacuum.  For water or O2 sensitive reactions, 
glassware was dried again before use by a hot air gun and cooled under a nitrogen atmosphere. 
 
1) Solvents and Reagents 
 
Solvents were removed in vacuo using a Büchi rotary evaporator attached to a pump at 40 ºC.  
Reagents were obtained from commercial suppliers or redistilled if required.  Petroleum ether 
refers to distilled light petroleum of fraction 40-60 ºC.  Anhydrous dichloromethane and toluene 
were purified by distillation from calcium hydride.  Anhydrous tetrahydrofuran and diethyl ether 
were freshly distilled from sodium benzophenone.  Sodium hydride was obtained as a 60% 
dispersion in mineral oil and was washed with petrol (40-60) followed by drying in vacuo prior to 
use. 
 
2) Chromatography 
 
In all cases of chromatography, distilled solvents were used as eluents.  Flash column 
chromatography was performed using Merck Kiesegal 60 silica gel (230-400 mesh).  Thin layer 
chromatography (TLC) was performed using Kiesegal 60 F254 (230-400 mesh) fluorescent treated 
silica; the plates were visualised by UV irradiation (254 nm) and stained with 5% w/v dodeca-
molybdophosphoric acid in ethanol or an aqueous potassium permanganate solutions, as 
appropriate, followed by heating.  Enantiomeric excesses were determined by using high 
performance liquid chromatography (HPLC) performed on a Hewlett-Packard Series 1050 system.  
 
3) Melting points 
 
Melting points were recorded on a Gallenkamp or Leica-Galen III apparatus and remain 
uncorrected. 
 
4) Infrared Spectroscopy 
 
Infrared spectra were recorded on a Bruker Tensor 27 FT-IR or Perkin Elmer Spectrum RX1 FTIR 
spectrometer deposited as thin film on a sodium chloride plate, with absorption maxima (νmax) 
recorded in cm
-1
, and labelled as broad (br), strong (s), medium (m), or weak (w).  Only selected 
absorbencies are reported. 
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5) NMR Spectroscopy 
 
All 
1
H and 
13
C NMR spectra were recorded using Bruker 500 MHz, 400 MHz and 300 MHz 
spectrometers, and a Varian 300 MHz spectrometer using the solvent SiMe4 as an internal 
reference.  Chemical shifts (δ) are reported in parts per million (ppm), and coupling constants (J) 
are reported in Hertz (Hz).  The 
1
H NMR spectra are reported as follows: ---/ ppm (multiplicity, 
number of protons, coupling constants J / Hz, and assignment).  Multiplicities are recorded as a 
singlet (s), apparent singlet (app. s), broad singlet (br s), doublet (d), apparent doublet (app. d), 
triplet (t), apparent triplet (app. t), quartet (q), doublet of doublets (dd), doublet of triplets (dt), triplet 
of doublets (td), pentet (p), or multiplet (m).  DEPT135 and two-dimensional NMR spectroscopy 
(COSY, HMQC, HMBC) were used where appropriate to assist the assignment of signals in the 
1
H 
and 
13
C NMR spectra. 
 
6) Mass Spectra 
 
Low resolution mass spectra were recorded on a Micromass Trio 2000 quadropole mass 
spectrometer (electron impact (EI), chemical ionisation (CI)) or a Micromass Platform II 
spectrometer (electrospray) using electrospray ionisation (ES) in the positive and negative mode.  
Selected mass-to-charge peaks (m/z) are quoted in Daltons as a percentage of the base peak.  
High resolution mass spectra were recorded on a Thermo Finnigan Mat 95XP mass spectrometer 
using electrospray ionisation (ES). 
 
7) X-ray Crystallographic Data 
 
X-ray crystallographic data was measured on a Bruker Smart Apex CCD diffractometer.  Crystals 
were mounted on drop of fomblin (perfluoromethyl isopropyl ether) oil in a Hamilton Cryoloop. 
 
8) Polarimetry 
 
Optical rotations were recorded using an Optical Activity AA-1000 or Perkin Elmer 241 polarimeter; 
specific rotations ([α]D
t
) were calculated by 100α/(cl), in which, c (concentration) is quoted in g/100 
mL; l equals to 0.5 dm or 1.0 dm; D refers to the D-line of sodium (589 nm); temperature (t) is given 
in degrees Celsius (ºC). 
 
Where a compound has been synthesised more than once in different enantioselectivity, the optical 
rotation is quoted for the compound with the greatest enantioselectivity. 
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7.2 Experimental for chapter 2 
 
7.2.1 Synthesis of α,β-unsaturated amide (2.51)  
 
7.2.1.1 Synthesis and characterisation of benzyl (2S)-2-[(3S)-3-(hydroxymethyl)-4-methoxy-4-
oxobutanoyl]pyrrolidine-1-carboxylate (2.47)
34
  
 
 
 
To a solution of L-serine methyl ester hydrochloride (2.00 g, 14 mmol) in CH2Cl2 (15 mL) at 0 °C 
under N2 were added NEt3 (2.2 ml, 16 mmol), Cbz-protected L-proline (3.50 g, 14 mmol) and HOBt 
(2.10 g, 16 mmol).  The solution was stirred at 0 °C under N2 for 15 minutes before the addition of 
DCC (3.20 g, 16 mmol).  After stirring at room temperature for 12 hours the reaction mixture was 
filtered to remove the dicyclohexyl urea and the residue was washed with CH2Cl2 (3 x 20 mL).  The 
solution was washed with a 10% NaHCO3 solution (30 mL) and the aqueous layer then extracted 
with CH2Cl2 (5 x 20 mL).  The combined organic layers were washed with brine (40 mL) and a 5% 
HCl solution (30 mL).  The acidic layer was washed with CH2Cl2 (5 x 20 mL) and the combined 
organic layers were washed with brine (40 mL), dried over MgSO4 and the solvent evaporated in 
vacuo to afford the crude product (5.36 g).  This was purified by flash silica gel chromatography 
using EtOAc to give the title compound as a set of rotamers (1 : 1) as a colourless solid (3.15 g, 
64%).  
 
M.P. 98-100 °C (lit. 103-107 °C); [α]D
25 
= - 18.9 (c = 2.00 in CHCl3) (lit. [α]D
25
 = -29.0 (c = 2.00 in 
CHCl3)); 
1
H NMR: δH (500 MHz, CD3OD) 1.81-1.90 (m, 1H, NCH2CHAHBCH2), 1.93-2.00 (m, 1H, 
NCH2CHAHBCH2), 2.03-2.10 (m, 1H, NCH2CH2CHAHB), 2.16-2.31 (m, 1H, NCH2CH2CHAHB), 3.45-
3.53 (m, 1H, NCHAHBCH2), 3.56-3.64 (m, 1H, NCHAHBCH2), 3.69 (s, 3H, CO2CH3, rotamer at 3.72 
ppm), 3.83-3.98 (m, 2H, CHCH2OH), 4.42 (dd, 1H, J = 8.5 Hz, J = 3.9 Hz, CHCH2CH2), 4.50-4.61 
(m, 1H, NHCHCO2CH3), 5.06-5.17 (m, 2H, CO2CH2), 7.26-7.41 (m, 5H, 5 x Ar-H); 
13
C NMR: δC 
(125 MHz, CD3OD) 24.7 (NCH2CH2CH2, rotamer at 25.2 ppm), 31.5 (NCH2CH2CH2, rotamer at 32.6 
ppm), 48.3 (NCH2CH2, rotamer at 48.7 ppm), 53.1 (CO2CH3), 56.1 (CHCH2OH, rotamer at 56.2 
ppm), 61.3 (CHCH2CH2, rotamer at 61.6 ppm), 63.0 (CH2OH), 68.3 (CO2CH2), 128.8 (ArC-H), 129.0 
(ArC-H), 129.1 (ArC-H), 129.6 (ArC-H), 129.7 (ArC-H), 138.2 (ArC-quat), 156.4 (CO, rotamer at 
156.8 ppm), 172.3 (CO, rotamer at 172.8 ppm), 175.0 (CO, rotamer at 175.4 ppm).  
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7.2.1.2 Synthesis and characterisation of (3S,8aS)-3-(hydroxymethyl)hexahydropyrrolo[1,2-
a]pyrazine-1,4-dione (2.49)
34  
 
 
 
To a flask containing Pd/C (1.18 g) under N2 was added a solution of protected dipeptide (2.47) 
(11.8 g, 0.034 mol) in MeOH (500 mL) under N2.  The system was flushed with H2 and stirred 
overnight at room temperature under an atmosphere of H2.   The reaction mixture was filtered 
through a Celite
® 
pad and washed with MeOH (3 x 100 mL) before reduction of the solvent in vacuo 
to approximately 500 ml.  The solution was heated to reflux for 4 days before evaporating the 
solvent in vacuo to afford the crude product.  The crude was triturated with CH2Cl2 (100 mL) to 
afford the product (3.67 g, 59%) as a colourless solid.  
 
M.P. 128-131 °C (lit. 134-136 °C); [α]D
25 
= -65.1 (c = 2.17 in DMSO) (lit. [α]D
25 
= -114.8 (c = 2.00 in 
DMSO); 
1
H NMR: δH  (500 MHz, D6-DMSO) 1.76-1.89 (m, 3H, NCH2CH2CH2, NCH2CH2CHAHB), 
2.09-2.17 (m, 1H, NCH2CH2CHAHB), 3.40-3.47 (m, 2H, NCH2CH2), 3.66-3.75 (m, 2H, CH2OH), 4.03 
(t, 1H,  J = 3.6 Hz, CHCH2OH), 4.14 (app. t, 1H,  J = 7.5 Hz, NCHCH2), 4.72 (t, 1H, J = 5.8 Hz, 
CH2OH), 7.82 (br s, 1H, N-H); 
13
C NMR: δC (75 MHz, D6-DMSO) 22.3 (NCH2CH2CH2), 29.5 
(NCH2CH2CH2), 45.6 (NCH2CH2), 59.0 (CHCH2OH), 60.4 (NCHCH2), 64.3 (CH2OH), 165.4 (CO), 
169.9 (CO). 
  
7.2.1.3 Synthesis and characterisation of [(3S,8aS)-1,4-dioxooctahydropyrrolo[1,2-a]pyrazin-3-
yl]methyl methanesulfonate (2.50) 
 
 
  
To a solution of primary alcohol (2.49) (100 mg, 0.54 mmol) in dry CH2Cl2 (3 mL) under N2 was 
added anhydrous NEt3 (90 μl, 0.65 mmol).  The solution was cooled to 0 °C and a solution of MsCl 
(42 μL, 0.55 mmol) in dry CH2Cl2 (2 ml) under N2 was added.  The solution was warmed to room 
temperature and stirred for 24 hours before evaporation of the solvent in vacuo to obtain the crude 
product.  Flash silica gel chromatography with increasing polarity from dichloromethane to 
dichloromethane : methanol, 9 : 1 afforded the product (116 mg, 82%) as a colourless solid. 
 
M.P. 122-124°C; [α]D
26 
= - 88.0 (c = 0.55 in MeOH); νmax(film)/cm
-1
 3235 (br w, N-H), 1685 (s, 
C=O), 1646 (s, C=O), 1350 (s, S=O); 
1
H NMR: δH (500 MHz, CDCl3) 1.82-1.91 (m, 1H, 
NCH2CH2CHAHB), 1.96-2.08 (m, 2H, NCH2CH2CHAHB, NCH2CHAHB), 2.28-2.35 (m, 1H, 
NCH2CHAHB), 3.05 (s, 3H, SO2CH3), 3.47-3.60 (m, 2H, NCH2CH2), 4.07-4.11 (m, 1H, 
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NCHCH2CH2), 4.33-4.36 (m, 1H, CHCH2OH), 4.49 (dd, 1H, J = 10.9 Hz, J = 3.2 Hz, CHCHAHBOH), 
4.64 (dd, 1H, J = 10.9 Hz, J = 3.2 Hz, CHCHAHBOH), 7.14 (br s, 1H, N-H); 
13
C NMR: δC (75 MHz, 
CDCl3) 22.1 (NCH2CH2CH2), 29.4 (NCH2CH2CH2), 38.0 (SO2CH3), 46.0 (NCH2CH2), 57.6 
(CHCH2OH), 58.7 (NCHCH2CH2), 70.7 (CHCH2OH), 162.1 (CO), 169.4 (CO); m/z (ES
+
) 285 
([M+Na]
+
, 100%); HRMS ES (+) Found 285.0522 for C9H14N2O5SNa
+
 [M+Na]
+
, requires 285.0516. 
  
7.2.1.4 Synthesis and characterisation of (8aS)-3-methylenehexahydropyrrolo[1,2-a]pyrazine-1,4-
dione (2.51) 
 
 
To a flask containing sodium hydride (8.4 mg, 0.35 mmol) at 0 °C under N2 was added a solution of 
mesylated primary alcohol (2.50) (84 mg, 0.32 mmol) in DMF (4 mL) at 0 °C under N2.  The solution 
was stirred at 0 °C for 30 minutes before being warmed to room temperature and stirring for 12 
hours.  The solution was quenched with 5% aqueous HCl until neutral and the solvent evaporated 
in vacuo.  MeOH (5 mL) was added to the solid which was subsequently filtered before evaporating 
the solvent in vacuo to form the crude. Flash silica gel chromatography using dichloromethane : 
methanol, 9.5 : 0.5 afforded the product (38 mg, 71%) as a colourless solid.  
 
M.P. 244-246 °C (dec.); [α]D
32 
= - 10.0 (c = 0.64 in CHCl3); νmax(film)/cm
-1
  3195 (br w, N-H), 1671 
(s, C=O), 1630 (s, C=O); 
1
H NMR: δH (500 MHz, CDCl3) 1.82-1.97 (m, 2H, NCHCH2), 1.99-2.05 (m, 
1H, NCH2CHAHB), 2.35-2.41 (m, 1H, NCH2CHAHB), 3.49-3.55 (m, 1H, NCHAHB), 3.69-3.76 (m, 1H, 
NCHAHB), 4.16 (dd, 1H, J = 10.4 Hz, J = 6.3 Hz, NCHCH2), 4.82 (app. s, 1H, CHAHBCC(O)), 5.53 
(app. s, 1H, CHAHBCC(O)), 8.35 (br s, 1H, N-H); 
13
C NMR: δC (75 MHz, D6-DMSO) 22.0 (CHCH2), 
29.3 (NCH2CH2), 45.7 (NCH2CH2), 59.6 (CHCH2), 99.9 (CH2CC(O)), 137.1 (CH2CC(O)), 157.4 
(CO), 166.8 (CO); m/z (ES
-
) 165 ([M-H]
-
, 100%); HRMS ES (+) Found 189.0634 for C8H10N2O2Na
+
 
[M+Na]
+
, requires 189.0634. 
 
7.2.2 Synthesis of α,β-unsaturated amide (2.51) via tertiary alcohol (2.53) 
 
7.2.2.1 Synthesis and characterisation of methyl 1-acetoacetyl-L-prolinate (2.52) 
 
 
 
A solution of pyruvic acid (0.57 mL, 8.2 mmol), anhydrous DMF (0.51 mL, 6.6 mmol) and SOCl2 
(0.70 mL, 9.0 mmol) was stirred at room temperature for 2 hours under N2.  A solution of L-proline 
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methyl ester hydrochloride (680 mg, 4.1 mmol) in dry CH2Cl2 (5 mL) was added dropwise, followed 
by NEt3 (1.9 mL, 14 mmol) in dry CH2Cl2 (5 mL).  The solution was stirred for 1 hour at room 
temperature before being poured into a separating funnel containing distilled water (20 mL) and 
extracting with CH2Cl2 (3 x 20 mL).  The combined organic layers were dried over MgSO4 and the 
solvent evaporated in vacuo to afford the product as a yellow oil existing as two rotamers (1 : 1.6) 
(802 mg, 98%) which did not require further purification. 
 
[α]D
25 
= - 69.3 (c = 3.49 in MeOH); νmax(film)/cm
-1
 1745 (s, C=O), 1716 (s, C=O), 1638 (s, C=O); 
1
H 
NMR: δH (500 MHz, CDCl3) 1.78-1.86 (m, 1H, NCH2CHAHB, rotamer at 2.01 ppm), 1.87-1.94 (m, 
1H, NCH2CHAHB, rotamer at 2.01 ppm), 2.14-2.23 (m, 1H, NCHCHAHB, rotamer at 2.01 ppm) 2.27-
2.36 (m, 1H, NCHCHAHB, rotamer at 2.18 ppm), 2.45 (s, 3H, C(O)CH3, rotamer at 2.43 ppm), 3.54-
3.61 (m, 1H, NCHAHBCH2, rotamer at 3.72 ppm), 3.68-3.76 (m, 3H, CO2CH3, rotamer at 3.75 ppm), 
3.77-3.87 (m, 1H, NCHAHBCH2, rotamer underneath), 4.85-4.89 (m, 1H, NCHCH2, rotamer at 4.50 
ppm); 
13
C NMR: δC (125 MHz, CDCl3) 22.1 (NCH2CH2, rotamer at 25.3  ppm), 26.6 (C(O)CH3, 
rotamer at 27.1 ppm), 31.4 (NCHCH2, rotamer at 28.6 ppm), 47.5 (NCH2CH2, rotamer at 48.2 ppm), 
52.6 (CO2CH3, rotamer at 52.4 ppm), 59.6 (NCHCH2), 162.7 (CO, rotamer at 162.0 ppm), 172.7 
(CO, rotamer at 171.9 ppm), 198.3 (CO, rotamer at 197.6 ppm); m/z (ES
+
) 222 ([M+Na]
+
, 100%); 
HRMS ES (+) Found 222.0741 for C9H13NO4Na
+
 [M+Na]
+
, requires 222.0737. 
 
7.2.2.2 Synthesis and characterisation of (8aS)-3-hydroxy-3methylhexahydropyrrolo[1,2a]pyrazine-
1,4-dione (2.52) 
  
 
 
Anhydrous NH3 was bubbled through a solution of proline methyl ester derivative (2.52) (403 mg, 
2.0 mmol) in distilled MeOH (7 mL) at 0 °C for 30 minutes before warming the solution to room 
temperature and stirring under a NH3 atmosphere for 1 hour.  The reaction was monitored by TLC 
analysis and on completion the solvent was evaporated in vacuo to afford the crude product as a 
yellow solid.  Purification by flash silica gel chromatography with increasing polarity from 
dichloromethane to dichloromethane : methanol, 9.5 : 0.5 afforded the product (350 mg, 84%) as a 
colourless solid and as a mixture of diastereomers (8:1).  
 
M.P. 156-158 °C; [α]D
26 
= - 39.0 (c = 1.11 in MeOH); νmax(film)/cm
-1
 3319 (br w, N-H, O-H), 1684 
(m, C=O), 1646 (s, C=O); 
1
H NMR: δH (500 MHz, CD3OD) 1.47 (s, 3H, CCH3), 1.78-1.89 (m, 2H, 
NCHCH2), 1.90-1.98 (m, 1H, NCH2CHAHB), 2.20-2.29 (m, 1H, NCH2CHAHB), 3.38-3.48 (m, 2H, 
NCH2), 4.27 (dd, 1H, J = 9.9 Hz, J = 6.6 Hz, CHCH2, minor diastereomer at 4.19 ppm); 
13
C NMR: 
δC (75 MHz, D6-DMSO) 22.8 (NCHCH2, minor diastereomer at 22.7 ppm), 24.6 (CCH3, minor 
diastereomer), 29.0 (NCH2CH2, minor diastereomer at 29.4 ppm), 45.7 (NCH2CH2), 59.5 
(NCHCH2), 80.7 (CCH3, minor diastereomer at 81.5 ppm), 166.1 (CO, minor diastereomer at 167.6 
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ppm), 171.7 (CO, minor diastereomer at 171.6 ppm); m/z (ES
+
) 207 ([M+Na]
+
, 100%); HRMS ES 
(+) Found 207.0733 for C8H12N2O3Na
+
 [M+Na]
+
, requires 207.0740. 
 
 
7.2.2.3 Synthesis of (8aS)-3-methylenehexahydropyrrolo[1,2-a]pyrazine-1,4-dione (2.51) 
 
 
 
To a solution of tertiary alcohol (2.53) (92 mg, 0.5 mmol) in dry toluene (10 mL) under N2 was 
added P2O5 (142 mg, 1.0 mmol) and the solution was refluxed for 1 hour.  While still hot the solution 
was filtered though a cotton wool plug and the solvent evaporated in vacuo to afford the product (80 
mg, 96%) as a colourless solid which did not require further purification.  The spectroscopic data of 
the titled product was identical to that previously described (7.2.1.4). 
 
7.2.3 Diastereoselective addition reactions of N-heteroaromatics to DKP (2.53) 
 
 
 
General procedure for the addition of N-heteroaromatics to DKP (2.53) 
To a solution of DKP (2.53) (1 equivalent) in anhydrous CH2Cl2 (8 mL/mmol) under N2, was added 
the N-heteroatomatic compound (1.2 equivalents) and p-TsOH (10 mol%) and the solution was 
stirred at room temperature until completion of the reaction.  NEt3 (50 mol%) was added to the 
reaction and the solvent evaporated in vacuo to afford the crude reaction mixture which was 
purified by flash silica gel chromatography.   
 
7.2.3.1 Synthesis and characterisation of 3-(1H-indol-3-yl)-3-methylhexahydropyrrolo[1,2-
a]pyrazine-1,4-dione (2.54) 
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Following the general procedure (0.3 mmol scale) the titled compound (as separable mixtures of 
diastereomers (4.5 : 1) was obtained after 24 hours at room temperature as a colourless solid 
following flash silica gel chromatography (ethyl acetate) (major: 67 mg, minor: 14 mg, 95%).  The dr 
was determined by analysis of the crude 
1
H NMR.  The major diastereomer was recrystalised 
(EtOAc/petroleum ether) and the relative configuration was proved by X-ray analysis. 
 
MAJOR 
M.P. 198-200 °C (dec.); [α]D
29 
= - 20.6 (c = 0.62 in MeOH); νmax(film)/cm
-1
 3256 (br m, N-H), 1642 
(br s, C=O); 
1
H NMR: δH (500 MHz, CDCl3) 1.56-1.65 (m, 1H, NCHCHAHB), 1.81-1.90 (m, 4H, 
CCH3, NCHCHAHB), 1.97-2.06 (m, 1H, NCH2CHAHB), 2.14-2.20 (m, 1H, NCH2CHAHB), 3.30-3.39 
(m, 1H, NCHAHBCH2), 3.51-3.58 (m, 1H, NCHAHBCH2), 3.86 (dd, 1H, J = 9.6 Hz, J = 7.3 Hz, 
NCHCH2), 6.99 (d, 1H, J = 8.1 Hz, Ar-H), 7.01-7.06 (m, 1H, Ar-H), 7.13 (t, 1H, J = 7.6 Hz, Ar-H), 
7.28 (d, 1H, J = 8.2 Hz, Ar-H), 7.49 (br s, 1H, N-H), 7.91 (d, 1H, J = 8.1 Hz, Ar-H), 8.75 (br s, 1H, N-
H); 
13
C NMR: δC (125 MHz, CDCl3) 22.6 (NCHCH2), 25.6 (CCH3), 28.5 (NCH2CH2), 45.9 
(NCH2CH2), 58.9 (NCHCH2), 60.5 (CH3C), 111.5 (ArC-H), 116.8 (ArC-quat), 120.2 (ArC-quat), 
120.6 (ArC-H), 121.0 (ArC-H), 122.7 (ArC-H), 124.4 (ArC-quat), 137.3 (ArC-quat), 167.1 (CO), 
171.8 (CO); m/z (ES
+
) 306 ([M+Na]
+
, 100%); HRMS EI (+) Found 306.1210 for C16H17N3O2Na
+
 
[M+Na]
+
, requires 306.1213. 
 
MINOR 
M.P. 130-134°C; [α]D
25 
= - 20.7 (c = 0.60 in CHCl3); νmax(film)/cm
-1
 3253 (br m, N-H), 1652 (br s, 
C=O); 
1
H NMR: δH (400 MHz, CDCl3) 1.53-1.74 (m, 1H, NCHCHAHB), 1.82-1.95 (m, 4H, CH3C, 
NCH2CHAHB), 1.99-2.08 (m, 1H, NCH2CHAHB), 2.23-2.30 (m, 1H, NCHCHAHB), 3.54-3.61 (m, 1H, 
NCHAHBCH2), 3.65-3.73 (m, 1H, NCHAHBCH2), 4.18 (dd, 1H, J = 10.6 Hz, J = 6.5 Hz, NCHCH2), 
6.64 (d, 1H, J = 2.6 Hz, NHCH), 7.06-7.16 (m, 4H, 3 x Ar-H, N-H), 7.33-7.37 (m, 1H, Ar-H), 9.19 (br 
d, 1H, J = 1.8 Hz, N-H); 
13
C NMR: δC (100 MHz, CDCl3) 22.2 (NCH2CH2), 24.9 (CH3C), 28.8 
(NCHCH2), 45.9 (NCH2CH2), 58.8 (NCHCH2), 59.7 (CH3C), 111.8 (ArC-H), 114.7 (ArC-quat), 119.3 
(ArC-H), 119.4 (ArC-H), 121.9 (ArC-H), 124.0 (NHCH), 124.8 (ArC-quat), 137.1 (ArC-quat), 168.3 
(CO), 169.0 (CO); m/z (ES
+
) 306 ([M+Na]
+
, 35%), 589 ([M+Na]
+
, 70%); HRMS EI (+) Found 
306.1213 for C16H17N3O2Na
+
 [M+Na]
+
, requires 306.1213. 
 
 
7.2.3.2 Synthesis and characterisation of 3-methyl-3-(1H-pyrrol-2-yl)hexahydropyrrolo[1,2-
a]pyrazine-1,4-dione (2.55) 
 
 
 
Following the general procedure (0.61 mmol scale) the titled compound (as separable mixtures of 
diastereomers (3.2 : 1) was obtained after 24 hours at room temperature as a colourless solid 
following flash silica gel chromatography (increasing polarity from ethyl acetate : petroleum ether, 1 
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: 1 to ethyl acetate) (major: 117 mg, minor: 23 mg, 98%).  The dr was determined by analysis of the 
crude 
1
H NMR.  The major diastereomer was recrystalised (EtOAc) and the relative configuration 
was proved by X-ray analysis. 
 
MAJOR 
M.P. 220-224 ºC; [α]D
25 
= - 44.0 (c = 1.38 in CHCl3); νmax(film)/cm
-1
 3253 (br w, N-H), 1654 (br s, 
C=O); 
1
H NMR: δH (400 MHz, CDCl3) 1.70 (s, 3H, CH3C), 1.71-1.83 (m, 1H, NCH2CHAHB), 1.91-
2.06 (m, 2H, NCH2CHAHB, NCHCHAHB), 2.23-2.32 (m, 1H, NCHCHAHB), 3.42 (ddd, 1H, J = 11.6 
Hz, J = 9.1 Hz, J = 2.7 Hz, NCHAHBCH2), 3.50-3.57 (m, 1H, NCHAHBCH2), 3.95 (dd, 1H, J = 10.0 
Hz, J = 6.7 Hz, NCHCH2), 6.05 (app. t, 2H, J = 2.4 Hz, NHCHCHCH, NHCHCHCH), 6.19 (br s, 1H, 
N-H), 6.71 (dd, 1H, J = 4.6 Hz, J = 2.4 Hz, NHCH), 8.51 (br s, 1H, N-H); 
13
C NMR: δC (100 MHz, 
CDCl3) 22.4 (NCH2CH2), 26.5 (CH3C), 28.5 (NCHCH2), 45.7 (NCH2CH2), 58.7 (NCHCH2), 59.8 
(CH3C), 105.0 & 108.1 (NHCHCHCH, NHCHCHCH), 119.4 (NHCH), 130.7 (ArC-quat), 166.4 (CO), 
170.3 (CO); m/z (ES
+
) 256 ([M+Na]
+
, 100%); HRMS ES (+) Found 256.1049 for C12H15N3O2Na
+
 
[M+Na]
+
, requires 256.1056. 
 
MINOR 
M.P. 48-53 ºC; [α]D
25 
= - 33.3 (c = 0.81 in CHCl3); νmax(film)/cm
-1
 3267 (br w, N-H), 1655 (br s, 
C=O);
 1
H NMR: δH (400 MHz, CDCl3) 1.76 (s, 3H, CH3C), 1.81-2.04 (m, 3H, NCH2CH2CH2, 
NCHCHAHB), 2.36-2.41 (m, 1H, NCHCHAHB), 3.48 (ddd, 1H, J = 12.1 Hz, J = 9.2 Hz, J = 2.7 Hz, 
NCHAHBCH2CH2), 3.56-3.62 (m, 1H, NCHAHBCH2CH2), 4.13 (dd, 1H, J = 10.1 Hz, J = 6.5 Hz, 
NCHCH2), 6.07-6.10 (m, 2H, NHCCHCH, NHCCHCH), 6.49 (br s, 1H, N-H), 6.70-6.72 (m, 1H, 
NHCHCH), 9.31 (br s, 1H, N-H);
 13
C NMR: δC (100 MHz, CDCl3) 22.0 (NCH2CH2), 27.2 (CH3C), 
29.2 (NCHCH2), 45.8 (NCH2CH2), 58.8 (NCHCH2), 59.7 (CH3C), 105.6 & 107.9 (NHCHCHCH, 
NHCHCHCH), 118.9 (NHCH), 131.0 (ArC-quat), 167.1 (CO), 168.1 (CO); m/z (ES
+
) 256 ([M+Na]
+
, 
40%); HRMS ES (+) Found 256.1063 for C12H15N3O2Na
+
 [M+Na]
+
, requires 256.1056. 
 
7.2.4 Synthesis of tryptamine and diketopiperazine starting materials  
 
7.2.4.1 Synthesis and characterisation of N-[2-(1H-indol-3-yl)ethyl]-4-nitrobenzenesulfonamide 
(2.67) 
 
 
 
To a solution of tryptamine (900 mg, 5.6 mmol) in CH2Cl2 (10 mL) at room temperature, was added 
4-nitrobenzenesulfonyl chloride (1.24 g, 5.6 mmol) and NEt3 (0.78 mL, 5.6 mmol) and the solution 
was stirred at room temperature for 24 hours before being quenched with 1 M aqueous HCl (10 
mL). The biphasic solution was extracted with CH2Cl2 (3 x 20 mL) and the combined organic layers 
were dried over MgSO4, before evaporating the solvent in vacuo to afford the product (1.60 g, 83%) 
as a brown solid which did not require further purification. 
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M.P. 128-132 ºC; νmax(film)/cm
-1
 3411 (br w, N-H), 1528 (s, N-O), 1349 (s, N-O); 
1
H NMR: δH (400 
MHz, D6-DMSO) 2.80 (t, 2H, J = 7.2 Hz NCH2CH2), 3.09-3.16 (m, 2H, NCH2CH2), 6.92 (t, 1H, J = 
7.4 Hz, Ar-H indole), 7.01 (t, 1H, J = 7.5 Hz, Ar-H indole), 7.09 (d, 1H, J = 1.4 Hz, NHCH), 7.25 (d, 
1H, J = 8.0 Hz, Ar-H indole), 7.36 (d, 1H, J = 7.8 Hz, Ar-H indole), 7.91 (d, 2H, J = 8.7 Hz, 2 x Ar-
H), 8.12 (t, 1H, J = 5.5 Hz, NHCH2), 8.26 (d, 2H, J = 8.7 Hz, 2 x Ar-H), 10.79 (br s, 1H, N-H indole); 
13
C NMR: δC (100 MHz, D6-DMSO) 26.2 (NCH2CH2), 44.2 (NCH2CH2), 111.5 (ArC-quat), 112.2 
(ArC-H indole), 118.8 (ArC-H indole), 119.1 (ArC-H indole), 121.7 (ArC-H indole), 124.0 (ArC-H 
indole), 125.1 (2 x ArC-H), 127.7 (ArC-quat), 128.6 (2 x ArC-H), 137.0 (ArC-quat), 147.0 (ArC-quat), 
150.0 (ArC-quat); m/z (ES
+
) 368 ([M+Na]
+
, 52%), 492 (100%); HRMS ES (+) Found 368.0677 for 
C16H15N3O4SNa
+
 [M+Na]
+
, requires 368.0675. 
 
7.2.4.2 Synthesis and characterisation of N-[2-(1H-indol-3-yl)ethyl]-2,4,6-
triisopropylbenzenesulfonamide (2.68) 
 
 
 
To a solution of tryptamine (373 mg, 2.32 mmol) in CH2Cl2 (10 mL) at room temperature, was 
added 2,4,6-triisopropylbenzenesulfonyl chloride (703 mg, 2.32 mmol) and triethylamine (0.32 mL, 
2.32 mmol) and the solution was stirred at room temperature for 24 hours before being quenched 
with 1 M aqueous HCl (10 mL). The biphasic solution was extracted with CH2Cl2 (3 x 20 mL) and 
the combined organic layers were dried over MgSO4, before evaporating the solvent in vacuo to 
afford the product (925 mg, 93%) as a brown solid which did not require further purification. 
 
M.P. 126-130 ºC; νmax(film)/cm
-1
 3387 (br w, N-H), 1317 (br m, S=O), 1150 (br s, S-O); 
1
H NMR: 
δH (400 MHz, CDCl3) 1.19 (d, 12H, J = 6.7 Hz, 4 x CH3CH), 1.26 (d, 6H, J = 6.8 Hz, 2 x CH3CH), 
2.86-2.93 (m, 1H, (CH3)2CH), 3.02 (t, 2H, J = 6.6 Hz, NHCH2CH2), 3.29 (t, 2H, J = 6.6 Hz, 
NHCH2CH2), 4.07-4.15 (m, 2H, 2 x (CH3)2CH), 4.41 (br s, 1H, N-H), 7.03 (s, 1H, NHCHC), 7.08 (t, 
1H, J = 7.5 Hz, Ar-H indole), 7.14 (s, 2H, 2 x CHCCH), 7.19 (t, 1H, J = 7.6 Hz, Ar-H indole), 7.37 (d, 
1H, J = 8.1 Hz, Ar-H indole), 7.49 (d, 1H, J = 7.9 Hz, Ar-H indole), 8.13 ( br s, 1H, N-H); 
13
C NMR: 
δC (100 MHz, CDCl3) 23.6 (2 x (CH3)2CH), 24.7 (2 x (CH3)2CH), 25.6 (NCH2CH2), 29.6 ((CH3)2CH), 
34.1 ((CH3)2CH), 42.9 (NCH2CH2), 111.3 & 111.8 (ArC-quat, ArC-H), 118.5 (ArC-H), 119.6 (ArC-H), 
122.3 (ArC-H), 122.5 (ArC-H), 123.7 (2 x ArC-H), 127.0 (ArC-quat), 132.1 (ArC-quat), 136.4 (ArC-
quat), 150.3 (2 x ArC-quat), 152.6 (ArC-quat); m/z (ES
-
) 425 ([M-H]
-
, 60%), 709 (100%); HRMS ES 
(+) Found 449.2229 for C25H34N2O2SNa
+
 [M+Na]
+
, requires 449.2233. 
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7.2.4.2 Synthesis and characterisation of (8aS)-3-hydroxy-3-propylhexahydropyrrolo[1,2-
a]pyrazine-1,4-dione (2.56) 
 
 
 
A solution of 2-oxovaleric acid (1.5 mL, 14.3 mmol), anhydrous DMF (0.88 mL, 11.5 mmol) and 
SOCl2 (1.15 mL, 15.8 mmol) was stirred at room temperature for 2 hours under N2.  A solution of L-
proline methyl ester hydrochloride (1.18 g, 7.2 mmol) in dry CH2Cl2 (15 mL) was added dropwise, 
followed by NEt3 (3.30 mL, 25.6 mmol) in dry CH2Cl2 (15 mL).  The solution was stirred for 1 hour at 
room temperature before being poured into a separating funnel containing distilled water (30 mL) 
and extracting with CH2Cl2 (3 x 30 mL).  The combined organic layers were dried over MgSO4 and 
the solvent evaporated in vacuo to afford the crude (2.34 g) which was used in the following step 
without purification. 
  
The crude was dissolved in freshly distilled MeOH (7 mL) and cooled to 0 °C where anhydrous NH3 
was bubbled through the solution for 30 minutes before warming the solution to room temperature 
and stirring under a NH3 atmosphere for 1 hour.  The reaction was monitored by TLC analysis and 
on completion the solvent was evaporated in vacuo to afford the crude.  Trituration with ethyl 
acetate afforded the product as a single diastereomer (745 mg, 49% yield over 2 steps) as a 
colourless solid. 
 
M.P. 172-174 ºC; [α]D
25 
= - 9.6 (c = 1.06 in CHCl3); νmax(film)/cm
-1
 3281 (br w, N-H, O-H), 1672 (s, 
C=O), 1653 (s, C=O); 
1
H NMR: δH (400 MHz, D6-DMSO) 0.82 (t, 3H, J = 7.3 Hz, CH3CH2), 1.11-
1.28 (m, 2H, CH2CH3), 1.54-1.63 (m, 1H, CHAHBCH2CH3), 1.69-1.93 (m, 4H, CHAHBCH2CH3, 
NCHCHAHB, NCH2CH2), 2.14-2.20 (m, 1H, NCHCHAHB), 3.30-3.45 (m, 2H, NCH2CH2), 4.19 (dd, 
1H, J = 9.7 Hz, J = 6.8 Hz, NCHCH2), 6.38 (br s, 1H, O-H), 8.70 (br s, 1H, N-H); 
13
C NMR: δC (100 
MHz, D6-DMSO) 14.9 (CH3), 17.9 (CH2), 22.6 (CH2), 29.3 (CH2), 31.6 (CH2), 45.6 (CH2), 59.2 
(NCHCH2), 83.3 (C(O)CNH), 165.4 (CO), 171.6 (CO); m/z (ES
+
) 235 ([M+Na]
+
, 45%), 447 
([2M+Na]
+
, 100%); HRMS ES (+) Found 235.1052 for C10H16N2O3Na
+
 [M+Na]
+
, requires 235.1053. 
 
7.2.5 The addition of 3-substituted indoles to L-proline derived DKPs 
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General procedure for the addition of 3-substituted indoles to DKP (2.53) or (2.56) 
 
To a solution of DKP (2.53) or (2.56) (1 equivalent) in anhydrous CH2Cl2 (8 mL/mmol) under N2, 
was added the 3-substituted indole compound (1.2 equivalents) and p-TsOH (10 mol%) and the 
solution was stirred at room temperature until completion of the reaction.  NEt3 (50 mol%) was 
added to the reaction and the solvent evaporated in vacuo to afford the crude reaction mixture 
which was purified by flash silica gel chromatography.   
 
7.2.5.1 Synthesis and characterisation of N-(2-{2-[(3R,8aS)-3-methyl-1,4-
dioxooctahydropyrrolo[1,2-a]pyrazin-3-yl]-1H-indol-3-yl}ethyl)-4-nitrobenzenesulfonamide (2.57) 
 
 
 
Following the general procedure (0.54 mmol scale) the titled compound (as a mixtures of 
diastereomers (1 : 27) was obtained after 72 hours at room temperature as a colourless solid 
following flash silica gel chromatography (increasing polarity from ethyl acetate : petroleum ether, 1 
: 1 to ethyl acetate) (260 mg, 94%).  The dr was determined by analysis of the crude 
1
H NMR.   
 
M.P. 130-135 ºC; [α]D
25 
= - 41.1 (c = 1.09 in CHCl3); νmax(film)/cm
-1
 3273 (br w, N-H), 1675 (s, 
C=O), 1608 (s, C=O) 1582 (s, N=O), 1349 (s, N-O), 1309 (br s, S=O), 1161 (s, S-O); 
1
H NMR: δH 
(400 MHz, CDCl3) 1.72-1.83 (m, 1H, NCH2CHAHBCH2), 1.86 (s, 3H, CH3C), 1.99-2.04 (m, 1H, 
NCH2CHAHBCH2), 2.06-2.14 (m, 1H, NCHCHAHB), 2.29-2.32 (m, 1H, NCHCHAHB), 2.92 (dt, 1H, J = 
14.7 Hz, J = 5.6 Hz, NCH2CHAHBC), 3.13 (dt, 1H, J = 14.7 Hz, J = 10.1 Hz, NCH2CHAHBC), 3.23 
(dd, 2H, J = 10.1 Hz, J = 5.6 Hz, NCH2CH2C), 3.52 (ddd, 1H, J = 11.9 Hz, J = 8.9 Hz, J = 2.7 Hz, 
NCHAHBCH2CH2), 3.57-3.64 (m, 1H, NCHAHBCH2CH2), 3.91 (dd, 1H, J = 9.8 Hz, J = 7.1 Hz, 
NCHCH2), 5.92 (br s, 1H, NHSO2), 6.98 (t, 1H, J = 7.4 Hz, Ar-H indole), 7.07 (t, 1H, J = 7.5 Hz, Ar-
H indole), 7.13 (d, 1H, J = 8.1 Hz, Ar-H indole), 7.24 (d, 1H, J = 7.9 Hz, Ar-H indole), 7.61 (d, 2H, J 
= 8.6 Hz, 2 x Ar-H), 7.92 (d, 2H, J = 8.6 Hz, 2 x Ar-H), 8.05 (br s, 1H, N-H), 8.84 (br s, 1H, N-H); 
13
C 
NMR: δC (100 MHz, CDCl3) 22.9 (CH2), 24.1 (NCH2CH2C), 27.0 (CH3C), 28.5 (CH2), 43.5 
(NCH2CH2C), 46.6 (NCH2CH2CH2), 59.2 (NHCHCH2), 61.0 (CH3C), 108.5 (ArC-quat), 111.7 (ArC-H 
indole), 118.6 (ArC-H indole), 120.3 (ArC-H indole), 123.3 (ArC-H indole), 123.9 (2 x ArC-H), 127.9 
(2 x ArC-H), 128.2 (ArC-quat), 132.4 (ArC-quat), 135.6 (ArC-quat), 145.5 (ArC-quat), 149.6 (ArC-
quat), 167.1 (CO), 172.0 (CO); m/z (ES
-
) 510 ([M-H]
-
, 100%); HRMS ES (+) Found 534.1442 for 
C24H25N5O6SNa
+
 [M+Na]
+
, requires 534.1429. 
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7.2.5.2 Synthesis and characterisation of tert-butyl (2-{2-[(3R,8aS)-3-methyl-1,4-
dioxooctahydropyrrolo[1,2-a]pyrazin-3-yl]-1H-indol-3-yl}ethyl)carbamate (2.58) 
 
 
 
Following the general procedure (0.77 mmol scale) the titled compound (as a mixtures of 
diastereomers (1 : 18) was obtained after 24 hours at room temperature as a colourless solid 
following flash silica gel chromatography (increasing polarity from ethyl acetate : petroleum ether, 1 
: 1 to ethyl acetate) as a mixture of rotamers (1 : 4.6) (253 mg, 77%).  The dr was determined by 
analysis of the crude 
1
H NMR.   
 
M.P. 130-135 ºC; [α]D
24 
= - 18.2 (c = 0.99 in CHCl3); νmax(film)/cm
-1
 3316 (br w, N-H), 1682 (br s, 
C=O); 
1
H NMR: δH (500 MHz, CDCl3) 1.36 (br s, 9H, C(CH3)3), 1.68-1.78 (m, 1H, NCHCH2CHAHB), 
1.85 (s, 3H, CH3C), 1.89-1.96 (m, 1H, NCHCH2CHAHB), 2.01-2.11 (m, 1H, NCHCHAHB), 2.17-2.24 
(m, 1H, NCHCHAHB), 2.91-3.05 (m, 2H, NCH2CH2C), 3.18-3.25 (m, 2H, NCH2CH2C), 3.45-3.50 (m, 
1H, NCHAHBCH2CH2), 3.55-3.61 (m, 1H, NCHAHBCH2CH2), 3.81-3.86 (m, 1H, NCHCH2), 4.97 (br s, 
1H, NHCH2CH2C, rotamer at 5.64 ppm), 7.03 (t, 1H, J = 7.2 Hz, Ar-H), 7.10 (t, 1H, J = 7.4 Hz, Ar-
H), 7.25 (d, 1H, J = 8.1 Hz, Ar-H), 7.49 (d, 1H, J = 7.9 Hz, Ar-H), 8.17 (br s, 1H, N-H, rotamer at 
8.24 ppm), 9.03 (br s, 1H, N-H, rotamer at 8.97 ppm); 
13
C NMR: δC (125 MHz, CDCl3) 22.7 
(NCH2CH2CH2), 24.9 (NCH2CH2C), 26.5 (CH3C), 28.1 (NCHCH2), 28.5 (C(CH3)3), 42.0 
(NCH2CH2C), 46.0 (NCH2CH2CH2), 58.8 (NCHCH2), 60.4 (C-quat, rotamer at 60.8), 79.6 (C-quat), 
109.8 (ArC-quat), 111.1 (ArC-H), 118.6 (ArC-H), 119.7 (ArC-H), 122.7 (ArC-H), 128.8 (ArC-quat), 
132.1 (ArC-quat), 135.2 (ArC-quat), 156.6 (CO), 166.9 (CO), 171.0 (CO, rotamer at 171.2); m/z 
(ES
+
) 449 ([M+Na]
+
, 100%); HRMS ES (+) Found 449.2173 for C23H30N4O4Na
+
 [M+Na]
+
, requires 
449.2170. 
 
7.2.5.3 Synthesis and characterisation of 4-methyl-N-(2-{2-[(3R,8aS)-3-methyl-1,4-
dioxooctahydropyrrolo[1,2-a]pyrazin-3-yl]-1H-indol-3-yl}ethyl)benzene sulfonamide (2.59) 
 
 
 
Following the general procedure (0.58 mmol scale) the titled compound (as a mixtures of 
diastereomers (1 : 8) was obtained after 24 hours at room temperature as a colourless solid 
  Chapter 7 
103 
following flash silica gel chromatography (increasing polarity from ethyl acetate : petroleum ether, 1 
: 1 to ethyl acetate) (267 mg, 96%).  The dr was determined by analysis of the crude 
1
H NMR. 
 
M.P. 144-148 ºC; [α]D
24 
= - 42.3 (c = 1.27 in CHCl3); νmax(film)/cm
-1
 3284 (br m, N-H), 1680 (s, 
C=O), 1659 (s, C=O), 1325 (br m, S=O), 1157 (s, S-O); 
1
H NMR: δH (500 MHz, CDCl3) 1.62-1.73 
(m, 1H, NCH2CHAHBCH2), 1.80 (s, 3H, CH3), 1.86-1.93 (m, 1H, NCH2CHAHBCH2), 2.01-2.10 (m, 1H, 
NCHCHAHB), 2.16-2.22 (m, 1H, NCHCHAHB), 2.26 (s, 3H, CH3), 2.91-2.98 (m, 1H, NCH2CHAHBC), 
3.02-3.14 (m, 3H, NCH2CHAHBC, NCH2CH2C), 3.39 (ddd, 1H, J = 11.7 Hz, J = 8.8 Hz, J = 2.7 Hz, 
NCHAHBCH2CH2), 3.48-3.55 (m, 1H, NCHAHBCH2CH2), 3.85 (dd, 1H, J = 9.4 Hz, J = 7.4 Hz, 
NCHCH2), 5.63 (t, 1H, J = 5.7 Hz, NHCH2), 6.96 (t, 1H, J = 7.5 Hz, Ar-H indole), 7.04-7.08 (m, 3H, 
Ar-H indole, 2 x Ar-H), 7.22 (d, 1H, J = 8.1 Hz, Ar-H indole), 7.30 (d, 1H, J = 7.9 Hz, Ar-H indole), 
7.50 (d, 2H, J = 8.3 Hz, 2 x Ar-H), 8.15 (br s, 1H, N-H), 9.13 (br s, 1H, N-H); 
13
C NMR: δC (125 
MHz, CDCl3) 21.8 (CH3), 22.9 (CH2), 24.6 (CH2), 26.6 (CH3), 28.3 (CH2), 43.9 (NCH2CH2C), 46.4 
(NCH2CH2CH2), 59.1 (NCHCH2), 61.0 (CH3C), 108.9 (ArC-quat), 111.6 (ArC-H indole), 118.7 (ArC-
H indole), 120.1 (ArC-H indole), 123.0 (ArC-H indole), 127.3 (2 x ArC-H), 128.7 (ArC-quat), 129.8 (2 
x ArC-H), 132.7 (ArC-quat), 135.5 (ArC-quat), 136.9 (ArC-quat), 143.4 (ArC-quat), 167.1 (CO), 
171.8 (CO); m/z (ES
+
) 503 ([M+Na]
+
, 100%); HRMS ES (+) Found 503.1731 for C25H28N4O4SNa
+
 
[M+Na]
+
, requires 503.1734. 
 
7.2.5.4 Synthesis and characterisation of methyl N-(tert-butoxycarbonyl)-2-[(3R,8aS)-3-methyl-1,4-
dioxooctahydropyrrolo[1,2-a]pyrazin-3-yl]-L-tryptophanate (2.60) 
 
 
 
Following the general procedure (0.38 mmol scale) the titled compound (as a mixtures of 
diastereomers (1 : 19) was obtained after 24 hours at room temperature as a colourless solid 
following flash silica gel chromatography  (increasing polarity from ethyl acetate : petroleum ether, 1 
: 1 to ethyl acetate) as a mixture of rotamers (1 : 1.8) (165 mg, 90%).  The dr was determined by 
analysis of the crude 
1
H NMR. 
M.P. 141-144 ºC; [α]D
24 
= - 13.4 (c = 2.15 in CHCl3); νmax(film)/cm
-1
 3320 (br w, N-H), 1745 (s, 
C=O), 1669 (br s, C=O); 
1
H NMR: δH (500 MHz, CDCl3) 1.30 (s, 9H, C(CH3)3, rotamer at 0.76 ppm), 
1.69-1.80 (m, 1H, NCH2CHAHBCH2), 1.91 (s, 3H, CH3C, rotamer at 1.92 ppm), 1.93-1.96 (m, 1H, 
NCH2CHAHBCH2), 2.07-2.16 (m, 1H, NCHCHAHB), 2.25-2.32 (m, 1H, NCHCHAHB), 3.13-3.22 (m, 
2H, NHCHCH2C), 3.49 (s, 3H, OCH3, rotamer at 3.67 ppm), 3.51-3.64 (m, 2H, NCH2CH2CH2), 3.93-
4.01 (m, 1H, NCHCH2), 4.43 (dd, 1H, J = 15.2 Hz, J = 7.9 Hz, NHCHCH2C, rotamer at 4.61 ppm), 
6.07 (d, 1H, J = 8.1 Hz, NHCHCH2C, rotamer at 6.41 ppm), 7.02-7.17 (m, 2H, 2 x Ar-H), 7.24-7.31 
(m, 1H, Ar-H), 7.45 (d, 1H, J = 7.8 Hz, Ar-H, rotamer at 7.54 ppm), 8.80-8.84 (m, 2H, 2 x N-H, 
rotamer at 9.14 ppm); 
13
C NMR: δC (125 MHz, CDCl3) 22.6 (NCH2CH2CH2), 26.7 (CH3C), 26.8 & 
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27.1 & 27.4 & 28.0 & 28.1 & 28.4 (NCHCH2, NHCHCH2C, C(CH3)3, 3 x rotamers), 46.1 
(NCH2CH2CH2), 52.3 (CO2CH3), 55.1 (NHCHCH2C, rotamer at 54.9 ppm), 58.6 (NCHCH2), 61.0 (C-
quat, rotamer at 61.2 ppm), 79.9 (C-quat, rotamer at 79.5 ppm), 108.0 (ArC-quat, rotamer at 107.8 
ppm), 111.2 (ArC-H, rotamer at 111.3 ppm), 118.4 (ArC-H), 119.9 (ArC-H), 122.7 (ArC-H), 128.7 
(ArC-quat), 132.5 (ArC-quat, rotamer at 132.9 ppm), 135.6 (ArC-quat, rotamer at 135.2 ppm), 155.9 
(CO, rotamer at 155.0 ppm), 167.0 (CO), 171.7 (CO, rotamer at 171.2 ppm), 173.4 (CO, rotamer at 
173.1 ppm); m/z (ES
+
) 507 ([M+Na]
+
, 100%); HRMS ES (+) Found 507.2222 for C25H32N4O6Na
+
 
[M+Na]
+
, requires 507.2225. 
 
7.2.5.5 Synthesis and characterisation of methyl 2-[(3R,8aS)-3-methyl-1,4-
dioxooctahydropyrrolo[1,2-a]pyrazin-3-yl]-N-[(4-methylphenyl)sulfonyl]-L-tryptophanate (2.61) 
 
Following the general procedure (0.62 mmol scale) the titled compound (as a mixtures of 
diastereomers (1 : 18) was obtained after 48 hours at room temperature as a colourless solid 
following flash silica gel chromatography (increasing polarity from ethyl acetate : petroleum ether, 1 
: 1 to ethyl acetate) (177 mg, 53%).  The dr was determined by analysis of the crude 
1
H NMR. 
M.P. 132-134 ºC; [α]D
24 
= - 50.2 (c = 2.21 in CHCl3); νmax(film)/cm
-1
 3232 (br m, N-H), 1747 (m, 
C=O), 1669 (br s, C=O) 1341 (br m, S=O), 1158 (s, S-O); 
1
H NMR: δH (500 MHz, CDCl3) 1.73-1.83 
(m, 4H, CH3C, NCH2CHAHBCH2), 1.94-2.02 (m, 1H, NCH2CHAHBCH2), 2.08-2.17 (m, 4H, CH3, 
NCHCHAHB), 2.46-2.53 (m, 1H, NCHCHAHB), 2.95-3.09 (m, 2H, NHCHCH2C), 3.46-3.60 (m, 2H, 
NCH2CH2CH2), 3.63 (s, 3H, CO2CH3), 4.11-4.17 (m, 2H, NCHCH2, NHCHCH2C), 6.62 (d, 2H, J = 
8.1 Hz, 2 x Ar-H), 6.97 (d, 2H, J = 8.2 Hz, 2 x Ar-H), 7.00 (d, 1H, J = 7.4 Hz, Ar-H indole), 7.08-7.13 
(m, 1H, Ar-H indole), 7.16-7.20 (m, 1H, Ar-H indole), 7.24 (br d, 1H, J = 10.5 Hz, N-H) 7.31 (d, 1H, J 
= 7.9 Hz, Ar-H indole), 8.62 (br s, 1H, N-H), 9.46 (br s, 1H, N-H); 
13
C NMR: δC (100 MHz, CDCl3) 
21.4 (CH3C), 22.6 (NCH2CH2CH2), 27.4 & 27.5 & 28.0 (NHCHCH2C, NCHCH2, CH3), 46.2 
(NCH2CH2CH2), 52.6 (CO2CH3), 56.1 & 58.6 (NHCHCH2C, NCHCH2), 61.0 (CH3C), 106.9 (ArC-
quat), 111.2 (ArC-H indole), 117.8 (ArC-H indole), 120.0 (ArC-H indole), 122.8 (ArC-H indole), 
126.1 (2 x ArC-H), 127.5 (ArC-quat), 128.7 (2 x ArC-H), 132.2 (ArC-quat), 135.4 (ArC-quat), 136.6 
(ArC-quat), 142.5 (ArC-quat), 166.3 (CO), 173.0 (CO); m/z (ES
+
) 561 ([M+Na]
+
, 100%); HRMS ES 
(+) Found 561.1785 for C27H30N4O6SNa
+
 [M+Na]
+
, requires 561.1789. 
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7.2.5.6 Synthesis and characterisation of 2,4,6-triisopropyl-N-(2-{2-[(3R,8aS)-3-methyl-1,4-
dioxooctahydropyrrolo[1,2-a]pyrazin-3-yl]-1H-indol-3-yl}ethyl)benzenesulfonamide (2.62) 
 
 
Following the general procedure (0.54 mmol scale) the titled compound (as a mixtures of 
diastereomers (1 : 17) was obtained after 48 hours at room temperature as a colourless solid 
following flash silica gel chromatography (increasing polarity from ethyl acetate : petroleum ether, 1 
: 1 to ethyl acetate) (225 mg, 70%).  The dr was determined by analysis of the crude 
1
H NMR. The 
major diastereomer was recrystalised (EtOAc/petroleum ether) and the absolute stereochemistry 
was proved by X-ray analysis. 
 
M.P. 132-134 ºC; [α]D
24 
= - 39.8 (c = 1.91 in CHCl3); νmax(film)/cm
-1
 3299 (br m, N-H), 1675 (br s, 
C=O), 1313 (br m, S=O), 1149 (br s, S-O); 
1
H NMR: δH (400 MHz, CDCl3) 1.12 (d, 6H, J = 6.8 Hz, 
CH(CH3)2), 1.15-1.19 (m, 12H, 2 x CH(CH3)2), 1.65-1.76 (m, 1H, NCH2CHAHBCH2), 1.87 (s, 3H, 
CH3C), 1.89-1.96 (m, 1H, NCH2CHAHBCH2), 2.01-2.11 (m, 1H, NCHCHAHB), 2.18-2.25 (m, 1H, 
NCHCHAHB), 2.82 (sept., 1H, J = 6.8 Hz, (CH3)2CHCCHCCSO2), 2.92-2.98 (m, 1H, 
NHCH2CHAHBC), 3.05-3.16 (m, 2H, NHCH2CH2C), 3.25-3.34 (m, 1H, NHCH2CHAHBC), 3.41 (ddd, 
1H, J = 11.9 Hz, J = 8.9 Hz, J = 3.1 Hz, NCHAHBCH2CH2), 3.51-3.58 (m, 1H, NCHAHBCH2CH2), 
3.80-3.84 (m, 1H, NCHCH2), 3.99-4.05 (m, 2H, 2 x (CH3)2CHCCSO2), 4.79 (t, 1H, J = 6.0 Hz, 
NHCH2), 6.98-7.02 (m, 1H, Ar-H indole), 7.08 (s, 2H, 2 x Ar-H), 7.10-7.14 (m, 1H, Ar-H indole), 7.24 
(d, 1H, J = 8.1 Hz, Ar-H indole), 7.32 (d, 1H, J = 7.9 Hz, Ar-H indole), 7.82 (br s, 1H, N-H), 8.81 (br 
s, 1H, N-H); 
13
C NMR: δC (100 MHz, CDCl3) 22.6 (NCH2CH2CH2), 23.6 (CH(CH3)2), 24.4 
(NHCH2CH2C), 24.8 (CH(CH3)2), 24.9 (CH(CH3)2), 26.5 (CH3C), 28.1 (NCHCH2), 29.6 (2 x 
(CH3)2CHCCSO2), 34.1 ((CH3)2CHCCHCCSO2), 43.2 (NHCH2CH2C), 46.0 (NCH2CH2CH2), 58.8 
(CHCH2), 60.7 (CH3C), 108.6 (ArC-quat), 111.3 (ArC-H indole), 118.4 (ArC-H indole), 119.9 (2 x 
ArC-H indole), 122.8 (ArC-quat), 123.8 (2 x ArC-H) , 128.4 (ArC-quat), 131.8 (ArC-quat) 132.7 
(ArC-quat), 135.2 (ArC-quat), 150.5 (ArC-quat), 152.7 (ArC-quat), 166.7 (CO), 171.1 (CO); m/z 
(ES
+
) 615 ([M+Na]
+
, 100%); HRMS ES (+) Found 615.2975 for C33H44N4O4SNa
+
 [M+Na]
+
, requires 
615.2986. 
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7.2.5.7 Synthesis and characterisation of (3R,8aS)-3-[3-(2-hydroxyethyl)-1H-indol-2-yl]-3-
methylhexahydropyrrolo[1,2-a]pyrazine-1,4-dione (2.63) 
 
 
 
 
Following the general procedure (2.88 mmol scale) the titled compound (as a mixtures of 
diastereomers (1 : 14) was obtained after 24 hours at room temperature as a colourless solid 
following flash silica gel chromatography (increasing polarity from ethyl acetate : petroleum ether, 1 
: 1 to ethyl acetate) (902 mg, 96%).  The dr was determined by analysis of the crude 
1
H NMR. 
 
M.P. 75-77 ºC; [α]D
24 
= - 75.0 (c = 1.39 in CHCl3); νmax(film)/cm
-1
 3300 (br w, N-H, O-H), 1659 (br s, 
C=O); 
1
H NMR: δH (500 MHz, CDCl3) 1.71-1.79 (m, 1H, NCH2CHAHBCH2), 1.84 (s, 3H, CH3C), 
1.93-2.08 (m, 2H, NCH2CHAHBCH2, NCHCHAHB), 2.25-2.31 (m, 1H, NCHCHAHB), 2.99 (app. dt, 1H, 
J = 15.0 Hz, J = 4.4 Hz, OCH2CHAHB), 3.11 (ddd, 1H, J = 15.0 Hz, J = 9.7 Hz J = 4.4 Hz, 
OCH2CHAHB), 3.45 (ddd, 1H, J = 12.1 Hz, J = 9.1 Hz, J = 2.9 Hz, NCHAHBCH2CH2), 3.57-3.63 (m, 
1H, NCHAHBCH2CH2), 3.70 (app. dt, 1H, J = 9.7 Hz, J = 3.8 Hz, OCHAHBCH2), 3.87 (dd, 1H, J = 
10.0 Hz, J = 6.9 Hz, NCHCH2), 3.97 (app. dt, 1H, J = 9.7 Hz, J = 4.4 Hz, OCHAHBCH2), 7.03-7.07 
(m, 1H, Ar-H), 7.12-7.16 (m, 1H, Ar-H), 7.25 (d, 1H, J = 8.1 Hz, Ar-H), 7.44 (d, 1H, J = 7.9 Hz, Ar-
H), 7.54 (br s, 1H, N-H), 8.56 (br s, 1H, N-H); 
13
C NMR: δC (75 MHz, CDCl3) 22.7 (CH2), 26.9 (CH2), 
27.5 (CH3), 28.6 (CH2), 46.2 (NCH2CH2), 59.1 (NCHCH2), 61.1 (CH3C), 63.3 (OCH2CH2), 109.5 
(ArC-quat), 111.4 (ArC-H), 118.7 (ArC-H), 119.9 (ArC-H), 123.0 (ArC-H), 128.9 (ArC-quat), 133.0 
(ArC-quat), 135.6 (ArC-quat), 167.1 (CO), 171.1 (CO); m/z (ES
-
) 326 ([M-H], 100%); HRMS ES (+) 
Found 350.1478 for C18H21N3O3Na
+
 [M+Na]
+
, requires 350.1475. 
 
 
7.2.5.8 Synthesis and characterisation of (3R,8aS)-3-[3-(2-hydroxyethyl)-1H-indol-2-yl]-3-
propylhexahydropyrrolo[1,2-a]pyrazine-1,4-dione (2.64) 
 
 
 
Following the general procedure (0.54 mmol scale) the titled compound (as a mixtures of 
diastereomers (1 : 11) was obtained after 72 hours at room temperature as a colourless solid 
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following flash silica gel chromatography (increasing polarity from ethyl acetate : petroleum ether, 1 
: 1 to ethyl acetate) (165 mg, 86%).  The dr was determined by analysis of the crude 
1
H NMR. 
 
M.P. 80-85 ºC; [α]D
25 
= - 64.3 (c = 1.25 in CHCl3); νmax(film)/cm
-1
 3273 (br w, N-H, O-H), 1660 (br s, 
C=O); 
1
H NMR: δH (400 MHz, CDCl3) 0.85 (t, 3H, J = 7.3 Hz, CH3CH2CH2), 1.26-1.38 (m, 2H, 
CH3CH2CH2), 1.67-1.79 (m, 1H, NCH2CHAHBCH2), 1.83-2.04 (m, 3H, NCH2CHAHBCH2, NCHCHAHB, 
CH3CH2CHAHB), 2.24-2.41 (m, 2H, NCHCHAHB, CH3CH2CHAHB), 2.64 (br s, 1H, O-H), 2.99-3.14 
(m, 2H, OCH2CH2C), 3.43 (ddd, 1H, J = 11.9 Hz, J = 9.3 Hz, J = 2.5 Hz, NCHAHBCH2CH2), 3.56-
3.65 (m, 1H, NCHAHBCH2CH2), 3.67-3.74 (m, 1H, OCHAHBCH2C), 3.85-3.93 (m, 2H, OCHAHBCH2C, 
NCHCH2), 7.01-7.05 (m, 1H, Ar-H), 7.09-7.14 (m, 1H, Ar-H), 7.24 (d, 1H, J = 8.1 Hz, Ar-H), 7.45 (d, 
1H, J = 7.9 Hz, Ar-H), 8.01 (br s, 1H, N-H), 8.78 (br s, 1H, N-H); 
13
C NMR: δC (100 MHz, CDCl3) 
14.0 (CH3CH2CH2), 17.6 (CH3CH2CH2), 22.2 (NCH2CH2CH2), 26.8 (OCH2CH2C), 28.6 
(CH3CH2CH2), 42.5 (NCHCH2CH2), 45.7 (NCH2CH2CH2), 58.6 (NCHCH2), 63.1 (OCH2CH2C), 64.4 
(CH2C), 109.4 (ArC-quat), 111.0 (ArC-H), 118.4 (ArC-H), 119.6 (ArC-H), 122.7 (ArC-H), 128.6 (ArC-
quat), 132.3 (ArC-quat), 135.3 (ArC-quat), 165.9 (CO), 170.5 (CO); m/z (ES
+
) 378 ([M+Na]
+
, 100%); 
HRMS ES (+) Found 378.1781 for C20H25N3O3Na
+
 [M+Na]
+
, requires 378.1788. 
 
7.2.5.9 Synthesis and characterisation of N-(2-{2-[(3R,8aS)-1,4-dioxo-3-
propyloctahydropyrrolo[1,2-a]pyrazin-3-yl]-1H-indol-3-yl}ethyl)-4-methylbenzenesulfonamide (2.65) 
 
 
 
Following the general procedure (0.45 mmol scale) the titled compound (as a mixtures of 
diastereomers (1 : 9) was obtained after 72 hours at room temperature as a colourless solid 
following flash silica gel chromatography (increasing polarity from ethyl acetate : petroleum ether, 1 
: 1 to ethyl acetate) (141 mg, 51%).  The dr was determined by analysis of the crude 
1
H NMR. 
 
M.P. 110-115 ºC; [α]D
25 
= - 30.6 (c = 0.66 in CHCl3); νmax(film)/cm
-1
 3284 (br w, N-H), 1656 (s, 
C=O), 1618 (s, C=O); 
1
H NMR: δH (400 MHz, CDCl3) 0.84 (t, 3H, J = 7.3 Hz, CH3CH2CH2), 1.17-
1.27 (m, 1H, CH3CHAHB) , 1.30-1.41 (m, 1H, CH3CHAHB), 1.65-1.75 (m, 1H, NCH2CHAHBCH2), 
1.88-1.96 (m, 1H, NCH2CHAHBCH2), 1.97-2.07 (m, 2H, NCHCHAHB, CH3CH2CHAHB), 2.20-2.27 (m, 
2H, NCHCHAHB, CH3CH2CHAHB), 2.30 (s, 3H, CH3CCH), 2.95-3.01 (m, 1H, NHCH2CHAHBC), 3.06-
3.17 (m, 3H, NHCH2CHAHBC, NCH2CH2C), 3.41 (ddd, 1H, J = 11.8 Hz, J = 9.1 Hz, J = 2.6 Hz, 
NCHAHBCH2CH2), 3.50-3.56 (m, 1H, NCHAHBCH2CH2), 3.85 (dd, 1H, J = 9.8 Hz, J = 7.1 Hz, 
NCHCH2), 5.35 (t, 1H, J = 5.9 Hz, NHCH2), 6.99 (t, 1H, J = 7.5 Hz, Ar-H indole), 7.07-7.13 (m, 3H, 
Ar-H indole, 2 x Ar-H), 7.22 (d, 1H, J = 8.1 Hz, Ar-H indole), 7.33 (d, 1H, J = 7.9 Hz, Ar-H indole), 
7.56 (d, 2H, J = 8.1 Hz, 2 x Ar-H), 7.86 (br s, 1H, N-H), 8.81 (br s, 1H, N-H); 
13
C NMR: δC (100 
MHz, CDCl3) 14.0 (CH3CH2CH2), 17.5 (CH3CH2CH2), 21.5 (CH3CCH), 22.4 (NCH2CH2CH2), 24.5 
(NHCH2CH2C), 28.2 (CH2), 41.2 (CH2), 43.8 (NHCH2CH2C), 45.9 (NCH2CH2CH2), 58.5 (NCHCH2), 
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64.3 (CH2C), 109.0 (ArC-quat), 111.2 (ArC-H indole), 118.5 (ArC-H indole), 119.8 (ArC-H indole), 
122.7 (ArC-H indole), 127.1 (2 x ArC-H), 128.6 (ArC-quat), 129.5 (2 x ArC-H), 131.6 (ArC-quat), 
135.1 (ArC-quat), 136.7 (ArC-quat), 143.2 (ArC-quat), 165.9 (CO), 171.5 (CO); m/z (ES
+
) 531 
([M+Na]
+
, 100%); HRMS ES (+) Found 531.2060 for C27H32N4O4SNa
+
 [M+Na]
+
, requires 531.2036. 
 
7.2.5.10 Synthesis and characterisation of N-(2-{2-[(3R,8aS)-1,4-dioxo-3-
propyloctahydropyrrolo[1,2-a]pyrazin-3-yl]-1H-indol-3-yl}ethyl)-2,4,6-
triisopropylbenzenesulfonamide (2.66) 
 
 
 
Following the general procedure (0.43 mmol scale) the titled compound (as a mixtures of 
diastereomers (1 : 9) was obtained after 72 hours at room temperature as a colourless solid 
following flash silica gel chromatography (increasing polarity from ethyl acetate : petroleum ether, 1 
: 1 to ethyl acetate) (73 mg, 37%).  The dr was determined by analysis of the crude 
1
H NMR. 
 
M.P. 132-134 ºC; [α]D
25 
= - 14.3 (c = 1.35 in CHCl3); νmax(film)/cm
-1
 3270 (br w, N-H), 1657 (br s, 
C=O), 1316 (br w, S=O), 1149 (s, S-O); 
1
H NMR: δH (500 MHz, CDCl3) 0.83 (t, 3H, J = 7.3 Hz, 
CH3CH2), 1.11 (d, 6H, J = 6.7 Hz, (CH3)2CH), 1.14-1.18 (m, 12H, 2 x (CH3)2CH), 1.21-1.30 (m, 1H, 
CHH), 1.33-1.42 (m, 1H, CHH), 1.64-1.74 (m, 1H, CHH), 1.86-1.94 (m, 1H, CHH), 1.98-2.12 (m, 
2H, 2 x CHH), 2.16-2.30 (m, 2H, 2 x CHH), 2.81 ( sept., 1H, J = 6.9 Hz, (CH3)2CHCCHCCSO2) 
2.98-3.04 (m, 1H, NHCH2CHAHBC), 3.06-3.13 (m, 2H, NHCH2CH2C), 3.17-3.23 (m, 1H, 
NHCH2CHAHBC), 3.37-3.42 (m, 1H, NCHAHBCH2CH2), 3.50-3.57 (m, 1H, NCHAHBCH2CH2), 3.82 
(dd, 1H, J = 9.4 Hz, J = 7.3 Hz, NCHCH2), 4.02-4.10 (m, 2H, 2 x (CH3)2CHCCSO2), 5.15 (t, 1H, J = 
6.0 Hz, NHCH2), 6.96 (t, 1H, J = 7.5 Hz, Ar-H indole), 7.05-7.09 (m, 3H, Ar-H indole, 2 x Ar-H), 7.23 
(d, 1H, J = 8.1 Hz, Ar-H indole), 7.29 (d, 1H, J = 7.9 Hz, Ar-H indole), 7.84 (br s, 1H, N-H), 8.90 (br 
s, 1H, N-H); 
13
C NMR: δC (75 MHz, CDCl3) 14.2 (CH3CH2CH2), 17.8 ((CH3)2CH), 22.7 (CH2), 23.9 
(CH2), 24.9 (CH2), 25.1 ((CH3)2CH), 25.2 ((CH3)2CH), 28.4 (CH2), 29.9 (2 x (CH3)2CHCCSO2), 34.4 
((CH3)2CHCCHCCSO2), 41.5 (CH2), 43.6 (NHCH2CH2C), 46.1 (NCH2CH2CH2), 58.8 (NCHCH2), 
64.5 (CH2C), 109.2 (ArC-quat), 111.5 (ArC-H indole),118.7 (ArC-H indole), 120.1 (ArC-H indole), 
123.0 (ArC-H indole), 124.0 (2 x ArC-H), 128.9 (ArC-quat), 132.2 (ArC-quat), 132.2 (ArC-quat), 
135.4 (ArC-quat), 150.8 (2 x ArC-quat), 153.0 (ArC-quat), 166.2 (CO), 171.5 (CO); m/z (ES
+
) 643 
([M+Na]
+
, 100%); HRMS ES (+) Found 643.3302 for C35H48N4O4SNa
+
 [M+Na]
+
, requires 643.3288. 
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7.3 Experimental for chapter 3 
 
7.3.1 Synthesis of the fused pentacycle 
 
7.3.1 Synthesis and characterisation of 4-methyl-N-(2-{2-[(3R,8aS)-3-methyl-1,4-
dioxooctahydropyrrolo[1,2-a]pyrazin-3-yl]-1H-indol-3-yl}ethyl)benzenesulfonamide (3.36) 
 
 
 
To a solution of primary alcohol (2.63) (562 mg, 1.72 mmol) in THF (3 mL), was added NEt3 (263 
μL,1.89 mmol) and Ts2O (616 mg, 1.89 mmol) and the solution was stirred at room temperature for 
24 hours before evaporating the solvent in vacuo to afford the crude.  Purification of the crude 
residue by flash silica gel chromatography (increasing polarity from ethyl acetate : petroleum ether, 
1 : 1 to ethyl acetate : petroleum ether, 3 : 1) afforded the titled compound as a colourless solid 
(674 mg, 82%). 
 
M.P. 120-122 ºC; [α]D
25 
= - 52.3 (c = 1.19 in CHCl3); νmax(film)/cm
-1
 3263 (br w, N-H), 1675 (s, 
C=O), 1659 (s, C=O); 
1
H NMR: δH (500 MHz, CDCl3) 1.71-1.79 (m, 1H, NCHCH2CHAHB), 1.82 (s, 
3H, CH3), 1.89-1.96 (m, 1H, NCHCH2CHAHB), 2.04-2.13 (m, 1H, NCHCHAHB), 2.20-2.26 (m, 1H, 
NCHCHAHB), 2.28 (s, 3H, CH3), 3.12 (app. dt, 1H, J = 14.9 Hz, J = 5.9 Hz, S(O)2OCH2CHAHB), 
3.22-3.29 (m, 1H, S(O)2OCH2CHAHB), 3.43 (ddd, 1H, J = 11.9 Hz, J = 8.8 Hz, J = 3.2 Hz, 
NCHAHBCH2), 3.54-3.61 (m, 1H, NCHAHBCH2), 3.87 (dd, 1H, J = 9.5 Hz, J = 7.3 Hz, NCHCH2), 
4.03-4.09 (m, 1H, S(O)2OCHAHB), 4.17 (app. dt, 1H, J = 9.5 Hz, J = 5.9 Hz, S(O)2OCHAHB), 6.96 (t, 
1H, J = 7.6 Hz, Ar-H), 7.05-7.12 (m, 3H, 3 x Ar-H), 7.23 (d, 2H, J = 8.8 Hz, 2 x Ar-H), 7.41 (s, 1H, 
N-H amide), 7.50 (d, 2H, J = 8.3 Hz, 2 x Ar-H), 8.85 (s, 1H, N-H indole); 
13
C NMR: δC (125 MHz, 
CDCl3) 21.6 (CH3), 22.6 (NCHCH2CH2), 23.6 (S(O)2OCH2CH2), 26.7 (CH3), 28.1 (NCHCH2), 46.1 
(NCH2CH2), 58.7 (NCHCH2), 60.8 (CH3C), 69.9 (S(O)2OCH2CH2), 106.7 (ArC-quat), 111.2 (ArC-H), 
118.2 (ArC-H), 119.9 (ArC-H), 122.8 (ArC-H), 126.1 (ArC-H), 127.8 (ArC-H), 128.2 (ArC-quat), 
129.3 (ArC-H), 129.7 (ArC-H), 132.2 (ArC-quat), 132.8 (ArC-quat), 135.2 (ArC-quat), 144.7 (ArC-
quat), 166.3 (CO), 171.2 (CO); m/z (ES
+
) 504 ([M+Na]
+
, 100%); HRMS ES (+) Found 504.1562 for 
C25H27O5N3SNa
+
 [M+Na]
+
, requires 504.1564. 
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7.3.1.2 Synthesis and characterisation of (3R,8aS)-3-[3-(2-chloroethyl)-1H-indol-2-yl]-3-
methylhexahydropyrrolo[1,2-a]pyrazine-1,4-dione (3.37) 
 
 
 
To a suspension of NaH (4.8 mg, 0.20 mmol), in CH2Cl2 (1 mL), under N2 was added a solution of 
tosylate (3.36) (47 mg, 0.1 mmol) in CH2Cl2 (1 mL) and the solution was stirred at room 
temperature for 3 hours before the addition of 1 M aqueous HCl (5 mL).  The aqueous layer was 
extracted with CH2Cl2 (3 x 10 mL) and the combined organic layers were dried over MgSO4 and the 
solvent evaporated in vacuo to afford the crude. Purification of the crude by flash silica gel 
chromatography (increasing polarity from ethyl acetate : petroleum ether, 1 : 1 to ethyl acetate : 
petroleum ether, 3 : 1) afforded the titled compound as a pale yellow solid (24 mg, 72%) 
 
M.P. 220-124 ºC; [α]D
25 
= - 57.0 (c = 1.22 in CHCl3); νmax(film)/cm
-1
 3275 (br w, N-H), 1677 (s, 
C=O), 1659 (s, C=O); 
1
H NMR: δH (500 MHz, CDCl3) 1.69-1.80 (m, 1H, NCH2CHAHB), 1.87 (s, 3H, 
CH3), 1.92-2.00 (m, 1H, NCH2CHAHB), 2.03-2.13 (m, 1H, NCHCHAHB), 2.21-2.27 (m, 1H, 
NCHCHAHB), 3.30 (dd, 2H, J = 7.4 Hz, J = 6.5 Hz, ClCH2CH2), 3.46 (ddd, 1H, J = 11.9 Hz, J = 8.9 
Hz, J = 3.0 Hz, NCHAHBCH2), 3.55-3.67 (m, 2H, NCHAHBCH2, ClCHAHBCH2), 3.76 (dt, 1H, J = 10.6 
Hz, J = 6.5 Hz, ClCHAHBCH2), 3.87 (dd, 1H, J = 9.6 Hz, J = 7.2 Hz, NCHCH2), 7.07 (t, 1H, J = 7.4 
Hz, Ar-H), 7.16 (t, 1H, J = 7.3 Hz, Ar-H), 7.25 (d, 1H, J = 6.9 Hz, Ar-H), 7.28 (br s, 1H, N-H), 7.46 
(d, 1H, J = 7.9 Hz, Ar-H), 8.65 (br s, 1H, N-H); 
13
C NMR: δC (125 MHz, CDCl3) 22.6 (NCH2CH2), 
27.8 (ClCH2CH2), 27.2 (CH3), 28.1 (NCHCH2), 45.2 (ClCH2CH2), 46.0 (NCH2CH2), 58.8 (NCHCH2), 
60.9 (CH3C), 108.7 (ArC-quat), 111.2 (ArC-H), 118.3 (ArC-H), 120.0 (ArC-H),123.0 (ArC-H), 128.4 
(ArC-quat), 132.6 (ArC-quat), 135.2 (ArC-quat), 166.3 (CO), 170.6 (CO); m/z (ES
-
) 344 ([M-H]
-
, 
55%), 689 ([2M-H]
-
, 100%); HRMS ES (+) Found 368.1136 for C18H20N3O2
35
ClNa
+
 [M+Na]
+
, 
requires 368.1136. 
 
7.3.1.3 Synthesis and characterisation of (3R,8aS)-3-methyl-3-(spiro[cyclopropane-1,3'-indol]-2'-
yl)hexahydropyrrolo[1,2-a]pyrazine-1,4-dione (3.39) 
 
 
 
To a solution of primary alcohol (2.63) (143 mg, 0.44 mmol) in THF (6 mL) under N2, was added 
PPh3 (172 mg, 0.66 mmol) and the solution was cooled to 0 ºC before the addition of DIAD (0.13 
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mL, 0.66 mmol).  The solution was allowed to warm to room temperature where it was stirred for 2 
hours before evaporating the solvent in vacuo to afford the crude.  Purification of the crude by flash 
silica gel chromatography (increasing polarity from diethyl ether to diethyl ether : methanol, 9.5 : 
0.5) afforded the titled compound as a colourless solid (78 mg, 58%). 
 
M.P. 77-80 ºC; [α]D
25 
= - 7.0 (c = 1.4 in CHCl3); νmax(film)/cm
-1
 3249 (br w, N-H), 1725 (s, CO), 
1674 (s, CO); 
1
H NMR: δH (500 MHz, CDCl3) 1.60-1.65 (m, 1H, CHH), 1.66 (s, 3H, CH3), 1.69-1.80 
(m, 2H, 2 x CHH), 1.89-1.96 (m, 1H, CHH), 2.00-2.08 (m, 1H, CHH), 2.24-2.33 (m, 3H, 3 x CHH), 
3.42 (ddd, 1H, J = 11.8 Hz, J = 8.8 Hz, J = 2.9 Hz, NCHAHBCH2), 3.53-3.60 (m, 1H, NCHAHBCH2), 
3.99 (dd, 1H, J = 9.7 Hz, J = 7.2 Hz, NCHCH2), 6.32 (br s, 1H, N-H), 6.91 (d, 1H, J = 7.4 Hz, Ar-H), 
7.23 (t, 1H, J = 7.4 Hz, Ar-H), 7.32 (t, 1H, J = 7.6 Hz, Ar-H), 7.68 (d, 1H, J = 7.7 Hz, Ar-H); 
13
C 
NMR: δC (100 MHz, CDCl3) 19.4 (CH2), 20.5 (CH2), 22.7 (CH2), 23.2 (CH3), 28.5 (CH2), 35.7 (C-
quat), 46.1 (NCH2CH2), 59.4 (NCHCH2), 63.2 (C-quat), 116.9 (ArC-H), 121.3 (ArC-H), 125.7 (ArC-
H), 126.7 (ArC-H), 142.5 (ArC-quat), 151.8 (ArC-quat), 164.7 (ArC-quat), 171.9 (CO), 178.2 (CO); 
m/z (ES
+
) 332 ([M+Na]
+
, 30%), 641 ([2M+Na]
+
, 100%); HRMS ES (+) Found 332.1369 for 
C18H19N3O2Na
+
 [M+Na]
+
, requires 332.1369. 
 
7.3.1.4 Synthesis and characterisation of (3aR,12bR)-12b-methyl-1,2,3,3a,6,7,12,12b-octahydro-
4H,13H-pyrrolo[1'',2'':4',5']pyrazino[1',2':1,2]pyrido[3,4-b]indole-4,13-dione (3.38)
50
 
 
 
 
To a solution of tosylate (3.36) (650 mg, 1.35 mmol) in THF (50 mL) was added 45% aqueous 
solution of KOH (576 μL, 6.75 mmol) and the solution was stirred at room temperature for 24 hours 
before diluting with water (30 mL) and extracting with EtOAc (3 x 80 mL).  The combined organic 
layers were dried over MgSO4 and the solvent evaporated in vacuo to afford the crude.  Purification 
of the crude by flash silica gel chromatography (increasing polarity from ethyl acetate : petroleum 
ether, 1 : 1 to ethyl acetate : petroleum ether, 3 : 1) afforded cyclised product (3.38) (208 mg, 29%) 
and cyclopropane (3.39) (122 mg, 50%) in a total yield of 79%.    
 
M.P. 87-90 ºC; [α]D
30 
= - 154.6 (c = 0.95 in CHCl3) (lit. [α]D
23 
= - 132.5 (c = 0.33 in CHCl3)); 
1
H NMR: 
δH (400 MHz, CDCl3) 1.78 (s, 3H, CH3C), 1.80-2.00 (m, 3H, NCHCHAHB, NCH2CH2CH2), 2.39-2.46 
(m,1H, NCHCHAHB), 2.73-2.78 (m, 2H, NCH2CH2C), 3.00-3.08 (m, 1H, NCHAHBCH2C), 3.50-3.58 
(m, 2H, NCH2CH2CH2), 4.08 (dd, 1H, J = 9.8 Hz, J = 6.4 Hz, NCHCH2), 4.93-4.99 (m, 1H, 
NCHAHBCH2C) , 6.99-7.04 (m, 1H, Ar-H), 7.08-7.13 (m, 1H, Ar-H), 7.29 (d, 1H, J = 8.1 Hz, Ar-H), 
7.40 (d, 1H, J = 7.8 Hz, Ar-H), 9.35 (br s, 1H, N-H); 
13
C NMR: δC (75 MHz, CDCl3) 20.6 
(NCH2CH2C), 21.8 (NCH2CH2CH2), 26.2 (CH3C), 29.9 (NCH2CH2CH2), 37.1 (NCH2CH2C), 45.9 
(NCH2CH2CH2), 58.6 (NCHCH2), 61.4 (CH3C), 109.7 (ArC-quat), 111.6 (ArC-H), 118.4 (ArC-H), 
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119.6 (ArC-H), 122.5 (ArC-H), 126.2 (ArC-quat), 132.8 (ArC-quat), 136.9 (ArC-quat), 165.9 (CO), 
166.6 (CO); m/z (ES
+
) 332 ([M+Na]
+
, 100%). 
 
7.3.1.5 Synthesis and characterisation of (3aS,12bR)-12b-methyl-1,2,3,3a,6,7,12,12b-octahydro-
4H,13H-pyrrolo[1'',2'':4',5']pyrazino[1',2':1,2]pyrido[3,4-b]indole-4,13-dione (3.30)
49
 
 
 
 
To a solution of cyclopropane (3.39) (19 mg, 0.06 mmol) in THF (2 mL), was added NaI (18.5 mg, 
0.12 mmol) and the solution was stirred at room temperature for 48 hours before evaporating the 
solvent in vacuo to afford the crude.  Purification of the crude by flash silica gel chromatography 
(increasing polarity from ethyl acetate : petroleum ether, 1 : 1 to ethyl acetate : petroleum ether, 3 : 
1) afforded cyclised product (3.30) (18.6 mg, 99%).  
 
M.P. 169-172 ºC (lit. 196-198 ºC); [α]D
30 
= - 143.4 (c = 0.70 in CHCl3) (lit. [α]D
23 
= - 168.5 (c = 1.06 in 
CHCl3)); 
1
H NMR: δH (400 MHz, CDCl3) 1.73-1.88 (m, 2H, NCH2CH2CH2), 1.90 (s, 3H, CCH3), 1.95-
2.06 (m, 1H, NCHCHAHB), 2.42-2.50 (m, 1H, NCHCHAHB), 2.71 (dd, 1H, J = 15.7 Hz, J = 4.6 Hz, 
NCHCH2), 2.88 (ddd, 1H, J = 14.5 Hz, J = 10.9 Hz, J = 5.9 Hz, NCH2CHAHBC), 3.21 (ddd, 1H, J = 
14.5 Hz, J = 12.0 Hz, J = 4.2 Hz, NCH2CHAHBC), 3.31 (ddd, 1H, J = 12.9 Hz, J = 10.9 Hz, J = 4.2 
Hz, NCHAHBCH2C), 3.88-4.00 (m, 2H, NCH2CH2CH2), 5.00 (ddd, 1H, J = 12.9 Hz, J = 5.9 Hz, J = 
0.9 Hz, NCHAHBCH2C), 7.03 (t, 1H, J = 7.6 Hz, Ar-H), 7.09-7.14 (m, 1H, Ar-H), 7.27 (d, 1H, J = 8.1 
Hz, Ar-H), 7.41 (d, 1H, J = 7.8 Hz, Ar-H), 8.97 (br s, 1H, N-H); m/z (ES
+
) 332 ([M+Na]
+
, 100%). 
 
7.3.2 Studies towards DKP cleavage 
 
 7.3.2.1 Synthesis and characterisation of (3aR,12bR)-12b-methyl-1,2,3,3a,6,7,12,12b-octahydro-
4H,13H-pyrrolo[1'',2'':4',5']pyrazino[1',2':1,2]pyrido[3,4-b]indole-4,13-dithione (3.48) 
 
 
 
To a solution of cyclised product (3.47) (608 mg, 1.97 mmol, 1.4 : 1 dr) in toluene (10 mL), was 
added Lawesson‘s Reagent (1.91 g, 4.72 mmol) and the solution was refluxed for 24 hours before 
cooling and evaporating the solvent in vacuo to afford the crude.  Isolation of one diastereomer by 
flash silica gel chromatography (increasing polarity from ethyl acetate : petroleum ether, 0.5 : 9.5 to 
ethyl acetate : petroleum ether, 1 : 4) afforded cyclised product (3.48) as a colourless solid (241 
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mg, 36%).  This was recrystalised (EtOAc/petroleum ether) and the absolute stereochemistry was 
proved by X-ray analysis.  
 
M.P. 46-50 ºC; [α]D
25 
= - 61.0 (c = 0.34 in CHCl3); νmax(film)/cm
-1
 3327 (br w, N-H); 
1
H NMR: δH 
(500 MHz, CDCl3) 2.02 (s, 3H, CH3), 2.04-2.09 (m, 1H, NCH2CHAHBCH2), 2.12-2.19 (m, 1H, 
NCH2CHAHBCH2), 2.36-2.45 (m, 1H, NCHCHAHB), 2.91-3.00 (m, 3H, NCHCHAHB, NCH2CH2C), 
3.38 (td, 1H, J = 12.5 Hz, J = 4.2 Hz, NCHAHBCH2C), 3.85-3.92 (m, 1H, NCHAHBCH2CH2), 4.16 
(dd, 1H, J = 14.3 Hz, J = 9.2 Hz, NCHAHBCH2CH2), 4.43 (dd, 1H, J = 11.3 Hz, J = 5.8 Hz, 
NCHCH2), 6.26 (ddd, 1H, J = 12.5 Hz, J = 4.2 Hz, J = 1.8 Hz, NCHAHBCH2C), 7.14 (t, 1H, J = 7.3 
Hz, Ar-H), 7.25 (t, 1H, J = 7.2 Hz, Ar-H), 7.45 (d, 1H, J = 8.1 Hz, Ar-H), 7.52 (d, 1H, J = 7.9 Hz, Ar-
H), 9.90 (br s, 1H, N-H); 
13
C NMR: δC (125 MHz, CDCl3) 20.2 (NCH2CH2C), 21.2 (NCH2CH2CH2), 
27.3 (CH3), 35.4 (NCHCH2), 47.4 (NCH2CH2C), 54.9 (NCH2CH2CH2), 66.8 (NCHCH2), 70.4 (CH3C), 
111.9 (2C, ArC-quat, ArC-H), 118.7 (ArC-H), 119.9 (ArC-H), 122.9 (ArC-H), 126.1 (ArC-quat), 
132.9 (ArC-quat), 137.2 (ArC-quat), 192.3 (CS), 194.4 (CS) ; m/z (ES
-
) 340 ([M-H]
-
, 90%); HRMS 
ES (-) Found 340.0955 for C18H18N3S2 [M-H]
-
, requires 340.0948. 
 
 
7.3.2.2 Synthesis and characterisation of (12bR)-12b-methyl-2,3,6,7,12,12b-hexahydro-1H,13H-
pyrrolo[1'',2'':4',5']pyrazino[1',2':1,2]pyrido[3,4-b]indol-13-one (3.51) 
 
 
 
To a solution of cyclised product (3.47) (204 mg, 0.66 mmol, 1.4 : 1 dr) in dry THF (7 mL), under N2 
at -100 ºC was added DIBAl (1 M in hexane) (0.76 mL, 0.76 mmol) dropwise over 10 minutes under 
N2.  The solution was stirred at -100 ºC for 7 hours before quenching with MeOH (1.2 mL), warming 
to room temperature and adding diethyl ether (15 mL) and 1 M aqueous HCl (5 mL).  The solution 
was stirred at room temperature for 5 minutes before extracting with diethyl ether (3 x 15 mL).  The 
combined organic layers were dried over Na2SO4 and the solvent evaporated in vacuo to afford the 
crude (180 mg, 93%) as a colourless solid which did not require further purification.  
 
M.P. 67-72 ºC; [α]D
25 
= - 17.1 (c = 0.73 in CHCl3); νmax(film)/cm
-1
 3400 (br w, N-H), 1641 (s, C=O); 
1
H NMR: δH (400 MHz, CDCl3) 1.57 (s, 3H, CH3C), 1.83-1.94 (m, 2H, NCH2CH2CH2), 2.45-2.66 (m, 
3H, NCH2CH2CH2, NCH2CHAHBC), 2.90 (ddd, 1H, J = 15.2 Hz, J = 11.5 Hz J = 5.9 Hz, 
NCH2CHAHBC), 3.18 (ddd, 1H, J = 12.7 Hz, J = 5.9 Hz, J = 1.4 Hz, NCHAHBCH2C), 3.50 (ddd, 1H, J 
= 12.7 Hz, J = 11.5 Hz, J = 4.3 Hz, NCHAHBCH2C), 3.54-3.64 (m, 2H, NCH2CH2CH2), 5.47 (t, 1H, J 
= 1.6 Hz, NCHC), 6.98-7.03 (m, 1H, Ar-H), 7.06-7.11 (m, 1H, Ar-H), 7.28 (d, 1H, J = 8.1 Hz, Ar-H), 
7.41 (d, 1H, J = 7.8 Hz, Ar-H), 8.96 (br s, 1H, N-H); 
13
C NMR: δC (100 MHz, CDCl3) 20.7 (CH3C), 
22.7 (NCH2CH2C), 26.6 (NCH2CH2CH2), 31.6 (NCH2CH2CH2), 45.6 (NCH2CH2CH2), 46.3 
(NCH2CH2C), 59.7 (CH3C), 107.9 (C-quat), 111.4 (ArC-H), 113.2 (NCCH), 116.4 (ArC-H), 118.1 (C-
quat), 119.2 (ArC-H), 122.0 (ArC-H), 126.8 (C-quat), 134.6 (C-quat), 136.4 (C-quat), 164.4 (CO); 
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m/z (ES
+
) 316 ([M+Na]
+
, 50%), 609 ([2M+Na]
+
, 100%); HRMS ES (+) Found 316.1420 for 
C18H19N3ONa
+
 [M+Na]
+
, requires 316.1420. 
 
7.3.2.3 Synthesis and characterisation of (1R)-1-methyl-1-[(2-oxopyrrolidin-1-yl)carbonyl]-1,3,4,9-
tetrahydro-2H--carboline-2-carbaldehyde (3.52) 
 
 
 
A procedure developed by Jin and co-workers was followed.
54
  To a solution of enamine (3.51) (50 
mg, 0.17 mmol) in dioxane:water 3:1 (2 mL), was added lutidine (39 μL, 0.34 mmol), OsO4 (2.5% in 
2-methyl-2-propanol) (2 μL, 0.005 mmol) and NaIO4 (55 mg, 0.26 mmol).  The solution was stirred 
at room temperature for 2 hours before diluting with water (5 mL) and extracting with CH2Cl2 (3 x 10 
mL).  The combined organic layers were dried over MgSO4 and the solvent evaporated in vacuo to 
afford the crude.  Purification of the crude by flash silica gel chromatography (ethyl acetate) 
afforded formamide (3.52) as a colourless solid (42 mg, 76%). 
 
M.P. 206-208 ºC; [α]D
25 
= + 13.5 (c = 1.18 in CHCl3); νmax(film)/cm
-1
 3307 (br w, N-H), 1765 (s, 
C=O), 1668 (br s, C=O); 
1
H NMR: δH (500 MHz, CDCl3) 1.62-1.70 (m, 5H, CH3, NC(O)CH2CH2CH2), 
2.22 (t, 2H, J = 8.0 Hz, NC(O)CH2CH2CH2), 2.79 (app. dd, 1H, J = 15.0 Hz, J = 3.6 Hz, 
CH3CNCH2CHAHB), 3.03-3.13 (m, 1H, CH3CNCH2CHAHB), 3.36-3.51 (m, 2H, CH3CNCHAHBCH2, 
NC(O)CH2CH2CHAHB), 3.72 (dt, 1H, J = 10.4 Hz, J = 7.4 Hz, NC(O)CH2CH2CHAHB), 4.10 (app. dd, 
1H, J = 13.1 Hz, J = 5.0 Hz, CH3CNCHAHBCH2), 6.97 (t, 1H, J = 7.4 Hz, Ar-H), 7.05 (t, 1H, J = 7.5 
Hz, Ar-H), 7.28 (d, 1H, J = 8.0 Hz, Ar-H), 7.43 (d, 1H, J = 7.7 Hz, Ar-H), 8.13 (br s, 1H, N-H), 10.90 
(br s, 1H, CHO); 
13
C NMR: δC (100 MHz, CDCl3) 18.5 (CH3CNCH2CH2), 21.0 (NC(O)CH2CH2CH2), 
24.3 (CH3), 33.2 (NC(O)CH2CH2CH2), 42.7 (CH3CNCH2CH2), 47.6 (NC(O)CH2CH2CH2), 62.5 
(CH3C), 109.4 (ArC-quat), 112.5 (ArC-H), 119.0 (ArC-H), 119.6 (ArC-H), 122.2 (ArC-H), 126.5 (ArC-
quat), 131.2 (ArC-quat), 137.5 (ArC-quat), 162.9 (CO), 170.1 (CO), 174.2 (CO); m/z (ES
+
) 348 
([M+Na]
+
, 50%), 673 ([2M+Na]
+
, 100%); HRMS ES (+) Found 348.1324 for C18H19N3O3Na
+
 
[M+Na]
+
, requires 348.1319.  
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7.3.2.4 Synthesis and characterisation of methyl 5-({[(1R)-1-methyl-2,3,4,9-tetrahydro-1H--
carbolin-1-yl]carbonyl}amino)-5-oxopentanoate (3.53) 
 
 
 
A solution of formamide (3.52) (13 mg, 0.04 mmol) in 1 M aqueous HCl (5 mL) and MeOH (3 mL) 
was refluxed for 12 hours before cooling and neutralising with a saturated solution of NaHCO3.  The 
solution was evaporated in vacuo, water added (10 mL) and extracted with EtOAc (3 x 10 mL) 
before drying over Na2SO4 and evaporating the solvent in vacuo to afford the crude (12 mg, 90%) 
as a colourless oil which did not require further purification.   
 
[α]D
25 
= + 7.0 (c = 1.86 in CHCl3); νmax(film)/cm
-1
 3325 (br m, N-H), 1734 (s, C=O), 1657 (s, C=O); 
1
H NMR: δH (500 MHz, CDCl3) 1.65 (s, 3H, CH3C), 1.85 (p, 2H, J = 7.2 Hz, NCH2CH2CH2), 2.34 (t, 
2H, J = 7.2 Hz, NCH2CH2CH2), 2.65-2.72 (m, 1H, NCH2CHAHBC), 2.73-2.79 (m, 1H, 
NCH2CHAHBC),  2.87-2.94 (ddd, 1H, J = 13.2 Hz, J = 9.3 Hz, J = 4.1 Hz, NCHAHBCH2C), 3.22-3.34 
(m, 3H, NCH2CH2CH2, NCHAHBCH2C), 3.65 (s, 3H, OCH3), 7.08 (t, 1H, J = 7.4 Hz, Ar-H), 7.15 (t, 
1H, J = 7.6 Hz, Ar-H), 7.35 (d, 1H, J = 8.1 Hz, Ar-H), 7.48 (d, 1H, J = 7.8 Hz, Ar-H), 7.98 (br s, 1H, 
N-H), 8.83 (br s, 1H, N-H); 
13
C NMR: δC (125 MHz, CDCl3) 22.9 (NCH2CH2C), 24.8 (NCH2CH2CH2), 
28.3 (CH3C), 31.4 (NCH2CH2CH2), 38.5 (NCH2CH2CH2), 41.5 (NCH2CH2C), 51.7 (OCH3), 58.0 
(CH3C), 108.9 (ArC-quat), 111.3 (ArC-H), 118.2 (ArC-H), 119.2 (ArC-H), 121.8 (ArC-H), 126.7 (ArC-
quat), 134.8 (ArC-quat), 136.2 (ArC-quat), 173.5 (CO), 174.7 (CO); m/z (ES
+
) 330 ([M+H]
+
, 75%), 
352 ([M+Na]
+
, 65%); HRMS ES (+) Found 352.1630 for C18H23N3O3Na
+
 [M+Na]
+
, requires 
352.1632. 
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7.4 Experimental for chapter 4 
 
7.4.1 Synthesis of oxazolidinone (4.85) and oxazolidinethione (4.90) 
 
7.4.1.1 Synthesis and characterisation of (±)-4-hydroxy-3-[2-(1H-indol-3-yl)ethyl]-4-methyl-1,3-
oxazolidin-2-one (4.87) 
 
 
 
To a stirring solution of CDI (5.06 g, 31.2 mmol) in anhydrous CH2Cl2 (75 mL) was added a solution 
of hydroxy acetone (2.13 mL, 31.2 mmol) in anhydrous CH2Cl2 (75 mL) at 0 ºC and the solution was 
stirred at room temperature for 1.5 hours before the portion wise addition of tryptamine (5 g, 31.2 
mmol).  The solution was stirred at room temperature for 12 hours before the addition of a saturated 
solution of NaHCO3 (75 mL).  The aqueous layer was extracted with CH2Cl2 (3 x 75 mL) and the 
combined organic layers were washed with brine (50 mL) before filtering through a phase separator 
funnel and evaporating the solvent in vacuo to afford the crude. Purification of the crude residue by 
flash silica gel chromatography (increasing polarity from ethyl acetate : petroleum ether, 1 : 1 to 3 : 
1) afforded the titled compound as a colourless solid (4.12 g, 51%) 
 
M.P. 132-134 ºC; νmax(film)/cm
-1
 3324 (br w, N-H, O-H), 1731 (s, C=O); 
1
H NMR: δH (400 MHz, D6-
DMSO) 1.37 (s, 3H, CH3C), 2.89-3.04 (m, 2H, NCH2CH2), 3.30-3.39 (m, 2H, NCH2CH2), 4.07 (d, 
1H, J = 9.3 Hz, CO2CHAHB), 4.11 (d, 1H, J = 9.3 Hz, CO2CHAHB), 6.35 (br s, 1H, O-H), 7.00 (t, 1H, 
J = 7.4 Hz, Ar-H), 7.08 (t, 1H, J = 7.5 Hz, Ar-H), 7.21 (d, 1H, J = 1.7 Hz, NHCH), 7.35 (d, 1H, J = 
7.8 Hz, Ar-H), 7.57 (d, 1H, J = 7.8 Hz, Ar-H), 10.85 (br s, 1H, N-H); 
13
C NMR: δC (100 MHz, D6-
DMSO) 25.3 (CH3C), 26.0 (NCH2CH2), 41.0 (NCH2CH2), 75.7 (CO2CH2), 86.7 (CH3C), 112.2 (ArC-
quat), 112.3 (ArC-H), 119.0 (ArC-H), 119.2 (ArC-H), 121.8 (ArC-H), 123.7 (NHCH), 128.0 (ArC-
quat), 137.1 (ArC-quat), 157.5 (CO); m/z (ES
+
) 283 ([M+Na]
+
, 35%), 543 ([2M+Na]
+
, 100%); HRMS 
ES (+) Found 283.1052 for C14H16N2O3Na
+
 [M+Na]
+
, requires 283.1053. 
 
7.4.1.2 Synthesis and characterisation of 11b-methyl-5,6,11,11b-tetrahydro-1H-
[1,3]oxazolo[3',4':1,2]pyrido[3,4-b]indol-3-one (4.85) 
 
 
 
To a solution of aminol (4.87) (78 mg, 0.3 mmol) in refluxing mesitylene (63 mL) was added catalyst 
(4.23) (26 mg, 0.03 mmol) and the solution was refluxed for 15 minutes before cooling and 
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evaporating the solvent in vacuo to afford the crude.  Purification of the crude residue by flash silica 
gel chromatography (ethyl acetate : petroleum ether, 2 : 3) afforded the titled compound as a 
colourless solid (60 mg, 83%).  The ee was determined by HPLC using a Chiralpak OD-H column 
(80:20 hexane/isopropanol) flow rate 1 ml/min, 220 nm, major tR = 8.0 min, minor tR = 11.6 min 
(44% ee). 
 
M.P. 145-150 ºC; [α]D
25 
= + 55.4 (c = 1.28 in CHCl3); νmax(film)/cm
-1
 3294 (br w, N-H), 1729 (s, 
C=O); 
1
H NMR: δH (400 MHz, CDCl3) 1.74 (s, 1H, CH3), 2.80 (app. dd, 1H, J = 15.7 Hz, J = 4.7 Hz, 
NCH2CHAHB), 3.04 (ddd, 1H, J = 15.7 Hz, J = 12.0 Hz, J = 6.2 Hz, NCH2CHAHB), 3.35 (ddd, 1H, J = 
13.7 Hz, J = 12.0 Hz, J = 4.7 Hz, NCHAHBCH2), 4.21 (app. dd, 1H, J = 13.7 Hz, J = 6.2 Hz, 
NCHAHBCH2), 4.37-4.41 (m, 1H, OCHAHBC), 4.49-4.53 (m, 1H, OCHAHBC), 7.15 (t, 1H, J = 7.4 Hz, 
Ar-H), 7.21 (t, 1H, J = 7.0 Hz, Ar-H), 7.37 (d, 1H, J = 8.0 Hz, Ar-H), 7.51 (d, 1H, J = 7.8 Hz, Ar-H), 
9.22 (br s, 1H, N-H); 
13
C NMR: δC (100 MHz, CDCl3) 20.4 (CH2), 25.5 (CH3), 37.4 (CH2), 58.3 
(CH3C), 74.1 (OCH2C), 107.6 (ArC-quat), 111.5 (ArC-H), 118.5 (ArC-H), 119.8 (ArC-H), 122.5 (ArC-
H), 126.4 (ArC-quat), 134.4 (ArC-quat), 136.4 (ArC-quat), 158.5 (CO); m/z (ES
+
) 265 ([M+Na]
+
, 
25%), 507 ([2M+Na]
+
, 85%); HRMS ES (+) Found 265.0947 for C14H14NO2Na
+
 [M+Na]
+
, requires 
265.0947. 
 
7.4.1.3 Synthesis and characterisation of (±)-4-hydroxy-3-[2-(1H-indol-3-yl)ethyl]-4-methyl-1,3-
oxazolidine-2-thione (4.89) 
 
 
 
To a stirring solution of CSI (5.56 g, 31.2 mmol) in anhydrous CH2Cl2 (75 mL) was added a solution 
of hydroxy acetone (2.13 mL, 31.2 mmol) in anhydrous CH2Cl2 (75 mL) at 0 ºC and the solution was 
stirred at room temperature for 2 hours before the portion wise addition of tryptamine (5 g, 31.2 
mmol).  The solution was stirred at room temperature for 12 hours before the addition of a saturated 
solution of NaHCO3 (75 mL).  The aqueous layer was extracted with CH2Cl2 (3 x 75 mL) and the 
combined organic layers were washed with brine (50 mL) before filtering through a phase separator 
funnel and evaporating the solvent in vacuo to afford the crude. Purification of the crude residue by 
flash silica gel chromatography (ethyl acetate : hexane, 1 : 1) afforded the titled compound as a 
colourless solid (6 g, 70%). 
 
M.P. 114-117 ºC; νmax(film)/cm
-1
 3409 (br m, N-H, O-H), 1168 (m, C=S); 
1
H NMR: δH (400 MHz, 
D6-DMSO) 1.49 (s, 3H, CH3), 3.02-3.26 (m, 2H, NCH2CH2), 3.62-3.74 (m, 2H, NCH2CH2), 4.31 (d, 
1H, J = 9.9 Hz, CH3CCHAHB), 4.37 (d, 1H, J = 9.9 Hz, CH3CCHAHB), 6.89 (s, 1H, O-H), 7.02 (t, 1H, 
J = 7.4 Hz, Ar-H), 7.09 (t, 1H, J = 7.4 Hz, Ar-H), 7.23 (d, 1H, J = 2.0 Hz, NHCH), 7.36 (d, 1H, J = 
8.1 Hz, Ar-H), 7.73 (d, 1H, J = 7.8 Hz, Ar-H), 10.88 (br s, 1H, N-H); 
13
C NMR: δC (100 MHz, D6-
DMSO) 24.7 (NCH2CH2), 25.0 (CH3), 44.4 (NCH2CH2), 79.1 (OCH2C), 90.8 (CH3C), 111.9 (ArC-H), 
112.3 (ArC-H), 119.3 (2 x ArC-H) , 121.9 (ArC-quat), 123.9 (NHCH), 128.0 (ArC-quat), 137.1 (ArC-
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quat), 187.2 (CS); m/z (ES
+
) 299 ([M+Na]
+
, 55%), 575 ([2M+Na]
+
, 100%); HRMS ES (+) Found 
299.0821 for C14H16N2O2SNa
+
 [M+Na]
+
, requires 299.0825. 
 
7.4.1.4 Synthesis and characterisation of 11b-methyl-5,6,11,11b-tetrahydro-1H-
[1,3]oxazolo[3',4':1,2]pyrido[3,4-b]indole-3-thione (4.90) 
 
 
 
To a solution of aminol (4.89) (83 mg, 0.3 mmol) in refluxing toluene (42 mL) was added catalyst 
(4.57) (23 mg, 0.03 mmol) and the solution was refluxed for 24 hours before cooling and 
evaporating the solvent in vacuo to afford the crude.  Purification of the crude residue by flash silica 
gel chromatography (CH2Cl2) afforded the titled compound as a colourless solid (76 mg, 98%).  
The ee was determined by HPLC using a Chiralpak IB column (80:20 hexane/isopropanol) flow 
rate 1 ml/min, 220 nm, minor tR = 6.6 min, major tR = 8.3 min (18% ee). 
 
M.P. 65-69 ºC; [α]D
25 
= + 36.0 (c = 0.95 in CHCl3); νmax(film)/cm
-1
 3264 (br w, N-H), 1227 (s, C=S); 
1
H NMR: δH (400 MHz, CDCl3) 1.73 (s, 3H, CH3), 2.87 (app. dd, 1H, J = 15.6 Hz, J = 4.8 Hz, 
NCH2CHAHB), 3.01-3.11 (m, 1H, NCH2CHAHB), 3.51 (app. td, 1H, J = 13.0 Hz, J = 4.8 Hz, 
NCHAHBCH2), 4.48 (dd, 1H, J = 8.6 Hz, J = 2.4 Hz, OCHAHBC), 4.62 (dd, 1H, J = 8.6 Hz, J = 2.4 Hz, 
OCHAHBC), 4.75 (dd, 1H, J = 13.0 Hz, J = 6.1 Hz, NCHAHBCH2), 7.11-7.21 (m, 2H, 2 x Ar-H), 7.35 
(d, 1H, J = 7.9 Hz, Ar-H), 7.50 (d, 1H, J = 7.7 Hz, Ar-H), 8.90 (br d, 1H, J = 5.8 Hz, N-H); 
13
C NMR: 
δC (100 MHz, CDCl3) 20.4 (NCH2CH2), 25.2 (CH3), 40.9 (NCH2CH2), 62.2 (CH3C), 78.0 (OCH2C), 
107.6 (ArC-quat), 111.5 (ArC-H), 118.7 (ArC-H), 120.1 (ArC-H), 122.8 (ArC-H), 126.1 (ArC-quat), 
133.0 (ArC-quat), 136.5 (ArC-quat), 186.2 (CS); m/z (ES
-
) 257 ([M-H]
-
, 100%); HRMS ES (+) Found 
281.0719 for C14H14N2OSNa
+
 [M+Na]
+
, requires 281.0719. 
 
7.4.2 Synthetic strategy to 3-methylene amide (4.96) 
 
7.4.2.1 Synthesis and characterisation of ethyl 3-(dimethoxyphosphoryl)-4-oxopentanoate (4.93) 
 
 
 
A solution of dimethyl (2-oxopropyl)phosphonate (4.85 mL, 25 mmol) in THF (5 mL) under N2, was 
added to a stirring solution of NaH (1 g, 25 mmol) in THF (50 mL) at 0 ºC.  The solution was 
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warmed to room temperature and stirred for 1 hour before the addition of ethyl bromoacetate (3.32 
mL, 25 mmol).  The solution was stirred at room temperature for 12 hours before the pouring into a 
5% aqueous HCl solution (100 mL) and extracting with CH3Cl (3 x 50 mL).  The combined organic 
layers were filtered through a phase separator funnel and the solvent evaporated in vacuo to afford 
the crude.  The crude was purified by vacuum distillation (120 ºC, 1 mbar) to afford the titled 
product (4.15 g, 66%) as a colourless oil. 
 
νmax(film)/cm
-1
 1720 (br s, C=O), 1247 (br s, P=O), 1032 (br s, P-O); 
1
H NMR: δH (400 MHz, CDCl3) 
1.21 (t, 3H, J = 7.2 Hz, CH2CH3), 2.39 (s, 3H, C(O)CH3), 2.62-2.71 (ddd, 1H, J = 17.8 Hz, J = 9.4 
Hz, J = 3.2 Hz, CHAHBCO2Et), 3.05-3.16 (m, 1H, CHAHBCO2Et), 3.63-3.72 (m, 1H, C(O)CH), 3.73 
(s, 3H, P(O)OCH3), 3.76 (s, 3H, P(O)OCH3), 4.09 (q, 1H, J = 7.2 Hz, CH2CH3); 
13
C NMR: δC (100 
MHz, CDCl3) 14.1 (CH2CH3), 31.2 (d, J = 2.7 Hz, C(O)CH2CH), 31.4 (C(O)CH3), 47.3 (P(O)OCH3), 
48.5 (P(O)OCH3), 53.5 (dd, J = 28.0 Hz, J = 6.7Hz, C(O)CH), 61.2 (CH2CH3), 171.3 (d, J = 19.4 Hz, 
CO), 202.2 (d, J = 4.4 Hz, CO); m/z (ES
+
) 253 ([M+H]
+
, 75%), 275 ([M+Na]
+
, 80%); HRMS ES (+) 
Found 275.0657 for C9H17O6PNa
+
 [M+Na]
+
, requires 275.0655. 
 
7.4.2.2 Synthesis and characterisation of ethyl 3-methylene-4-oxopentanoate (4.94) 
 
 
 
To a solution of NaH (307 mg, 7.7 mmol) in anhydrous DME (14 mL) under N2, was added a 
solution of phosphonate (4.93) (1.6 g, 7.7 mmol) in anhydrous DME (6 mL) under N2 at -20 ºC.  The 
solution was warmed to room temperature and stirred for 1 hour before the addition of 
paraformaldehyde (232 mg, 7.7 mmol).  The solution was stirred at room temperature for 12 hours 
and water (100 mL) was added.  The aqueous phase was extracted with diethyl ether (3 x 50 mL) 
and the combined organic phases were filtered through a phase separator funnel and the solvent 
evaporated in vacuo to afford the crude (1.2 g, 99%) as a colourless oil which did not require further 
purification.    
 
νmax(film)/cm
-1
 1736 (s, C=O), 1681 (s, C=O); 
1
H NMR: δH (400 MHz, CDCl3) 1.25 (t, 3H, J = 7.1 
Hz, CH2CH3), 2.38 (s, 3H, C(O)CH3), 3.29 (s, 2H, CCH2C(O)), 4.14 (q, 2H, J = 7.1 Hz, CH2CH3), 
5.95-5.97 (m, 1H, CHAHB=C), 6.17 (d, 1H, J = 3.5 Hz, CHAHB=C); 
13
C NMR: δC (100 MHz, CDCl3) 
14.1 (CH2CH3), 25.4 (C(O)CH3), 36.8 (CCH2C(O)), 60.8 (CH2CH3), 128.0 (CH2=C), 142.5 (CH2=C), 
171.0 (CO), 198.5 (CO); m/z (ES
+
) 179 ([M+Na]
+
, 25%), 335 ([2M+Na]
+
, 65%); HRMS ES (+) Found 
179.0679 for C8H12O3Na
+
 [M+Na]
+
, requires 179.0679. 
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7.4.2.3 Synthesis and characterisation of 4-acetyl-1-[2-(1H-indol-3-yl)ethyl]pyrrolidin-2-one (4.95) 
 
 
 
To a solution of tryptamine (120 mg, 0.75 mmol) in THF (3 mL) at 0 ºC under N2 was added AlMe3 
and alkene (4.94) (51 mg, 0.38 mmol) and the solution was refluxed for 3 hours before cooling and 
adding a saturated solution of NaHCO3 (10 mL).  The aqueous phase was extracted with diethyl 
ether (3 x 10 mL) and the combined organic phases were filtered through a phase separator funnel 
and the solvent evaporated in vacuo to afford the crude.  The crude was purified by flash silica gel 
chromatography (ethyl acetate : hexane, 1 : 1) to afford the titled compound as a colourless solid 
(77 mg, 77%). 
 
M.P. 101-103 ºC; νmax(film)/cm
-1
 3283 (br w, N-H), 1722 (s, C=O), 1666 (s, C=O); 
1
H NMR: δH (400 
MHz, CDCl3) 2.12 (s, 3H, C(O)CH3), 2.61 (d, 2H, J = 8.0 Hz, C(O)CH2CH), 3.02 (t, 2H, J = 7.2 Hz, 
NCH2CH2), 3.13-3.23 (m, 1H, C(O)CH), 3.35-3.42 (m, 1H, NCHAHBCH), 3.52 (dd, 1H, J = 9.7 Hz, J 
= 6.3 Hz, NCHAHBCH), 3.57-3.70 (m, 2H, NCH2CH2), 7.04 (d, 1H, J = 1.0 Hz, NHCH), 7.13 (t, 1H, J 
= 7.7 Hz, Ar-H), 7.20 (t, 1H, J = 7.7 Hz, Ar-H), 7.37 (d, 1H, J = 7.7 Hz, Ar-H), 7.61 (d, 1H, J = 7.7 
Hz, Ar-H), 8.27 (br s, 1H, N-H); 
13
C NMR: δC (100 MHz, CDCl3) 23.2 (C(O)CH2CH), 28.3 
(C(O)CH3), 33.3 (NCH2CH2), 43.1 (NCH2CH2), 43.5 (C(O)CH), 48.1 (NCH2CH), 111.3 (ArC-H), 
112.6 (ArC-quat), 118.5 (ArC-H), 119.4 (ArC-H), 122.0 & 122.1 (ArC-H, NHCH), 127.3 (ArC-quat), 
136.3 (ArC-quat), 172.1 (CO), 206.0 (CO); m/z (ES
+
) 293 ([M+Na]
+
, 30%), 563 ([2M+Na]
+
, 100%); 
HRMS ES (+) Found 293.1254 for C16H18N2O2Na
+
 [M+Na]
+
, requires 293.1260. 
 
7.4.3 Synthesis of iodo compounds (4.99a) and (4.99b) 
 
7.4.3.1 Synthesis and characterisation of 2-chloro-N-[2-(1H-indol-3-yl)ethyl]acetamide (4.97a)
82
 
 
 
 
To a solution of tryptamine (10 g, 62.4 mmol) in dry THF (100 mL) was added a solution of 
chloroacetyl chloride (5.9 mL, 74.9 mmol) in dry THF (100 mL) followed by the addition of a 
solution of NEt3 (20.7 mL, 150 mmol) in dry THF (150 mL) at room temperature.  The solution was 
stirred at room temperature for 32 hours before filtering through a sintered funnel. The solvent was 
evaporated in vacuo and the residue was redissolved in CH2Cl2 (100 mL), then successively 
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washed with 0.5 M aqueous HCl (100 mL), saturated aqueous Na2CO3 (100 mL) and water (100 
mL), and dried over Na2SO4. The solvent was removed in vacuo to afford the crude (13.8 g, 94%), 
which did not require further purification. 
M.P. 69-74 ºC; 
1
H NMR: δH (400 MHz, CDCl3) 3.05 (t, 2H, J = 6.8 Hz, NHCH2CH2), 3.67 (app. dd, 
2H, J = 12.8 Hz, J = 2.6 Hz, NHCH2CH2), 4.04 (s, 2H, C(O)CH2Cl) , 6.68 (br s, 1H, N-H), 7.08 (d, 
1H, J = 2.0 Hz, NHCH), 7.17(t, 1H, J = 7.6 Hz, Ar-H), 7.25 (t, 1H, J = 7.5 Hz, Ar-H), 7.41 (d, 1H, J = 
8.1 Hz, Ar-H), 7.64 (d, 1H, J = 7.9 Hz, Ar-H), 8.13 (br s, 1H, N-H); m/z (ES
+
) 237  ([M+H]
+
, 90%). 
7.4.3.2 Synthesis and characterisation of N-[2-(1H-indol-3-yl)ethyl]-2-iodoacetamide (4.99a) 
 
 
 
Chloride (4.97a) (13.8 g, 58.3 mmol) was dissolved in acetone (250 mL) and NaI (9.35 g, 62.4 
mmol) was added in one portion. The suspension was refluxed for 2 hours before cooling to room 
temperature and filtering. The solution was concentrated in vacuo to afford the crude title product 
which was further purified by flash silica gel chromatography (petroleum ether : ethyl acetate, 1 : 1), 
to yield a pale yellow solid (16.8 g, 82%). 
M.P. 78-82 
o
C; νmax(film)/cm
-1
 3292 (br w, O-H, N-H), 1647 (C=O); 
1
H NMR: δH (400 MHz, D6-
DMSO) 2.81 (t, 2H, J = 7.5 Hz, NCH2CH2C), 3.29-3.40 (m, 2H, NCH2CH2C), 3.64 (s, 2H, 
ICH2C(O)N), 6.95-7.01 (m, 1H, Ar-H), 7.02-7.09 (m, 1H, Ar-H), 7.15 (d, 1H, J = 2.0 Hz, NHCH), 
7.33 (d, 1H, J = 8.0 Hz, Ar-H), 7.53 (d, 1H, J = 8.0 Hz, Ar-H), 8.37 (t, 1H, J = 5.5 Hz, NHCH2), 
10.84 (br s, 1H, N-H); 
13
C NMR: δC (100 MHz, D6-DMSO) 2.0 (ICH2C(O)N), 25.6 (NCH2CH2C), 
40.8 (NCH2CH2C), 112.2 (ArC-quat), 112.3 (ArC-H), 119.1 (2 x ArC-H), 121.8 (ArC-H), 123.6 
(NHCH), 128.0 (ArC-quat), 137.1 (ArC-quat), 168.3 (CO); m/z (ES
+
) 387 ([M+MeCN+NH4]
+
, 100%); 
HRMS ES (+) Found 350.9965 for C12H13N2OINa
+
 [M+Na]
+
 requires 350.9965. 
 
7.4.3.2 Synthesis and characterisation of 2-iodo-N-[2-(7-methyl-1H-indol-3-yl)ethyl]acetamide 
(4.99b) 
 
 
To a solution of 7-methyl tryptamine (939 mg, 5.39 mmol) in dry THF (20 mL) was added a solution 
of chloroacetyl chloride (515 μL, 6.47 mmol) in dry THF (20 mL) followed by the addition of a 
solution of NEt3 (1.80 mL, 12.94 mmol) in dry THF (30 mL) at room temperature.  The solution was 
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stirred at room temperature for 32 hours before filtering through a sintered funnel. The solvent was 
evaporated in vacuo and the residue was redissolved in CH2Cl2 (20 mL), then successively washed 
with 0.5 M aqueous HCl (20 mL), saturated aqueous Na2CO3 (20 mL) and water (20 mL), and dried 
over Na2SO4. The solvent was removed in vacuo to afford crude 2-chloro-N-[2-(1H-indol-3-
yl)ethyl]acetamide (1.35 g), which did not require further purification. 
The crude was dissolved in acetone (20 mL) and NaI (807 mg, 5.39 mmol) was added in one 
portion. The suspension was refluxed for 2 hours before cooling to room temperature and filtering. 
The solution was concentrated in vacuo to afford the crude title product which was further purified 
by flash silica gel chromatography (petroleum ether : ethyl acetate, 1 : 1), to yield a pale yellow 
solid (1.51 g, 82%).   
M.P. 110-112 
o
C; νmax(film)/cm
-1
 3407 (m br, N-H), 3291 (m br, N-H), 1651 (s, C=O); 
1
H NMR: δH 
(400 MHz, CDCl3) 2.51 (s, 3H, CH3C), 3.00 (t, 2H, J = 6.5 Hz, NCH2CH2C), 3.58-3.65 (m, 4H, 
NCH2CH2C, ICH2C(O)N), 6.14 (br s, 1H, N-H), 7.02-7.12 (m, 3H, NHCH, 2 x Ar-H), 7.48 (d, 1H, J = 
7.5 Hz, Ar-H), 8.09 (br s, 1H, N-H); 
13
C NMR: δC (100 MHz, CDCl3) -0.2 (ICH2C(O)N), 16.7 (CH3C), 
25.1 (NCH2CH2C), 40.6 (NCH2CH2C), 113.0 (ArC-quat), 116.4 (ArC-H), 119.8 (ArC-H), 120.6 (ArC-
quat), 122.1 (NHCH), 122.8 (ArC-H), 126.7 (ArC-quat), 136.1 (ArC-quat), 166.8 (CO); m/z (ES
+
) 
401 ([M+MeCN+NH4]
+
, 100%); HRMS (ES+) Found 365.0116 for C13H15IN2ONa
+
 [M+Na]
+
, requires 
365.0121. 
7.4.4 Synthesis of hydroxylactams (4.100)-(4.112) 
 
Entry 
Compound 
no. 
R1 R2 EWG Yield 
1 (4.100) H Me P(O)(OMe)2 60% 
2 (4.106) H Me P(O)(OEt)2 40% 
3 (4.107) H Me CO2Me 56% 
4 (4.108) H Me CO2Et 38% 
5 (4.109) H Et CO2Me 43% 
6 (4.110) H n-pentyl P(O)(OMe)2 34% 
7 (4.111) H Me SO2Me 62% 
8 (4.112) 7-Me Me SO2Ph 89% 
 
General procedure for the preparation of hydroxylactams (4.100)-(4.112) 
Method A: 
To a stirred solution of nucleophile (2 equivalents) in THF (10 mL per mmol of nucleophile) under 
N2, at 0 °C, was added a solution of KHMDS 0.5 M in toluene (1.2 equivalents), and the solution 
was warmed to room temperature and stirred for 1 hour.  The solution was cooled to 0 °C and a 
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solution of tryptamine derivative (1 equivalent) in THF (2.5 mL per mmol of electrophile) was 
added.  The solution was allowed to warm up to room temperature and stirred until the reaction had 
reached completion before quenching with water (10 mL per mmol of electrophile) and extracting 
with CH2Cl2 (3 x 15 mL per mmol of electrophile).  The combined organic layers were dried over 
Na2SO4 and the solvent was removed in vacuo. The solid residue was either triturated with ethyl 
acetate or purified by column chromatography on silica gel (petroleum ether/ethyl acetate) before 
triturating with ethyl acetate to afford the hydroxylactam. 
 
Method B: 
To a solution of NaH (1 equivalent) in THF (13 mL per mmol) under N2 at 0 °C was added a 
solution of nucleophile (1 equivalent) in THF (2 mL per mmol), and the solution was stirred at room 
temperature for 1 hour. Solid tryptamine derivative (1 equivalent) was added to the solution, and 
the mixture was stirred at room temperature until the reaction had reached completion. The 
reaction was quenched by addition of water (30 mL per mmol) and extracted with CH2Cl2 (3 x 30 
mL per mmol). The combined organic layers were dried over Na2SO4 and the solvent was 
evaporated in vacuo. The crude residue was further purified by chromatography on silica gel 
eluting with petroleum ether/ethyl acetate. 
Method C: 
Same procedure as method A using a solution of LHMDS (1M in toluene) instead of KHMDS. 
A column chromatography on silica gel was performed as purification method, eluting with 
petroleum ether/ethyl acetate. 
 
7.4.4.1 Synthesis and characterisation of (±)-dimethyl {2-hydroxy-1-[2-(1H-indol-3-yl)ethyl]-2-
methyl-5-oxopyrrolidin-3-yl}phosphonate (4.100) 
 
 
 
Following general procedure A (1.0 mmol scale of tryptamine derivative) the titled compound was 
obtained after 72 hours at room temperature as a colourless solid following trituration with ethyl 
acetate (208 mg, 60%). 
 
M.P. 141-144 
o
C; νmax(film)/cm
-1
  3268 (br w, N-H, O-H), 1681 (s, C=O), 1266 (s, P=O), 1100 (s, 
P-O); 
1
H NMR: δH (400 MHz, D6-DMSO) 0.74 (s, 3H, CH3C), 1.48-1.59 (m, 1H, C(O)CHAHBCH), 
1.66-1.79 (m, 1H, C(O)CHAHBCH), 1.87-2.02 (m, 2H, NCH2CHAHBC, C(O)CH2CH), 2.03-2.14 (m, 
1H, NCH2CHAHBC), 2.38-2.48 (m, 1H, NCHAHBCH2C), 2.50-2.58 (m, 1H, NCHAHBCH2C), 3.63 (d, 
3H, J = 5.6 Hz, OCH3), 3.66 (d, 3H, J = 5.6 Hz, OCH3), 6.22 (s, 1H, O-H), 7.00 (t, 1H, J = 7.7 Hz, 
Ar-H), 7.05-7.10 (m, 1H, Ar-H), 7.19 (d, 1H, J = 2.2 Hz, NHCH), 7.34 (d, 1H, J = 7.7 Hz, Ar-H), 7.58 
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(d, 1H, J = 7.7 Hz, Ar-H), 10.84 (br s, 1H, N-H); 
13
C NMR: δC (100 MHz, D6-DMSO) 25.0 
(C(O)CH2CH), 26.1 (CH3C), 30.6 (d, J = 4 Hz, NCH2CH2C), 40.1 (NCH2CH2C), 41.2 (d, J = 152 Hz, 
C(O)CH2CH), 51.7 (d, J = 6 Hz, OCH3), 52.7 (d, J = 6 Hz, OCH3), 88.9 (CH3C), 111.5 (NHCH), 
111.7 (ArC-quat), 118.3 (ArC-H), 118.3 (ArC-H), 121.0 (ArC-H), 122.8 (ArC-H), 127.1 (ArC-
quat),136.2 (ArC-quat), 166.8 (CO); m/z (ES
+
) 425 ([M+MeCN+NH4]
+
, 100%); HRMS ES (+) Found 
389.1221 for C17H23N2O5PNa
+
 [M+Na]
+
, requires 389.1237. 
 
 
7.4.4.2 Synthesis and characterisation of (±)-diethyl {2-hydroxy-1-[2-(1H-indol-3-yl)ethyl]-2-methyl-
5-oxopyrrolidin-3-yl}phosphonate (4.106) 
 
 
 
Following general procedure B (3.0 mmol scale of tryptamine derivative) the titled compound was 
obtained as a mixture of diastereomers (9.5 : 1) after 24 hours at room temperature as a colourless 
solid following trituration with ethyl acetate (481 mg, 40%). 
 
M.P. 138-142 ºC; νmax(film)/cm
-1
 3283 (br w, N-H, O-H), 1679 (s, C=O), 1225 (s, P=O), 1056 (s, P-
O), 1023 (s, P-O); 
1
H NMR: δH (400 MHz, D6-DMSO) 1.16-1.27 (m, 6H, 2 x CH2CH3, minor 
diastereomer underneath), 1.59 (s, 3H, CH3C), 2.33-2.42 (m, 1H, C(O)CHAHBCH), 2.52-2.77 (m, 
2H, C(O)CHAHBCH, C(O)CH2CH), 2.78-2.99 (m, 2H, CH2), 3.23-3.43 (m, 2H, CH2, minor 
diastereomer at 3.67 ppm), 3.95-4.11 (m, 4H, 2 x CH2CH3, minor diastereomers at 3.76-3.87 ppm), 
6.12 (s, 1H, O-H), 7.00 (t, 1H, J = 7.4 Hz, Ar-H), 7.07 (t, 1H, J = 7.5 Hz, Ar-H), 7.15-7.20 (m, 1H, 
NHCH, minor diastereomer underneath), 7.34 (d, 1H, J = 8.0 Hz, Ar-H), 7.58 (d, 1H, J = 7.8 Hz, Ar-
H, minor diastereomer at 7.49 ppm), 10.84 (br s, 1H, N-H, minor diastereomer at 10.89 ppm); 
13
C 
NMR: δC (100 MHz, D6-DMSO) 17.2 (app. t, J = 5.3 Hz, 2 x CH2CH3), 25.9 (NCH2CH2), 27.1 
(CH3C), 31.5 (d, 1H, J = 3.3 Hz, C(O)CH2CH), 40.5 (NCH2CH2), 42.5 (d, J = 153.2 Hz, 
C(O)CH2CH), 61.7 (d, J = 6.3 Hz, CH2CH3), 62.4 (d, J = 6.1 Hz, CH2CH3), 89.9 (CH3C), 112.3 
(ArC-H), 112.6 (ArC-quat), 119.1 (ArC-H), 119.2 (ArC-H), 121.8 (ArC-H), 123.6 (NHCH), 128.0 
(ArC-quat), 137.1 (ArC-quat), 173.1 (d, J = 15.9 Hz, CO); m/z (ES
+
) 417 ([M+Na]
+
, 35%), 811 
([2M+Na]
+
, 100%); HRMS ES (+) Found 417.1548 for C19H27N2O5PNa
+
 [M+Na]
+
, requires 
417.1550. 
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7.4.4.3 Synthesis and characterisation of (±)-methyl 2-hydroxy-1-[2-(1H-indol-3-yl)ethyl]-2-methyl-
5-oxopyrrolidine-3-carboxylate (4.107) 
 
 
 
Following general procedure A (1.0 mmol scale of tryptamine derivative) the titled compound was 
obtained as a mixture of diastereomers (3 : 1) after 72 hours at room temperature as a colourless 
solid following trituration with ethyl acetate (178 mg, 56%). 
 
M.P. 111-114 
o
C; νmax(film)/cm
-1
 3401 (br w, N-H, O-H), 1735 (s, C=O), 1676 (s, C=O); 
1
H NMR: 
δH (400 MHz, D6-DMSO) 1.60 (s, 3H, CH3C), 2.35 (dd, 1H, J = 16.5 Hz, J = 9.0 Hz, 
C(O)CHAHBCH), 2.74-2.98 (m, 3H, C(O)CHAHBCH, NCH2CH2C), 3.13-3.43 (m, 3H, NCH2CH2C, 
C(O)CH2CH minor diastereomer for C(O)CH2CH at 3.66-3.70 ppm), 3.66 (s, 3H, OCH3, minor 
diastereomer at 3.68 ppm), 6.06 (s, 1H, O-H, minor diastereomer at 6.37 ppm), 6.99 (t, 1H, J = 7.4 
Hz, Ar-H), 7.07 (t, 1H, J = 7.0 Hz, Ar-H), 7.18 (d, 1H, J = 2.0 Hz, NHCH, minor diastereomer at 
7.17 ppm), 7.34 (d, 1H, J = 8.1 Hz, Ar-H), 7.57 (d, 1H, J = 7.6 Hz, Ar-H, minor diastereomer 
underneath), 10.84 (br s, 1H, N-H); 
13
C NMR: δC (100 MHz, D6-DMSO) 25.9 (NCH2CH2C), 26.9 
(CH3C), 31.9 (C(O)CH2CH), 40.6 (NCH2CH2C), 49.9 (C(O)CH2CH), 52.6 (OCH3), 89.8 (CH3C), 
112.3 (ArC-H), 112.5 (ArC-quat), 119.1 (ArC-H), 119.2 (ArC-H), 121.8 (ArC-H), 123.6 (NHCH), 
128.0 (ArC-quat), 137.1 (ArC-quat), 171.0 (CO), 173.2 (CO); m/z (ES
+
)  375 ([M+MeCN+NH4]
+
, 
100%); HRMS ES (+) Found 399.1309 for C17H20N2O4Na
+
 [M+Na]
+
, requires 339.1315. 
 
7.4.4.4 Synthesis and characterisation of (±)-ethyl 2-hydroxy-1-[2-(1H-indol-3-yl)ethyl]-2-methyl-5-
oxopyrrolidine-3-carboxylate (4.108) 
 
 
 
Following general procedure B (4.0 mmol scale of tryptamine derivative) the titled compound was 
obtained as a mixture of diastereomers (7 : 1) after 24 hours at room temperature as a colourless 
solid following flash silica gel chromatography (ethyl acetate : hexane, 1 : 1) (501 mg, 38%). 
 
M.P. 145-149 ºC; νmax(film)/cm
-1
 3339 (br w, N-H, O-H), 1731 (m, C=O), 1676 (s, C=O); 
1
H NMR: 
δH (400 MHz, CDCl3) 1.22 (t, 1H, J = 7.1 Hz, CH2CH3), 1.60 (s, 3H, CH3C), 2.34 (dd, 1H, J = 16.7 
Hz, J = 9.1 Hz, C(O)CHAHBCH), 2.75-2.99 (m, 3H, C(O)CHAHBCH, CH2), 3.19 (app. t, 1H, J = 9.1 
Hz, C(O)CH2CH), 3.25-3.44 (m, 2H, CH2), 4.07-4.17 (m, 2H, CH2CH3), 6.04 (br s, 1H, O-H), 7.00 (t, 
1H, J = 7.4 Hz, Ar-H), 7.07 (t, 1H, J = 7.5 Hz, Ar-H), 7.18 (d, 1H, J = 1.7 Hz, NHCH), 7.34 (d, 1H, J 
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= 8.1 Hz, Ar-H), 7.58 (d, 1H, J = 7.7 Hz, Ar-H), 10.83 (br s, 1H, N-H); 
13
C NMR: δC (100 MHz, 
CDCl3) 15.0 (CH3CH2), 25.9 (CH2), 26.8 (CH3C), 31.8 (C(O)CH2CH), 40.5 (CH2), 49.9 
(C(O)CH2CH), 61.1 (OCH2CH3), 89.8 (CH3C), 112.3 (ArC-H), 112.5 (ArC-quat), 119.1 (ArC-H), 
119.2 (ArC-H), 121.8 (ArC-H), 123.6 (NHCH), 128.0 (ArC-quat), 137.1 (ArC-quat), 170.5 (CO), 
173.3 (CO); m/z (ES
+
) 353 ([M+Na]
+
, 30%), 683 ([2M+Na]
+
, 100%); HRMS ES (+) Found 353.1465 
for C18H22N2O4Na
+
 [M+Na]
+
, requires 353.1472. 
 
7.4.4.5 Synthesis and characterisation of (±)-methyl 2-ethyl-2-hydroxy-1-[2-(1H-indol-3-yl)ethyl]-5-
oxopyrrolidine-3-carboxylate (4.109) 
 
Following general procedure B (3.0 mmol scale of tryptamine derivative) the titled compound was 
obtained as a mixture of diastereomers (1 : 2) after 48 hours at room temperature as a colourless 
solid following flash silica gel chromatography (ethyl acetate : petroleum ether, 1:1) (429 mg, 43%). 
 
M.P. 60-65 ºC; νmax(film)/cm
-1
 3366 (br w, N-H, O-H), 1733 (s, C=O), 1673 (s, C=O); 
1
H NMR: δH 
(400 MHz, D6-DMSO) 0.85 (t, 3H, J = 7.2 Hz, CH2CH3, minor diastereomer at 0.77 ppm), 1.85-1.96 
(m, 1H, CHAHBCH3, minor diastereomer at 1.63-1.84 ppm), 1.99-2.09 (m, 1H, CHAHBCH3, minor 
diastereomer at 1.63-1.84 ppm), 2.38 (dd, 1H, J = 16.8 Hz, J = 9.3 Hz, C(O)CHAHBCH), 2.75-3.02 
(m, 3H, C(O)CHAHBCH, CH2), 3.13-3.49 (m, 3H, C(O)CH2CH, CH2, minor diastereomer for CH2 at 
2.52-2.65 ppm), 3.66 (s, 3H, CH3O, minor diastereomer at 3.69 ppm), 6.12 (s, 1H, O-H, minor 
diastereomer at 6.32 ppm), 7.00 (t, 1H, J = 7.4 Hz, Ar-H), 7.07 (t, 1H, J = 7.5 Hz, Ar-H), 7.19 (s, 1H, 
NHCH), 7.34 (d, 1H, J = 8.0 Hz, Ar-H), 7.61 (d, 1H, J = 7.8 Hz, Ar-H, minor diastereomer at 7.54 
ppm), 10.83 (br s, 1H, N-H, minor diastereomer at 10.88 ppm); 
13
C NMR: δC (100 MHz, D6-DMSO) 
9.3 (CH2CH3), 25.2 (CH2, minor diastereomer at 25.8 ppm),  29.6 (CH2, minor diastereomer at 30.5 
ppm), 32.2 (CH2, minor diastereomer at 33.7 ppm), 40.7 (CH2), 45.4 (C(O)CH2CH), 52.6 (CH3O, 
minor diastereomer at 52.8 ppm), 93.1 (CH2C), 112.3 (ArC-H), 112.5 (ArC-quat, minor diastereomer 
at 112.6 ppm), 119.2 (ArC-H), 121.8 (ArC-H), 123.5 (2C, NHCH, ArC-H), 127.9 (ArC-quat), 137.1 
(ArC-quat), 171.4 & 173.7 (2 x CO, minor diastereomers at 172.0 and 172.6 ppm); m/z (ES
+
) 353 
([M+Na]
+
, 30%), 683 ([2M+Na]
+
, 100%); HRMS ES (+) Found 353.1475 for C18H22N2O4Na
+
 
[M+Na]
+
, requires 353.1472. 
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7.4.4.6 Synthesis and characterisation of (±)-dimethyl (1-{[2-(1H-indol-3-yl)ethyl]amino}-1,4-
dioxononan-3-yl)phosphonate (4.110) 
 
 
Following general procedure A (1.0 mmol scale of tryptamine derivative) the titled compound was 
obtained after 72 hours at room temperature as a clear oil following flash silica gel chromatography 
(ethyl acetate : petroleum ether, 1 : 1) (142 mg, 34%). 
 
νmax(film)/cm
-1
 3282 (br w, N-H), 1735 (s, C=O), 1679 (s, C=O), 1237 (s, P-O, P=O); 
1
H NMR: δH 
(400 MHz, CDCl3) 0.87 (t, 3H, J = 7.0 Hz, CH3CH2), 1.27 (m, 4H, CH3CH2, CH3CH2CH2), 1.58 (app. 
p, 2H, J = 7.5 Hz, CH3CH2CH2CH2), 2.51 (ddd, 1H, J = 16.0 Hz, J = 10.0 Hz, J = 3.0 Hz, 
NHC(O)CHAHBCH), 2.66 (m, 1H, C(O)CHAHBCH2), 2.88 (m, 4H, NHC(O)CHAHBCH, 
C(O)CHAHBCH2, NHCH2CH2C), 3.51 (m, 2H, NHCH2CH2C), 3.71 (s, 3H, OCH3), 3.74 (s, 3H, 
OCH3), 3.82 (ddd, 1H, J = 24.0 Hz, J = 11.0 Hz, J = 3.0 Hz, NHC(O)CH2CH), 5.91 (br s, 1H, 
NHCH2CH2C), 6.99 (s, 1H, NHCH), 7.11 (t, 1H, J = 7.5 Hz, Ar-H), 7.19 (t, 1H, J = 7.5 Hz, Ar-H), 
7.36 (d, 1H, J = 8.0 Hz, Ar-H), 7.57 (d, 1H, J = 7.5 Hz, Ar-H), 8.52 (br s, 1H, N-H); 
13
C NMR: δC 
(100 MHz, CDCl3) 13.9 (CH3CH2), 22.4 (CH2), 23.0 (CH3CH2CH2CH2), 25.1 (NHCH2CH2), 31.0 
(CH2), 32.7 (NHC(O)CH2CH), 39.9 (NHCH2CH2), 44.1 (C(O)CH2CH2), 47.2 (d, J = 137 Hz, 
C(O)CH2CH), 53.2 (d, J = 7 Hz, OCH3), 53.3 (d, J = 7 Hz, OCH3), 111.3 (ArC-H), 112.5 (ArC-quat), 
118.6 (ArC-H), 119.3 (ArC-H), 122.0 (ArC-H), 122.3 (NHCH), 127.2 (ArC-quat), 136.4 (ArC-quat), 
169.7 (d, J = 17 Hz, CO), 205.2 (d, J = 4 Hz, CO); m/z (ES
+
) 481 ([M+MeCN+NH4]
+
, 100%); HRMS 
ES (+) Found 445.1861 for C21H31N2O5PNa
+
 [M+Na]
+
, requires 445.1863. 
 
7.4.4.7 Synthesis and characterisation of (±)-5-hydroxy-1-[2-(1H-indol-3-yl)ethyl]-5-methyl-4-
(methylsulfonyl)pyrrolidin-2-one (4.111) 
 
 
 
Following general procedure B (3.0 mmol scale of tryptamine derivative) the titled compound was 
obtained after 24 hours at room temperature as a pale yellow solid following trituration with ethyl 
acetate (622 mg, 62%). 
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M.P. 152-155 ºC; νmax(film)/cm
-1
 3398 (br w, N-H, O-H), 1667 (s, C=O), 1312 (s, S=O), 1277 (s, 
S=O), 1143 (s, S-O), 1130 (s, S-O); 
1
H NMR: δH (400 MHz, D6-DMSO) 1.65 (s, 3H, CCH3) 2.64 (dd, 
1H, J = 16.6 Hz, J = 9.3 Hz, C(O)CHAHBCH), 2.79-2.30 (m, 3H, C(O)CHAHBCH, NCH2CH2), 3.06 (s, 
3H, SO2CH3), 3.26-3.44 (m, 2H, NCH2CH2), 3.94 (app. t, 1H, J = 9.3 Hz, C(O)CH2CH), 6.57 (s, 1H, 
O-H), 7.00 (t, 1H, J = 7.4 Hz, Ar-H), 7.08 (t, 1H, J = 7.5 Hz, Ar-H), 7.20 (s, 1H, NHCH), 7.35 (d, 1H, 
J = 8.0 Hz, Ar-H), 7.58 (d, 1H, J = 7.8 Hz, Ar-H), 10.85 (br s, 1H, N-H); 
13
C NMR: δC (100 MHz, D6-
DMSO) 25.8 (NCH2CH2), 26.7 (CH3C), 31.5 (C(O)CH2CH), 40.4 (NCH2CH2), 40.9 (SO2CH3), 65.2 
(C(O)CH2CH), 89.0 (CH3C), 112.3 (ArC-H), 112.4 (ArC-quat), 119.1 (ArC-H), 119.2 (ArC-H), 121.9 
(ArC-H), 123.7 (NHCH), 127.9 (ArC-quat),137.1 (ArC-quat), 171.1 (CO); m/z (ES
+
) 359 ([M+Na]
+
, 
40%), 695 ([2M+Na]
+
, 90%); HRMS ES (+) Found 359.1033 for C16H20N2O4SNa
+
 [M+Na]
+
, requires 
359.1036. 
 
 
7.4.4.7 Synthesis and characterisation of (±)-5-hydroxy-5-methyl-1-[2-(7-methyl-1H-indol-3-yl)ethyl]-
4-(phenylsulfonyl)pyrrolidin-2-one (4.112) 
 
 
 
Following general procedure B (1.5 mmol scale of tryptamine derivative) the titled compound was 
obtained as a mixture of diastereomers (3 : 1) after 24 hours at room temperature as a white 
crystalline solid following flash silica gel chromatography (ethyl acetate : petroleum ether, 1 : 1) 
(552 mg, 89%). 
 
M.P. 88-90 
o
C; νmax(film)/cm
-1
 3376 (br w, O-H, N-H), 1652 (C=O); 
1
H NMR: δH (400 MHz, D6-
DMSO) 1.50 (s, 3H, CH3, minor diastereomer at 1.68 ppm), 2.43 (s, 3H, CH3), 2.56 (dd, 1H, J = 8.0 
Hz, J = 2.5 Hz, C(O)CHAHBCH), 2.71-2.97 (m, 3H, C(O)CHAHBCH, NCH2CH2C), 3.18-3.44 (m, 2H, 
NCH2CH2C), 4.21 (t, 1H, J = 9.0 Hz, C(O)CH2CH minor diastereomer at 4.12 ppm), 6.37 (s, 1H, O-
H, minor distereomer at 6.64 ppm), 6.83-6.95 (m, 2H, 2 x Ar-H), 7.13-7.20 (m, 1H, NHCH), 7.33-
7.45 (m, 1H, Ar-H), 7.62-7.74 (m, 2H, Ar-H), 7.74-7.84 (m, 1H, Ar-H), 7.88-8.00 (m, 2H, 2 x Ar-H), 
10.80 (br s, 1H, N-H); 
13
C NMR: δC (100 MHz, D6-DMSO) 17.7 (CH3), 25.9 (NCH2CH2C), 26.7 
(CH3, diastereomer at 23.5 ppm), 31.6 (C(O)CH2CH), 40.2 (NCH2CH2C), 65.9 (C(O)CH2CH, 
diastereomer at 67.7 ppm), 89.4 (CH3C, diastereomer at 90.1 ppm), 112.8 (ArC-quat), 116.7 (ArC-
H), 119.4 (ArC-H), 121.4 (ArC-quat), 122.4 (ArC-H), 123.4 (NHCH), 127.6 (ArC-quat), 129.0 (ArC-
H), 129.8 (ArC-H), 130.0 (ArC-H), 130.5 (ArC-H), 134.8 (ArC-H), 136.6 (ArC-quat), 140.1 (ArC-
quat), 170.7 (CO); m/z (ES
+
) 471 ([M+MeCN+NH4]
+
, 100%); HRMS ES (+) Found 435.1345 for 
C22H24N2O4SNa
+
 [M+Na]
+
, requires 435.1349. 
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7.4.5 Enantioselective and diastereoselective Pictet-Spengler reaction of aminols (4.101)-(4.121) 
 
 
 
General procedure for the preparation of cyclised β-carbolines 
 
To a solution of catalyst (4.23) or (4.57) (0.1 equivalents) in toluene (63 mL), at reflux, was added 
the solid hydroxylactam (4.113) (1 equivalent) and the solution was stirred under reflux for 24-72 
hours.  The mixture was allowed to cool to room temperature and the solvent was removed in 
vacuo.  The residue was purified by chromatography on silica gel eluting with petroleum ether/ethyl 
acetate. 
 
Note: All racemates were prepared using para-toluenesulfonic acid (catalytic amount) in refluxing 
toluene. Only one single diastereomer was obtained in all cyclization reactions. 
 
7.4.5.1  Synthesis and characterisation of  dimethyl ((1R,11bS)-11b-methyl-3-oxo-2,3,5,6,11,11b-
hexahydro-1H-indolizino[8,7-b]indol-1-yl)phosphonate (4.101) 
 
 
 
Following the general procedure (0.3 mmol scale) the titled compound was obtained after 48 hours 
at reflux in the presence of (4.57) as a colourless solid following flash silica gel chromatography 
(increasing polarity from ethyl acetate : petroleum ether, 1 : 1 to ethyl acetate) (85 mg, 85%).  The 
ee was determined by HPLC using a Chiralpak OJ column (60:40 hexane/isopropanol) flow rate 1 
ml/min, 220 nm, major tR = 6.9 min, minor tR = 14.5 min (85% ee). 
 
M.P. 174-177 
o
C; [α]D
21 
= + 31.9 (c = 0.92 in CHCl3); νmax(film)/cm
-1
 3300 (br w, N-H), 1696 (s, 
C=O), 1220 (s, P=O), 1033 (s, P-O); 
1
H NMR: δH (400 MHz, D6-DMSO) 1.63 (s, 3H, CH3C), 2.47-
2.82 (m, 4H, NCH2CH2C, C(O)CH2CH), 3.02 (ddd, 1H, J = 16.8 Hz, J = 12.2 Hz, J = 8.4 Hz, 
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C(O)CH2CH), 3.11 (td, 1H, J = 12.5 Hz, J = 4.7 Hz, NCHAHBCH2C), 3.73 (d, 3H, J = 10.9 Hz, 
OCH3), 3.83 (d, 3H, J = 10.7 Hz, OCH3), 4.23 (app. dd, 1H, J = 13.2 Hz, J = 6.2 Hz, 
NCHAHBCH2C), 7.01 (t, 1H, J = 7.4 Hz, Ar-H), 7.10 (m, 1H, J = 7.5 Hz, Ar-H), 7.43 (d, 1H, J = 7.9 
Hz, Ar-H), 7.45 (d, 1H, J = 8.1 Hz, Ar-H), 10.16 (br s, 1H, N-H); 
13
C NMR: δC (100 MHz, D6-DMSO) 
20.2 (NCH2CH2C), 21.1 (CH3C), 31.1 (C(O)CH2CH), 33.4 (NCH2CH2C), 39.7 (d, J = 34 Hz, 
C(O)CH2CH), 52.3 (d, J = 7 Hz, OCH3), 52.4 (d, J = 7 Hz, OCH3), 58.7 (CH3C), 104.8 (ArC-quat), 
111.2 (ArC-H), 117.6 (ArC-H), 118.4 (ArC-H), 121.0 (ArC-H), 125.5 (ArC-quat), 134.9 (ArC-quat), 
136.6 (ArC-quat), 166.2 (d, J = 18 Hz, CO); m/z (ES
+
) 407 ([M+MeCN+NH4]
+
, 100%); HRMS ES 
(+) Found 371.1131 for C17H21N2O4PNa
+
 [M+Na]
+
, requires 371.1131. 
 
7.4.5.2  Synthesis and characterisation of diethyl ((1R,11bS)-11b-methyl-3-oxo-2,3,5,6,11,11b-
hexahydro-1H-indolizino[8,7-b]indol-1-yl)phosphonate (4.115) 
 
 
 
Following the general procedure (0.3 mmol scale) the titled compound was obtained after 24 hours 
at reflux in the presence of (4.57) as a clear oil following flash silica gel chromatography (ethyl 
acetate : petroleum ether, 1 : 1) (106 mg, 94%).  The ee was determined by HPLC using a 
Chiralpak AD column (90:10 hexane/isopropanol) flow rate 1 ml/min, 220 nm, major tR = 9.1 min, 
minor tR = 12.2 min (69% ee). 
 
[α]D
25 
= + 45.6 (c = 0.91 in CHCl3); νmax(film)/cm
-1
 3314 (br w, N-H), 1695 (s, C=O), 1217 (m, 
P=O), 1051 (s, P-O), 1023 (P-O); 
1
H NMR: δH (400 MHz, CDCl3) 1.34 (t, 3H, J = 7.1 Hz, CH2CH3), 
1.44 (t, 3H, J = 7.1 Hz, CH2CH3), 1.72 (s, 3H, CH3C), 2.58-2.77 (m, 2H, C(O)CHAHBCH, 
C(O)CH2CH), 2.79-2.94 (m, 3H, C(O)CHAHBCH, NCH2CH2), 3.06-3.16 (m, 1H, NCHAHBCH2), 4.04-
4.21 (m, 2H, P(O)CH2CH3), 4.22-4.37 (m, 2H, P(O)CH2CH3), 4.43-4.50 (m, 1H, NCHAHBCH2), 7.10 
(t, 1H, J = 7.4 Hz, Ar-H), 7.18 (t, 1H, J = 7.6 Hz, Ar-H), 7.40 (d, 1H, J = 8.1 Hz, Ar-H), 7.48 (d, 1H, J 
= 7.8 Hz, Ar-H), 10.00 (br s, 1H, N-H); 
13
C NMR: δC (100 MHz, CDCl3) 16.4 (d, J = 2.1 Hz, 
P(O)CH2CH3), 16.5 (d, J = 1.8 Hz, P(O)CH2CH3), 21.2 (NCH2CH2), 21.8 (d, J = 1.7 Hz, CH3C), 32.6 
(d, J = 4.6 Hz, C(O)CH2CH), 34.8 (NCH2CH2), 41.8 (d, J = 152.2 Hz, C(O)CH2CH), 60.2 (d, J = 3.8 
Hz, CH3C), 62.5 (d, J = 7.2 Hz, P(O)CH2CH3), 62.8 (d, 1H, J = 6.3 Hz, P(O)CH2CH3), 105.8 (ArC-
quat), 111.7 (ArC-H), 118.5 (ArC-H), 119.5 (ArC-H), 122.2 (ArC-H), 126.3 (ArC-quat), 136.0 (ArC-
quat), 136.8 (ArC-quat), 169.6 (d, J = 17.6 Hz, CO); m/z (ES
-
) 375 ([M-H]
-
, 100%); HRMS ES (+) 
Found 399.1444 for C19H25N2O4PNa
+
 [M+Na]
+
, requires 399.1444. 
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7.4.5.3  Synthesis and characterisation of methyl (1R,11bR)-11b-methyl-3-oxo-2,3,5,6,11,11b-
hexahydro-1H-indolizino[8,7-b]indole-1-carboxylate  (4.116) 
 
 
 
Following the general procedure (0.3 mmol scale) the titled compound was obtained after 72 hours 
at reflux in the presence of (4.23) as a colourless solid following flash silica gel chromatography 
(increasing polarity from ethyl acetate : petroleum ether, 1 : 1 to ethyl acetate) (74 mg, 82%).  The 
ee was determined by HPLC using a Chiralpak IB column (80:20 hexane/isopropanol) flow rate 1 
ml/min, 220 nm, major tR = 14.3 min, minor tR = 22.1 min (92% ee). 
 
M.P. 205-207 
o
C; [α]D
21 
= + 66.9 (c = 0.41 in CHCl3); νmax(film)/cm
-1
 3388 (br w, N-H), 1741 (s, 
C=O), 1678 (s, C=O); 
1
H NMR: δH (400 MHz, D6-DMSO) 1.48 (s, 3H, CH3C), 2.41-2.55 (m, 1H, 
C(O)CHAHBCH), 2.62 (ddd, 1H, J = 15.5 Hz, J = 11.5 Hz, J = 6.0 Hz, NCH2CHAHBC), 2.74 (dd, 1H, 
J =15.5 Hz, J = 4.0 Hz, NCH2CHAHBC), 2.88 (dd, 1H, J = 16.5 Hz, J = 11.0 Hz, C(O)CHAHBCH), 
3.04 (td, 1H, J = 12.7 Hz, J = 4.5 Hz, NCHAHBCH2), 3.41 (dd, 1H, J = 11.0 Hz, J = 9.0 Hz, 
C(O)CH2CH), 3.85 (s, 3H, OCH3), 4.25 (dd, 1H, J = 12.7 Hz, J = 5.5 Hz, NCHAHBCH2), 7.00 (t, 1H, 
J = 7.4 Hz, Ar-H), 7.10 (t, 1H, J = 7.5 Hz, Ar-H), 7.42 (d, 1H, J = 7.8 Hz, Ar-H), 7.48 (d, 1H, J = 8.1 
Hz, Ar-H), 10.25 (br s, 1H, N-H); 
13
C NMR: δC (100 MHz, D6-DMSO) 20.4 (NCH2CH2C, CH3C), 
32.2 (C(O)CH2CH), 34.0 (NCH2CH2C), 47.6 (C(O)CH2CH), 52.0 (OCH3), 59.5 (CH3C), 105.5 (ArC-
quat), 111.3 (ArC-H), 117.5 (ArC-H), 118.2 (ArC-H), 120.8 (ArC-H), 125.4 (ArC-quat), 135.4 (ArC-
quat), 136.4 (ArC-quat), 168.9 (CO), 170.6 (CO); m/z (ES
+
)  357 ([M+MeCN+NH4]
+
, 100%); HRMS 
ES (+) Found 321.1206 for C17H18N2O3Na
+
 [M+Na]
+
, requires 321.1210. 
 
7.4.5.4 Synthesis and characterisation of ethyl (1R, 11bR)-11b-methyl-3-oxo-2,3,5,6,11,11b-
hexahydro-1H-indolizino[8,7-b]indole-1-carboxylate (4.118) 
 
 
 
Following the general procedure (0.3 mmol scale) the titled compound was obtained after 72 hours 
at reflux in the presence of (4.23) as a colourless solid following flash silica gel chromatography 
(dichloromethane : acetone, 9.5 : 0.5) (79 mg, 85%).  The ee was determined by HPLC using a 
Chiralpak IB column (80:20 hexane/isopropanol) flow rate 1 ml/min, 220 nm, major tR = 10.6 min, 
minor tR = 13.5 min (64% ee). 
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M.P. 137-142 ºC; [α]D
25 
= + 48.1 (c = 1.07 in CHCl3); νmax(film)/cm
-1
 3400 (br w, N-H), 1687 (s, 
C=O); 
1
H NMR: δH (400 MHz, CDCl3) 1.44 (t, 3H, J = 7.1 Hz, CH2CH3), 1.54 (s, 3H, CH3C), 2.68 
(dd, 1H, J = 16.8 Hz, J = 8.8 Hz, C(O)CHAHBCH), 2.83-2.87 (m, 2H, NCH2CH2), 2.98-3.15 (m, 2H, 
C(O)CHAHBCH, NCHAHBCH2), 3.34 (dd, 1H, J = 11.8 Hz, J = 8.8 Hz, C(O)CH2CH), 4.35-4.43 (m, 
2H, CH3CH2), 4.49-4.55 (m, 1H, NCHAHBCH2), 7.13 (t, 1H, J = 7.4 Hz, Ar-H), 7.22 (t, 1H, J = 7.6 
Hz, Ar-H), 7.39 (d, 1H, J = 8.1 Hz, Ar-H), 7.50 (d, 1H, J = 7.8 Hz, Ar-H), 9.13 ( br s, 1H, N-H); 
13
C 
NMR: δC (100 MHz, CDCl3) 14.2 (CH3CH2), 20.8 (CH3C), 21.1 (NCH2CH2), 32.6 (C(O)CH2CH), 
34.7 (NCH2CH2), 49.1 (C(O)CH2CH), 60.1 (CH3C), 62.2 (CH3CH2), 106.7 (ArC-quat), 111.3 (ArC-
H), 118.6 (ArC-H), 119.7 (ArC-H), 122.4 (ArC-H), 126.4 (ArC-quat), 136.0 (ArC-quat), 136.5 (ArC-
quat), 169.6 (CO), 171.5 (CO); m/z (ES
+
) 335 ([M+Na]
+
, 20%), 647 ([2M+Na]
+
, 80%); HRMS ES (+) 
Found 335.1362 for C18H20N2O3Na
+
 [M+Na]
+
, requires 335.1366. 
 
7.4.5.5 Synthesis and characterisation of methyl (1R, 11bR)-11b-ethyl-3-oxo-2,3,5,6,11,11b-
hexahydro-1H-indolizino[8,7-b]indole-1-carboxylate (4.118) 
 
 
 
Following the general procedure (0.3 mmol scale) the titled compound was obtained after 72 hours 
at reflux in the presence of (4.57) as a colourless solid following flash silica gel chromatography 
(dichloromethane : acetone, 9 : 1) (79 mg, 84%).  The ee was determined by HPLC using a 
Chiralpak IB column (80:20 hexane/isopropanol) flow rate 1 ml/min, 220 nm, major tR = 13.2 min, 
minor tR = 21.2 min (64% ee). 
 
M.P. 169-172 ºC; [α]D
25 
= + 26.9 (c = 1.01 in CHCl3); νmax(film)/cm
-1
 3403 (w, N-H), 1719 (w, C=O), 
1683 (s, C=O); 
1
H NMR: δH (400 MHz, CDCl3) 0.91 (app. t, 3H, J = 7.5 Hz, CH2CH3), 2.01 (dq, 1H, 
J = 15.1 Hz, J = 7.6 Hz, CHAHBCH3), 2.08-2.18 (m, 1H, CHAHBCH3), 2.65 (dd, 1H, J = 16.9 Hz, J = 
9.4 Hz, C(O)CHAHBCH), 2.83-2.87 (m, 2H, NCH2CH2), 3.13 (m, 2H, C(O)CHAHBCH, NCHAHBCH2), 
3.40 (dd, 1H, J = 11.8 Hz, J = 9.4 Hz, C(O)CH2CH), 3.93 (s, 3H, OCH3), 4.57-4.62 (m, 1H, 
NCHAHBCH2), 7.13 (t, 1H, J = 7.4 Hz, Ar-H), 7.21 (t, 1H, J = 7.1 Hz, Ar-H), 7.39 (d, 1H, J = 8.0 Hz, 
Ar-H), 7.50 (d, 1H, J = 7.8 Hz, Ar-H), 9.03 (br s, 1H, N-H); 
13
C NMR: δC (100 MHz, CDCl3) 9.0 
(CH2CH3), 21.0 (CH2), 29.2 (CH2), 33.6 (C(O)CH2CH), 35.7 (NCH2CH2), 48.6 (C(O)CH2CH), 52.9 
(OCH3), 63.6 (CH2CN), 106.7 (ArC-quat), 111.3 (ArC-H), 118.6 (ArC-H), 119.7 (ArC-H), 122.3 (ArC-
H), 126.5 (ArC-quat), 136.0 (ArC-quat), 136.2 (ArC-quat), 170.6 (CO), 172.1 (CO); m/z (ES
-
) 311 
([M-H]
-
, 100%); HRMS ES (+) Found 335.1366 for C18H20N2O3Na
+
 [M+Na]
+
, requires 335.1366. 
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7.4.5.6  Synthesis and characterisation of dimethyl ((1R,11bS)-3-oxo-11b-pentyl-2,3,5,6,11,11b-
hexahydro-1H-indolizino[8,7-b]indol-1-yl)phosphonate (4.119) 
 
 
 
Following the general procedure (0.3 mmol scale) the titled compound was obtained after 48 hours 
at reflux in the presence of (4.57), as a yellow oil following flash silica gel chromatography 
(increasing polarity from ethyl acetate : petroleum ether, 1 : 1 to ethyl acetate) (80 mg, 66%).  The 
ee was determined by HPLC using a Chiralpak AD column (90:10 hexane/isopropanol) flow rate 1 
ml/min, 220 nm, major tR = 9.1 min, minor tR = 13.9 min (91% ee). 
 
[α]D
21 
= + 48.8 (c = 0.33 in CHCl3); νmax(film)/cm
-1
 3317 (br w, O-H), 1695 (s, C=O); 
1
H NMR: δH 
(400 MHz, CDCl3) 0.79-0.87 (m, 3H, CH3CH2), 1.15-1.33 (m, 5H, CH3CH2, CH3CH2CH2, 
CH3CH2CH2CHAHB), 1.38-1.52 (m, 1H, CH3CH2CH2CHAHB), 2.12-2.27 (m, 2H, CCH2CH2CH2), 2.58 
(dd, 1H, J = 16.0 Hz, J = 8.0 Hz, C(O)CHAHBCH), 2.68-2.98 (m, 3H, C(O)CHAHBCH, NCH2CH2C), 
3.14-3.25 (m, 1H, NCHAHBCH2), 3.76 (d, 3H, J = 11.0 Hz, OCH3), 3.93 (d, 3H, J = 11.0 Hz, OCH3), 
4.57 (app. dd, 1H, J = 13.5 Hz, J = 6.5 Hz, NCHAHBCH2), 7.12 (td, 1H, J = 7.5 Hz, J = 1.0 Hz, Ar-
H), 7.20 (td, 1H, J = 7.5 Hz, J = 1.0 Hz, Ar-H), 7.42 (d, 1H, J = 8.1 Hz, Ar-H), 7.50 (d, 1H, J = 7.7 
Hz, Ar-H), 9.88 (br s, 1H, N-H); 
13
C NMR: δC (100 MHz, CDCl3,) 14.1 (CH3CH2), 20.9 (NCH2CH2C), 
22.5 (CH2), 24.7 (CH2), 32.4 (CH2), 33.1 (C(O)CH2CH), 37.0 (NCH2CH2C), 37.7 (CCH2CH2CH2), 
42.4 (d, J = 152 Hz, C(O)CH2CH), 52.8 (d, J = 74 Hz, OCH3), 53.2 (d, J = 74 Hz, OCH3), 63.3 (d, J 
= 45 Hz, CH2CN), 106.5 (ArC-quat), 111.7 (ArC-H), 118.5 (ArC-H), 119.5 (ArC-H), 122.1 (ArC-H), 
126.4 (ArC-quat), 135.6 (ArC-quat), 136.1 (ArC-quat), 170.6 (d, J = 180 Hz, CO); m/z (ES
+
) 463 
([M+MeCN+NH4]
+
, 100%); HRMS ES (+) Found 427.1748 for C21H29N2O4PNa
+
 [M+Na]
+
, requires 
427.1757. 
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7.4.5.7 Synthesis and characterisation of (1R,11bS)-11b-methyl-1-(methylsulfonyl)-1,2,5,6,11,11b-
hexahydro-3H-indolizino[8,7-b]indol-3-one (4.120) 
 
 
 
Following the general procedure (0.3 mmol scale) the titled compound was obtained after 72 hours 
at reflux in the presence of (4.57), as a colourless solid following flash silica gel chromatography 
(dichlorormethane : acetone, 9 : 1) (90 mg, 94%).  The ee was determined by HPLC using a 
Chiralpak AD column (80:20 hexane/isopropanol) flow rate 1 ml/min, 220 nm, major tR = 9.7 min, 
minor tR = 15.5 min (66% ee). 
 
M.P. 127-130 ºC; [α]D
25 
= + 37.5 (c = 1.40 in CHCl3); νmax(film)/cm
-1
 3398 (br w, N-H), 1692 (s, 
C=O); 
1
H NMR: δH (400 MHz, CDCl3) 1.83 (s, 3H, CH3C), 2.68 (dd, 1H, J = 16.0 Hz, J = 8.5 Hz, 
C(O)CHAHBCH), 2.78-2.85 (m, 2H, NCH2CH2), 2.95 (s, 3H, SO2CH3), 3.05-3.23 (m, 2H, 
C(O)CHAHBCH, NCHAHBCH2), 3.75-3.84 (m, 1H, C(O)CH2CH), 4.41-4.50 (m, 1H, NCHAHBCH2), 
7.08-7.19 (m, 2H, 2 x Ar-H), 7.32 (d, 1H, J = 7.6 Hz, Ar-H), 7.48 (d, 1H, J = 7.2 Hz, Ar-H), 9.14 (br 
s, 1H, N-H); 
13
C NMR: δC (100 MHz, CDCl3) 21.1 (CH2), 21.3 (CH3C), 33.4 (CH2), 34.8 (NCH2CH2), 
42.2 (SO2CH3), 61.2 (CH3C), 64.4 (C(O)CH2CH), 107.1 (ArC-quat), 111.6 (ArC-H), 118.7 (ArC-H), 
119.9 (ArC-H), 122.7 (ArC-H), 126.1 (ArC-quat), 134.9 (ArC-quat), 135.8  (ArC-quat), 166.9 (CO); 
m/z (ES
-
) 317 ([M-H]
-
, 70%); HRMS ES (+) Found 341.0931 for C16H18N2O3SNa
+
 [M+Na]
+
, requires 
341.0930. 
 
7.4.5.8 Synthesis and characterisation of (1R,11bS)-10,11b-dimethyl-1-(phenylsulfonyl)-
1,2,5,6,11,11b-hexahydro-3H-indolizino[8,7-b]indol-3-one (4.121) 
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Following the general procedure (0.3 mmol scale) the titled compound was obtained after 24 hours 
at reflux in the presence of (4.57) as a colourless solid following flash silica gel chromatography 
(ethyl acetate : petroleum ether, 3 : 2) (100 mg, 84%).  The ee was determined by HPLC using a 
Chiralpak OD-H column (80:20 hexane/isopropanol) flow rate 1 ml/min, 220 nm, minor tR = 14.3 
min, major tR = 17.1 min (72% ee). 
 
M.P. 112-116 
o
C; [α]D
21 
= + 222.3 (c = 0.53 in CHCl3); νmax(film)/cm
-1
 3401 (br w, N-H), 1698 (s, 
C=O), 1148 (s, OMe); 
1
H NMR: δH (400 MHz, CDCl3) 2.02 (s, 3H, CH3C), 2.41 (dd, 1H, J = 16.0 
Hz, J = 8.0 Hz, C(O)CHAHBCH), 2.61 (s, 3H, CH3C), 2.71-2.90 (m, 2H, NCH2CH2C), 3.15 (ddd, 1H, 
J = 11.5 Hz, J = 4.5 Hz, J = 1.0 Hz, NCHAHBCH2C), 3.24 (ddd, 1H, J = 16.0 Hz, J = 12.0 Hz, J = 1.5 
Hz, C(O)CHAHBCH), 3.79 (dd, 1H, J = 12.0 Hz, J = 8.0 Hz, C(O)CH2CH), 4.48 (ddd, 1H, J = 13.0 
Hz, J = 6.0 Hz, J = 1.0 Hz, NCHAHBCH2C), 7.05-7.13 (m, 2H, 2 x Ar-H indole), 7.36 (dd, 1H, J = 5.5 
Hz, J = 3.0 Hz, Ar-H indole), 7.58-7.64 (m, 2H, 2 x Ar-H), 7.72 (tt, 1H, J = 8.0 Hz, 1.0 Hz, Ar-H), 
7.87-7.93 (m, 2H, 2 x Ar-H), 9.42 (br s, 1H, N-H); 
13
C NMR: δC (100 MHz, CDCl3) 16.7 (CH3C), 
21.2 (NCH2CH2C), 21.6 (CH3), 33.5 (C(O)CH2CH), 35.0 (NCH2CH2C), 61.7 (CH3CN), 66.8 
(C(O)CH2CH), 107.7 (ArC-quat), 116.4 (ArC-H indole), 120.2 (ArC-H indole), 120.9 (ArC-quat), 
123.3 (ArC-H indole), 125.7 (ArC-quat), 128.1 (2 x ArC-H), 129.8 (2 x ArC-H), 134.7 (ArC-H), 134.8 
(ArC-quat), 135.6 (ArC-quat), 138.7 (ArC-quat), 167.0 (CO); m/z (ES
+
) 453 ([M+MeCN+NH4]
+
, 
65%); HRMS ES (+) Found 417.1234 for C22H22N2O3SNa
+
 [M+Na]
+
, requires 417.1243. 
 
7.4.6 Proof of (1R,11bS) configuration of (4.121) 
 
7.4.6.1 Synthesis and characterisation of (11bR)-10,11b-dimethyl-1,2,5,6,11,11b-hexahydro-3H-
indolizino[8,7-b]indol-3-one (4.83)
109
 
 
 
 
To a solution of (4.121) (54 mg, 0.136 mmol) in anhydrous MeOH (15 mL) under N2 were added 
magnesium turnings (108 mg, 4.46 mmol) and the solution was heated to 50 °C  before cooling to 
room temperature and stirring for 40 minutes.  The solution was then brought to reflux for 3 hours 
before cooling to room temperature and pouring onto 2M aqueous HCl (20 mL).  The mixture was 
extracted with diethyl ether (3 x 20 mL) and the combined organic layers dried over Na2SO4. The 
solvent was removed in vacuo and the residue purified by chromatography on silica gel eluting with 
ethyl acetate to yield the titled product as a colourless solid (17mg, 48%).  The ee was determined 
by HPLC using a Chiralpak OD column (90:10 hexane/isopropanol) flow rate 1.5 ml/min, 220 nm, 
major tR = 10.6 min, minor tR = 13.9 min (72% ee).  
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M.P. 175-180 ºC (lit.
78
 194-197 ºC); [α]D
21 
= + 176.7 (c = 1.25 in CHCl3) (lit. [α]D
21 
= + 215.6 (c = 
1.25 in CHCl3), 92% ee); 
1
H NMR: δH (400 MHz, CDCl3) 1.64 (s, 3H, CH3), 2.17-2.27 (m, 1H, 
C(O)CH2CHAHB), 2.32-2.39 (m, 1H, C(O)CH2CHAHB), 2.46-2.49 (m, 1H, C(O)CHAHBCH2), 2.51 (s, 
3H, CH3), 2.66-2.74 (m, 1H, C(O)CHAHBCH2), 2.77-2.90 (m, 2H, NCH2CH2C), 3.07-3.15 (m, 1H, 
NCHAHBCH2C), 4.46-4.51 (m, 1H, NCHAHBCH2C), 7.01 (d, 1H, J = 7.1 Hz, Ar-H), 7.07 (t, 1H, J = 
7.4 Hz, Ar-H), 7.35 (d, 1H, J = 7.7 Hz, Ar-H), 8.01 (br s, 1H, N-H); 
13
C NMR: δC (100 MHz, CDCl3) 
16.8 (CH3), 21.3 (NCH2CH2C), 25.5 (CH3), 30.7 (C(O)CH2CH2), 32.9 (C(O)CH2CH2), 35.0 
(NCH2CH2C), 59.6 (CH3CN), 107.5 (ArC-quat),116.2 (ArC-H), 120.1 (ArC-H), 120.2 (ArC-quat), 
122.9 (ArC-H), 126.3 (ArC-quat), 135.6 (ArC-quat), 137.4 (ArC-quat), 172.7 (CO); m/z (ES
+
) 313 
([M+MeCN+NH4]
+
, 95%). 
 
The HPLC retention times and the specific rotation confirmed the (R) configuration at the 
quaternary center hence confirming the (1R,11bS) configuration of (4.121). The configurations of 
the other cyclized products (4.101)-(4.120) were assigned by analogy. 
 
7.4.7 Preparation of enol lactones (4.131)-(4.134) 
 
 
 
 
Entry 
Compound 
no. 
R1 R2 
Yield of 
oxoacid 
(4.125) 
Yield of enol 
lactone 
(4.126a) 
1 (4.131) Me  CO2Me 40% 74% 
2 (4.132) Me  P(O)(OMe)2 46% 64% 
3 (4.133) n-pentyl P(O)(OMe)2 65% 41% 
4 (4.134) Me SO2Ph 57%* 15%
Ψ
 
     * Yield of isolated t-butyl oxoester.  
Ψ
Yield of enol lactone from t-butyl oxoester. 
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7.4.7.1 Preparation of 4-oxo carboxylic acids  
 
 
 
General procedure for the preparation of 4-oxo carboxylic acids 
 
To a solution of ketone (1 equivalent) in acetone (3 mL per 1 mmol of ketone) was added 
anhydrous K2CO3 (5 equivalents) followed by tert-butyl bromoacetate (1 equivalent). The 
heterogeneous mixture was heated to reflux for 16 hours.  It was allowed to cool to room 
temperature and water was added (volume identical to acetone). The solution was extracted with 
diethyl ether (3 x volume of water added). The combined organic layers were dried over Na2SO4 
and concentrated in vacuo to afford the crude tert-butyl 4-oxo carboxylate (for R2 = PhSO2, the tert-
butyl ester was isolated and purified and the dehydrative cyclisation to the enol lactone was carried 
out on the corresponding crude 4-oxo carboxylic acid).  The crude tert-butyl oxo ester mixture was 
dissolved in CH2Cl2 (3 mL per 1 g of mixture) and TFA was added. The solution was stirred at room 
temperature for 30 minutes and the solvents were removed under a nitrogen flow. The residue was 
purified by chromatography on silica gel to afford the title compound. 
 
7.4.7.1.1 Synthesis and characterisation of (±)-3-(methoxycarbonyl)-4-oxopentanoic acid (4.127) 
 
 
 
Following the general procedure (5g, 43 mmol scale of methyl acetoacetate) the titled compound 
was obtained as a colourless solid (2.98 g, 40% over 2 steps) following flash silica gel 
chromatography (dichloromethane : ethyl acetate, 9 : 1 to 4 : 1).   
 
M.P. 46-49 
o
C; νmax(film)/cm
-1
 3209 (br w, O-H), 1739 (s, C=O), 1718 (s, C=O), 1270 (s, C-O), 
1163 (s, C-O); 
1
H NMR: δH (400 MHz, CDCl3) 2.35 (s, 3H, CH3C(O)), 2.88 (dd, 1H, J = 8.0 Hz, J = 
6.5 Hz, CHAHBCO2H), 3.03 (dd, 1H, J = 18.0 Hz, J = 8.0 Hz, CHAHBCO2H), 3.76 (s, 3H, OCH3), 
3.96 (app. t, 1H, J = 7.0 Hz, CHCH2CO2H), 10.19 (br s, 1H, O-H); 
13
C NMR: δC (100 MHz, CDCl3) 
29.9 (CH3C(O)), 32.0 (CHCH2CO2H), 52.9 (OCH3), 54.1 (CHCH2CO2H), 168.6 (CO), 177.1 (CO), 
201.4 (CO); m/z (ES
+
) 197 ([M+Na]
+
, 50%), 387 ([2M+K]
+
, 100%); HRMS ES (+) Found 197.0413 
for C7H10O5Na
+
 [M+Na]
+
, requires 197.0420. 
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7.4.7.1.2 Synthesis and characterisation of (±)-3-(dimethoxyphosphoryl)-4-oxopentanoic acid 
(4.128) 
 
Following the general procedure (1.5 g, 9 mmol scale of dimethyl (2-oxopropyl)phosphonate) the 
titled compound was obtained as a colourless solid (415 mg, 46% over 2 steps) following flash 
silica gel chromatography (dichloromethane : ethyl acetate, 3 : 2).   
 
M.P. 97-100 
o
C; νmax(film)/cm
-1
 3412 (br w, O-H), 1792 (s, C=O), 1720 (s, C=O), 1238 (s, P=O), 
1209 (s, C-O / P-O), 1052 (s, C-O / P-O), 1033 (s, C-O / P-O); 
1
H NMR: δH (400 MHz, CDCl3) 2.40 
(s, 3H, CH3C(O)), 2.73 (ddd, 1H, J = 18.0 Hz, J = 9.5 Hz, J = 3.0 Hz, CHCHAHBCO2H), 3.16 (ddd, 
1H, J = 18.0 Hz, J = 11.0 Hz, J = 7.5 Hz, CHCHAHBCO2H), 3.72 (ddd, 1H, J = 25.0 Hz, J = 11.0 Hz, 
J = 3.0 Hz, CHCH2CO2H), 3.77 (d, 3H, J = 2.0 Hz, OCH3), 3.80 (d, 3H, J = 2.0 Hz, OCH3), 9.44 (br 
s, 1H, O-H); 
13
C NMR: δC (100 MHz, CDCl3) 30.8 (d, J = 3 Hz, CHCH2CO2H), 31.2 (CH3C(O)), 47.7 
(d, J = 127 Hz, CHCH2CO2H), 53.5 (d, J = 7 Hz, OCH3), 53.8 (d, J = 7 Hz, OCH3), 175.0 (d, J = 19 
Hz, CO), 199.8 (d, J = 5 Hz, CO); m/z (ES
-
) 223 ([M-H]
-
, 80%), 469 ([2(M-H)+K]
-
, 100%); HRMS ES 
(+) Found 247.0344 for C7H13O6PNa
+
 [M+Na]
+
, requires 247.0342. 
 
7.4.7.1.3 Synthesis and characterisation of (±)-3-(dimethoxyphosphoryl)-4-oxononanoic acid 
(4.129) 
 
 
Following the general procedure (1.03 mL, 5 mmol scale of dimethyl (2-oxoheptyl)phosphonate) the 
titled compound  was obtained as a colourless oil (922 mg, 65% over 2 steps) following flash silica 
gel chromatography (dichloromethane : ethyl acetate, 9 : 1).   
 
νmax(film)/cm
-1
 3413 (br s, O-H), 1719 (s, C=O), 1238 (s, P=O), 1034 (s, C-O/P-O); 
1
H NMR: δH 
(400 MHz, CDCl3) 0.89 (t, 3H, J = 7.0 Hz, CH3CH2), 1.20-1.40 (m, 4H, CH3CH2, CH3CH2CH2), 1.60 
(p, 2H, J = 7.0 Hz, C(O)CH2CH2), 2.63 (dt, 1H, J = 18.0 Hz, J = 7.0 Hz, C(O)CHAHBCH2), 2.75 (ddd, 
1H, J = 18.0 Hz, J = 9.5 Hz, J = 3.0 Hz, CHCHAHBCO2H), 2.85 (dt, 1H, J = 18.0 Hz, J = 7.5 Hz, 
C(O)CHAHBCH2), 3.20 (ddd, 1H, J = 18.0 Hz, J = 11.0 Hz, J = 7.5 Hz, CHCHAHBCO2H), 3.69 (ddd, 
1H, J = 11.0 Hz, J = 25.0 Hz, J = 3.0 Hz, CHCH2CO2H), 3.77 (s, 3H, OCH3), 3.79 (s, 3H, OCH3), 
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7.57 (br s, 1H, O-H); 
13
C NMR: δC (100 MHz, CDCl3) 13.9 (CH3CH2), 22.4 (CH3CH2), 23.0 
(C(O)CH2CH2), 30.8 (CHCH2CO2H), 31.0 (CH3CH2CH2), 43.9 (C(O)CH2CH2), 47.2 (d, J = 128 Hz, 
CHCH2CO2H), 53.4 (d, J = 7 Hz, OCH3), 53.7 (d, J = 7 Hz, OCH3), 175.2 (d, J = 19 Hz, CO), 204.2 
(d, J = 5 Hz, CO); m/z (ES
+
) 279 ([M-H]
-
, 100%); HRMS ES (+) Found 303.0969 for C11H21O6PNa
+
 
[M+Na]
+
, requires 303.0968. 
 
7.4.7.1.4 Synthesis and characterisation of (±)-tert-butyl 4-oxo-3-(phenylsulfonyl)pentanoate (4.130) 
 
 
 
Following the general procedure (991 mg , 5 mmol scale of dimethyl 1-(phenylsulfonyl)acetone) the 
titled compound was obtained as a colourless solid (891 mg, 57%) following flash silica gel 
chromatography (petroleum ether : ethyl acetate, 9 : 1).   
 
M.P. 116-118 
o
C; νmax(film)/cm
-1 
1724 (s, C=O), 1322 (s, S=O), 1149 (s, S=O); 
1
H NMR: δH (400 
MHz, CDCl3) 1.38 (s, 9H, C(CH3)3), 2.52 (s, 3H, CH3C(O)), 2.85 (m, 2H, C(O)CH2CH), 4.58 (dd, 1H, 
J = 11.5 Hz, J = 3.5 Hz, C(O)CH2CH), 7.59 (t, 2H, J = 7.5 Hz, 2 x Ar-H), 7.71 (t, 1H, J = 7.5 Hz, Ar-
H), 7.78 (d, 2H, J = 7.5 Hz, 2 x Ar-H); 
13
C NMR: δC (100 MHz, CDCl3) 27.9 (C(CH3)3), 32.2 
(CH3C(O)), 33.5 (C(O)CH2CH), 70.7 (C(O)CH2CH), 82.4 (C(CH3)3), 129.3 (2 x ArC-H), 129.4 (2 x 
ArC-H), 134.6 (ArC-H), 135.9 (ArC-quat), 168.7 (CO), 199.0 (CO); m/z (ES
+
) 335 ([M+Na]
+
, 50%), 
647 ([2M+Na]
+
, 100%); HRMS ES (+) Found 335.0917 for C15H20O5SNa
+
 [M+Na]
+
, requires 
335.0924. 
 
7.4.7.2 Preparation of enol lactones 
 
General procedure for the preparation of enol lactones 
To a solution of 4-oxo carboxylic acid (1 equivalent) in acetic anhydride (1 mL per 0.5 mmol of 
substrate) and acetic acid (1 mL per 0.5 mmol of substrate) was added p-TsOH (0.1 equivalents) 
and the solution was heated to 60 °C for 45 minutes to 5 hours (completion followed by TLC) and 
allowed to cool to room temperature. Water was added (10 mL per 1 mmol of starting material). 
The solution was extracted with ethyl acetate (3 x 20 mL per 1 mmol of starting material). The 
combined organic layers were dried over Na2SO4 and the solvent concentrated in vacuo. The 
product was purified by chromatography on silica gel. 
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7.4.7.2.1 Synthesis and characterisation of methyl 2-methyl-5-oxo-4,5-dihydrofuran-3-carboxylate 
(4.131) 
 
Following the general procedure (4.05 mmol scale of oxoacid) the titled compound was obtained 
after heating at 60 °C for 45 minutes as a colourless crystalline solid (469 mg, 74%) following flash 
silica gel chromatography (dichloromethane).   
 
M.P. 61-63 
o
C; νmax(film)/cm
-1  
1807 (s, C=O lactone), 1713 (s, C=O ester); 
1
H NMR: δH (400 MHz, 
CDCl3) 2.41 (t, 3H, J = 2.5 Hz, CH3C), 3.45 (m, 2H, C(O)CH2), 3.78 (s, 3H, OCH3); 
13
C NMR: δC 
(100 MHz, CDCl3) 13.8 (CH3C), 33.6 (C(O)CH2), 51.6 (OCH3), 105.9 (C-quat), 163.5 & 163.7 (C-
quat, CO), 172.8 (CO); HRMS CI (+) Found 174.0767 (100%) for C7H12NO4
+
 [M+NH4]
+
, requires 
174.0761. 
 
7.4.7.2.2 Synthesis and characterisation of dimethyl (2-methyl-5-oxo-4,5-dihydrofuran-3-
yl)phosphonae (4.132) 
 
 
 
Following the general procedure (1.44 mmol scale of oxoacid) the titled compound  was obtained 
after heating at 60 °C for 5 hours as a colourless oil (191 mg, 64%) following flash silica gel 
chromatography (dichloromethane : acetone, 4 : 1). 
 
νmax(film)/cm
-1
 1816 (s, C=O), 1238 (s, P=O), 1034 (s, C-O/P-O); 
1
H NMR: δH (400 MHz, CDCl3) 
2.32 (m, 3H, CH3C), 3.30 (m, 2H, C(O)CH2), 3.73 (s, 3H, OCH3), 3.76 (s, 3H, OCH3); 
13
C NMR: δC 
(100 MHz, CDCl3) 13.8 (CH3C), 34.9 (d, J = 9.0 Hz, C(O)CH2), 52.4 (2 x OCH3), 99.1 (d, J = 220 
Hz, C-quat), 165.0 (d, J = 25 Hz, C-quat), 173.6 (d, J = 18 Hz, CO); m/z (ES
+
)  229 ([M+Na]
+
, 
40%), 435 ([2M+Na]
+
, 90%); HRMS ES (+) Found 229.0239 for C7H11O5PNa
+
 [M+Na]
+
, requires 
229.0236. 
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7.4.7.2.3 Synthesis and characterisation of dimethyl (5-oxo-2-pentyl-4,5-dihydrofuran-3-
yl)phosphonate (4.133) 
 
 
 
Following the general procedure (0.58 mmol scale of oxoacid) the titled compound  was obtained 
after heating at 60 °C for 3 hours as a colourless oil (63 mg, 41%) following flash silica gel 
chromatography (dichloromethane : acetone, 9 : 1). 
 
νmax(film)/cm
-1 
1814 (s, C=O), 1235 (s, P=O), 1030 (s, C-O/P-O); 
1
H NMR: δH (400 MHz, CDCl3) 
0.89 (t, 3H, J = 7.0 Hz, CH3CH2), 1.33 (m, 4H, CH3CH2, CH3CH2CH2), 1.61 (p, 2H, J = 7.5 Hz, 
CCH2CH2), 2.71 (m, 2H, CCH2CH2), 3.31 (m, 2H, C(O)CH2C), 3.73 (s, 1H, 3H, OCH3), 3.76 (s, 3H, 
OCH3); 
13
C NMR: δC (100 MHz, CDCl3) 13.9 (CH3CH2), 22.2 (CH3CH2), 26.3 (d, J = 2 Hz, 
CCH2CH2), 27.5 (CCH2CH2), 31.1 (CH3CH2CH2), 34.9 (d, J = 9 Hz, C(O)CH2C), 52.4 (2 x OCH3), 
98.8 (d, J = 221 Hz, C-quat), 168.7 (d, J = 26 Hz, C-quat), 173.9 (d, J  = 18 Hz, CO); m/z (ES
+
)  285 
([M+Na]
+
, 40%); HRMS ES (+) Found 285.0860 for C11H19O5PNa
+
 [M+Na]
+
, requires 285.0862. 
 
7.4.7.2.4 Synthesis and characterisation of 5-methyl-4-(phenylsulfonyl)furan-2(3H)-one (4.134) 
 
 
 
Following the general procedure (1.56 mmol scale of tert-butyl oxoester) the titled compound  was 
obtained after heating at 60 °C for 45 minutes as a colourless solid (56 mg, 15% over 2 steps) 
following flash silica gel chromatography (increasing polarity from petroleum ether : ethyl acetate, 4 
: 1 to 3 : 2).   
 
M.P. 102-105 
o
C; νmax(film)/cm
-1
 1821 (s, C=O), 1319 (s, S=O), 1165 (s, S=O); 
1
H NMR: δH (400 
MHz, CDCl3) 2.48 (t, 3H, J = 2.5 Hz, CH3C), 3.36-3.41 (m, 2H, C(O)CH2C), 7.59 (t, 2H, J = 7.5 Hz, 
2 x Ar-H), 7.68 (t, 1H, J = 7.5 Hz, Ar-H), 7.88 (d, 2H, J = 7.5 Hz, 2 x Ar-H); 
13
C NMR: δC (100 MHz, 
CDCl3) 13.0 (CH3C), 33.8 (C(O)CH2C), 114.3 (C-quat), 127.2 (2 x ArC-H), 129.7 (2 x ArC-H), 134.0 
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(ArC-H), 140.3 (C-quat), 161.4 (C-quat), 170.3 (CO); m/z (ES
+
) 293 ([M+MeOH+Na]
+
, 60%); HRMS 
ES (+) Found 293.0465 for C12H14O5SNa
+
 [M+MeOH+Na]
+
, requires 293.0454. 
 
7.4.8 Preparation of cyclised β-carbolines from enol lactones  
 
 
 
General procedure for the preparation of cyclized β-carbolines from enol lactones 
 
Enol lactone (4.126a) (0.2 mmol, 1 equivalent) was dissolved in toluene (42 mL) and a tryptamine 
derivative (0.2 mmol, 1 equivalent) was added in one portion at room temperature, immediately 
followed by the addition of phosphoric acid catalyst (4.23) or (4.57) (0.02 mmol, 0.1 equivalents) in 
one portion.  The resulting suspension was heated under reflux for 34 hours. Another portion of 
catalyst (4.23) or (4.57) (0.02 mmol, 0.1 equivalents) was then added to the hot mixture, and the 
solution was heated under reflux for 2 to 6 days (48 to 144 hours).  The solvent was removed in 
vacuo, and the residue purified by chromatography on silica gel (see below for eluent systems). 
Note: All racemates were prepared using para-toluenesulfonic acid (catalytic amount) in refluxing 
toluene.  A single diastereomer was obtained in all cyclization reactions. 
7.4.8.1 Synthesis and characterisation of  methyl (1R,11bR)-11b-methyl-3-oxo-2,3,5,6,11,11b-
hexahydro-1H-indolizino[8,7-b]indole-1-carboxylate (4.116) 
 
Following the general procedure the titled compound was obtained after 34 + 96  hours at reflux in 
the presence of (4.23) as a colourless crystalline solid following flash silica chromatography 
(increasing polarity from ethyl acetate : petroleum ether, 1 : 1 to ethyl acetate) (44 mg, 74%).  The 
ee was determined by HPLC using a Chiralpak IB column (80:20 hexane/isopropanol) flow rate 1 
ml/min, 220 nm, major tR = 12.3 min, minor tR = 18.9 min (75% ee).  The spectroscopic data of the 
titled product was identical to that previously described (7.4.5.3). 
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7.4.8.2 Synthesis and characterisation of  dimethyl ((1R,11bS)-11b-methyl-3-oxo-2,3,5,6,11,11b-
hexahydro-1H-indolizino[8,7-b]indol-1-yl)phosphonate (4.101) 
 
 
Following the general procedure the titled compound was obtained after 34 + 48  hours at reflux in 
the presence of (4.57) as a colourless crystalline solid following flash silica gel chromatography 
(ethyl acetate : petroleum ether, 1 : 1) (63 mg, 95%).  The ee was determined by HPLC using a 
Chiralpak OJ column (60:40 hexane/isopropanol) flow rate 1 ml/min, 220 nm, major tR = 6.9 min, 
minor tR = 14.5 min (85% ee).  The spectroscopic data of the titled product was identical to that 
previously described (7.4.5.1). 
 
7.4.8.3 Synthesis and characterisation of  dimethyl ((1R,11bS)-3-oxo-11b-pentyl-2,3,5,6,11,11b-
hexahydro-1H-indolizino[8,7-b]indol-1-yl)phosphonate (4.119) 
 
 
Following the general procedure the titled compound was obtained after 34 + 144  hours at reflux in 
the presence of (4.57) as a colourless crystalline solid following flash silica gel chromatography 
(ethyl acetate : petroleum ether, 1 : 1) (73 mg, 90%).  The ee was determined by HPLC using a 
Chiralpak AD column (90:10 hexane/isopropanol) flow rate 1 ml/min, 220 nm, major tR = 9.1 min, 
minor tR = 13.9 min (91% ee).  The spectroscopic data of the titled product was identical to that 
previously described (7.4.5.6).   
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7.4.8.4 Synthesis and characterisation of (1R,11bS)-10,11b-dimethyl-1-(phenylsulfonyl)-
1,2,5,6,11,11b-hexahydro-3H-indolizino[8,7-b]indol-3-one (4.121) 
 
 
Following the general procedure the titled compound was obtained after 34 + 72  hours at reflux in 
the presence of (4.57) as a colourless crystalline solid following flash silica gel chromatography 
(ethyl acetate : petroleum ether, 3 : 2) (75 mg, 95%).  The ee was determined by HPLC using a 
Chiralpak OD-H column (80:20 hexane/isopropanol) flow rate 1 ml/min, 220 nm, minor tR = 14.3 
min, major tR = 17.1 min (72% ee).  The spectroscopic data of the titled product was identical to 
that previously described (7.4.5.8).   
 
7.4.9 Evidence for the proposed cyclisation mechanism: initial oxoamide formation 
7.4.9.1 Synthesis and characterisation of methyl methyl 2-acetyl-4-{[2-(1H-indol-3-yl)ethyl]amino}-
4-oxobutanoate (4.135) 
 
A cyclization reaction between tryptamine and enol lactone (4.131) was performed under the 
conditions aforementioned for doubly substituted lactones, on 0.2 mmol scale, but the reaction was 
stopped after 10 minutes.  The solvent was removed in vacuo and the residue immediately purified 
by column chromatography on silica gel eluting with dichloromethane : acetone, 9 : 1 to afford 41 
mg of oxoamide intermediate (4.135) (65%) as a colorless oil. 
 
νmax(film)/cm
-1 
 3396 (br w, N-H), 3309 (br w, N-H), 1740 (s, C=O), 1715 (s, C=O), 1653 (s, C=O); 
1
H NMR: δH (400 MHz, CDCl3) 2.35 (s, 3H, C(O)CH3), 2.61 (dd, 1H, J = 16.0 Hz, J = 6.5 Hz, 
CHAHBCHCO2CH3), 2.73 (dd, 1H, J = 16.0 Hz, J = 8.0 Hz, CHAHBCHCO2CH3), 2.93 (t, 2H, J = 7.0 
Hz, NHCH2CH2C), 3.54 (m, 2H, NHCH2CH2C), 3.72 (s, 3H, OCH3), 4.12 (dd, 1H, J = 8.0 Hz, J = 
6.5 Hz, CH2CHCO2CH3), 5.77 (br t, 1H, J = 5.0 Hz, NHCH2), 7.01 (d, 1H, J = 1.5 Hz, NHCH), 7.12 
(t, 1H, J = 7.5 Hz, Ar-H), 7.20 (t, 1H, J = 7.5 Hz, Ar-H), 7.37 (d, 1H, J = 8.1 Hz, Ar-H), 7.58 (d, 1H, J 
= 7.8 Hz, Ar-H), 8.33 (br s, 1H, N-H); 
13
C NMR: δC (100 MHz, CDCl3) 25.2 (NHCH2CH2C), 30.2 
(C(O)CH3), 34.2 (CH2CHCO2CH3), 39.8 (NHCH2CH2C), 52.7 (OCH3), 54.5 (CH2CHCO2CH3), 111.3 
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(ArC-H), 112.6 (ArC-quat), 118.6 (ArC-H), 119.4 (ArC-H), 122.1 (ArC-H), 122.3 (NHCH), 127.2 
(ArC-quat), 136.4 (ArC-quat), 169.4 (CO), 169.9 (CO), 202.7 (CO); m/z (ES
+
) 339 ([M+Na]
+
, 60%), 
655 ([2M+Na]
+
, 100%); HRMS ES (+) Found 339.1316 for C17H20N2O4Na
+
 [M+Na]
+
, requires 
339.1315 
7.4.10 Evidence for the proposed DYKAT mechanism: pro-chiral enamide 
7.4.10.1 Synthesis and characterisation of methyl 1-[2-(1H-indol-3-yl)ethyl]-2-methyl-5-oxo-4,5-
dihydro-1H-pyrrole-3-carboxylate (4.136) 
 
A cyclization reaction between tryptamine and enol lactone (4.131) was performed under the 
conditions previously mentioned for doubly substituted lactones, on 0.2 mmol scale, but the 
reaction was stopped after 50 minutes and quenched with triethylamine (150 μL for 0.2 mmol scale 
reaction).  The solvent was removed in vacuo and the residue immediately purified by column 
chromatography on deactivated silica gel (1% triethylamine in the eluent), eluting with petroleum 
ether : ethyl acetate : triethylamine, 60 : 40 : 1 to afford 26 mg of enamide intermediate (4.136) 
(43%) as a colorless solid. 
 
M.P. 158-160 
o
C; νmax(film)/cm
-1
 3337 (br w, N-H), 1688 (s, C=O), 1628 (s, C=C); 
1
H NMR: δH 
(400 MHz, D6-DMSO) 2.16 (t, 3H, J = 2.5 Hz, CH3C), 2.90 (t, 2H, J = 7.5 Hz, NCH2CH2C), 3.22 (q, 
2H, J = 2.5 Hz, C(O)CH2C), 3.61 (s, 3H, OCH3), 3.70 (t, 2H, J = 7.5 Hz, NCH2CH2C), 6.99 (t, 1H, J 
= 7.4 Hz, Ar-H), 7.07 (td, 1H, J = 7.5 Hz, J = 1.0 Hz, Ar-H), 7.15 (d, 1H, J = 2.0 Hz, NHCH), 7.34 (d, 
1H, J =  8.1 Hz, Ar-H), 7.54 (d, 1H, J = 7.8 Hz, Ar-H), 10.87 (br s, 1H, N-H); 
13
C NMR: δC (100 
MHz, D6-DMSO) 12.5 (CH3C), 25.1 (NCH2CH2C), 37.8 (C(O)CH2C), 41.5 (NCH2CH2C), 51.5 
(OCH3), 102.2 (C-quat), 111.4 (C-quat), 112.3 (ArC-H), 118.9 (ArC-H), 119.3 (ArC-H), 121.9 (ArC-
H), 124.1 (NHCH), 127.9 (ArC-quat), 137.0 (ArC-quat), 156.1 (ArC-quat), 165.8 (CO), 176.0 (CO); 
m/z (ES
+
) 357 ([M+MeCN+NH4]
+
, 100%); HRMS ES (+) Found 321.1210 for C17H18N2O3Na
+
 
[M+Na]
+
, requires 321.1210. 
In boiling toluene, in the presence of a catalytic amount of para-toluenesulfonic acid, the enamide 
readily cyclized to form a single diastereomer of (±)-(4.116). 
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7.4.11 Preparation of 4-oxo carboxylic acids (4.146) 
 
 
Entry Compound no. R1 R2 R3 
Yield of 
(4.146) 
1 (4.147) Me  Me Et 37% 
2 (4.148) Me Et Me 52% 
3 (4.149) Me Bu Et 47% 
4 (4.150) Me Bn Et 23% 
5 (4.151) -CH2CH2- -CH2- Et 49% 
6 (4.152) -CH2CH2CH2- -CH2CH2- Me 57% 
 
General procedure for the preparation of 4-oxo carboxylic acids 
To a solution of ketone (4.144) (1 equivalent) in acetone (3 mL per 1 mmol of ketone) was added 
anhydrous potassium carbonate (5 equivalents) followed by methyl 2-bromoacetate (1 equivalent). 
The heterogeneous mixture was heated to reflux for 16 hours. It was allowed to cool to room 
temperature and water was added (volume identical to acetone). The solution was extracted with 
diethyl ether (3 x volume of water added). The combined organic layers were concentrated in 
vacuo to afford the crude 2-alkylsuccinate.  
The crude 2-alkylsuccinate mixture was dissolved in 6 M HCl aq. (3 mL per 1 g of mixture) and 
acetic acid (3 mL per 1 g of mixture). The biphasic mixture was heated to reflux for 2 days. It was 
allowed to cool to room temperature and water was added (volume identical to the combined 
volume of 6 M HCl aq. and acetic acid). The solution was extracted with CH2Cl2 (3 x volume of 
water added). The combined organic layers were dried over sodium sulfate and concentrated in 
vacuo to afford the crude 4-oxo carboxylate. The residue was purified by chromatography on silica 
gel to afford the title compound. 
 
7.4.11.1 Synthesis and characterisation of (±)-3-methyl-4-oxopentanoic acid (4.147)
89
 
 
 
 
Synthesised on a 2.00 g scale (17 mmol) of ethyl 2-methyl-3-oxobutanoatete. The product was 
purified by chromatography on silica gel eluting with dichloromethane/ethyl acetate 9 : 1 to give 648 
mg of colorless oil (37% over 2 steps). 
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νmax(film)/cm
-1
 3350 (br w, O-H), 1713 (br m, C=O), 1279 (m, C-O), 1171 (m, C-O); 
1
H NMR: δH 
(400 MHz, CDCl3) 1.19 (d, 3H, J = 8.0 Hz, CH3CH), 2.22 (s, 3H, CH3C(O)), 2.34 (dd, 1H, J = 17.1 
Hz, J = 5.2 Hz, CHCHAHB), 2.81 (dd, 1H, J = 17.1 Hz, J = 8.7 Hz, CHCHAHB), 2.94-3.05 (m, 1H, 
CH3CH), 9.30 (br s, 1H, O-H); 
13
C NMR: δC (100 MHz, CDCl3) 16.5 (CH3CH), 28.3 (CH3C(O)), 36.5 
(CHCH2), 42.5 (CHCH2), 178.1 (CO), 210.7 (CO); m/z (ES
+
) 129 ([M-H]
-
, 50%). 
 
7.4.11.2 Synthesis and characterisation of (±)-3-ethyl-4-oxopentanoic acid  (4.148) 
 
 
 
Synthesised on 3.00 g scale of methyl 2-ethyl-3-oxobutanoate (20 mmol). The product was purified 
by chromatography on silica gel eluting with dichloromethane/ethyl acetate 9 : 1 to give 1.49 g of 
colorless oil (52% over 2 steps). 
 
νmax(film)/cm
-1
  3150 (br s, O-H), 1712 (br s, C=O); 
1
H NMR: δH (400 MHz, CDCl3) 0.91 (t, 3H, J = 
7.4 Hz, CH3CH2), 1.45-1.58 (m, 1H, CH3CHAHB), 1.63-1.75 (m, 1H, CH3CHAHB), 2.22 (s, 3H, 
CH3C(O)), 2.38 (dd, 1H, J = 17.1 Hz, J = 4.2 Hz, CHCHAHB), 2.79 (dd, 1H, J = 17.1 Hz, J = 9.8 Hz, 
CHCHAHB), 2.88-2.97 (m, 1H, CHCH2), 10.17 (br s, 1H, O-H); 
13
C NMR: δC (100 MHz, CDCl3) 11.1 
(CH3CH2), 24.2 (CH3CH2), 29.4 (CH3(CO)), 34.3 (CHCH2), 48.9 (CHCH2), 178.5 (CO), 210.8 (CO); 
m/z (ES
-
) 143 ([M-H]
-
, 40%), 309 ([2(M-H)+Na]
-
, 100%), HRMS ES (+) Found 167.0686 for 
C7H12O3Na
+
 [M+Na]
+
, requires 167.0679. 
 
7.4.11.3 Synthesis and characterisation of (±)-3-acetylheptanoic acid  (4.149) 
 
 
 
Synthesised on 2.00 g scale of ethyl 2-acetylhexanoate (11 mmol). The product was purified by 
chromatography on silica gel eluting with dichloromethane/ethyl acetate 9 : 1 to give 865 mg of 
colorless oil (47% over 2 steps). 
 
νmax(film)/cm
-1
 2200 (br w, O-H), 1712 (br s, C=O); 
1
H NMR: δH (400 MHz, CDCl3) 0.86 (t, 3H, J = 
6.9 Hz, CH3CH2), 1.17-1.33 (m, 4H, CH3CH2, CH3CH2CH2), 1.34-1.45 (m, 1H, CHCHAHBCH2), 
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1.54-1.64 (m, 1H, CHCHAHBCH2), 2.19 (s, 3H, CH3C(O)), 2.36 (dd, 1H, J = 17.2 Hz, J = 4.2 Hz, 
CHCHAHBCO2H), 2.76 (dd, 1H, J = 17.2 Hz, J = 9.9 Hz, CHCHAHBCO2H), 2.89-2.87 (m, 1H, 
CHCH2), 11.14 (br s, 1H, O-H); 
13
C NMR: δC (100 MHz, CDCl3) 13.8 (CH3CH2), 22.6 & 28.9  
(CH3CH2, CH3CH2CH2), 29.4 (CH3C(O)), 30.8 (CHCH2CH2) 34.8 (CHCH2CO2H), 47.6 (CHCH2), 
178.5 (CO), 210.8 (CO); m/z (ES
+
) 195 ([M+Na]
+
, 55%), 367 ([2M+Na]
+
, 100%); HRMS ES (+) 
Found 195.0997 for C9H16O3Na
+
 [M+Na]
+
, requires 195.0992. 
 
7.4.11.4 Synthesis and characterisation of (±)-3-benzyl-4-oxopentanoic acid (4.150)
90
 
 
 
Synthesized on 5.00 g scale of ethyl 2-benzylacetoacetate (23 mmol). The product was purified by 
chromatography on silica gel eluting with dichloromethane/ethyl acetate 9 : 1 to give 1.08 g of 
colourless solid (23% over 2 steps). 
 
M.P. 85-87 ºC; νmax(film)/cm
-1
 3087 (br w, O-H), 1710 (s, C=O); 
1
H NMR: δH (400 MHz, CDCl3) 
2.11 (s, 3H, C(O)CH3), 2.37 (dd, 1H, J = 17.6 Hz, J = 3.8 Hz, CHAHBCO2H), 2.61 (dd, 1H, J = 13.6 
Hz, J = 8.3 Hz, CHCCHAHBCH), 2.80 (dd, 1H, J = 17.6 Hz, J = 10.1 Hz, CHAHBCO2H), 2.94 (dd, 1H, 
J = 13.6 Hz, J = 6.9 Hz, CHCCHAHBCH), 3.20-3.29 (m, 1H, C(O)CH), 7.16 (d, 2H, J = 7.6 Hz, 2 x 
Ar-H), 7.21-7.27 (m, 1H, Ar-H), 7.31 (t, 2H, J = 7.6 Hz, 2 x Ar-H), 10.32 (br s, 1H, O-H); 
13
C NMR: 
δC (100 MHz, CDCl3) 30.2 (C(O)CH3), 34.9 (CH2CO2H), 37.6 (CHCCH2CH), 49.5 (C(O)CH), 126.9 
(ArC-H), 128.8 (2 x ArC-H), 128.9 (2 x ArC-H), 138.0 (CHCCH2), 178.2 (CO), 210.8 (CO); m/z (ES
-
) 
205 ([M-H]
-
, 75%); HRMS ES (+) Found 229.0833 for C12H14O3Na
+
 [M+Na]
+
, requires 229.0835. 
 
7.4.11.5 Synthesis and characterisation of (±)-(2-oxocyclopentyl)acetic acid  (4.151)
91
 
 
 
 
Synthesised on 3.00 g scale of ethyl 2-oxocyclopentanecarboxylate (19 mmol). The product was 
purified by chromatography on silica gel eluting with dichloromethane/ethyl acetate 9 : 1 to give 
1.06 g of colorless crystalline solid (49% over 2 steps). 
 
  Chapter 7 
149 
M.P. 43-45 
o
C (lit. 50-53 °C); νmax(film)/cm
-1
  3250 (br m, OH), 1734 (br s, C=O), 1273 (s, C-O), 
1163 (s, C-O); 
1
H NMR: δH (400 MHz, CDCl3) 1.57-1.70 (m, 1H, CHAHB), 1.75-1.89 (m, 1H, 
CHAHB), 2.02-2.23 (m, 2H, CH2) , 2.29-2.51 (m, 4H, CH2, CHCHAHBCO2H,  CHCH2), 2.74-2.83 (m, 
1H, CHCHAHBCO2H), 10.67 (br s, 1H, OH); 
13
C NMR: δC (100 MHz, CDCl3) 20.6 (CH2), 29.2 (CH2), 
33.7 (CHCH2CO2H), 37.4 (CH2), 45.4 (CHCH2), 178.1 (CO), 219.3 (CO); m/z (ES
+
) 165 ([M+Na]
+
, 
80%); HRMS ES (+) Found 165.0521 for C7H10O3Na
+
 [M+Na]
+
, requires 165.0522. 
 
7.4.11.6 Synthesis and characterisation of (±)-(2-oxocycloheptyl)acetic acid (4.152) 
 
 
 
Synthesised on 3.00 g scale of methyl 2-oxocycloheptanecarboxylate (19 mmol). The product was 
purified by chromatography on silica gel eluting with dichloromethane/ethyl acetate 9 : 1 to give 
1.87 g of colorless oil (57% over 2 steps). 
 
νmax(film)/cm
-1
  3095 (br s, O-H), 1699 (br s, C=O); 
1
H NMR: δH (400 MHz, CDCl3) 1.23-1.44 (m, 
2H, CH2), 1.50-1.62 (m, 1H, CHAHB), 1.68-1.96 (m, 5H, 2 x CH2, CHAHB), 2.34 (dd, 1H, J = 17.0 Hz, 
J = 6.6 Hz, CHCHAHBCO2H), 2.40-2.50 (m, 1H, C(O)CHAHBCH2), 2.63 (dt, 1H, J = 8.9 Hz, J = 4.2 
Hz, C(O)CHAHBCH2), 2.85 (dd, 1H, J = 17.1 Hz, J = 8.4 Hz, CHCHAHBCO2H), 3.04-3.12 (m, 1H, 
CHCH2), 10.33 (br s, 1H, O-H); 
13
C NMR: δC (100 MHz, CDCl3) 23.4 & 28.9 & 29.3 & 31.1 (4 x 
CH2), 36.4 (CHCH2CO2H), 43.3 (C(O)CH2CH2), 47.2 (CHCH2), 178.4 (CO), 214.3 (CO); m/z (ES
-
) 
169 ([M-H]
-
, 60%), 361 ([2(M-H)+Na]
-
, 100%); HRMS ES (+) Found 215.0655 for C9H13O3Na2
+
  [M-
H+2Na]
+
, requires 215.0655. 
 
7.4.11.7 Synthesis and characterisation of (±)-methyl (2-oxocyclohexyl)acetate (4.142) 
 
 
 
To a solution of ethyl 2-(2-oxocyclohexyl)acetate (2.00 mL, 11 mmol) in DME (30 mL) was added 
5% aqueous H2SO4 solution (30 mL) and the solution was heated to reflux for 2 days before 
quenching with water (30 mL) and extracting with CH2Cl2 (3 x 30 mL).  The combined organic 
layers were dried over sodium sulfate and concentrated in vacuo to afford the crude oxoacid.  It 
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was dissolved in methanol (20 mL) and cooled to 0 ºC before adding thionyl chloride (12 mmol, 
1.43 g, 0.88 mL) dropwise.  The solution was heated to reflux for 1 hour before cooling, 
evaporating the solution in vacuo and adding a saturated solution of NaHCO3 (20 mL).  The 
solution was extracted with ethyl acetate (3 x 20 mL) and the combined organic layers were dried 
over sodium sulfate and concentrated in vacuo to afford the crude oxoester. The product was 
purified by chromatography on silica gel eluting with dichloromethane/ethyl acetate 9 : 1 to give 
1.58 g of colorless oil (84%).   
 
νmax(film)/cm
-1
 1739 (s, C=O), 1712 (s, C=O); 
1
H NMR: δH (400 MHz, CDCl3) 1.34-1.47 (m, 1H, 
CHCHAHBCH2), 1.56-1.79 (m, 2H, C(O)CH2CHAHB, C(O)CH2CH2CHAHB), 1.84-1.92 (m, 1H, 
C(O)CH2CH2CHAHB), 2.06-2.18 (m, 3H, CHCHAHBCO2H, C(O)CH2CHAHB, CHCHAHBCH2), 2.31-
2.45 (m, 2H, C(O)CH2CH2), 2.73-2.81 (m, 1H, CHCHAHBCO2H), 2.81-2.91 (m, 1H, CHCH2), 3.66 
(s, 3H, CH3O); 
13
C NMR: δC (100 MHz, CDCl3) 25.2 (CHCH2CH2), 27.8 (C(O)CH2CH2), 33.9 
(CHCH2CH2), 34.0 (CHCH2CO2H), 41.8 (C(O)CH2CH2), 47.0 (CHCH2), 51.7 (CH3O), 173.1 (CO), 
211.1 (CO); m/z (ES
+
) 193 ([M+Na]
+
, 50%), 363 ([2M+Na]
+
, 100%); HRMS ES (+) Found 193.0842 
for C9H14O3Na
+
 [M+Na]
+
, requires 193.0835.  
 
7.4.11.8 Synthesis and characterisation of (±)-(2-oxocyclohexyl)acetic acid (4.143) 
 
 
 
To a solution of ethyl 2-(2-oxocyclohexyl)acetate (1.96 mL, 10.8 mmol) in DME (10 mL) was added 
3 M aqueous HCl (10 mL) and the solution was heated to reflux for 2 days. It was allowed to cool to 
room temperature and a saturated solution of Na2CO3 (20 mL) was added. The solution was 
extracted with diethyl ether (3 x 20 mL) and the combined organic layers were washed with a 
saturated solution of Na2CO3 (2 x 20 mL).  The combined aqueous layers were acidified to pH 1 
with 6 M aqueous HCl and extracted with CH2Cl2 (3 x 50 mL).  The combined organic layers were 
dried over sodium sulfate and concentrated in vacuo to afford the crude oxoacid. The product was 
purified by chromatography on silica gel eluting with dichloromethane/ethyl acetate 9 : 1 to give 431 
mg of colorless oil (26%).    
 
νmax(film)/cm
-1
  3095 (br m, O-H), 1709 (br s, C=O); 
1
H NMR: δH (400 MHz, CDCl3) 1.36-1.49 (m, 
1H, CHCHAHBCH2), 1.57-1.79 (m, 2H, C(O)CH2CHAHBCH2, CHCH2CHAHB), 1.85-1.93 (m, 1H, 
CHCH2CHAHB), 2.07-2.25 (m, 3H, CHCHAHBCO2H, CHCHAHBCH2, C(O)CH2CHAHBCH2), 2.31-2.48 
(m, 2H, C(O)CH2CH2), 2.77-2.89 (m, 2H, CHCH2, CHCHAHBCO2H),  10.01 (br s, 1H, O-H); 
13
C 
NMR: δC (100 MHz, CDCl3) 25.1 (CHCH2CH2), 27.7 (C(O)CH2CH2), 33.8 (CHCH2CH2), 34.3 
(CHCH2CO2H), 41.8 (C(O)CH2CH2), 46.9 (CHCH2), 178.5 (CO), 211.1 (CO); m/z (ES
-
)  155 ([M-H]
-
, 
90%); HRMS ES (+) Found 179.0679 for C8H12O3Na
+ 
 [M+Na]
+
, requires 179.0679. 
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7.4.12 Preparation of cyclised β-carbolines (4.175) 
 
 
 
General procedure for the preparation of cyclized β-carbolines (4.175) 
4-oxo carboxylate (4.174) (0.2 mmol, 1 equivalent) was dissolved in toluene (42 mL) and a 
tryptamine derivative (0.2 mmol, 1 equivalent) was added in one portion at room temperature, 
immediately followed by the addition of a phosphoric acid catalyst (0.02 mmol, 0.1 equivalents) in 
one portion. The resulting suspension was heated under reflux until complete consumption of 
starters (TLC monitoring). The solvent was removed in vacuo, and the residue purified by 
chromatography on silica gel (see below for eluent systems). 
 
Note: All racemates were prepared using para-toluenesulfonic acid (0.1 equivalents) in refluxing 
toluene, in conditions similar to the enantioselective cascade (identical concentration, same 
reagents purity etc.). 
 
7.4.12.1 Synthesis and characterisation of methyl (1R,11bR)-11b-methyl-3-oxo-2,3,5,6,11,11b-
hexahydro-1H-indolizino[8,7-b]indole-1-carboxylate  (4.116) 
 
 
 
Following the general procedure the titled compound was obtained as a single diastereomer after 
10 days at reflux in the presence of (4.23) as a colourless crystalline solid following flash silica gel 
chromatography (increasing polarity from ethyl acetate : petroleum ether, 1 : 1 to ethyl acetate) (47 
mg, 78%).  The ee was determined by HPLC using a Chiralpak IB column (80:20 
hexane/isopropanol) flow rate 1 ml/min, 220 nm, major tR = 12.6 min, minor tR = 20.1 min (69% ee).  
The spectroscopic data of the titled product was identical to that previously described (7.4.5.3). 
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7.4.12.2 Synthesis and characterisation of (1R,11bS)-10,11b-dimethyl-1-(phenylsulfonyl)-
1,2,5,6,11,11b-hexahydro-3H-indolizino[8,7-b]indol-3-one (4.121) 
 
 
 
Following the general procedure the titled compound was obtained as a single diastereomer after 7 
days at reflux in the presence of (4.57) as a colourless crystalline solid following flash silica gel 
chromatography (ethyl acetate : petroleum ether, 3 : 2) (64 mg, 81%).  The ee was determined by 
HPLC using a Chiralpak OD-H column (80:20 hexane/isopropanol) flow rate 1 ml/min, 220 nm, 
minor tR = 14.7 min, major tR = 17.4 min (68% ee).  The spectroscopic data of the titled product was 
identical to that previously described (7.4.5.8).  [α]D
21 
= + 222.3 (c = 0.528 in CHCl3). 
 
7.4.12.3 Synthesis and characterisation of (4aR,14bR)-1,2,3,4,4a,5,9,14-octahydro-6H,8H-
pyrido[3,4-b:1,2-i']diindol-6-one (4.141) 
 
 
 
Following the general procedure the reaction was carried out on a 0.1 mmol scale.  The titled 
compound was obtained after 24 hours at reflux in the presence of (4.102) as a colourless 
crystalline solid following flash silica gel chromatography (ethyl acetate) (18 mg, 63%).  The ee was 
determined by HPLC using a Chiralpak AD column (80:20 hexane/isopropanol) flow rate 1 ml/min, 
220 nm, major tR = 5.7 min, minor tR = 10.7 min (68% ee), >98:2 dr. 
 
M.P. 241-244 
o
C; [α]D
25 
= + 116.1 (c = 1.0 in CHCl3); νmax(film)/cm
-1
 3305 (br w, N-H), 1666 (s, 
C=O); 
1
H NMR: δH (400 MHz, CDCl3) 1.55-1.68 (m, 2H, CH2), 1.73-1.85 (m, 3H, NCCHAHBCH2, 
CH2), 1.87-2.04 (m, 2H, CHCH2CH2), 2.19-2.26 (m, 1H, NCCHAHBCH2), 2.37-2.45 (m, 1H, 
C(O)CHAHBCH), 2.48-2.59 (m, 2H, C(O)CHAHBCH, C(O)CH2CH), 2.78-2.94 (m, 2H, NCH2CH2), 
3.09-3.17 (m, 1H, NCHAHBCH2), 4.46 (dd, 1H, J = 13.2 Hz, J = 5.4 Hz, NCHAHBCH2), 7.14 (t, 1H, J 
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= 7.1 Hz, Ar-H), 7.21 (t, 1H, J = 7.5 Hz, Ar-H), 7.39 (d, 1H, J = 8.0 Hz, Ar-H), 7.51 (d, 1H, J = 7.7 
Hz, Ar-H), 8.36 (br s, 1H, N-H); 
13
C NMR: δC (CDCl3, 100 MHz) 20.3 & 21.1 (NCCH2CH2, 
CHCH2CH2), 22.0 (NCH2CH2), 26.2 (CHCH2CH2), 34.2 (NCCH2CH2), 34.7 (NCH2CH2), 35.6 
(C(O)CH2CH), 38.0 (CHCH2), 60.2 (CH2CN), 107.1 (ArC-quat), 111.1 (ArC-H), 118.5 (ArC-H), 
119.9 (ArC-H), 122.2 (ArC-H), 126.5 (ArC-quat), 135.9 (ArC-quat), 138.0 (ArC-quat), 172.0 (CO); 
m/z (ES
-
)  279 ([M-H]
-
, 100%); HRMS ES (+) Found 303.1467 for C18H20N2ONa
+
 [M+Na]
+
, requires 
303.1468. 
 
7.4.12.4 Synthesis and characterisation of (1R,11bR)-1,11b-dimethyl-1,2,5,6,11,11b-hexahydro-
3H-indolizino[8,7-b]indol-3-one (4.154) 
 
 
 
Following the general procedure the titled compound was obtained after 24 hours at reflux in the 
presence of (4.23) as a colourless oil following flash silica gel chromatography (ethyl acetate) (54 
mg, 99%).  The ee was determined by HPLC using a Chiralpak OD column (90:10 
hexane/isopropanol) flow rate 1 ml/min, 220 nm, minor tR = 25.3 min, major tR = 30.9 min (76% ee), 
dr = 97:3. 
 
[α]D
25 
= + 66.6 (c = 0.94 in CHCl3); νmax(film)/cm
-1
  3271 (br w, N-H), 1664 (s, C=O); 
1
H NMR: δH 
(500 MHz, CDCl3) 1.42 (d, 3H, J = 6.6 Hz, CH3CH), 1.51 (s, 3H, CH3C), 2.34-2.41 (m, 1H, 
C(O)CHAHBCH), 2.50-2.62 (m, 2H, C(O)CHAHBCH, C(O)CH2CH), 2.85-2.89 (m, 2H, NCH2CH2), 
3.05-3.12 (m, 1H, NCHAHBCH2), 4.53-4.58 (m, 1H, NCHAHBCH2), 7.17-7.21 (m, 1H, Ar-H), 7.24-
7.28 (m, 1H, Ar-H), 7.41 (d, 1H, J = 8.0 Hz, Ar-H), 7.55 (d, 1H, J = 7.8 Hz, Ar-H), 8.01 (br s, 1H, N-
H); 
13
C NMR: δC (100 MHz, CDCl3) 14.8 (CH3CH), 19.3 (CH3), 21.5 (NCH2CH2), 35.0 (NCH2CH2), 
38.8 (C(O)CH2CH), 39.2 (CHCH2), 61.6 (CH3C), 107.1 (ArC-quat), 111.0 (ArC-H), 118.5 (ArC-H), 
119.9 (ArC-H), 122.2 (ArC-H), 126.6 (ArC-quat), 136.1 (ArC-quat), 137.9 (ArC-quat), 171.9 (CO); 
m/z (ES
-
) 253 ([M-H]
-
, 100%); HRMS ES (+) Found 277.1312 for C16H18N2ONa
+ 
 [M+Na]
+
, requires 
277.1311. 
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7.4.12.5 Synthesis and characterisation of (1R,11bR)-1-ethyl-11b-methyl-1,2,5,6,11,11b-
hexahydro-3H-indolizino[8,7-b]indol-3-one (4.155) 
 
 
 
Following the general procedure the titled compound was obtained after 72 hours at reflux in the 
presence of (4.102) as a colourless crystalline solid following flash silica gel chromatography 
(dichloromethane : acetone, 9 : 1) (18 mg, 34%).  The ee was determined by HPLC using a 
Chiralpak AD column (95:5 hexane/isopropanol) flow rate 1 ml/min, 220 nm, major tR = 24.7 min, 
minor tR = 36.6 min (61% ee), >98:2 dr. 
 
M.P. 110-115 ºC; [α]D
25 
= + 58.0 (c = 2.0 in CHCl3); νmax(film)/cm
-1
 3276 (br w, N-H), 1668 (s, 
C=O); 
1
H NMR: δH (400 MHz, CDCl3) 1.04 (t, 3H, J = 7.3 Hz, CH2CH3), 1.47 (s, 3H, CCH3), 1.59-
1.72 (m, 1H, CHAHBCH3), 1.87-2.00 (m, 1H, CHAHBCH3), 2.23-2.35 (m, 2H, C(O)CH2CH, 
C(O)CHAHBCH), 2.57-2.69 (m, 1H, C(O)CHAHBCH), 2.80-2.85 (m, 2H, NCH2CH2), 3.00-3.09 (m, 
1H, NCHAHBCH2), 4.47-4.54 (m, 1H, NCHAHBCH2), 7.14 (t, 1H, J = 7.4 Hz, Ar-H), 7.21 (t, 1H, J = 
7.1 Hz, Ar-H), 7.37 (d, 1H, J = 8.0 Hz, Ar-H), 7.51 (d, 1H, J = 7.7 Hz, Ar-H), 8.18 (br s, 1H, N-H); 
13
C NMR: δC (100 MHz, CDCl3) 12.8 (CH2CH3), 19.8 (CCH3), 21.5 (CH2), 23.6 (CH2), 34.8 
(NCH2CH2), 36.6 (C(O)CH2CH), 46.5 (C(O)CH2CH), 61.6 (CH3C), 107.2 (ArC-quat), 111.0 (ArC-H), 
118.5 (ArC-H), 119.9 (ArC-H), 122.2 (ArC-H), 126.6 (ArC-quat), 136.0 (ArC-quat), 137.9 (ArC-quat), 
171.7 (CO); m/z (ES
-
) 267 ([M-H]
-
, 100%); HRMS ES (+) Found 291.1470 for C17H20N2ONa
+
 
[M+Na]
+
, requires 291.1468. 
 
7.4.12.6 Synthesis and characterisation of (1R,11bR)-1-butyl-11b-methyl-1,2,5,6,11,11b-
hexahydro-3H-indolizino[8,7-b]indol-3-one (4.156) 
 
 
 
Following the general procedure the reaction was carried out on a 0.1 mmol scale.  The titled 
compound was obtained after 72 hours at reflux in the presence of (4.102) as a colourless 
crystalline solid following flash silica gel chromatography (ethyl acetate : petroleum ether, 1 : 1) (30 
mg, 99%).  The ee was determined by HPLC using a Chiralpak OD column (90:10 
hexane/isopropanol) flow rate 1 ml/min, 220 nm, minor tR = 11.3 min, major tR = 24.5 min (59% ee), 
dr = 97:3. 
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M.P. 206-208 ºC; [α]D
25 
= + 51.4 (c = 0.74 in CHCl3); νmax(film)/cm
-1
 3274 (br w, N-H), 1667 (s, 
C=O); 
1
H NMR: δH (400 MHz, CDCl3) 0.95 (t, 3H, J = 6.6 Hz, CH3CH2), 1.20-1.44 (m, 4H, CH3CH2, 
CH3CH2CH2), 1.47 (s, 3H, CCH3), 1.58-1.70 (m, 1H, CHCHAHBCH2), 1.81-1.95 (m, 1H, 
CHCHAHBCH2), 2.24-2.41 (m, 2H, C(O)CH2CH, C(O)CHAHBCH), 2.61 (dd, 1H, J = 14.6 Hz, J = 6.5 
Hz, C(O)CHAHBCH), 2.80-2.86 (m, 2H, NCH2CH2), 2.99-3.09 (m, 1H, NCHAHBCH2), 4.47-4.54 (m, 
1H, NCHAHBCH2), 7.14 (t, 1H, J = 7.4 Hz, Ar-H), 7.21 (t, 1H, J = 7.4 Hz, Ar-H), 7.38 (d, 1H, J = 7.9 
Hz, Ar-H), 7.51 (d, 1H, J = 7.7 Hz, Ar-H), 8.26 (br s, 1H, N-H); 
13
C NMR: δC (100 MHz, CDCl3) 14.1 
(CH2CH3), 19.8 (CCH3), 21.5 (CH2), 22.9 (CH2), 30.4 (CHCH2CH2), 34.8 (NCH2CH2), 36.9 
(C(O)CH2CH), 44.7 (C(O)CH2CH), 61.6 (CH3C), 107.1 (ArC-quat), 111.0 (ArC-H), 118.5 (ArC-H), 
119.9 (ArC-H), 122.2 (ArC-H), 126.6 (ArC-quat), 136.1 (ArC-quat), 138.0 (ArC-quat), 171.8 (CO); 
m/z (ES
-
) 295 ([M-H]
-
, 100%); HRMS ES (+) Found 319.1782 for C19H24N2ONa
+
 [M+Na]
+
, requires 
319.1781. 
 
7.4.12.7 Synthesis and characterisation of (1R,11bR)-1-benzyl-11b-methyl-1,2,5,6,11,11b-
hexahydro-3H-indolizino[8,7-b]indol-3-one (4.157) 
 
 
 
Following the general procedure the titled compound was obtained after 6 days at reflux in the 
presence of (4.57) as a colourless crystalline solid following flash silica gel chromatography (ethyl 
acetate : petroleum ether, 1 : 1) (30 mg, 46%).  The ee was determined by HPLC using a Chiralpak 
AD column (85:15 hexane/isopropanol) flow rate 1 ml/min, 220 nm, minor tR = 10.6 min, major tR = 
14.4 min (32% ee), >98:2 dr. 
 
M.P. 100-104 ºC; [α]D
25 
= + 25.1 (c = 1.05 in CHCl3); νmax(film)/cm
-1
 3277 (br w, N-H), 1667 (s, 
C=O); 
1
H NMR: δH (400 MHz, CDCl3) 1.57 (s, 3H, CH3), 2.47 (dd, 1H, J = 16.4 Hz, J = 12.3 Hz, 
C(O)CHAHBCH2), 2.62 (dd, 1H, J = 16.4 Hz, J = 8.0 Hz, C(O)CHAHBCH2), 2.75-2.80 (m, 3H, 
C(O)CH2CH, NCH2CH2), 2.96-3.13 (m, 3H, NCHAHBCH2, CHCCH2), 4.51 (dt, 1H, J = 13.0 Hz, J = 
3.2 Hz, NCHAHBCH2), 6.43 (br s, 1H, N-H), 6.91 (d, 1H, J = 7.4 Hz, Ar-H), 7.02-7.22 (m, 3H, 3 x Ar-
H), 7.32-7.35 (m, 2H, 2 x Ar-H), 7.41-7.49 (m, 3H, 3 x Ar-H); 
13
C NMR: δC (100 MHz, CDCl3) 20.3 
(CH3), 21.5 (NCH2CH2), 34.9 (NCH2CH2), 36.3 (CHCCH2), 37.8 (C(O)CH2CH), 46.4 (C(O)CH2CH), 
62.1 (CH3C), 107.2 (ArC-quat), 110.8 (ArC-H), 118.3 (ArC-H), 119.5 (ArC-H), 122.0 (ArC-H), 126.1 
(ArC-quat), 127.2 (ArC-H), 129.4 (2 x ArC-H), 129.5 (2 x ArC-H), 135.6 (ArC-quat), 136.9 (ArC-
quat), 139.6 (ArC-quat), 171.0 (CO); m/z (ES
-
) 329 ([M-H]
-
, 100%); HRMS ES (+) Found 353.1625 
for C22H22N2ONa
+
 [M+Na]
+
, requires 353.1624. 
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7.4.12.8 Synthesis and characterisation of (3aR,13bR)-2,3,3a,4,8,13-hexahydro-7H-
cyclopenta[1,8a]indolizino[8,7-b]indol-5(1H)-one (4.158) 
 
 
Following the general procedure the titled compound was obtained after 48 hours at reflux in the 
presence of (4.60) as a colourless crystalline solid following flash silica gel chromatography (ethyl 
acetate : petroleum ether, 4 : 1) (30 mg, 57%).  The ee was determined by HPLC using a Chiralpak 
AD column (85:15 hexane/isopropanol) flow rate 1 ml/min, 220 nm, major tR = 8.9 min, minor tR = 
17.3 min (68% ee), >98:2 dr. 
 
M.P. 80-85 
o
C; [α]D
25 
= + 31.8 (c = 1.03 in CHCl3); νmax(film)/cm
-1
 3260 (br w, N-H), 1665 (s, C=O); 
1
H NMR: δH (400 MHz, CDCl3) 1.75-1.95 (m, 4H, NCCH2CH2, NCCH2CH2), 2.06-2.22 (m, 2H, 
CHCH2CH2), 2.28 (dd, 1H, J = 17.4 Hz, J = 4.1 Hz, C(O)CHAHBCH), 2.71-2.84 (m, 2H, 
NCH2CHAHB, C(O)CHAHBCH), 2.87-2.96 (m, 2H, NCH2CHAHB, CHCH2), 3.10 (td, 1H, J = 12.1 Hz, J 
= 4.3 Hz, NCHAHBCH2), 4.51 (dd, 1H, J = 13.1 Hz, J = 5.7 Hz, NCHAHBCH2), 7.10-7.14 (m, 1H, Ar-
H), 7.16-7.21 (m, 1H, Ar-H), 7.34 (d, 1H, J = 8.0 Hz, Ar-H), 7.47 (d, 1H, J = 7.7 Hz, Ar-H), 8.21 (br 
s, 1H, N-H); 
13
C NMR: δC (100 MHz, CDCl3) 20.9 (NCH2CH2), 24.6 & 35.2 (NCCH2CH2, 
NCCH2CH2), 36.8 (NCH2CH2), 39.0 (C(O)CH2CH), 40.2 (CHCH2CH2), 41.3 (CHCH2), 71.0 
(CH2CN), 108.1 (ArC-quat), 111.0 (ArC-H), 118.3 (ArC-H), 119.8 (ArC-H), 122.1 (ArC-H), 126.7 
(ArC-quat), 136.3 (ArC-quat), 136.7 (ArC-quat), 174.2 (CO); m/z (ES
-
) 265 ([M-H]
-
, 100%); HRMS 
ES (+) Found 289.1312 for C17H18N2ONa
+
 [M+Na]
+
, requires 289.1311. 
 
7.4.12.9 Synthesis and characterisation of (5aR,15bR)-2,3,4,5,5a,6,10,15-octahydro-9H-
cyclohepta[1,8a]indolizino[8,7-b]indol-7(1H)-one (4.159) 
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Following the general procedure the titled compound was obtained after 48 hours at reflux in the 
presence of (4.102) as a colourless crystalline solid following flash silica gel chromatography (ethyl 
acetate : petroleum ether, 1 : 1) (53 mg, 90%).  The ee was determined by HPLC using a Chiralpak 
AD column (80:20 hexane/isopropanol) flow rate 1 ml/min, 220 nm, major tR = 4.6 min, minor tR = 
9.7 min (86% ee), >98:2 dr. 
 
M.P. 244-247 
o
C; [α]D
25 
= + 58.2 (c = 0.86 in CHCl3); νmax(film)/cm
-1
 3264 (br w, N-H), 1662 (s, 
C=O); 
1
H NMR: δH (400 MHz, D6-DMSO) 1.21-1.47 (m, 2H, NCCH2CHAHB, CHCH2CHAHB), 1.55-
1.81 (m, 5H, NCCH2CHAHB, CHCHAHBCH2, CHCH2CH2CH2, CHCH2CHAHB), 1.95-2.13 (m, 2H, 
NCCH2CH2), 2.14-2.32 (m, 2H, C(O)CHAHBCH, CHCHAHBCH2), 2.44-2.52 (m, 1H, C(O)CHAHBCH), 
2.56-2.66 (m, 2H, NCH2CH2), 2.67-2.77 (m, 1H, CHCH2), 2.97-3.07 (m, 1H, NCHAHBCH2), 4.22 
(dd, 1H, J = 13.0 Hz, J = 4.7 Hz, NCHAHBCH2), 6.96 (t, 1H, J = 7.4 Hz, Ar-H), 7.05 (t, 1H, J = 7.5 
Hz, Ar-H), 7.32-7.36 (m, 2H, 2 x Ar-H), 10.90 (br s, 1H, N-H); 
13
C NMR: δC (100 MHz, D6-DMSO) 
21.3 (NCH2CH2), 23.8 (NCCH2CH2), 25.1 (NCCH2CH2CH2), 29.1 (CHCH2CH2), 31.3 (CHCH2CH2), 
35.4 & 35.5 (NCH2CH2, C(O)CH2CH), 38.3 (NCCH2CH2), 41.6 (CHCH2), 66.6 (CH2CN), 105.3 
(ArC-quat), 112.1 (ArC-H), 118.7 (ArC-H), 119.4 (ArC-H), 121.8 (ArC-H), 127.1 (ArC-quat), 136.9 
(ArC-quat), 141.4 (ArC-quat), 173.8 (CO); m/z (ES
-
) 293 ([M-H]
-
, 80%); HRMS ES (+) Found 
317.1624 for C19H22N2ONa
+
 [M+Na]
+
, requires 317.1624. 
 
7.4.12.10 Synthesis and characterisation of (4aR,14bR)-11-methoxy-1,2,3,4,4a,5,9,14-octahydro-
6H,8H-pyrido[3,4-b:1,2-i']diindol-6-one (4.163) 
 
 
 
Following the general procedure the titled compound was obtained after 24 hours at reflux in the 
presence of (4.102) as a colourless crystalline solid following flash silica gel chromatography (ethyl 
acetate : petroleum ether, 4 : 1) (56 mg, 90%).  The ee was determined by HPLC using a Chiralpak 
AD column (80:20 hexane/isopropanol) flow rate 1 ml/min, 220 nm, major tR = 7.4 min, minor tR = 
11.5 min (79% ee), >98:2 dr. 
 
M.P. 102-107 
o
C; [α]D
25 
= + 66.6 (c = 1.11 in CHCl3); νmax(film)/cm
-1
  3306 (br w, N-H), 1664 (s, 
C=O); 
1
H NMR: δH (500 MHz, CDCl3) 1.55-1.70 (m, 2H, CHAHB, CHAHB), 1.79-1.90 (m, 3H, CHAHB, 
CHAHB, CHAHB), 1.95-1.99 (m, 2H, C(O)CH2CH), 2.24-2.29 (m, 1H, CHAHB), 2.43 (dd, 1H, J = 14.0 
Hz, J = 6.3 Hz, CHAHB), 2.51-2.62 (m, 2H, CHCH2, CHAHB), 2.81 (dd, 1H, J = 15.3 Hz, J = 4.6 Hz, 
NCH2CHAHB), 2.90 (ddd, 1H, J = 15.3 Hz, J = 11.5 Hz, J = 6.4 Hz, NCH2CHAHB), 3.16 (td, 1H, J = 
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12.2 Hz, J = 5.1 Hz, NCHAHBCH2), 3.91 (s, 3H, CH3O), 4.49 (dd, 1H, J = 13.2Hz, J = 5.6 Hz, 
NCHAHBCH2), 6.91 (dd, 1H, J = 8.8 Hz, J = 2.5 Hz, Ar-H), 6.99 (d, 1H, J = 2.4 Hz, Ar-H), 7.32 (d, 
1H, J = 8.7 Hz, Ar-H), 7.96 (br s, 1H, N-H); 
13
C NMR: δC (100 MHz, CDCl3) 20.7 (NCH2CH2), 21.6 
(CH2), 22.6 (CH2), 26.7 (C(O)CH2CH), 34.6 (CH2), 35.1 (NCH2CH2), 35.9 (CH2), 38.6 (CHCH2), 
56.4 (CH3O), 60.6 (CH2CN), 101.0 (ArC-H), 107.6 (ArC-quat), 112.2 (ArC-H), 112.6 (ArC-H), 127.5 
(ArC-quat), 131.3 (ArC-quat), 139.4 (ArC-quat), 154.8 (ArC-quat), 173.1 (CO); m/z (ES
-
) 309 ([M-
H]
-
, 100%); HRMS ES (+) Found 333.1573 for C19H22N2ONa
+
 [M+Na]
+
, requires 333.1573. 
 
7.4.12.11 Synthesis and characterisation of (4aR,14bR)-11-bromo-1,2,3,4,4a,5,9,14-octahydro-
6H,8H-pyrido[3,4-b:1,2-i']diindol-6-one (4.164) 
 
 
 
Following the general procedure the titled compound was obtained after 48 hours at reflux in the 
presence of (4.102) as a colourless crystalline solid following flash silica gel chromatography (ethyl 
acetate) (64 mg, 88%).  The ee was determined by HPLC using a Chiralpak AD column (80:20 
hexane/isopropanol) flow rate 1 ml/min, 220 nm, major tR = 7.1 min, minor tR = 21.5 min (88% ee), 
>98:2 dr. 
 
M.P. 275-277 
o
C; [α]D
25 
= + 75.8 (c = 0.91 in CHCl3); νmax(film)/cm
-1
 3283 (br w, N-H), 1665 (s, 
C=O); 
1
H NMR: δH (400 MHz, CDCl3) 1.50-1.67 (m, 3H, NCCH2CHAHB, NCCH2CH2CH2), 1.74-1.87 
(m, 2H, NCCHAHBCH2, NCCH2CHAHB), 1.90-1.96 (m, 2H, CHCH2CH2), 2.17-2.25 (m, 1H, 
NCCHAHBCH2), 2.38 (dd, 1H, J = 12.9 Hz, J = 5.4 Hz, C(O)CHAHBCH), 2.45-2.59 (m, 2H, 
C(O)CHAHBCH, CHCH2), 2.71-2.88 (m, 2H, NCH2CH2), 3.10 (td, 1H, J = 12.3 Hz, J = 5.3 Hz, 
NCHAHBCH2), 4.44 (dd, 1H, J = 13.2 Hz, J = 6.0 Hz, NCHAHBCH2), 7.23-7.30 (m, 2H, 2 x Ar-H), 
7.62 (s, 1H, Ar-H), 8.09 (br s, 1H, N-H); 
13
C NMR: δC (100 MHz, CDCl3) 20.2 (CHCH2CH2), 20.9 
(NCH2CH2), 22.0 (NCCH2CH2), 26.1 (CHCH2CH2), 34.1 (NCH2CH2), 34.5 (NCCH2CH2), 35.4 
(C(O)CH2CH), 37.9 (CHCH2), 60.1 (CH2CN), 106.9 (ArC-quat), 112.5 (ArC-H), 113.1 (ArC-quat), 
121.1 (ArC-H), 124.9 (ArC-H), 128.3 (ArC-quat), 134.5 (ArC-quat), 139.3 (ArC-quat), 172.8 (CO); 
m/z (ES
-
) 357, 359 ([M-H]
-
, 70%); HRMS ES (+) Found 381.0573 and 383.0555 for 
C18H19N2OBrNa
+
 [M+Na]
+
, requires 381.0573 and 383.0553. 
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7.4.12.12 Synthesis and characterisation of (4aR,14bR)-13-methyl-1,2,3,4,4a,5,9,14-octahydro-
6H,8H-pyrido[3,4-b:1,2-i']diindol-6-one (4.165) 
 
 
 
Following the general procedure the titled compound was obtained after 48 hours at reflux in the 
presence of (4.102) as a colourless crystalline solid following flash silica gel chromatography (ethyl 
acetate : petroleum ether, 3 : 2) (52 mg, 89%).  The ee was determined by HPLC using a Chiralpak 
AD column (95:5 hexane/isopropanol) flow rate 1 ml/min, 220 nm, major tR = 10.9 min, minor tR = 
16.0 min (98% ee), >98:2 dr. 
 
 M.P. 113-117 
o
C; [α]D
25 
= + 24.6 (c = 0.89 in CHCl3); νmax(film)/cm
-1
  3293 (br w, N-H), 1669 (s, 
C=O); 
1
H NMR: δH (400 MHz, CDCl3) 1.50-1.70 (m, 2H, CHAHB, CHAHB), 1.76-1.88 (m, 3H, CHAHB, 
CHAHB, CHAHB), 1.90-1.96 (m, 2H, C(O)CH2CH), 2.17-2.24 (m, 1H, CHAHB), 2.35-2.44 (m, 1H, 
CHAHB), 2.48-2.52 (m, 5H, CHCH2 CH3C, CHAHB), 2.79 (dd, 1H, J = 15.4 Hz, J = 5.1 Hz, 
NCH2CHAHB), 2.84-2.93 (m, 1H, NCH2CHAHB), 3.11 (td, 1H, J = 12.3 Hz, J = 5.3 Hz, NCHAHBCH2), 
4.44 (dd, 1H, J = 13.1 Hz, J = 6.1 Hz, NCHAHBCH2), 7.02 (d, 1H, J = 7.1 Hz, Ar-H,), 7.08 (t, 1H,  J = 
7.4 Hz, Ar-H), 7.36 (d, 1H, J = 7.7 Hz, Ar-H), 7.70 (br s, 1H, N-H); 
13
C NMR: δC (100 MHz, CDCl3) 
17.1 (CH3), 20.9 (CH2), 21.4 (NCH2CH2), 22.4 (CH2), 27.1 (C(O)CH2CH), 34.5 (CH2), 35.3 
(NCH2CH2), 36.3 (CH2), 38.0 (CHCH2), 61.2 (CH2CN), 108.3 (ArC-quat), 116.5 (ArC-H), 120.5 & 
120.6 (ArC-H, ArC-quat), 123.3 (ArC-H), 126.6 (ArC-quat), 135.7 (ArC-quat), 138.2 (ArC-quat), 
174.5 (CO); m/z (ES
-
)  293 ([M-H]
-
, 100%); HRMS ES (+) Found 317.1619 for C19H22N2ONa
+
 
[M+Na]
+
, requires 317.1624. 
 
7.4.12.13 Synthesis and characterisation of (1R,11bR)-1,10,11b-trimethyl-1,2,5,6,11,11b-
hexahydro-3H-indolizino[8,7-b]indol-3-one (4.167) 
 
 
 
Following the general procedure the titled compound was obtained after 48 hours at reflux in the 
presence of (4.23) as a colourless crystalline solid following flash silica gel chromatography (ethyl 
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acetate : petroleum ether, 1 : 1) (62 mg, 95%).  The ee was determined by HPLC using a Chiralpak 
OD column (90:10 hexane/isopropanol) flow rate 1 ml/min, 220 nm, minor tR = 18.0 min, major tR = 
23.2 min (95% ee), dr = 97:3. 
 
M.P. 190-196 
o
C; [α]D
25 
= + 161.3 (c = 1.12 in CHCl3); νmax(film)/cm
-1
 3292 (br w, N-H), 1667 (s, 
C=O); 
1
H NMR: δH (400 MHz, CDCl3) 1.41 (d, 3H, J = 6.5 Hz, CH3CH), 1.49 (s, 3H, CH3), 2.27-2.39 
(m, 1H, CH3CH), 2.45-2.59 (m, 5H, C(O)CH2CH, CH3), 2.80-2.85 (m, 2H, NCH2CH2), 3.04 (m, 1H, 
NHAHBCH2), 4.50 (ddd, 1H, J = 12.9 Hz, J = 4.3 Hz, J = 2.8 Hz, NHAHBCH2), 7.02 (d, 1H, J = 7.1 
Hz, Ar-H), 7.08 (t, 1H, J = 7.5 Hz, Ar-H), 7.37 (d, 1H, J = 7.7 Hz, Ar-H), 8.03 (br s, 1H, N-H); 
13
C 
NMR: δC (100 MHz, CDCl3) 15.0 (CH3CH), 16.8 (CH3), 19.3 (CH3), 21.7 (NCH2CH2), 35.0 
(NCH2CH2), 38.8 C(O)CH2CH), 39.2 (CHCH2) 61.7 (CH3CN), 107.8 (ArC-quat), 116.2 (ArC-H), 
120.2 (ArC-H), 120.3 (ArC-quat), 123.0 (ArC-H), 126.3 (ArC-quat), 135.6 (ArC-quat), 137.8 (ArC-
quat), 171.9 (CO); m/z (ES
-
) 267 ([M-H]
-
, 100%); HRMS ES (+)  Found 291.1469 for C17H20N2ONa
+
 
[M+Na]
+
, requires 291.1468. 
 
7.4.12.14 Synthesis and characterisation of (1R,11bR)-1-ethyl-10,11b-dimethyl-1,2,5,6,11,11b-
hexahydro-3H-indolizino[8,7-b]indol-3-one (4.168) 
 
 
 
Following the general procedure the reaction was carried out on a 0.3 mmol scale.  The titled 
compound was obtained after 54 hours at reflux in the presence of (4.102) as a colourless 
crystalline solid following flash silica gel chromatography (ethyl acetate : petroleum ether, 3 : 2) (69 
mg, 81%).  The ee was determined by HPLC using a Chiralpak OD column (85:15 
hexane/isopropanol) flow rate 1 ml/min, 220 nm, minor tR = 8.4 min, major tR = 18.6 min (94% ee), 
dr = 97:3. 
 
M.P. 107-111 
o
C; [α]D
25 
= + 161.2 (c = 1.06 in CHCl3); νmax(film)/cm
-1
 3290 (br w, N-H), 1667 (s, 
C=O); 
1
H NMR: δH (400 MHz, CDCl3) 1.07 (t, 3H, J = 7.3 Hz, CH3CH2), 1.48 (s, 3H, CH3C), 1.62-
1.74 (m, 1H, CH3CHAHB), 1.89-2.00 (m, 1H, CH3CHAHB), 2.23-2.36 (m, 2H, C(O)CHAHBCH, 
CHCH2), 2.52 (s, 3H, CH3), 2.58-2.68 (m, 1H, C(O)CHAHBCH), 2.79-2.84 (m, 2H, NCH2CH2), 3.03 
(dt, 1H, J = 13.0 Hz, J = 8.4 Hz, NCHAHBCH2), 4.50 (dt, 1H, J = 6.9 Hz, J = 3.7 Hz, NCHAHBCH2), 
7.02 (d, 1H, J = 7.1 Hz, Ar-H), 7.08 (t, 1H, J = 7.4 Hz, Ar-H), 7.36 (d, 1H, J = 7.7 Hz, Ar-H), 7.85 (br 
s, 1H, N-H); 
13
C NMR: δC (100 MHz, CDCl3) 12.8 (CH3CH2), 16.8 (CH3), 19.8 (CH3), 21.6 
(NCH2CH2), 23.7 (CH3CH2), 34.8 (NCH2CH2), 36.5 (C(O)CH2CH), 46.5 (CHCH2), 61.6 (CH3CN), 
107.9 (ArC-quat), 116.2 (ArC-H), 120.2 (2C, ArC-H, ArC-quat), 123.0 (ArC-H), 126.2 (ArC-quat), 
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135.5 (ArC-quat), 137.7 (ArC-quat), 171.7 (CO); m/z (ES
-
) 281 ([M-H]
-
, 100%); HRMS ES (+) 
Found 305.1626 for C18H22N2ONa
+
 [M+Na]
+
, requires 305.1624. 
 
7.4.12.15 Synthesis and characterisation of (1R,11bR)-1-butyl-10,11b-dimethyl-1,2,5,6,11,11b-
hexahydro-3H-indolizino[8,7-b]indol-3-one (4.169) 
 
 
 
Following the general procedure the titled compound was obtained after 72 hours at reflux in the 
presence of (4.102) as a colourless crystalline solid following flash silica gel chromatography (ethyl 
acetate : petroleum ether, 1 : 1) (58 mg, 94%).  The ee was determined by HPLC using a Chiralpak 
OD column (90:10 hexane/isopropanol) flow rate 1 ml/min, 220 nm, minor tR = 6.6 min, major tR = 
12.9 min (98% ee), >98:2 dr. 
 
M.P. 208-210 
o
C; [α]D
25 
= + 100.9 (c = 0.91 in CHCl3); νmax(film)/cm
-1
 3296 (br w, N-H), 1668 (s, 
C=O); 
1
H NMR (400 MHz, CDCl3) 0.97 (t, 3H, J = 6.3 Hz, CH3CH2), 1.27-1.47 (m, 4H, CH3CH2, 
CH3CH2CH2), 1.49 (s, 3H, CH3), 1.61-1.72 (m, 1H, CHCHAHBCH2), 1.82-1.91 (m, 1H, 
CHCHAHBCH2), 2.23-2.42 (m, 2H, C(O)CHAHBCH, CHCH2), 2.53 (s, 3H, CH3), 2.60 (dd, 1H, J = 
15.0 Hz, J = 6.9 Hz, C(O)CHAHBCH), 2.79-2.84 (m, 2H, NCH2CH2), 2.98-3.07 (m, 1H, 
NCHAHBCH2), 4.47-4.53 (m, 1H, NCHAHBCH2), 7.02 (d, 1H, J = 7.0 Hz, Ar-H), 7.08 (t, 1H, J = 7.4 
Hz, Ar-H), 7.37 (d, 1H, J = 7.7 Hz, Ar-H), 7.91 (br s, 1H, N-H); 
13
C NMR: δC (100 MHz, CDCl3) 14.0 
(CH3CH2), 16.8 (CH3), 19.7 (2C, CH3, CH2), 21.7 (CH2), 22.8 (NCH2CH2), 30.4 (CHCH2CH2), 34.9 
(NCH2CH2), 36.9 (C(O)CH2CH), 44.7 (CHCH2), 61.6 (CH3CN), 107.9 (ArC-quat), 116.2 (ArC-H), 
120.2 (2C, ArC-H, ArC-quat), 123.0 (ArC-H), 126.2 (ArC-quat), 135.5 (ArC-quat), 137.8 (ArC-quat), 
171.7 (CO); m/z (ES
-
) 309 ([M-H]
-
, 100%); HRMS ES (+) Found 333.1937 for C20H26N2ONa
+
 
[M+Na]
+
, requires 333.1937. 
 
7.4.12.16 Synthesis and characterisation of (5aR,15bR)-14-methyl-2,3,4,5,5a,6,10,15-octahydro-
9H-cyclohepta[1,8a]indolizino[8,7-b]indol-7(1H)-one (4.170) 
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Following the general procedure the reaction was carried out on a 0.3 mmol scale.  The titled 
compound was obtained after 48 hours at reflux in the presence of (4.102) as a colourless 
crystalline solid following flash silica gel chromatography (ethyl acetate : petroleum ether, 1 : 1) (84 
mg, 91%).  The ee was determined by HPLC using a Chiralpak AD column (90:10 
hexane/isopropanol) flow rate 1 ml/min, 220 nm, major tR = 7.5 min, minor tR = 9.9 min (93% ee), 
>98:2 dr. 
 
M.P. 128-133 
o
C; [α]D
25 
= + 15.1 (c = 0.67 in CHCl3); νmax(film)/cm
-1
 3279 (br w, N-H), 1662 (s, 
C=O); 
1
H NMR: δH (400 MHz, CDCl3) 1.46-1.58 (m, 2H, CH2), 1.69-1.76 (m, 1H, CHAHB), 1.80-1.88 
(m, 2H, CH2), 1.90-1.96 (m, 1H, CHAHB), 2.03-2.13 (m, 3H, CH2, CHAHB), 2.28 (dd, 1H, J = 15.1 
Hz, J = 8.8 Hz, CHAHB), 2.49-2.55 (m, 4H, C(O)CHAHBCH, CH3) 2.68-2.79 (m, 2H, NCH2CHAHB, 
C(O)CHAHBCH), 2.92-3.01 (m, 2H, NCH2CHAHB, H-7), 3.15 (td, 1H, J = 12.5 Hz, J = 4.7 Hz, 
NCHAHBCH2), 4.56 (dd, 1H, J = 13.2 Hz, J = 6.3 Hz, NCHAHBCH2), 7.05 (d, 1H, J = 6.9 Hz, Ar-H), 
7.10 (t, 1H, J = 7.4 Hz, Ar-H), 7.38 (d, 1H, J = 7.6 Hz, Ar-H), 7.90 (br s, 1H, N-H); 
13
C NMR: δC 
(100 MHz, CDCl3) 17.2 (CH3), 21.4 (NCH2CH2), 23.9 (CH2), 25.3 (CH2), 30.3 (CH2), 31.5 (CH2), 
35.5 & 35.8  (NCH2CH2, C(O)CH2CH), 38.5 (CH2), 41.6 (CHCH2), 66.9 (CH2CN), 107.7 (ArC-quat), 
116.6 (ArC-H), 120.6 (2C, ArC-H, ArC-quat), 123.3 (ArC-H), 126.7 (ArC-quat), 135.8 (ArC-quat), 
139.8 (ArC-quat), 174.1 (CO); m/z (ES
-
) 307 ([M-H]
-
, 100%); HRMS ES (+) Found 331.1780 for 
C20H24N2ONa
+
 [M+Na]
+
, requires 331.1781. 
 
7.4.13 Attempt at δ-lactam formation  
 
7.4.13.1 Synthesis and characterisation of ethyl 4-acetyl-5-{[2-(1H-indol-3-yl)ethyl]amino}hex-4-
enoate (4.172) 
 
 
 
Ethyl 4-acetyl-5-oxohexanoate (4.171) (38 μL, 0.2 mmol) was dissolved in xylene (42 mL) and 
tryptamine (32 mg, 0.2 mmol) was added in one portion at room temperature, immediately followed 
by the addition of phosphoric acid catalyst (4.23) (17.3 mg, 0.02 mmol) in one portion. The resulting 
suspension was heated under reflux for 5 days.  The solvent was removed in vacuo, and the 
residue purified by chromatography on silica gel (ethyl acetate : petroleum ether, 1 : 1) to yield a 
colourless crystalline solid (25 mg, 37%). 
 
M.P. 65-69 ºC; νmax(film)/cm
-1
 3234 (br w, N-H), 1729 (s, C=O), 1593 (s, C=O); 
1
H NMR: δH (400 
MHz, CDCl3) 1.26 (t, 3H, J = 7.1 Hz, CH2CH3), 1.94 (s, 3H, CH3), 2.16 (s, 3H, CH3), 2.27-2.33 (m, 
2H, CH2), 2.54-2.60 (m, 2H, CH2), 3.06 (t, 2H, J = 6.8 Hz, NCH2CH2), 3.55-3.62 (m, 2H, NCH2CH2), 
4.13 (q, 2H, J = 7.1 Hz, CH2CH3), 7.09-7.14 (m, 2H, NHCH, Ar-H), 7.18 (t, 1H, J = 7.5 Hz, Ar-H), 
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7.34 (d, 1H, J = 8.0 Hz, Ar-H), 7.57 (d, 1H, J = 7.8 Hz, Ar-H), 8.57 (br s, 1H, N-H), 12.24 (br s, 1H, 
N-H); 
13
C NMR: δC (100 MHz, CDCl3) 14.2 (CH2CH3), 14.9 (CH3), 24.9 (CH2), 26.0 (NCH2CH2), 
27.4 (CH3), 35.8 (CH2), 44.1 (NCH2CH2), 60.4 (CH2CH3), 101.9 (C-quat), 111.4 (ArC-H), 112.1 (C-
quat), 118.4 (ArC-H), 119.3 & 121.9 & 122.9 (2 x ArC-H, NHCH), 127.0 (ArC-quat), 136.4 (ArC-
quat), 163.2 (ArC-quat), 173.2 (CO), 194.2 (CO); m/z (ES
+
) 365 ([M+Na]
+
, 30%), 707 ([2M+Na]
+
, 
100%); HRMS ES (+) Found 365.1830 for C20H26N2O3Na
+
 [M+Na]
+
, requires 365.1836. 
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7.5 Experimental for chapter 5 
7.5.1 Studies towards the synthesis of ketone (4.84) 
 
7.5.1.1 Synthesis and characterisation of ethyl 4-oxo-3-[(phenylthio)methyl]pentanoate (5.10) 
 
 
 
To a solution of PhSH (51 µL, 0.7 mmol) in anhydrous THF (3 mL) at 0 ºC under N2 was added 
NEt3 (9 µL, 0.06 mmol) and a solution of alkene (4.94) (100 mg, 0.64 mmol) in THF (3 mL) under N2 
and the solution was heated to reflux for 3 hours before cooling and evaporating the solvent in 
vacuo to afford the crude.  Purification of the crude residue by flash silica gel chromatography (ethyl 
acetate : petroleum ether, 4 : 1) afforded the titled compound as a colourless oil (143 mg, 84%). 
 
νmax(film)/cm
-1
 1731 (br s, C=O); 
1
H NMR: δH (400 MHz, CDCl3) 1.23 (t, 3H, J = 7.1 Hz, CH2CH3), 
2.25 (s, 3H, C(O)CH3), 2.58-2.64 (m, 1H, CHH), 2.80 (dd, 1H, J = 16.9 Hz, J = 8.6 Hz, CHH), 2.89-
2.98 (m, 1H, CHH), 3.13-3.23 (m, 2H, CHH, CHCH2), 4.10 (q, 2H, J = 7.1 Hz, CH2CH3), 7.20-7.40 
(m, 5H, 5 x Ar-H); 
13
C NMR: δC (100 MHz, CDCl3) 14.1 (CH2CH3), 30.2 (C(O)CH3), 35.1 (CH2), 35.2 
(CH2), 47.2 (CHCH2), 60.8 (CH2CH3), 126.8 (ArC-H), 129.2 (2 x ArC-H), 130.0 (2 x ArC-H), 135.1 
(SCCH), 171.8 (CO), 209.0 (CO); m/z (ES
+
) 289 ([M+Na]
+
, 55%), 555 ([2M+Na]
+
, 100%); HRMS ES 
(+) Found 289.0868 for C14H18O3SNa
+
 [M+Na]
+
, requires 289.0869.  
 
7.5.1.2 Synthesis and characterisation of (11bR)-11b-methyl-1,2,5,6,11,11b-hexahydro-3H-
indolizino[8,7-b]indol-3-one (4.74)
78
 
 
 
 
To a solution of (5.10) (53 mg, 0.2 mmol) in toluene (42 mL), was added tryptamine (32 mg, 0.2 
mmol) and catalyst (4.23) (17 mg, 0.02 mmol) and the solution was refluxed for 4 days before 
cooling and evaporating the solvent in vacuo to afford the crude.  Purification of the crude residue 
by flash silica gel chromatography (ethyl acetate) afforded the titled compound as a colourless solid 
(25 mg, 51%).  The ee was determined by HPLC using a Chiralpak OD column (80:20 
hexane/isopropanol) flow rate 2 ml/min, 220 nm, major tR = 3.7 min, minor tR = 4.4 min (60% ee). 
 
M.P. 214-219 
o
C; [α]D
25 
= + 17.2 (c = 0.80 in CHCl3) (lit. [α]D
23 
= + 179.0 (c = 1.0 in CHCl3), 96% 
ee); 
1
H NMR: δH  (400 MHz, CDCl3) 1.60 (s, 3H, CH3C), 2.13-2.23 (m, 1H, CHAHBCH2C(O)), 2.29 
(ddd, 1H, J = 11.0 Hz, J = 8.9 Hz, J = 2.0 Hz, CHAHBCH2C(O)), 2.47 (ddd, 1H, J = 16.8 Hz, J = 9.5 
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Hz, J = 2.0 Hz, CHAHBC(O)), 2.62-2.73 (m, 1H, CHAHBC(O)), 2.77-2.90 (m, 2H, NCH2CH2C), 3.06-
3.15 (m, 1H, NCHAHBCH2C), 4.45-4.51 (m, 1H, NCHAHBCH2C), 7.13 (t, 1H, J = 7.4 Hz, Ar-H), 7.19 
(t, 1H, J = 7.5 Hz, Ar-H), 7.34 (d, 1H, J = 8.0 Hz, Ar-H), 7.49 (d, 1H, J = 7.7 Hz, Ar-H), 8.43 (br s, 
1H, N-H); m/z (ES
+
) 263 ([M+Na]
+
, 30%), 503 ([2M+Na]
+
, 100%). 
 
7.5.1.3 Synthesis and characterisation of tert-butyl (4E)-3-hydroxy-4-methylhept-4-enoate (5.13) 
 
 
 
A procedure developed by Kobayashi et al. was followed.
94
  To a solution of tert-butyl acetate (2.46 
mL, 18.3 mmol) in THF (10 mL) at -78 ºC under N2 was added a solution of LDA in THF (30 mL, 
18.3 mmol).  The solution was stirred at -78 ºC for 30 minutes before the addition of alkene (5.12) 
(1.16 mL, 10.2 mmol) in THF (10 mL) at -78 ºC.  The solution was stirred at -78 ºC for 2 hours 
before quenching with a saturated solution of NH4Cl (5 mL) and warming to room temperature.  The 
aqueous layer was extracted with diethyl ether (3 x 20 mL) and the combined organic layers were 
dried over Na2SO4 and the solvent evaporated in vacuo to afford the crude.  Purification of the 
crude residue by flash silica gel chromatography (petroleum ether : ethyl acetate, 7 : 3) afforded the 
titled compound as a colourless oil (2.16 g, 99%).  
 
νmax(film)/cm
-1
 3438 (br m, O-H), 2968 (s, C-H alkene), 1730 (s, C=O); 
1
H NMR: δH (400 MHz, 
CDCl3) 0.93 (t, 3H, J = 7.6 Hz, CH2CH3), 1.43 (s, 9H, C(CH3)3), 1.60 (s, 3H, CH3C), 1.94-2.07 (m, 
2H, CH2CH3), 2.37-2.51 (m, 2H, C(O)CH2), 3.00 (br s, 1H, O-H), 4.35 (dd, 1H, J = 8.6 Hz, J = 4.1 
Hz, C(O)CH2CH), 5.43 (t, 1H, J = 7.0 Hz, CH3CH2CH); 
13
C NMR: δC (100 MHz, CDCl3) 11.6 
(CH3C), 13.9 (CH2CH3), 20.8 (CH2CH3), 28.0 (C(CH3)3), 41.2 (C(O)CH2), 73.5 (C(O)CH2CH), 81.1 
(C-quat), 128.4 (CH3CH2CH), 134.6 (C-quat), 172.1 (CO); m/z (ES
+
) 237 ([M+Na]
+
, 50%), 451 
([2M+Na]
+
, 100%); HRMS ES (+) Found 237.1459 for C12H22O3Na
+
 [M+Na]
+
, requires 237.1461. 
 
7.5.1.4 Synthesis and characterisation of tert-butyl 3-hydroxy-4-oxopentanoate (5.14) 
 
 
 
A procedure developed by Kobayashi et al. was followed.
94
  O3 was bubbled through a solution of 
alkene (5.13) (1.0 g, 4.66 mmol) in MeOH (35 mL) at -78 ºC for 30 minutes before quenching with 
DMS (685 µL, 9.33 mmol).  The solution was slowly warmed to room temperature and allowed to 
stir at room temperature for 2 hours before adding more DMS (3.42 mL, 46.6 mmol) and stirring for 
12 hours.  The solution was evaporated in vacuo to afford the crude.  Purification of the crude 
residue by flash silica gel chromatography (petroleum ether : ethyl acetate, 3 : 2) afforded the titled 
compound as a colourless oil (822 mg, 95%).  
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νmax(film)/cm
-1
 3467 (m, O-H), 1723 (br s, C=O); 
1
H NMR: δH (400 MHz, CDCl3) 1.45 (s, 9H, 
C(CH3)3), 2.28 (s, 3H, C(O)CH3), 2.71 (dd, 1H, J = 16.3 Hz, J = 5.6 Hz, C(O)CHAHB), 2.79 (dd, 1H, 
J = 16.3 Hz, J = 4.5 Hz, C(O)CHAHB), 3.81 (br s, 1H, O-H), 4.31 (app. t, 1H, J = 5.0 Hz, 
C(O)CH2CH); 
13
C NMR: δC (100 MHz, CDCl3) 25.3 (C(O)CH3), 28.0 (C(CH3)3), 39.2 (C(O)CH2), 
74.0 (C(O)CH2CH), 82.0 (C(CH3)3), 170.0 (CO), 208.5 (CO); m/z (ES
+
) 211 ([M+Na]
+
, 50%), 399 
([2M+Na]
+
, 100%); HRMS ES (+) Found 211.0939 for C9H16O4Na
+
 [M+Na]
+
, requires 211.0941. 
 
7.5.1.5 Synthesis and characterisation of 1-[2-(1H-indol-3-yl)ethyl]-5-methylpyrrolidine-2,4-dione 
(5.15) 
 
 
 
To a solution of (5.14) (37 mg, 0.2 mmol) in toluene (42 mL), was added tryptamine (32 mg, 0.2 
mmol) and catalyst (4.23) (17 mg, 0.02 mmol) and the solution was refluxed for 2 days before 
cooling and evaporating the solvent in vacuo to afford the crude.  Purification of the crude residue 
by flash silica gel chromatography (dichloromethane : acetone, 9 : 1) afforded the titled compound 
as a colourless solid (22 mg, 43%).  
 
M.P. 116-118 ºC; [α]D
25 
= + 7.0 (c = 1.86 in CHCl3); νmax(film)/cm
-1
 3294 (w, N-H), 1770 (w, C=O), 
1677 (s, C=O); 
1
H NMR: δH (500 MHz, CDCl3) 1.28 (d, 3H, J = 7.0 Hz, CH3CH), 3.00-3.07 (m, 3H, 
C(O)CH2, NCH2CHAHB), 3.15 (ddd, 1H, J = 14.7 Hz, J = 8.3 Hz, J = 6.5 Hz, NCH2CHAHB), 3.36-3.43 
(m, 1H, NCHAHBCH2), 3.78 (q, 1H, J = 7.0 Hz, CHCH3), 4.13-4.21 (m, 1H, NCHAHBCH2), 7.06 (d, 
1H, J = 1.8 Hz, NHCH), 7.12-7.16 (m, 1H, Ar-H), 7.19-7.23 (m, 1H, Ar-H), 7.37 (d, 1H, J = 8.1 Hz, 
Ar-H), 7.62 (d, 1H, J = 7.9 Hz, Ar-H), 8.19 (br s, 1H, N-H); 
13
C NMR: δC (125 MHz, CDCl3) 15.3 
(CH3CH), 23.3 (NCH2CH2), 40.6 & 40.7 (C(O)CH2, NCH2CH2), 62.8 (CH3CH), 111.4 (ArC-H), 112.4 
(ArC-quat), 118.3 (ArC-H), 119.6 (ArC-H), 121.9 & 122.3 (ArC-H, NHCH), 127.2 (ArC-quat), 136.3 
(ArC-quat), 168.4 (CO), 207.0 (CO); m/z (ES
+
) 279 ([M+Na]
+
, 70%), 535 ([2M+Na]
+
, 100%); HRMS 
ES (+) Found 279.1103 for C15H16N2O2Na
+
 [M+Na]
+
, requires 279.1104. 
 
7.5.1.6 Synthesis and characterisation of tert-butyl 3-acetoxy-4-oxopentanoate (5.16) 
 
 
 
To a solution of alcohol (5.14) (172 mg, 0.92 mmol) in pyridine (4 mL) under N2 was added acetic 
anhydride (157 µL, 1.66 mmol) and the solution was stirred at room temperature for 24 hours 
before diluting with EtOAc (10 mL) and adding a saturated solution of CuSO4 (10 mL).  The organic 
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layer was washed with a saturated solution of CuSO4 (3 x 10 mL) before drying over Na2SO4 and 
evaporating the solvent in vacuo to afford the crude.  Purification of the crude residue by flash silica 
gel chromatography (petroleum ether : diethyl ether, 3 : 2) afforded the titled compound as a 
colourless oil (210 mg, 99%).  
 
νmax(film)/cm
-1
 1731 (br s, C=O); 
1
H NMR: δH (400 MHz, CDCl3) 1.43 (s, 9H, C(CH3)3), 2.14 (s, 3H, 
CH3), 2.21 (s, 3H, CH3), 2.72-2.75 (m, 2H, C(O)CH2), 5.34 (t, 1H, J = 5.9 Hz, C(O)CH2CH); 
13
C 
NMR: δC (100 MHz, CDCl3) 20.6 (CH3), 26.4 (CH3), 27.9 (C(CH3)3), 36.8 (C(O)CH2), 74.8 
(C(O)CH2CH), 81.7 (C(CH3)3), 168.5 (CO), 170.1 (CO), 204.5 (CO); m/z (ES
+
) 253 ([M+Na]
+
, 40%), 
483 ([2M+Na]
+
, 100%); HRMS ES (+) Found 253.1045 for C11H18O5Na
+
, [M+Na]
+
, requires 
253.1046. 
 
7.5.1.7 Synthesis and characterisation of N-[2-(1H-indol-3-yl)ethyl]acetamide (5.17)
95
 
 
 
 
To a solution of β-nitroester (5.18) (35 mg, 0.2 mmol) in toluene (42 mL), was added tryptamine (32 
mg, 0.2 mmol) and catalyst (4.23) (17 mg, 0.02 mmol) and the solution was refluxed for 2 days 
before cooling and evaporating the solvent in vacuo to afford the crude.  Purification of the crude 
residue by flash silica gel chromatography (increasing polarity from dichloromethane : acetone, 9 : 
1 to 4 : 1) afforded the titled compound as a colourless oil (23 mg, 58%).   
 
1
H NMR: δH (400 MHz, CDCl3) 1.97 (s, 3H, C(O)CH3), 3.03 (t, 2H, J = 6.8 Hz, NHCH2CH2), 3.65 
(app. q, 2H, J = 6.6 Hz, NHCH2CH2), 5.66 (br s, 1H, NHCH2), 7.08 (d, 1H, J = 2.4 Hz, NHCH), 7.16-
7.21 (m, 1H, Ar-H), 7.24-7.29 (m, 1H, Ar-H), 7.43 (d, 1H, J = 7.9 Hz, Ar-H), 7.65 (d, 1H, J = 7.9 Hz, 
Ar-H), 8.38 (br s, 1H, N-H); m/z (ES
+
) 225 ([M+Na]
+
, 95%). 
 
7.5.2 Studies towards subincanadine B from methyl ester (±)-(4.116) 
 
7.5.2.1 Synthesis and characterisation of (±)-(11b-methyl-2,3,5,6,11,11b-hexahydro-1H-
indolizino[8,7-b]indol-1-yl)methanol (±)-(5.20) 
 
 
 
To a solution of methyl ester (±)-(4.116) (500 mg, 1.67 mmol) in THF (16 mL) at -10 ºC under N2 
was added LiAlH4 (6.7 mL, 6.70 mmol, 1.0 M sol. in THF) and the solution was stirred at room 
temperature for 7 hours before cooling to 0 ºC and adding Na2SO4
.
10H2O.  The solution was stirred 
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at room temperature for 10 minutes and then filtered through a celite pad to remove the salts.  The 
solvent was evaporated in vacuo to afford the crude (425 mg, 99%) which did not require further 
purification. 
 
M.P. 195-197 ºC; νmax(film)/cm
-1
 3397 (br w, N-H, OH); 
1
H NMR: δH (400 MHz, CD3OD) 1.47 (s, 
3H, CH3C), 1.56-1.66 (m, 1H, CHAHBCHCH2OH), 1.86-1.95 (m, 1H, CHAHBCHCH2OH), 2.39-2.48 
(m, 1H, CHCH2OH), 2.54-2.61 (dt, 1H, J = 15.7 Hz, J = 3.2 Hz, CHAHB), 2.87-2.97 (m, 3H, 
NCH2CH2CH, CHAHB), 3.16-3.21 (m, 2H, CH2), 3.70 (dd, 1H, J = 10.4 Hz, J = 7.1 Hz, 
CHCHAHBOH), 3.92 (dd, 1H, J = 10.4 Hz, J = 7.9 Hz, CHCHAHBOH), 6.97 (t, 1H, J = 7.4 Hz, Ar-H), 
7.04 (t, 1H, J = 7.5 Hz, Ar-H), 7.29 (d, 1H, J  = 7.9 Hz, Ar-H), 7.39 (d, 1H, J = 7.8 Hz, Ar-H); 
13
C 
NMR: δC (100 MHz, CD3OD) 16.7 (CH2), 20.8 (CH3), 27.0 (CH2), 43.4 (CH2), 48.3 (NCH2CH2CH), 
49.6 (NCH2CH2CH), 61.3 (CH3C), 62.5 (CH2OH), 104.8 (ArC-quat), 110.8 (ArC-H), 117.8 (ArC-H), 
118.7 (ArC-H), 121.0 (ArC-H), 127.2 (ArC-quat), 136.7 (ArC-quat), 140.1 (ArC-quat); m/z (ES
+
) 257 
([M+H]
+
, 100%); HRMS ES (+) Found 257.1648 for C16H21N2O+ [M+H]
+
, requires 257.1648. 
 
 7.2.2.2 Synthesis and characterisation of (±)-(11b-methyl-2,3,5,6,11,11b-hexahydro-1H-
indolizino[8,7-b]indol-1-yl)methyl methanesulfonate (±)-(5.23) 
 
 
 
To a solution of alcohol (±)-(5.20) (100 mg, 0.39 mmol) in CH2Cl2 (18 mL) at 0 ºC was added MsCl 
(45 µL, 0.59 mmol) and NEt3 (98 µL, 0.70 mmol) and the solution was stirred at 0 ºC for 2 hours.  
CH2Cl2 (10 mL) and a saturated solution of NH4Cl (20 mL) were added and the solution was 
extracted with CH2Cl2 (3 x 20 mL).  The combined organic layers were dried over Na2SO4 and the 
solvent evaporated in vacuo to afford the crude as a colourless solid (129 mg, 99%) which did not 
require further purification.   
 
M.P. 50-52 ºC; νmax(film)/cm
-1
 3447 (br w, N-H), 1349 (br s, S=O), 1174 (br s, S-O); 
1
H NMR: δH 
(400 MHz, CDCl3) 1.53 (s, 3H, CH3C), 1.56-1.66 (m, 1H, NCH2CHAHBCH) 1.88-1.95 (m, 1H, 
NCH2CHAHBCH), 2.55-2.62 (m, 1H, NCH2CHAHBC), 2.67-2.76 (m, 1H, NCH2CH2CH), 2.90-3.02 (m, 
3H, NCH2CHAHBC, NCH2CH2CH), 3.13 (s, 3H, OSO2CH3), 3.20-3.30 (m, 2H, NCH2CH2C), 4.44-
4.48 (m, 2H, OCH2CH), 7.10 (t, 1H, J = 7.4 Hz, Ar-H), 7.17 (t, 1H, J = 7.5 Hz, Ar-H), 7.36 (d, 1H, J = 
7.9 Hz, Ar-H), 7.50 (d, 1H, J = 7.8 Hz, Ar-H), 8.27 (br s, 1H, N-H); 
13
C NMR: δC (100 MHz, CDCl3) 
16.5 (NCH2CH2C), 22.5 (CCH3), 26.8 (NCH2CH2CH), 37.7 (OSO2CH3), 42.9 (NCH2CH2C), 47.4 
(NCH2CH2CH), 48.3 (NCH2CH2CH), 60.2 (CH3C), 71.1 (OCH2CH), 106.2 (ArC-quat), 111.1 (ArC-
H), 118.2 (ArC-H), 119.3 (ArC-H), 121.7 (ArC-H), 126.8 (ArC-quat), 135.9 (ArC-quat), 139.1 (ArC-
quat); m/z (ES
+
) 335 ([M+H]
+
, 80%); HRMS ES (+) Found 335.1417 for C17H23N2O3S
+
 [M+H]
+
, 
requires 335.1424. 
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7.5.2.3 Synthesis and characterisation of methyl (11bR)-2-anilino-11b-methyl-3-oxo-5,6,11,11b-
tetrahydro-3H-indolizino[8,7-b]indole-1-carboxylate (5.33) 
 
 
 
To a solution of (4.107) (95 mg, 0.3 mmol) in toluene (63 mL), was added nitrosobenzene (96 mg, 
0.9 mmol) and catalyst (4.60) (23 mg, 0.03 mmol) and the solution was refluxed for 4 hours before 
cooling and evaporating the solvent in vacuo to afford the crude.  Purification of the crude residue 
by flash silica gel chromatography (increasing polarity from petroleum ether : ethyl acetate, 9 : 1 to 
4 : 1) afforded the titled compound as a colourless solid (44 mg, 37%).  The ee was determined by 
HPLC using a Chiralpak AS column (85:15 hexane/isopropanol) flow rate 1 ml/min, 220 nm, minor 
tR = 9.5 min, major tR = 13.0 min (44% ee). 
 
M.P. 147-152 ºC; [α]D
25 
= + 48.1 (c = 1.28 in CHCl3); νmax(film)/cm
-1
 3387 (br w, N-H), 1702 (s, 
C=O), 1675 (s, C=O); 
1
H NMR: δH (400 MHz, CDCl3) 1.87 (s, 3H, CH3C), 2.83-3.00 (m, 2H, 
NCH2CH2), 3.39 (ddd, 1H, J = 12.9 Hz, J = 11.6 Hz, J = 5.3 Hz, NCHAHBCH2), 3.66 (s, 3H, OCH3), 
4.66 (app. dd, 1H, J = 12.9 Hz, J = 6.0 Hz, NCHAHBCH2), 7.05-7.24 (m, 5H, 5 x Ar-H), 7.31 (t, 2H, J 
= 7.7 Hz, 2 x Ar-H), 7.40 (d, 1H, J = 8.1 Hz, Ar-H), 7.50 (d, 1H, J = 7.8 Hz, Ar-H), 7.59 (br s, 1H, N-
H), 9.59 (br s, 1H, N-H); 
13
C NMR: δC (100 MHz, CDCl3) 21.5 (NCH2CH2), 25.9 (CH3C), 36.2 
(NCH2CH2), 51.5 (OCH3), 60.9 (CH3C), 105.8 (C-quat), 110.7 (C-quat), 111.3 (ArC-H), 118.6 (ArC-
H), 119.5 (ArC-H), 122.2 (ArC-H), 122.9 (2 x ArC-H), 125.1 (ArC-H), 126.4 (C-quat), 128.5 (2 x 
ArC-H), 135.6 (C-quat), 138.9 (2 x C-quat), 141.3 (C-quat), 164.2 (CO), 165.8 (CO); m/z (ES
+
) 410 
([M+Na]
+
, 55%), 797 ([2M+Na]
+
, 100%); HRMS ES (+) Found 410.1481 for C23H21N3O3Na
+
 
[M+Na]
+
, requires 410.1475. 
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Appendix 1: Crystallographic data for (2.54) 
 
 
 
Data obtained at School of Chemistry, The University of Manchester, Oxford Road, Manchester, 
M13 9PL, UK. 
Refinement: 
The structure was solved by the direct methods. All non-H atoms were refined anisotropically. H 
atoms were included in calculated positions, except those bonded to the N atoms, which were 
found by difference Fourier techniques and refined isotropically.  
Experimental: 
Crystal data 
C16H17N3O2 V = 1326.0 (4) Å
3
 
Mr = 283.33 Z = 4 
Orthorhombic, P212121 Mo Kα radiation, λ = 0.71073 Å 
a = 6.6240 (11) Å µ = 0.10 mm
−1
 
b = 7.5141 (12) Å T = 100 K 
c = 26.640 (4) Å 0.45 × 0.40 × 0.40 mm 
Data collection 
CCD area detector  
diffractometer 
1462 reflections with I > 2σ(I) 
7708 measured reflections Rint = 0.039 
1609 independent reflections  
Refinement 
R[F
2
 > 2σ(F
2
)] = 0.030 0 restraints 
wR(F
2
) = 0.070 
H atoms treated by a mixture of 
independent and constrained 
refinement 
S = 1.02 Δρmax = 0.17 e Å
−3
 
1609 reflections Δρmin = −0.18 e Å
−3
 
199 parameters  
Table 1 
Hydrogen-bond geometry (Å, º) 
D—H···A D—H H···A D···A D—H···A 
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N1—H1N···O1
i
 0.90 (2) 2.16 (2) 3.031 (2) 163.5 (19) 
 Data collection: Bruker SMART; cell refinement: Bruker SMART; data reduction: Bruker SAINT; 
program(s) used to solve structure: SHELXS97 (Sheldrick, 1990); program(s) used to refine 
structure: SHELXL97 (Sheldrick, 1997); molecular graphics: Bruker SHELXTL; software used to 
prepare material for publication: Bruker SHELXTL. 
References: 
Bruker (2001). SMART (Version 5.625), SADABS (Version 2.03a) and SHELXTL (Version 6.12). 
Bruker AXS Inc., Madison, Wisconsin, USA. 
Bruker (2002). SAINT. Version 6.36a. Bruker AXS Inc., Madison, Wisconsin, USA. 
M. C. Burla, R. Caliandro, M. Camalli, B. Carrozzini, G. L. Cascarano, L. De Caro,C. Giacovazzo, 
G. Polidori and R. Spagna SIR2004: an improved tool for crystal structure determination and 
refinement J. Appl. Cryst. (2005). 38, 381-388 
Sheldrick, G. M. (1997). SHELXS97 and SHELXL97. University of Göttingen, Germany. 
Sheldrick, G. M. (2005). CELL_NOW. University of Göttingen, Germany. 
Sheldrick, G. M. (2007). TWINABS. University of Göttingen, Germany. 
Spek, A. L. (2003). J.Appl.Cryst. 36, 2003, 7-13. 
Crystal data: 
C16H17N3O2 Dx = 1.419 Mg m
−3
 
Mr = 283.33 Mo Kα radiation, λ = 0.71073 Å 
Orthorhombic, P212121 Cell parameters from 891 reflections 
a = 6.6240 (11) Å θ = 2.8–26.1° 
b = 7.5141 (12) Å µ = 0.10 mm
−1
 
c = 26.640 (4) Å T = 100 K 
V = 1326.0 (4) Å
3
 Prismatic, Colourless 
Z = 4 0.45 × 0.40 × 0.40 mm 
F(000) = 600  
Data collection: 
CCD area detector  
diffractometer 
1462 reflections with I > 2σ(I) 
Radiation source: fine-focus sealed 
tube 
Rint = 0.039 
graphite θmax = 26.4°, θmin = 2.8° 
phi and ω scans h = −7→8 
7708 measured reflections k = −9→9 
1609 independent reflections l = −25→33 
Refinement: 
Refinement on F
2
 
Primary atom site location: Structure-
invariant direct methods 
Least-squares matrix: Full 
Secondary atom site location: 
Difference Fourier map 
R[F
2
 > 2σ(F
2
)] = 0.030 
Hydrogen site location: Inferred from 
neighbouring sites 
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wR(F
2
) = 0.070 
H atoms treated by a mixture of 
independent and constrained 
refinement 
S = 1.02 
w = 1/[σ
2
(Fo
2
) + (0.0402P)
2
]  
where P = (Fo
2
 + 2Fc
2
)/3 
1609 reflections (Δ/σ)max = 0.001 
199 parameters Δρmax = 0.17 e Å
−3
 
0 restraints Δρmin = −0.18 e Å
−3
 
Special details: 
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated 
using the full covariance matrix. The cell esds are taken into account individually in the estimation 
of esds in distances, angles and torsion angles; correlations between esds in cell parameters are 
only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell 
esds is used for estimating esds involving l.s. planes. 
Refinement. Refinement of F
2
 against ALL reflections. The weighted R-factor wR and goodness of 
fit S are based on F
2
, conventional R-factors R are based on F, with F set to zero for negative F
2
. 
The threshold expression of F
2
 > 2sigma(F
2
) is used only for calculating R-factors(gt) etc. and is 
not relevant to the choice of reflections for refinement. R-factors based on F
2
 are statistically about 
twice as large as those based on F, and R- factors based on ALL data will be even larger. 
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å
2
) 
 x y z Uiso*/Ueq 
O1 0.2982 (2) 0.60524 (16) 0.99067 (5) 0.0180 (3) 
O2 0.87722 (19) 0.29889 (17) 0.88890 (5) 0.0189 (3) 
N1 0.5748 (2) 0.6367 (2) 0.94178 (6) 0.0149 (3) 
H1N 0.622 (3) 0.729 (3) 0.9596 (8) 0.025 (6)* 
N2 0.5493 (2) 0.2922 (2) 0.91212 (5) 0.0142 (3) 
N3 0.4163 (3) 0.7607 (2) 0.79123 (6) 0.0180 (4) 
H3N 0.314 (3) 0.818 (3) 0.7787 (7) 0.022 (6)* 
C1 0.7041 (3) 0.5813 (2) 0.89963 (6) 0.0142 (4) 
C2 0.4082 (3) 0.5509 (2) 0.95689 (6) 0.0139 (4) 
C3 0.3638 (3) 0.3787 (2) 0.92952 (6) 0.0139 (4) 
H3 0.2758 0.4047 0.8999 0.017* 
C4 0.2637 (3) 0.2364 (2) 0.96165 (7) 0.0171 (4) 
H4A 0.1152 0.2510 0.9620 0.021* 
H4B 0.3145 0.2403 0.9966 0.021* 
C5 0.3244 (3) 0.0629 (2) 0.93578 (7) 0.0186 (4) 
H5A 0.2315 0.0353 0.9077 0.022* 
H5B 0.3229 −0.0375 0.9598 0.022* 
C6 0.5388 (3) 0.0969 (2) 0.91632 (7) 0.0176 (4) 
H6A 0.6410 0.0516 0.9402 0.021* 
H6B 0.5599 0.0396 0.8833 0.021* 
C7 0.7207 (3) 0.3763 (2) 0.90010 (6) 0.0138 (4) 
C8 0.9118 (3) 0.6643 (3) 0.90812 (7) 0.0184 (4) 
H8A 0.9663 0.6234 0.9403 0.028* 
H8B 0.8994 0.7943 0.9085 0.028* 
H8C 1.0029 0.6285 0.8810 0.028* 
C9 0.6166 (3) 0.6385 (2) 0.84944 (6) 0.0135 (4) 
C10 0.4372 (3) 0.7218 (2) 0.84129 (7) 0.0160 (4) 
H10 0.3406 0.7490 0.8665 0.019* 
C11 0.5846 (3) 0.7053 (2) 0.76602 (7) 0.0165 (4) 
  Appendix 1 
173 
C12 0.6367 (3) 0.7248 (3) 0.71558 (7) 0.0208 (4) 
H12 0.5487 0.7822 0.6925 0.025* 
C13 0.8198 (3) 0.6580 (3) 0.70045 (7) 0.0212 (4) 
H13 0.8605 0.6721 0.6665 0.025* 
C14 0.9483 (3) 0.5691 (3) 0.73413 (7) 0.0208 (4) 
H14 1.0720 0.5208 0.7223 0.025* 
C15 0.8978 (3) 0.5507 (2) 0.78411 (6) 0.0164 (4) 
H15 0.9853 0.4900 0.8066 0.020* 
C16 0.7148 (3) 0.6233 (2) 0.80118 (7) 0.0144 (4) 
Atomic displacement parameters (Å
2
) 
 U
11
 U
22
 U
33
 U
12
 U
13
 U
23
 
O1 0.0186 (7) 0.0201 (7) 0.0152 (6) 0.0020 (6) 0.0040 (6) −0.0023 (5) 
O2 0.0171 (7) 0.0214 (7) 0.0183 (7) 0.0044 (6) 0.0020 (6) 0.0003 (6) 
N1 0.0177 (8) 0.0140 (7) 0.0130 (8) −0.0004 (7) 0.0004 (6) −0.0043 (6) 
N2 0.0151 (8) 0.0130 (7) 0.0145 (8) 0.0029 (7) 0.0009 (6) −0.0004 (6) 
N3 0.0180 (9) 0.0177 (8) 0.0183 (9) 0.0042 (7) −0.0035 (7) 0.0019 (7) 
C1 0.0133 (9) 0.0163 (9) 0.0131 (9) −0.0003 (8) 0.0012 (7) −0.0009 (8) 
C2 0.0156 (9) 0.0146 (9) 0.0116 (9) 0.0037 (8) −0.0041 (8) 0.0009 (7) 
C3 0.0132 (9) 0.0165 (9) 0.0122 (9) 0.0005 (8) −0.0004 (7) −0.0018 (7) 
C4 0.0151 (10) 0.0183 (9) 0.0178 (10) −0.0001 (8) −0.0015 (7) 0.0010 (8) 
C5 0.0218 (11) 0.0156 (9) 0.0183 (10) −0.0022 (9) −0.0020 (8) 0.0012 (8) 
C6 0.0229 (10) 0.0120 (9) 0.0178 (10) 0.0012 (8) −0.0012 (8) −0.0012 (8) 
C7 0.0169 (9) 0.0173 (9) 0.0072 (9) 0.0022 (8) −0.0002 (7) 0.0000 (7) 
C8 0.0154 (10) 0.0209 (10) 0.0188 (10) −0.0008 (9) −0.0002 (8) −0.0022 (8) 
C9 0.0151 (9) 0.0107 (8) 0.0147 (9) −0.0033 (8) −0.0006 (7) −0.0004 (7) 
C10 0.0179 (10) 0.0139 (9) 0.0161 (10) −0.0031 (8) 0.0004 (7) −0.0009 (7) 
C11 0.0206 (10) 0.0119 (9) 0.0168 (9) −0.0042 (8) −0.0008 (8) −0.0007 (8) 
C12 0.0271 (11) 0.0187 (10) 0.0166 (10) −0.0061 (9) −0.0049 (8) 0.0024 (8) 
C13 0.0288 (11) 0.0197 (10) 0.0152 (10) −0.0078 (9) 0.0041 (8) −0.0004 (8) 
C14 0.0198 (10) 0.0214 (10) 0.0211 (10) −0.0053 (9) 0.0040 (8) −0.0040 (8) 
C15 0.0173 (10) 0.0150 (9) 0.0169 (9) −0.0013 (8) 0.0008 (8) −0.0005 (7) 
C16 0.0174 (9) 0.0112 (8) 0.0147 (9) −0.0048 (8) −0.0006 (8) 0.0001 (7) 
Geometric parameters (Å, º) 
O1—C2 1.228 (2) C5—H5A 0.9900 
O2—C7 1.226 (2) C5—H5B 0.9900 
N1—C2 1.340 (3) C6—H6A 0.9900 
N1—C1 1.472 (2) C6—H6B 0.9900 
N1—H1N 0.90 (2) C8—H8A 0.9800 
N2—C7 1.338 (2) C8—H8B 0.9800 
N2—C3 1.465 (2) C8—H8C 0.9800 
N2—C6 1.474 (2) C9—C10 1.361 (3) 
N3—C11 1.366 (2) C9—C16 1.445 (2) 
N3—C10 1.372 (2) C10—H10 0.9500 
N3—H3N 0.87 (2) C11—C12 1.395 (3) 
C1—C9 1.519 (2) C11—C16 1.415 (3) 
C1—C8 1.528 (3) C12—C13 1.373 (3) 
C1—C7 1.544 (3) C12—H12 0.9500 
C2—C3 1.514 (2) C13—C14 1.406 (3) 
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C3—C4 1.522 (3) C13—H13 0.9500 
C3—H3 1.0000 C14—C15 1.380 (3) 
C4—C5 1.528 (3) C14—H14 0.9500 
C4—H4A 0.9900 C15—C16 1.405 (3) 
C4—H4B 0.9900 C15—H15 0.9500 
C5—C6 1.533 (3)   
    
C2—N1—C1 124.90 (16) C5—C6—H6A 111.0 
C2—N1—H1N 120.1 (14) N2—C6—H6B 111.0 
C1—N1—H1N 114.7 (14) C5—C6—H6B 111.0 
C7—N2—C3 125.26 (15) H6A—C6—H6B 109.0 
C7—N2—C6 121.93 (15) O2—C7—N2 123.46 (16) 
C3—N2—C6 112.23 (15) O2—C7—C1 122.12 (17) 
C11—N3—C10 109.29 (16) N2—C7—C1 114.39 (16) 
C11—N3—H3N 126.7 (13) C1—C8—H8A 109.5 
C10—N3—H3N 123.9 (13) C1—C8—H8B 109.5 
N1—C1—C9 111.67 (15) H8A—C8—H8B 109.5 
N1—C1—C8 107.20 (14) C1—C8—H8C 109.5 
C9—C1—C8 111.00 (15) H8A—C8—H8C 109.5 
N1—C1—C7 108.50 (15) H8B—C8—H8C 109.5 
C9—C1—C7 108.44 (14) C10—C9—C16 106.70 (15) 
C8—C1—C7 110.01 (15) C10—C9—C1 127.15 (16) 
O1—C2—N1 123.30 (17) C16—C9—C1 126.07 (16) 
O1—C2—C3 121.46 (17) C9—C10—N3 109.96 (16) 
N1—C2—C3 115.24 (16) C9—C10—H10 125.0 
N2—C3—C2 111.63 (15) N3—C10—H10 125.0 
N2—C3—C4 103.37 (14) N3—C11—C12 130.02 (18) 
C2—C3—C4 114.47 (15) N3—C11—C16 107.74 (16) 
N2—C3—H3 109.1 C12—C11—C16 122.20 (18) 
C2—C3—H3 109.1 C13—C12—C11 117.56 (18) 
C4—C3—H3 109.1 C13—C12—H12 121.2 
C3—C4—C5 103.38 (15) C11—C12—H12 121.2 
C3—C4—H4A 111.1 C12—C13—C14 121.43 (18) 
C5—C4—H4A 111.1 C12—C13—H13 119.3 
C3—C4—H4B 111.1 C14—C13—H13 119.3 
C5—C4—H4B 111.1 C15—C14—C13 121.09 (19) 
H4A—C4—H4B 109.1 C15—C14—H14 119.5 
C4—C5—C6 104.70 (16) C13—C14—H14 119.5 
C4—C5—H5A 110.8 C14—C15—C16 118.88 (17) 
C6—C5—H5A 110.8 C14—C15—H15 120.6 
C4—C5—H5B 110.8 C16—C15—H15 120.6 
C6—C5—H5B 110.8 C15—C16—C11 118.73 (16) 
H5A—C5—H5B 108.9 C15—C16—C9 134.99 (17) 
N2—C6—C5 103.62 (15) C11—C16—C9 106.28 (16) 
N2—C6—H6A 111.0   
    
C2—N1—C1—C9 80.6 (2) C8—C1—C7—N2 155.74 (15) 
C2—N1—C1—C8 −157.65 (16) N1—C1—C9—C10 −3.5 (3) 
C2—N1—C1—C7 −38.9 (2) C8—C1—C9—C10 −123.1 (2) 
C1—N1—C2—O1 −176.39 (16) C7—C1—C9—C10 116.0 (2) 
C1—N1—C2—C3 4.0 (2) N1—C1—C9—C16 172.72 (16) 
C7—N2—C3—C2 −28.7 (2) C8—C1—C9—C16 53.2 (2) 
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C6—N2—C3—C2 142.67 (15) C7—C1—C9—C16 −67.8 (2) 
C7—N2—C3—C4 −152.19 (16) C16—C9—C10—N3 −0.3 (2) 
C6—N2—C3—C4 19.15 (19) C1—C9—C10—N3 176.54 (16) 
O1—C2—C3—N2 −149.71 (16) C11—N3—C10—C9 −0.9 (2) 
N1—C2—C3—N2 29.9 (2) C10—N3—C11—C12 −176.1 (2) 
O1—C2—C3—C4 −32.7 (2) C10—N3—C11—C16 1.7 (2) 
N1—C2—C3—C4 146.86 (16) N3—C11—C12—C13 178.73 (18) 
N2—C3—C4—C5 −32.86 (18) C16—C11—C12—C13 1.2 (3) 
C2—C3—C4—C5 −154.49 (16) C11—C12—C13—C14 1.6 (3) 
C3—C4—C5—C6 35.14 (18) C12—C13—C14—C15 −2.1 (3) 
C7—N2—C6—C5 174.32 (15) C13—C14—C15—C16 −0.3 (3) 
C3—N2—C6—C5 2.6 (2) C14—C15—C16—C11 2.9 (3) 
C4—C5—C6—N2 −23.41 (18) C14—C15—C16—C9 −176.58 (19) 
C3—N2—C7—O2 174.92 (16) N3—C11—C16—C15 178.50 (16) 
C6—N2—C7—O2 4.4 (3) C12—C11—C16—C15 −3.5 (3) 
C3—N2—C7—C1 −7.1 (2) N3—C11—C16—C9 −1.87 (19) 
C6—N2—C7—C1 −177.63 (15) C12—C11—C16—C9 176.15 (17) 
N1—C1—C7—O2 −143.21 (16) C10—C9—C16—C15 −179.14 (19) 
C9—C1—C7—O2 95.3 (2) C1—C9—C16—C15 4.0 (3) 
C8—C1—C7—O2 −26.2 (2) C10—C9—C16—C11 1.31 (19) 
N1—C1—C7—N2 38.8 (2) C1—C9—C16—C11 −175.55 (16) 
C9—C1—C7—N2 −82.69 (18)   
Hydrogen-bond geometry (Å, º) 
D—H···A D—H H···A D···A D—H···A 
N1—H1N···O1
i
 0.90 (2) 2.16 (2) 3.031 (2) 163.5 (19) 
Symmetry code: (i) x+1/2, −y+3/2, −z+2. 
 
 
 
  Appendix 2 
176 
Appendix 2: Crystallographic data for (2.55) 
 
 
 
Data obtained at School of Chemistry, The University of Manchester, Oxford Road, Manchester, 
M13 9PL, UK. 
Refinement 
The structure was solved by the direct methods. All non-H atoms were refined anisotropically. H 
atoms were included in calculated positions, except those bonded to the N atoms, which were 
found by difference Fourier techniques and refined isotropically.  
Experimental: 
Crystal data 
C12H15N3O2 Z = 6 
Mr = 233.27 Mo Kα radiation, λ = 0.71073 Å 
Hexagonal, P65 µ = 0.09 mm
−1
 
a = 9.0807 (10) Å T = 100 K 
c = 24.309 (5) Å 0.50 × 0.20 × 0.20 mm 
V = 1735.9 (5) Å
3
  
Data collection 
CCD area detector  
diffractometer 
1176 reflections with I > 2σ(I) 
5932 measured reflections Rint = 0.055 
1225 independent reflections  
Refinement 
R[F
2
 > 2σ(F
2
)] = 0.035 1 restraint 
wR(F
2
) = 0.086 
H atoms treated by a mixture of 
independent and constrained 
refinement 
S = 1.09 Δρmax = 0.25 e Å
−3
 
1225 reflections Δρmin = −0.20 e Å
−3
 
163 parameters  
Table 1 
Hydrogen-bond geometry (Å, º) 
D—H···A D—H H···A D···A D—H···A 
N3—H3N···O1
i
 0.85 (3) 2.17 (3) 2.896 (3) 143 (3) 
  Appendix 2 
177 
N1—H1N···O2
ii
 0.86 (3) 1.98 (3) 2.837 (3) 170 (3) 
  
Data collection: Bruker SMART; cell refinement: Bruker SMART; data reduction: Bruker SAINT; 
program(s) used to solve structure: SHELXS97 (Sheldrick, 1990); program(s) used to refine 
structure: SHELXL97 (Sheldrick, 1997); molecular graphics: Bruker SHELXTL; software used to 
prepare material for publication: Bruker SHELXTL. 
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Supplementary materials 
Crystal data 
C12H15N3O2 Dx = 1.339 Mg m
−3
 
Mr = 233.27 Mo Kα radiation, λ = 0.71073 Å 
Hexagonal, P65 Cell parameters from 743 reflections 
a = 9.0807 (10) Å θ = 2.6–25.4° 
c = 24.309 (5) Å µ = 0.09 mm
−1
 
V = 1735.9 (5) Å
3
 T = 100 K 
Z = 6 Rod, Colourless 
F(000) = 744 0.50 × 0.20 × 0.20 mm 
Data collection 
CCD area detector  
diffractometer 
1176 reflections with I > 2σ(I) 
Radiation source: fine-focus sealed 
tube 
Rint = 0.055 
graphite θmax = 26.5°, θmin = 2.6° 
phi and ω scans h = −8→11 
5932 measured reflections k = −9→10 
1225 independent reflections l = −29→30 
Refinement 
Refinement on F
2
 
Primary atom site location: Structure-
invariant direct methods 
Least-squares matrix: Full Secondary atom site location: 
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Difference Fourier map 
R[F
2
 > 2σ(F
2
)] = 0.035 
Hydrogen site location: Inferred from 
neighbouring sites 
wR(F
2
) = 0.086 
H atoms treated by a mixture of 
independent and constrained 
refinement 
S = 1.09 
w = 1/[σ
2
(Fo
2
) + (0.0538P)
2
]  
where P = (Fo
2
 + 2Fc
2
)/3 
1225 reflections (Δ/σ)max = 0.001 
163 parameters Δρmax = 0.25 e Å
−3
 
1 restraint Δρmin = −0.20 e Å
−3
 
Special details 
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated 
using the full covariance matrix. The cell esds are taken into account individually in the estimation 
of esds in distances, angles and torsion angles; correlations between esds in cell parameters are 
only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell 
esds is used for estimating esds involving l.s. planes. 
Refinement. Refinement of F
2
 against ALL reflections. The weighted R-factor wR and goodness of 
fit S are based on F
2
, conventional R-factors R are based on F, with F set to zero for negative F
2
. 
The threshold expression of F
2
 > 2sigma(F
2
) is used only for calculating R-factors(gt) etc. and is 
not relevant to the choice of reflections for refinement. R-factors based on F
2
 are statistically about 
twice as large as those based on F, and R- factors based on ALL data will be even larger. 
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å
2
) 
 x y z Uiso*/Ueq 
O1 0.6964 (2) 0.2577 (2) 0.81311 (6) 0.0217 (4) 
O2 0.4726 (2) 0.0378 (2) 1.01420 (7) 0.0218 (4) 
N1 0.5889 (3) 0.2944 (3) 0.89273 (7) 0.0164 (4) 
N2 0.6488 (3) 0.0626 (2) 0.94511 (8) 0.0155 (4) 
N3 0.6937 (3) 0.4417 (3) 1.03856 (8) 0.0190 (5) 
C1 0.5577 (3) 0.2733 (3) 0.95235 (9) 0.0156 (5) 
C2 0.6725 (3) 0.2358 (3) 0.86337 (9) 0.0148 (5) 
C3 0.7447 (3) 0.1434 (3) 0.89480 (8) 0.0153 (5) 
H3 0.8653 0.2259 0.9048 0.018* 
C4 0.7386 (3) −0.0061 (3) 0.86378 (10) 0.0221 (6) 
H4A 0.8358 0.0331 0.8381 0.027* 
H4B 0.6312 −0.0702 0.8429 0.027* 
C5 0.7497 (4) −0.1140 (4) 0.91022 (10) 0.0248 (6) 
H5A 0.7024 −0.2336 0.8984 0.030* 
H5B 0.8690 −0.0687 0.9220 0.030* 
C6 0.6435 (3) −0.1006 (3) 0.95650 (9) 0.0183 (5) 
H6A 0.5253 −0.1971 0.9554 0.022* 
H6B 0.6936 −0.0981 0.9929 0.022* 
C7 0.5557 (3) 0.1122 (3) 0.97286 (9) 0.0166 (5) 
C8 0.3842 (3) 0.2566 (3) 0.96375 (10) 0.0204 (5) 
H8A 0.3864 0.3614 0.9526 0.031* 
H8B 0.3587 0.2372 1.0031 0.031* 
H8C 0.2964 0.1605 0.9428 0.031* 
C9 0.6978 (3) 0.4251 (3) 0.98236 (9) 0.0155 (5) 
C10 0.8394 (3) 0.5654 (3) 0.96276 (10) 0.0181 (5) 
H10 0.8749 0.5878 0.9254 0.022* 
C11 0.9239 (3) 0.6716 (3) 1.00865 (10) 0.0219 (5) 
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H11 1.0257 0.7787 1.0077 0.026* 
C12 0.8311 (3) 0.5908 (3) 1.05449 (10) 0.0215 (5) 
H12 0.8581 0.6318 1.0912 0.026* 
H3N 0.622 (4) 0.368 (4) 1.0602 (13) 0.024 (8)* 
H1N 0.552 (4) 0.354 (4) 0.8763 (12) 0.024 (8)* 
Atomic displacement parameters (Å
2
) 
 U
11
 U
22
 U
33
 U
12
 U
13
 U
23
 
O1 0.0284 (10) 0.0291 (10) 0.0088 (8) 0.0151 (8) 0.0014 (7) 0.0023 (7) 
O2 0.0320 (10) 0.0210 (9) 0.0137 (8) 0.0142 (8) 0.0075 (7) 0.0043 (7) 
N1 0.0224 (11) 0.0196 (10) 0.0093 (9) 0.0121 (9) −0.0009 (8) 0.0024 (8) 
N2 0.0199 (10) 0.0172 (10) 0.0097 (9) 0.0094 (9) 0.0006 (7) 0.0024 (7) 
N3 0.0229 (11) 0.0239 (11) 0.0111 (10) 0.0124 (10) 0.0031 (8) 0.0025 (8) 
C1 0.0200 (12) 0.0200 (12) 0.0094 (10) 0.0120 (10) 0.0026 (8) 0.0021 (8) 
C2 0.0132 (11) 0.0141 (11) 0.0124 (11) 0.0033 (9) −0.0017 (9) 0.0009 (8) 
C3 0.0162 (11) 0.0193 (12) 0.0087 (10) 0.0075 (10) −0.0004 (9) 0.0012 (9) 
C4 0.0316 (14) 0.0263 (14) 0.0135 (11) 0.0182 (12) 0.0053 (10) 0.0013 (9) 
C5 0.0337 (15) 0.0267 (14) 0.0208 (13) 0.0203 (12) 0.0023 (10) 0.0008 (10) 
C6 0.0270 (13) 0.0177 (12) 0.0130 (11) 0.0131 (11) −0.0009 (9) −0.0008 (9) 
C7 0.0210 (12) 0.0157 (11) 0.0099 (10) 0.0069 (10) −0.0024 (9) −0.0019 (9) 
C8 0.0209 (12) 0.0261 (13) 0.0164 (12) 0.0135 (11) 0.0018 (9) 0.0013 (10) 
C9 0.0228 (13) 0.0183 (12) 0.0099 (10) 0.0136 (10) 0.0008 (9) −0.0001 (8) 
C10 0.0207 (12) 0.0199 (12) 0.0158 (11) 0.0116 (11) 0.0016 (9) 0.0028 (9) 
C11 0.0213 (12) 0.0218 (13) 0.0208 (12) 0.0094 (10) −0.0026 (10) −0.0018 (10) 
C12 0.0275 (13) 0.0264 (13) 0.0137 (11) 0.0159 (11) −0.0048 (10) −0.0057 (10) 
Geometric parameters (Å, º) 
O1—C2 1.239 (3) C4—C5 1.531 (3) 
O2—C7 1.235 (3) C4—H4A 0.9900 
N1—C2 1.331 (3) C4—H4B 0.9900 
N1—C1 1.471 (3) C5—C6 1.526 (3) 
N1—H1N 0.86 (3) C5—H5A 0.9900 
N2—C7 1.324 (3) C5—H5B 0.9900 
N2—C3 1.468 (3) C6—H6A 0.9900 
N2—C6 1.484 (3) C6—H6B 0.9900 
N3—C12 1.360 (3) C8—H8A 0.9800 
N3—C9 1.377 (3) C8—H8B 0.9800 
N3—H3N 0.85 (3) C8—H8C 0.9800 
C1—C9 1.516 (3) C9—C10 1.366 (3) 
C1—C8 1.531 (3) C10—C11 1.422 (3) 
C1—C7 1.537 (3) C10—H10 0.9500 
C2—C3 1.507 (3) C11—C12 1.368 (4) 
C3—C4 1.529 (3) C11—H11 0.9500 
C3—H3 1.0000 C12—H12 0.9500 
    
C2—N1—C1 126.0 (2) C4—C5—H5A 110.9 
C2—N1—H1N 118.7 (19) C6—C5—H5B 110.9 
C1—N1—H1N 115 (2) C4—C5—H5B 110.9 
C7—N2—C3 125.1 (2) H5A—C5—H5B 108.9 
C7—N2—C6 122.47 (19) N2—C6—C5 103.65 (19) 
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C3—N2—C6 111.69 (18) N2—C6—H6A 111.0 
C12—N3—C9 109.3 (2) C5—C6—H6A 111.0 
C12—N3—H3N 125 (2) N2—C6—H6B 111.0 
C9—N3—H3N 126 (2) C5—C6—H6B 111.0 
N1—C1—C9 109.67 (18) H6A—C6—H6B 109.0 
N1—C1—C8 108.25 (18) O2—C7—N2 123.2 (2) 
C9—C1—C8 110.94 (19) O2—C7—C1 119.8 (2) 
N1—C1—C7 110.68 (19) N2—C7—C1 116.93 (19) 
C9—C1—C7 108.33 (18) C1—C8—H8A 109.5 
C8—C1—C7 108.98 (19) C1—C8—H8B 109.5 
O1—C2—N1 123.6 (2) H8A—C8—H8B 109.5 
O1—C2—C3 119.9 (2) C1—C8—H8C 109.5 
N1—C2—C3 116.40 (19) H8A—C8—H8C 109.5 
N2—C3—C2 112.73 (19) H8B—C8—H8C 109.5 
N2—C3—C4 102.61 (19) C10—C9—N3 108.0 (2) 
C2—C3—C4 114.34 (19) C10—C9—C1 130.6 (2) 
N2—C3—H3 109.0 N3—C9—C1 121.4 (2) 
C2—C3—H3 109.0 C9—C10—C11 107.2 (2) 
C4—C3—H3 109.0 C9—C10—H10 126.4 
C3—C4—C5 102.71 (19) C11—C10—H10 126.4 
C3—C4—H4A 111.2 C12—C11—C10 107.3 (2) 
C5—C4—H4A 111.2 C12—C11—H11 126.4 
C3—C4—H4B 111.2 C10—C11—H11 126.4 
C5—C4—H4B 111.2 N3—C12—C11 108.3 (2) 
H4A—C4—H4B 109.1 N3—C12—H12 125.8 
C6—C5—C4 104.2 (2) C11—C12—H12 125.8 
C6—C5—H5A 110.9   
    
C2—N1—C1—C9 92.7 (3) C3—N2—C7—C1 −3.8 (3) 
C2—N1—C1—C8 −146.1 (2) C6—N2—C7—C1 −173.0 (2) 
C2—N1—C1—C7 −26.7 (3) N1—C1—C7—O2 −152.9 (2) 
C1—N1—C2—O1 −179.6 (2) C9—C1—C7—O2 86.8 (3) 
C1—N1—C2—C3 −1.5 (3) C8—C1—C7—O2 −33.9 (3) 
C7—N2—C3—C2 −25.1 (3) N1—C1—C7—N2 28.7 (3) 
C6—N2—C3—C2 145.0 (2) C9—C1—C7—N2 −91.6 (2) 
C7—N2—C3—C4 −148.6 (2) C8—C1—C7—N2 147.6 (2) 
C6—N2—C3—C4 21.6 (2) C12—N3—C9—C10 0.0 (3) 
O1—C2—C3—N2 −154.5 (2) C12—N3—C9—C1 −178.2 (2) 
N1—C2—C3—N2 27.4 (3) N1—C1—C9—C10 −1.5 (3) 
O1—C2—C3—C4 −37.8 (3) C8—C1—C9—C10 −121.0 (3) 
N1—C2—C3—C4 144.1 (2) C7—C1—C9—C10 119.4 (3) 
N2—C3—C4—C5 −36.0 (2) N1—C1—C9—N3 176.2 (2) 
C2—C3—C4—C5 −158.4 (2) C8—C1—C9—N3 56.7 (3) 
C3—C4—C5—C6 38.0 (3) C7—C1—C9—N3 −62.9 (3) 
C7—N2—C6—C5 172.4 (2) N3—C9—C10—C11 −0.4 (3) 
C3—N2—C6—C5 2.0 (2) C1—C9—C10—C11 177.6 (2) 
C4—C5—C6—N2 −24.8 (3) C9—C10—C11—C12 0.6 (3) 
C3—N2—C7—O2 177.8 (2) C9—N3—C12—C11 0.4 (3) 
C6—N2—C7—O2 8.6 (3) C10—C11—C12—N3 −0.6 (3) 
Hydrogen-bond geometry (Å, º) 
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D—H···A D—H H···A D···A D—H···A 
N3—H3N···O1
i
 0.85 (3) 2.17 (3) 2.896 (3) 143 (3) 
N1—H1N···O2
ii
 0.86 (3) 1.98 (3) 2.837 (3) 170 (3) 
Symmetry codes: (i) −x+y+1, −x+1, z+1/3; (ii) x−y, x, z−1/6. 
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Appendix 3: Crystallographic data for (2.62) 
 
 
 
 
 
Data obtained at School of Chemistry, The University of Manchester, Oxford Road, Manchester, 
M13 9PL, UK. 
Refinement 
The structure was solved by direct methods. The non-hydrogen atoms were refined anisotropically. 
H atoms were included in calculated positions with C—H lengths of 0.95(CH), 0.99(CH2) & 
0.98(CH3)Å; Uiso(H) values were fixed at 1.2Ueq(C) except for CH3 where it was 1.5Ueq(C). 
Experimental: 
Crystal data 
C33H44N4O4S V = 7171.3 (15) Å
3
 
Mr = 592.78 Z = 8 
Monoclinic, C2 Mo Kα radiation, λ = 0.71073 Å 
a = 34.745 (4) Å µ = 0.13 mm
−1
 
b = 10.7638 (12) Å T = 100 K 
c = 25.643 (3) Å 0.30 × 0.25 × 0.10 mm 
β = 131.602 (5)°  
Data collection 
CCD area detector  
diffractometer 
6382 reflections with I > 2σ(I) 
28840 measured reflections Rint = 0.097 
14299 independent reflections  
Refinement 
R[F
2
 > 2σ(F
2
)] = 0.101 H-atom parameters constrained 
wR(F
2
) = 0.299 Δρmax = 1.40 e Å
−3
 
S = 0.95 Δρmin = −0.48 e Å
−3
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14299 reflections 
Absolute structure: Flack H D (1983), 
Acta Cryst. A39, 876-881 
771 parameters Flack parameter: −0.05 (17) 
22 restraints  
Table 1 
Hydrogen-bond geometry (Å, º) 
D—H···A D—H H···A D···A D—H···A 
N5—H5A···O3
i
 0.88 1.95 2.819 (9) 169 
N1—H1···O7
ii
 0.88 1.98 2.850 (8) 171 
N7—H7A···O6
iii
 0.88 2.21 2.849 (10) 129 
N6—H6···O6
iii
 0.88 2.41 3.195 (12) 150 
N3—H3A···O1
iv
 0.88 2.35 3.002 (8) 131 
N2—H2···O1
iv
 0.88 2.17 3.010 (8) 160 
 
Data collection: Bruker SMART; cell refinement: Bruker SMART; data reduction: Bruker SAINT; 
program(s) used to solve structure: SHELXS97 (Sheldrick, 1990); program(s) used to refine 
structure: SHELXL97 (Sheldrick, 1997); molecular graphics: Bruker SHELXTL; software used to 
prepare material for publication: Bruker SHELXTL. 
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Supplementary materials 
Crystal data 
C33H44N4O4S F(000) = 2544 
Mr = 592.78 Dx = 1.098 Mg m
−3
 
Monoclinic, C2 Mo Kα radiation, λ = 0.71073 Å 
a = 34.745 (4) Å Cell parameters from 1493 reflections 
b = 10.7638 (12) Å θ = 2.3–17.8° 
c = 25.643 (3) Å µ = 0.13 mm
−1
 
β = 131.602 (5)° T = 100 K 
V = 7171.3 (15) Å
3
 Plate, White 
Z = 8 0.30 × 0.25 × 0.10 mm 
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Data collection 
CCD area detector  
diffractometer 
6382 reflections with I > 2σ(I) 
Radiation source: fine-focus sealed 
tube 
Rint = 0.097 
graphite θmax = 26.4°, θmin = 1.2° 
phi and ω scans h = −43→43 
28840 measured reflections k = −13→13 
14299 independent reflections l = −31→32 
Refinement 
Refinement on F
2
 
Secondary atom site location: 
Difference Fourier map 
Least-squares matrix: Full 
Hydrogen site location: Inferred from 
neighbouring sites 
R[F
2
 > 2σ(F
2
)] = 0.101 H-atom parameters constrained 
wR(F
2
) = 0.299 
w = 1/[σ
2
(Fo
2
) + (0.1303P)
2
]  
where P = (Fo
2
 + 2Fc
2
)/3 
S = 0.95 (Δ/σ)max = 1.966 
14299 reflections Δρmax = 1.40 e Å
−3
 
771 parameters Δρmin = −0.48 e Å
−3
 
22 restraints 
Absolute structure: Flack H D (1983), 
Acta Cryst. A39, 876-881 
Primary atom site location: Structure-
invariant direct methods 
Flack parameter: −0.05 (17) 
Special details 
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated 
using the full covariance matrix. The cell esds are taken into account individually in the estimation 
of esds in distances, angles and torsion angles; correlations between esds in cell parameters are 
only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell 
esds is used for estimating esds involving l.s. planes. 
Refinement. Refinement of F
2
 against ALL reflections. The weighted R-factor wR and goodness of 
fit S are based on F
2
, conventional R-factors R are based on F, with F set to zero for negative F
2
. 
The threshold expression of F
2
 > 2sigma(F
2
) is used only for calculating R-factors(gt) etc. and is 
not relevant to the choice of reflections for refinement. R-factors based on F
2
 are statistically about 
twice as large as those based on F, and R- factors based on ALL data will be even larger. 
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å
2
) 
 x y z Uiso*/Ueq 
C19 0.7773 (3) 0.6722 (7) 0.3568 (4) 0.0195 (17) 
C20 0.8129 (3) 0.7554 (8) 0.3683 (4) 0.0258 (19) 
H20 0.8088 0.8422 0.3700 0.031* 
C21 0.8538 (4) 0.7115 (9) 0.3773 (5) 0.040 (2) 
H21 0.8782 0.7681 0.3852 0.047* 
C22 0.8600 (4) 0.5833 (9) 0.3748 (5) 0.047 (3) 
H22 0.8881 0.5544 0.3797 0.057* 
C23 0.8254 (4) 0.4971 (9) 0.3652 (6) 0.044 (3) 
H23 0.8304 0.4103 0.3652 0.052* 
C24 0.7845 (3) 0.5424 (8) 0.3559 (4) 0.0257 (19) 
C25 0.7114 (3) 0.5681 (7) 0.3364 (4) 0.0180 (17) 
C26 0.6638 (3) 0.5194 (7) 0.3191 (4) 0.0181 (17) 
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C27 0.6361 (3) 0.6141 (8) 0.3292 (4) 0.0224 (17) 
C28 0.6311 (3) 0.6954 (8) 0.4159 (4) 0.031 (2) 
H28A 0.5993 0.6540 0.3995 0.037* 
H28B 0.6228 0.7816 0.3978 0.037* 
C29 0.6727 (3) 0.6935 (7) 0.4953 (4) 0.0262 (19) 
H29A 0.6574 0.6975 0.5168 0.031* 
H29B 0.6969 0.7637 0.5127 0.031* 
C30 0.6998 (3) 0.5687 (8) 0.5108 (4) 0.028 (2) 
H30A 0.6802 0.4999 0.5094 0.033* 
H30B 0.7350 0.5699 0.5572 0.033* 
C31 0.7015 (3) 0.5540 (7) 0.4523 (4) 0.0236 (18) 
H31 0.7329 0.5967 0.4670 0.028* 
C32 0.7005 (3) 0.4242 (7) 0.4309 (4) 0.0212 (18) 
C33 0.6255 (3) 0.4763 (9) 0.2426 (4) 0.036 (2) 
H33A 0.6415 0.4114 0.2356 0.054* 
H33B 0.6162 0.5469 0.2119 0.054* 
H33C 0.5945 0.4431 0.2314 0.054* 
C52 0.9233 (4) 0.5840 (8) 0.2304 (6) 0.047 (3) 
C53 0.8869 (6) 0.5048 (12) 0.2228 (9) 0.100 (6) 
H53 0.8905 0.4170 0.2243 0.119* 
C54 0.8465 (5) 0.5574 (13) 0.2133 (9) 0.090 (5) 
H54 0.8209 0.5054 0.2052 0.108* 
C55 0.8427 (5) 0.6836 (15) 0.2156 (7) 0.081 (4) 
H55 0.8167 0.7169 0.2142 0.097* 
C56 0.8762 (5) 0.7646 (13) 0.2198 (8) 0.098 (6) 
H56 0.8719 0.8522 0.2170 0.118* 
C57 0.9171 (3) 0.7076 (9) 0.2286 (5) 0.038 (2) 
C58 0.9868 (3) 0.6738 (7) 0.2447 (4) 0.0200 (17) 
C59 1.0319 (3) 0.7160 (7) 0.2518 (4) 0.028 (2) 
C60 1.0764 (3) 0.6201 (9) 0.2879 (4) 0.0297 (19) 
C61 1.1526 (3) 0.5409 (9) 0.4074 (5) 0.036 (2) 
H61A 1.1493 0.4555 0.3905 0.043* 
H61B 1.1817 0.5831 0.4159 0.043* 
C62 1.1596 (3) 0.5401 (8) 0.4713 (5) 0.035 (2) 
H62A 1.1962 0.5299 0.5139 0.043* 
H62B 1.1391 0.4732 0.4695 0.043* 
C63 1.1392 (3) 0.6707 (8) 0.4685 (4) 0.030 (2) 
H63A 1.1306 0.6737 0.4984 0.037* 
H63B 1.1651 0.7356 0.4841 0.037* 
C64 1.0911 (3) 0.6889 (8) 0.3922 (4) 0.028 (2) 
H64 1.0604 0.6543 0.3830 0.034* 
C65 1.0808 (3) 0.8222 (8) 0.3663 (4) 0.0269 (19) 
C66 1.0133 (3) 0.7469 (8) 0.1803 (4) 0.030 (2) 
H66A 0.9891 0.8165 0.1600 0.045* 
H66B 0.9961 0.6742 0.1497 0.045* 
H66C 1.0428 0.7698 0.1850 0.045* 
N2 0.7437 (2) 0.4839 (6) 0.3426 (3) 0.0230 (15) 
H2 0.7389 0.4029 0.3387 0.028* 
N3 0.6774 (2) 0.4117 (6) 0.3644 (3) 0.0216 (15) 
H3A 0.6698 0.3365 0.3465 0.026* 
N4 0.6555 (2) 0.6246 (6) 0.3941 (3) 0.0219 (14) 
N6 0.9560 (3) 0.7613 (7) 0.2378 (4) 0.042 (2) 
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H6 0.9607 0.8420 0.2391 0.051* 
N7 1.0550 (3) 0.8298 (6) 0.2971 (4) 0.0301 (17) 
H7A 1.0519 0.9022 0.2786 0.036* 
N8 1.1031 (2) 0.6132 (7) 0.3562 (3) 0.0296 (16) 
O3 0.5983 (2) 0.6739 (6) 0.2801 (3) 0.0355 (15) 
O4 0.7219 (2) 0.3398 (5) 0.4723 (3) 0.0314 (14) 
O7 1.0852 (2) 0.5622 (5) 0.2554 (3) 0.0312 (14) 
O8 1.0928 (2) 0.9119 (5) 0.4026 (3) 0.0363 (15) 
C1 0.6991 (3) 1.1304 (8) 0.2043 (4) 0.0261 (19) 
C2 0.6471 (3) 1.1362 (7) 0.1418 (4) 0.0287 (19) 
C3 0.6378 (3) 1.1386 (8) 0.0791 (4) 0.033 (2) 
H3 0.6032 1.1399 0.0360 0.040* 
C4 0.6768 (4) 1.1392 (10) 0.0783 (5) 0.045 (2) 
C5 0.7272 (4) 1.1423 (9) 0.1406 (5) 0.044 (2) 
H5 0.7540 1.1468 0.1395 0.052* 
C6 0.7401 (3) 1.1391 (8) 0.2053 (4) 0.032 (2) 
C7 0.6002 (3) 1.1466 (8) 0.1349 (4) 0.035 (2) 
H7 0.6127 1.1600 0.1826 0.042* 
C8 0.5671 (3) 1.0304 (8) 0.1048 (5) 0.037 (2) 
H8A 0.5549 1.0145 0.0582 0.056* 
H8B 0.5376 1.0422 0.1015 0.056* 
H8C 0.5876 0.9594 0.1352 0.056* 
C9 0.5680 (4) 1.2591 (9) 0.0903 (5) 0.040 (2) 
H9A 0.5902 1.3324 0.1077 0.060* 
H9B 0.5414 1.2737 0.0928 0.060* 
H9C 0.5516 1.2435 0.0418 0.060* 
C10 0.6635 (4) 1.1404 (13) 0.0085 (5) 0.073 (4) 
H10 0.6968 1.1370 0.0188 0.087* 
C11 0.6374 (5) 1.2650 (12) −0.0291 (6) 0.070 (4) 
H11A 0.6368 1.2749 −0.0676 0.105* 
H11B 0.6567 1.3336 0.0039 0.105* 
H11C 0.6020 1.2653 −0.0476 0.105* 
C12 0.6328 (6) 1.0335 (12) −0.0360 (6) 0.081 (4) 
H12A 0.6051 1.0187 −0.0358 0.122* 
H12B 0.6549 0.9598 −0.0182 0.122* 
H12C 0.6180 1.0506 −0.0838 0.122* 
C13 0.7970 (3) 1.1494 (8) 0.2674 (5) 0.039 (2) 
H13 0.8013 1.1680 0.3093 0.047* 
C14 0.8212 (5) 1.2566 (10) 0.2582 (6) 0.060 (3) 
H14A 0.8255 1.2315 0.2255 0.091* 
H14B 0.8548 1.2772 0.3034 0.091* 
H14C 0.7987 1.3295 0.2397 0.091* 
C15 0.8253 (4) 1.0294 (10) 0.2812 (6) 0.055 (3) 
H15A 0.8108 0.9620 0.2892 0.083* 
H15B 0.8619 1.0394 0.3225 0.083* 
H15C 0.8216 1.0092 0.2408 0.083* 
S1 0.71209 (7) 1.10994 (17) 0.28479 (10) 0.0201 (4) 
O1 0.6993 (2) 1.2256 (5) 0.2999 (3) 0.0275 (14) 
O2 0.7639 (2) 1.0636 (5) 0.3355 (3) 0.0268 (13) 
N1 0.6735 (2) 1.0097 (6) 0.2728 (3) 0.0234 (16) 
H1 0.6462 1.0343 0.2658 0.028* 
C16 0.6828 (3) 0.8732 (6) 0.2733 (4) 0.0187 (17) 
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H16A 0.7033 0.8611 0.2597 0.022* 
H16B 0.6493 0.8308 0.2382 0.022* 
C17 0.7106 (3) 0.8144 (6) 0.3435 (4) 0.0188 (17) 
H17A 0.6867 0.8055 0.3519 0.023* 
H17B 0.7395 0.8684 0.3805 0.023* 
C18 0.7312 (3) 0.6870 (7) 0.3464 (4) 0.0205 (18) 
C34 0.9092 (3) 0.1454 (8) 0.0958 (4) 0.0218 (17) 
C35 0.8566 (4) 0.1511 (10) 0.0599 (4) 0.044 (2) 
C36 0.8220 (4) 0.1471 (11) −0.0146 (5) 0.053 (3) 
H36 0.7860 0.1453 −0.0407 0.064* 
C37 0.8394 (4) 0.1459 (11) −0.0496 (5) 0.052 (3) 
C38 0.8937 (3) 0.1496 (10) −0.0091 (5) 0.048 (3) 
H38 0.9063 0.1585 −0.0324 0.057* 
C39 0.9279 (3) 0.1409 (8) 0.0613 (4) 0.035 (2) 
C40 0.8308 (3) 0.1472 (12) 0.0899 (5) 0.060 (4) 
H40 0.8579 0.1523 0.1419 0.072* 
C41 0.7939 (5) 0.2594 (11) 0.0624 (8) 0.090 (5) 
H41A 0.8139 0.3365 0.0813 0.135* 
H41B 0.7742 0.2512 0.0772 0.135* 
H41C 0.7701 0.2614 0.0114 0.135* 
C42 0.7992 (7) 0.0267 (11) 0.0694 (10) 0.138 (9) 
H42A 0.7784 0.0105 0.0195 0.207* 
H42B 0.7765 0.0365 0.0793 0.207* 
H42C 0.8226 −0.0432 0.0965 0.207* 
C43 0.7995 (4) 0.1469 (14) −0.1308 (5) 0.083 (5) 
H43 0.7666 0.1167 −0.1444 0.099* 
C44 0.7887 (5) 0.2872 (12) −0.1561 (6) 0.091 (5) 
H44A 0.8193 0.3221 −0.1454 0.136* 
H44B 0.7807 0.3353 −0.1319 0.136* 
H44C 0.7595 0.2908 −0.2065 0.136* 
C45 0.8110 (8) 0.060 (3) −0.1612 (7) 0.30 (2) 
H45A 0.8199 0.1053 −0.1851 0.452* 
H45B 0.7808 0.0075 −0.1949 0.452* 
H45C 0.8401 0.0078 −0.1245 0.452* 
C46 0.9838 (3) 0.1290 (9) 0.0953 (5) 0.040 (2) 
H46 1.0048 0.1142 0.1463 0.048* 
C47 1.0032 (5) 0.2483 (10) 0.0866 (7) 0.068 (4) 
H47A 0.9872 0.2569 0.0378 0.102* 
H47B 1.0407 0.2440 0.1164 0.102* 
H47C 0.9942 0.3201 0.1001 0.102* 
C48 0.9909 (4) 0.0197 (9) 0.0656 (5) 0.042 (3) 
H48A 0.9752 0.0383 0.0176 0.063* 
H48B 0.9744 −0.0538 0.0658 0.063* 
H48C 1.0277 0.0036 0.0940 0.063* 
S2 0.95557 (8) 0.1332 (2) 0.18921 (11) 0.0404 (6) 
O5 0.9292 (3) 0.1577 (10) 0.2141 (3) 0.086 (3) 
O6 0.9827 (3) 0.0188 (7) 0.2060 (4) 0.071 (3) 
N5 0.9968 (3) 0.2380 (8) 0.2169 (6) 0.085 (4) 
H5A 1.0293 0.2176 0.2418 0.103* 
C49 0.9800 (5) 0.3832 (12) 0.2000 (6) 0.097 (6) 
H49A 0.9984 0.4282 0.1886 0.116* 
H49B 0.9425 0.3919 0.1608 0.116* 
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C50 0.9952 (5) 0.4289 (15) 0.2654 (6) 0.131 (9) 
H50A 1.0330 0.4365 0.3027 0.157* 
H50B 0.9818 0.3752 0.2816 0.157* 
C51 0.9675 (4) 0.5626 (9) 0.2400 (7) 0.060 (4) 
Atomic displacement parameters (Å
2
) 
 U
11
 U
22
 U
33
 U
12
 U
13
 U
23
 
C19 0.017 (4) 0.016 (4) 0.022 (4) 0.003 (3) 0.012 (3) 0.005 (3) 
C20 0.029 (5) 0.023 (4) 0.026 (5) −0.002 (4) 0.018 (4) 0.001 (4) 
C21 0.035 (5) 0.045 (6) 0.039 (6) −0.009 (5) 0.025 (5) 0.006 (5) 
C22 0.029 (5) 0.052 (7) 0.066 (7) 0.018 (5) 0.034 (6) 0.009 (5) 
C23 0.042 (6) 0.027 (5) 0.070 (8) 0.006 (5) 0.040 (6) 0.004 (5) 
C24 0.020 (4) 0.025 (5) 0.028 (5) 0.006 (4) 0.014 (4) 0.004 (4) 
C25 0.019 (4) 0.016 (4) 0.011 (4) 0.002 (3) 0.007 (3) −0.002 (3) 
C26 0.017 (4) 0.018 (4) 0.015 (4) −0.007 (3) 0.009 (3) −0.003 (3) 
C27 0.015 (4) 0.023 (4) 0.024 (4) 0.004 (4) 0.011 (3) 0.001 (4) 
C28 0.037 (5) 0.017 (4) 0.044 (5) 0.001 (4) 0.029 (5) 0.001 (4) 
C29 0.037 (5) 0.017 (4) 0.030 (5) −0.002 (4) 0.025 (4) −0.005 (4) 
C30 0.024 (4) 0.039 (5) 0.021 (4) −0.007 (4) 0.015 (4) −0.002 (4) 
C31 0.029 (5) 0.018 (4) 0.025 (4) 0.003 (4) 0.018 (4) 0.002 (3) 
C32 0.020 (4) 0.019 (4) 0.033 (5) 0.006 (4) 0.021 (4) 0.002 (4) 
C33 0.032 (5) 0.045 (6) 0.024 (5) −0.004 (4) 0.016 (4) −0.001 (4) 
C52 0.048 (6) 0.026 (6) 0.094 (9) 0.010 (4) 0.058 (7) 0.017 (5) 
C53 0.101 (11) 0.040 (8) 0.217 (19) 0.024 (7) 0.131 (13) 0.050 (9) 
C54 0.083 (10) 0.060 (9) 0.180 (16) 0.022 (8) 0.110 (12) 0.057 (10) 
C55 0.052 (8) 0.103 (12) 0.119 (12) −0.010 (8) 0.070 (9) −0.014 (9) 
C56 0.064 (9) 0.078 (10) 0.155 (15) −0.015 (8) 0.073 (10) −0.070 (10) 
C57 0.031 (5) 0.049 (6) 0.048 (6) 0.002 (5) 0.032 (5) −0.013 (5) 
C58 0.015 (4) 0.022 (4) 0.020 (4) 0.002 (3) 0.010 (3) 0.001 (3) 
C59 0.022 (4) 0.017 (4) 0.035 (5) −0.001 (3) 0.015 (4) −0.001 (4) 
C60 0.016 (4) 0.038 (5) 0.032 (4) −0.014 (4) 0.015 (4) −0.002 (4) 
C61 0.023 (5) 0.032 (5) 0.051 (6) 0.011 (4) 0.023 (5) 0.017 (4) 
C62 0.020 (5) 0.025 (5) 0.038 (5) 0.002 (4) 0.010 (4) 0.005 (4) 
C63 0.031 (5) 0.031 (5) 0.021 (4) −0.005 (4) 0.014 (4) 0.000 (4) 
C64 0.036 (5) 0.028 (5) 0.028 (5) 0.003 (4) 0.024 (4) 0.001 (4) 
C65 0.015 (4) 0.031 (5) 0.033 (5) 0.002 (4) 0.015 (4) 0.001 (4) 
C66 0.031 (5) 0.033 (5) 0.028 (5) −0.003 (4) 0.020 (4) 0.001 (4) 
N2 0.026 (4) 0.017 (4) 0.023 (4) 0.006 (3) 0.015 (3) 0.005 (3) 
N3 0.023 (4) 0.011 (3) 0.031 (4) −0.006 (3) 0.018 (3) −0.008 (3) 
N4 0.022 (3) 0.015 (3) 0.027 (3) 0.003 (3) 0.016 (3) −0.004 (3) 
N6 0.028 (4) 0.028 (4) 0.065 (6) −0.002 (4) 0.028 (4) −0.023 (4) 
N7 0.036 (4) 0.021 (4) 0.030 (4) 0.001 (3) 0.020 (4) 0.006 (3) 
N8 0.028 (4) 0.021 (4) 0.036 (4) 0.007 (3) 0.020 (3) 0.008 (3) 
O3 0.023 (3) 0.044 (4) 0.030 (3) 0.008 (3) 0.014 (3) 0.005 (3) 
O4 0.043 (4) 0.023 (3) 0.034 (3) 0.010 (3) 0.027 (3) 0.007 (3) 
O7 0.020 (3) 0.038 (4) 0.037 (4) −0.001 (3) 0.019 (3) −0.010 (3) 
O8 0.038 (4) 0.019 (3) 0.035 (4) 0.002 (3) 0.017 (3) −0.002 (3) 
C1 0.041 (5) 0.028 (5) 0.016 (4) 0.014 (4) 0.022 (4) 0.011 (4) 
C2 0.042 (5) 0.012 (4) 0.038 (5) 0.000 (4) 0.029 (4) −0.004 (4) 
C3 0.036 (5) 0.034 (5) 0.022 (4) 0.008 (4) 0.016 (4) 0.007 (4) 
C4 0.058 (6) 0.051 (7) 0.035 (5) 0.009 (6) 0.035 (5) 0.003 (5) 
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C5 0.048 (6) 0.048 (7) 0.053 (6) 0.019 (5) 0.042 (5) 0.010 (5) 
C6 0.050 (5) 0.028 (5) 0.035 (5) 0.011 (4) 0.035 (4) 0.008 (4) 
C7 0.034 (5) 0.036 (6) 0.022 (4) 0.011 (4) 0.013 (4) 0.006 (4) 
C8 0.036 (5) 0.030 (5) 0.036 (5) 0.005 (4) 0.020 (5) 0.000 (4) 
C9 0.041 (6) 0.039 (6) 0.038 (6) 0.014 (5) 0.026 (5) 0.009 (5) 
C10 0.052 (6) 0.142 (13) 0.042 (6) 0.015 (9) 0.039 (6) 0.008 (8) 
C11 0.068 (8) 0.102 (10) 0.035 (6) −0.010 (7) 0.032 (6) 0.028 (7) 
C12 0.115 (12) 0.084 (10) 0.056 (8) −0.036 (9) 0.061 (9) −0.025 (7) 
C13 0.048 (6) 0.033 (6) 0.053 (6) 0.000 (5) 0.041 (5) 0.003 (5) 
C14 0.086 (9) 0.062 (8) 0.073 (8) −0.005 (7) 0.069 (8) 0.005 (6) 
C15 0.038 (6) 0.061 (8) 0.059 (7) 0.008 (6) 0.029 (6) 0.007 (6) 
S1 0.0292 (11) 0.0142 (9) 0.0247 (10) −0.0004 (9) 0.0212 (9) −0.0007 (8) 
O1 0.041 (4) 0.021 (3) 0.033 (3) −0.009 (3) 0.030 (3) −0.007 (3) 
O2 0.027 (3) 0.024 (3) 0.030 (3) −0.004 (2) 0.019 (3) 0.002 (2) 
N1 0.017 (4) 0.024 (4) 0.026 (4) 0.006 (3) 0.013 (3) 0.005 (3) 
C16 0.019 (4) 0.009 (4) 0.020 (4) 0.005 (3) 0.010 (4) 0.004 (3) 
C17 0.023 (4) 0.007 (4) 0.031 (4) −0.003 (3) 0.019 (4) −0.001 (3) 
C18 0.018 (4) 0.023 (4) 0.014 (4) −0.006 (3) 0.008 (3) −0.002 (3) 
C34 0.014 (4) 0.028 (5) 0.017 (4) 0.012 (3) 0.008 (3) 0.010 (3) 
C35 0.046 (6) 0.057 (7) 0.028 (5) 0.006 (5) 0.024 (5) 0.006 (5) 
C36 0.031 (5) 0.089 (9) 0.041 (6) 0.003 (6) 0.025 (5) −0.001 (6) 
C37 0.049 (6) 0.074 (8) 0.032 (5) 0.033 (6) 0.026 (5) 0.018 (5) 
C38 0.042 (6) 0.067 (8) 0.052 (6) 0.027 (6) 0.039 (5) 0.017 (6) 
C39 0.030 (5) 0.029 (5) 0.037 (5) 0.016 (4) 0.018 (4) 0.013 (4) 
C40 0.034 (5) 0.122 (11) 0.027 (5) 0.005 (7) 0.022 (4) 0.005 (6) 
C41 0.127 (13) 0.061 (9) 0.172 (15) 0.000 (9) 0.137 (13) −0.011 (9) 
C42 0.27 (2) 0.046 (8) 0.30 (3) 0.034 (12) 0.27 (2) 0.036 (12) 
C43 0.046 (6) 0.165 (15) 0.035 (6) 0.058 (9) 0.026 (5) 0.020 (8) 
C44 0.061 (8) 0.120 (13) 0.058 (8) −0.001 (8) 0.025 (7) 0.059 (8) 
C45 0.19 (2) 0.56 (5) 0.027 (8) 0.24 (3) 0.023 (11) −0.031 (16) 
C46 0.031 (5) 0.053 (6) 0.044 (5) 0.001 (5) 0.029 (4) −0.003 (5) 
C47 0.064 (8) 0.054 (8) 0.111 (11) −0.003 (6) 0.068 (8) 0.001 (7) 
C48 0.034 (5) 0.046 (6) 0.047 (6) 0.020 (5) 0.028 (5) 0.010 (5) 
S2 0.0301 (12) 0.0451 (16) 0.0223 (11) 0.0036 (12) 0.0074 (10) −0.0036 (11) 
O5 0.054 (4) 0.171 (10) 0.031 (4) 0.002 (6) 0.028 (4) −0.016 (5) 
O6 0.055 (5) 0.043 (5) 0.051 (5) 0.012 (4) 0.009 (4) 0.014 (4) 
N5 0.020 (4) 0.043 (6) 0.122 (9) 0.002 (4) 0.017 (5) −0.061 (6) 
C49 0.059 (8) 0.177 (17) 0.043 (8) −0.074 (10) 0.029 (7) −0.042 (9) 
C50 0.036 (7) 0.32 (3) 0.039 (8) 0.017 (12) 0.024 (7) 0.034 (12) 
C51 0.052 (7) 0.020 (5) 0.134 (11) 0.016 (5) 0.073 (8) 0.020 (6) 
Geometric parameters (Å, º) 
C19—C20 1.391 (11) C5—H5 0.9500 
C19—C24 1.422 (10) C6—C13 1.508 (12) 
C19—C18 1.446 (10) C7—C8 1.518 (11) 
C20—C21 1.365 (12) C7—C9 1.526 (11) 
C20—H20 0.9500 C7—H7 1.0000 
C21—C22 1.405 (13) C8—H8A 0.9800 
C21—H21 0.9500 C8—H8B 0.9800 
C22—C23 1.404 (13) C8—H8C 0.9800 
C22—H22 0.9500 C9—H9A 0.9800 
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C23—C24 1.365 (11) C9—H9B 0.9800 
C23—H23 0.9500 C9—H9C 0.9800 
C24—N2 1.374 (10) C10—C12 1.464 (14) 
C25—N2 1.366 (9) C10—C11 1.546 (15) 
C25—C18 1.393 (10) C10—H10 1.0000 
C25—C26 1.495 (10) C11—H11A 0.9800 
C26—N3 1.480 (9) C11—H11B 0.9800 
C26—C27 1.538 (10) C11—H11C 0.9800 
C26—C33 1.539 (10) C12—H12A 0.9800 
C27—O3 1.236 (9) C12—H12B 0.9800 
C27—N4 1.321 (8) C12—H12C 0.9800 
C28—N4 1.499 (9) C13—C15 1.517 (12) 
C28—C29 1.525 (11) C13—C14 1.536 (12) 
C28—H28A 0.9900 C13—H13 1.0000 
C28—H28B 0.9900 C14—H14A 0.9800 
C29—C30 1.534 (11) C14—H14B 0.9800 
C29—H29A 0.9900 C14—H14C 0.9800 
C29—H29B 0.9900 C15—H15A 0.9800 
C30—C31 1.547 (10) C15—H15B 0.9800 
C30—H30A 0.9900 C15—H15C 0.9800 
C30—H30B 0.9900 S1—O2 1.439 (6) 
C31—N4 1.479 (9) S1—O1 1.458 (5) 
C31—C32 1.493 (10) S1—N1 1.584 (6) 
C31—H31 1.0000 N1—C16 1.503 (9) 
C32—O4 1.208 (9) N1—H1 0.8800 
C32—N3 1.323 (10) C16—C17 1.506 (9) 
C33—H33A 0.9800 C16—H16A 0.9900 
C33—H33B 0.9800 C16—H16B 0.9900 
C33—H33C 0.9800 C17—C18 1.527 (10) 
C52—C57 1.344 (13) C17—H17A 0.9900 
C52—C51 1.402 (12) C17—H17B 0.9900 
C52—C53 1.427 (14) C34—C35 1.399 (11) 
C53—C54 1.379 (16) C34—C39 1.406 (11) 
C53—H53 0.9500 C34—S2 1.796 (7) 
C54—C55 1.369 (17) C35—C36 1.431 (12) 
C54—H54 0.9500 C35—C40 1.520 (12) 
C55—C56 1.398 (18) C36—C37 1.375 (12) 
C55—H55 0.9500 C36—H36 0.9500 
C56—C57 1.422 (14) C37—C38 1.427 (12) 
C56—H56 0.9500 C37—C43 1.556 (13) 
C57—N6 1.340 (11) C38—C39 1.353 (11) 
C58—C51 1.338 (12) C38—H38 0.9500 
C58—N6 1.345 (10) C39—C46 1.515 (11) 
C58—C59 1.521 (11) C40—C41 1.549 (13) 
C59—N7 1.502 (10) C40—C42 1.549 (14) 
C59—C66 1.524 (11) C40—H40 1.0000 
C59—C60 1.554 (12) C41—H41A 0.9800 
C60—O7 1.228 (9) C41—H41B 0.9800 
C60—N8 1.335 (9) C41—H41C 0.9800 
C61—C62 1.490 (12) C42—H42A 0.9800 
C61—N8 1.514 (10) C42—H42B 0.9800 
C61—H61A 0.9900 C42—H42C 0.9800 
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C61—H61B 0.9900 C43—C45 1.435 (15) 
C62—C63 1.555 (12) C43—C44 1.586 (16) 
C62—H62A 0.9900 C43—H43 1.0000 
C62—H62B 0.9900 C44—H44A 0.9800 
C63—C64 1.521 (11) C44—H44B 0.9800 
C63—H63A 0.9900 C44—H44C 0.9800 
C63—H63B 0.9900 C45—H45A 1.0006 
C64—N8 1.481 (10) C45—H45B 1.0004 
C64—C65 1.520 (11) C45—H45C 1.0006 
C64—H64 1.0000 C46—C48 1.510 (11) 
C65—O8 1.207 (10) C46—C47 1.535 (12) 
C65—N7 1.359 (10) C46—H46 1.0000 
C66—H66A 0.9800 C47—H47A 0.9800 
C66—H66B 0.9800 C47—H47B 0.9800 
C66—H66C 0.9800 C47—H47C 0.9800 
N2—H2 0.8800 C48—H48A 0.9800 
N3—H3A 0.8800 C48—H48B 0.9800 
N6—H6 0.8800 C48—H48C 0.9800 
N7—H7A 0.8800 S2—O6 1.433 (7) 
C1—C6 1.410 (10) S2—O5 1.446 (7) 
C1—C2 1.413 (10) S2—N5 1.575 (8) 
C1—S1 1.811 (7) N5—C49 1.623 (13) 
C2—C3 1.413 (10) N5—H5A 0.8800 
C2—C7 1.520 (11) C49—C50 1.467 (13) 
C3—C4 1.369 (11) C49—H49A 0.9900 
C3—H3 0.9500 C49—H49B 0.9900 
C4—C5 1.380 (12) C50—C51 1.609 (15) 
C4—C10 1.524 (12) C50—H50A 0.9900 
C5—C6 1.404 (11) C50—H50B 0.9900 
    
C20—C19—C24 119.6 (8) C7—C8—H8A 109.5 
C20—C19—C18 133.4 (7) C7—C8—H8B 109.5 
C24—C19—C18 107.0 (7) H8A—C8—H8B 109.5 
C21—C20—C19 119.5 (8) C7—C8—H8C 109.5 
C21—C20—H20 120.2 H8A—C8—H8C 109.5 
C19—C20—H20 120.2 H8B—C8—H8C 109.5 
C20—C21—C22 120.5 (9) C7—C9—H9A 109.5 
C20—C21—H21 119.7 C7—C9—H9B 109.5 
C22—C21—H21 119.8 H9A—C9—H9B 109.5 
C21—C22—C23 121.1 (9) C7—C9—H9C 109.5 
C21—C22—H22 119.5 H9A—C9—H9C 109.5 
C23—C22—H22 119.4 H9B—C9—H9C 109.5 
C24—C23—C22 117.7 (9) C12—C10—C11 111.9 (9) 
C24—C23—H23 121.1 C12—C10—C4 113.9 (10) 
C22—C23—H23 121.1 C11—C10—C4 109.5 (9) 
C23—C24—N2 131.6 (8) C12—C10—H10 107.1 
C23—C24—C19 121.5 (8) C11—C10—H10 107.0 
N2—C24—C19 106.8 (7) C4—C10—H10 107.1 
N2—C25—C18 108.8 (7) C10—C11—H11A 109.5 
N2—C25—C26 117.5 (7) C10—C11—H11B 109.5 
C18—C25—C26 133.6 (7) H11A—C11—H11B 109.5 
N3—C26—C25 109.2 (6) C10—C11—H11C 109.5 
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N3—C26—C27 107.1 (6) H11A—C11—H11C 109.5 
C25—C26—C27 114.3 (6) H11B—C11—H11C 109.5 
N3—C26—C33 108.7 (6) C10—C12—H12A 109.5 
C25—C26—C33 109.5 (6) C10—C12—H12B 109.5 
C27—C26—C33 107.9 (6) H12A—C12—H12B 109.5 
O3—C27—N4 123.2 (7) C10—C12—H12C 109.5 
O3—C27—C26 122.2 (6) H12A—C12—H12C 109.5 
N4—C27—C26 114.6 (6) H12B—C12—H12C 109.5 
N4—C28—C29 102.8 (6) C6—C13—C15 112.1 (8) 
N4—C28—H28A 111.2 C6—C13—C14 111.1 (8) 
C29—C28—H28A 111.2 C15—C13—C14 109.8 (7) 
N4—C28—H28B 111.2 C6—C13—H13 107.9 
C29—C28—H28B 111.2 C15—C13—H13 107.9 
H28A—C28—H28B 109.1 C14—C13—H13 107.9 
C28—C29—C30 103.4 (6) C13—C14—H14A 109.5 
C28—C29—H29A 111.1 C13—C14—H14B 109.5 
C30—C29—H29A 111.1 H14A—C14—H14B 109.5 
C28—C29—H29B 111.1 C13—C14—H14C 109.5 
C30—C29—H29B 111.1 H14A—C14—H14C 109.5 
H29A—C29—H29B 109.0 H14B—C14—H14C 109.5 
C29—C30—C31 104.5 (6) C13—C15—H15A 109.5 
C29—C30—H30A 110.8 C13—C15—H15B 109.5 
C31—C30—H30A 110.8 H15A—C15—H15B 109.5 
C29—C30—H30B 110.9 C13—C15—H15C 109.5 
C31—C30—H30B 110.9 H15A—C15—H15C 109.5 
H30A—C30—H30B 108.9 H15B—C15—H15C 109.5 
N4—C31—C32 111.3 (6) O2—S1—O1 118.4 (3) 
N4—C31—C30 102.5 (6) O2—S1—N1 109.2 (3) 
C32—C31—C30 116.4 (7) O1—S1—N1 105.4 (3) 
N4—C31—H31 108.8 O2—S1—C1 106.7 (3) 
C32—C31—H31 108.8 O1—S1—C1 108.1 (3) 
C30—C31—H31 108.8 N1—S1—C1 108.9 (4) 
O4—C32—N3 123.3 (7) C16—N1—S1 121.0 (5) 
O4—C32—C31 122.1 (7) C16—N1—H1 119.5 
N3—C32—C31 114.5 (7) S1—N1—H1 119.5 
C26—C33—H33A 109.5 N1—C16—C17 112.6 (6) 
C26—C33—H33B 109.5 N1—C16—H16A 109.1 
H33A—C33—H33B 109.5 C17—C16—H16A 109.1 
C26—C33—H33C 109.5 N1—C16—H16B 109.1 
H33A—C33—H33C 109.5 C17—C16—H16B 109.1 
H33B—C33—H33C 109.5 H16A—C16—H16B 107.8 
C57—C52—C51 107.6 (9) C16—C17—C18 110.0 (6) 
C57—C52—C53 118.6 (10) C16—C17—H17A 109.7 
C51—C52—C53 133.8 (9) C18—C17—H17A 109.7 
C54—C53—C52 119.0 (11) C16—C17—H17B 109.7 
C54—C53—H53 120.5 C18—C17—H17B 109.7 
C52—C53—H53 120.5 H17A—C17—H17B 108.2 
C55—C54—C53 121.0 (12) C25—C18—C19 106.5 (7) 
C55—C54—H54 119.5 C25—C18—C17 131.1 (7) 
C53—C54—H54 119.5 C19—C18—C17 122.3 (7) 
C54—C55—C56 121.6 (12) C35—C34—C39 122.4 (7) 
C54—C55—H55 119.2 C35—C34—S2 120.4 (6) 
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C56—C55—H55 119.2 C39—C34—S2 117.1 (5) 
C55—C56—C57 115.8 (12) C34—C35—C36 116.7 (8) 
C55—C56—H56 122.1 C34—C35—C40 128.0 (7) 
C57—C56—H56 122.1 C36—C35—C40 114.9 (8) 
N6—C57—C52 107.5 (8) C37—C36—C35 122.0 (9) 
N6—C57—C56 128.9 (10) C37—C36—H36 119.0 
C52—C57—C56 123.6 (11) C35—C36—H36 119.0 
C51—C58—N6 107.9 (7) C36—C37—C38 117.7 (8) 
C51—C58—C59 133.8 (7) C36—C37—C43 119.0 (9) 
N6—C58—C59 118.2 (7) C38—C37—C43 123.2 (8) 
N7—C59—C58 108.5 (7) C39—C38—C37 122.4 (8) 
N7—C59—C66 109.5 (7) C39—C38—H38 118.8 
C58—C59—C66 110.0 (6) C37—C38—H38 118.8 
N7—C59—C60 105.7 (6) C38—C39—C34 118.3 (7) 
C58—C59—C60 114.4 (7) C38—C39—C46 115.4 (8) 
C66—C59—C60 108.6 (7) C34—C39—C46 126.3 (7) 
O7—C60—N8 126.4 (8) C35—C40—C41 109.7 (9) 
O7—C60—C59 122.1 (7) C35—C40—C42 112.0 (9) 
N8—C60—C59 111.5 (7) C41—C40—C42 108.1 (9) 
C62—C61—N8 102.5 (7) C35—C40—H40 109.0 
C62—C61—H61A 111.3 C41—C40—H40 109.0 
N8—C61—H61A 111.3 C42—C40—H40 109.0 
C62—C61—H61B 111.3 C40—C41—H41A 109.5 
N8—C61—H61B 111.3 C40—C41—H41B 109.5 
H61A—C61—H61B 109.2 H41A—C41—H41B 109.5 
C61—C62—C63 102.0 (7) C40—C41—H41C 109.5 
C61—C62—H62A 111.4 H41A—C41—H41C 109.5 
C63—C62—H62A 111.4 H41B—C41—H41C 109.5 
C61—C62—H62B 111.4 C40—C42—H42A 109.5 
C63—C62—H62B 111.4 C40—C42—H42B 109.5 
H62A—C62—H62B 109.2 H42A—C42—H42B 109.5 
C64—C63—C62 104.7 (7) C40—C42—H42C 109.5 
C64—C63—H63A 110.8 H42A—C42—H42C 109.5 
C62—C63—H63A 110.8 H42B—C42—H42C 109.5 
C64—C63—H63B 110.8 C45—C43—C37 113.5 (10) 
C62—C63—H63B 110.8 C45—C43—C44 118.3 (14) 
H63A—C63—H63B 108.9 C37—C43—C44 108.2 (11) 
N8—C64—C65 109.2 (7) C45—C43—H43 105.2 
N8—C64—C63 102.0 (6) C37—C43—H43 105.2 
C65—C64—C63 115.0 (7) C44—C43—H43 105.2 
N8—C64—H64 110.1 C43—C44—H44A 109.5 
C65—C64—H64 110.1 C43—C44—H44B 109.5 
C63—C64—H64 110.1 H44A—C44—H44B 109.5 
O8—C65—N7 123.3 (8) C43—C44—H44C 109.5 
O8—C65—C64 123.8 (8) H44A—C44—H44C 109.5 
N7—C65—C64 112.8 (7) H44B—C44—H44C 109.5 
C59—C66—H66A 109.5 C43—C45—H45A 111.7 
C59—C66—H66B 109.5 C43—C45—H45B 111.6 
H66A—C66—H66B 109.5 H45A—C45—H45B 107.2 
C59—C66—H66C 109.5 C43—C45—H45C 111.7 
H66A—C66—H66C 109.5 H45A—C45—H45C 107.2 
H66B—C66—H66C 109.5 H45B—C45—H45C 107.2 
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C25—N2—C24 110.9 (7) C48—C46—C39 110.6 (8) 
C25—N2—H2 124.5 C48—C46—C47 110.0 (7) 
C24—N2—H2 124.5 C39—C46—C47 111.4 (8) 
C32—N3—C26 122.5 (6) C48—C46—H46 108.2 
C32—N3—H3A 118.8 C39—C46—H46 108.2 
C26—N3—H3A 118.8 C47—C46—H46 108.2 
C27—N4—C31 122.3 (6) C46—C47—H47A 109.5 
C27—N4—C28 124.8 (6) C46—C47—H47B 109.5 
C31—N4—C28 112.6 (6) H47A—C47—H47B 109.5 
C57—N6—C58 110.0 (8) C46—C47—H47C 109.5 
C57—N6—H6 125.0 H47A—C47—H47C 109.5 
C58—N6—H6 125.0 H47B—C47—H47C 109.5 
C65—N7—C59 120.6 (7) C46—C48—H48A 109.5 
C65—N7—H7A 119.7 C46—C48—H48B 109.5 
C59—N7—H7A 119.7 H48A—C48—H48B 109.5 
C60—N8—C64 123.4 (7) C46—C48—H48C 109.5 
C60—N8—C61 124.4 (7) H48A—C48—H48C 109.5 
C64—N8—C61 111.8 (7) H48B—C48—H48C 109.5 
C6—C1—C2 122.4 (6) O6—S2—O5 120.5 (6) 
C6—C1—S1 120.2 (6) O6—S2—N5 105.1 (4) 
C2—C1—S1 117.4 (6) O5—S2—N5 108.9 (5) 
C3—C2—C1 116.3 (7) O6—S2—C34 107.0 (4) 
C3—C2—C7 116.7 (7) O5—S2—C34 107.7 (4) 
C1—C2—C7 126.9 (7) N5—S2—C34 107.0 (5) 
C4—C3—C2 122.5 (8) S2—N5—C49 120.7 (6) 
C4—C3—H3 118.8 S2—N5—H5A 119.7 
C2—C3—H3 118.8 C49—N5—H5A 119.7 
C3—C4—C5 119.4 (8) C50—C49—N5 103.1 (10) 
C3—C4—C10 119.2 (8) C50—C49—H49A 111.1 
C5—C4—C10 121.3 (8) N5—C49—H49A 111.2 
C4—C5—C6 122.0 (8) C50—C49—H49B 111.2 
C4—C5—H5 119.0 N5—C49—H49B 111.2 
C6—C5—H5 119.0 H49A—C49—H49B 109.1 
C5—C6—C1 117.0 (7) C49—C50—C51 100.0 (10) 
C5—C6—C13 114.4 (7) C49—C50—H50A 111.8 
C1—C6—C13 128.5 (7) C51—C50—H50A 111.8 
C8—C7—C9 110.0 (7) C49—C50—H50B 111.8 
C8—C7—C2 112.9 (7) C51—C50—H50B 111.8 
C9—C7—C2 110.0 (7) H50A—C50—H50B 109.5 
C8—C7—H7 107.9 C58—C51—C52 107.0 (8) 
C9—C7—H7 107.9 C58—C51—C50 129.4 (9) 
C2—C7—H7 107.9 C52—C51—C50 120.6 (9) 
    
C24—C19—C20—C21 1.3 (12) C62—C61—N8—C64 19.6 (9) 
C18—C19—C20—C21 179.1 (8) C6—C1—C2—C3 6.2 (12) 
C19—C20—C21—C22 0.1 (14) S1—C1—C2—C3 −173.3 (6) 
C20—C21—C22—C23 −1.9 (17) C6—C1—C2—C7 −170.5 (8) 
C21—C22—C23—C24 2.3 (16) S1—C1—C2—C7 9.9 (12) 
C22—C23—C24—N2 177.0 (9) C1—C2—C3—C4 −2.0 (13) 
C22—C23—C24—C19 −0.9 (15) C7—C2—C3—C4 175.1 (9) 
C20—C19—C24—C23 −0.9 (14) C2—C3—C4—C5 −2.5 (15) 
C18—C19—C24—C23 −179.2 (8) C2—C3—C4—C10 179.3 (9) 
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C20—C19—C24—N2 −179.3 (7) C3—C4—C5—C6 3.0 (16) 
C18—C19—C24—N2 2.4 (9) C10—C4—C5—C6 −178.9 (10) 
N2—C25—C26—N3 46.9 (8) C4—C5—C6—C1 1.0 (15) 
C18—C25—C26—N3 −135.4 (9) C4—C5—C6—C13 −177.2 (9) 
N2—C25—C26—C27 166.8 (6) C2—C1—C6—C5 −5.8 (13) 
C18—C25—C26—C27 −15.5 (12) S1—C1—C6—C5 173.8 (7) 
N2—C25—C26—C33 −72.1 (8) C2—C1—C6—C13 172.2 (8) 
C18—C25—C26—C33 105.7 (10) S1—C1—C6—C13 −8.3 (13) 
N3—C26—C27—O3 −140.1 (7) C3—C2—C7—C8 71.4 (9) 
C25—C26—C27—O3 98.8 (9) C1—C2—C7—C8 −111.8 (9) 
C33—C26—C27—O3 −23.2 (10) C3—C2—C7—C9 −51.8 (10) 
N3—C26—C27—N4 39.0 (8) C1—C2—C7—C9 124.9 (9) 
C25—C26—C27—N4 −82.0 (8) C3—C4—C10—C12 −59.5 (14) 
C33—C26—C27—N4 155.9 (7) C5—C4—C10—C12 122.4 (12) 
N4—C28—C29—C30 −32.1 (8) C3—C4—C10—C11 66.6 (13) 
C28—C29—C30—C31 38.3 (8) C5—C4—C10—C11 −111.5 (11) 
C29—C30—C31—N4 −28.5 (8) C5—C6—C13—C15 −75.6 (10) 
C29—C30—C31—C32 −150.2 (7) C1—C6—C13—C15 106.4 (11) 
N4—C31—C32—O4 −152.9 (7) C5—C6—C13—C14 47.7 (11) 
C30—C31—C32—O4 −35.9 (11) C1—C6—C13—C14 −130.3 (10) 
N4—C31—C32—N3 31.4 (9) C6—C1—S1—O2 −19.5 (8) 
C30—C31—C32—N3 148.3 (7) C2—C1—S1—O2 160.1 (6) 
C57—C52—C53—C54 0 (2) C6—C1—S1—O1 108.8 (7) 
C51—C52—C53—C54 −179.4 (15) C2—C1—S1—O1 −71.6 (7) 
C52—C53—C54—C55 −4 (3) C6—C1—S1—N1 −137.2 (7) 
C53—C54—C55—C56 7 (3) C2—C1—S1—N1 42.4 (7) 
C54—C55—C56—C57 −6 (2) O2—S1—N1—C16 −36.8 (6) 
C51—C52—C57—N6 −1.0 (14) O1—S1—N1—C16 −164.9 (5) 
C53—C52—C57—N6 179.1 (11) C1—S1—N1—C16 79.4 (6) 
C51—C52—C57—C56 −179.7 (12) S1—N1—C16—C17 95.0 (7) 
C53—C52—C57—C56 0 (2) N1—C16—C17—C18 −165.2 (6) 
C55—C56—C57—N6 −176.2 (12) N2—C25—C18—C19 2.1 (8) 
C55—C56—C57—C52 2 (2) C26—C25—C18—C19 −175.8 (7) 
C51—C58—C59—N7 −144.8 (11) N2—C25—C18—C17 178.4 (7) 
N6—C58—C59—N7 39.2 (10) C26—C25—C18—C17 0.5 (14) 
C51—C58—C59—C66 95.4 (13) C20—C19—C18—C25 179.2 (8) 
N6—C58—C59—C66 −80.5 (9) C24—C19—C18—C25 −2.8 (9) 
C51—C58—C59—C60 −27.1 (14) C20—C19—C18—C17 2.6 (13) 
N6—C58—C59—C60 157.0 (7) C24—C19—C18—C17 −179.4 (7) 
N7—C59—C60—O7 −132.1 (8) C16—C17—C18—C25 −97.6 (9) 
C58—C59—C60—O7 108.6 (9) C16—C17—C18—C19 78.1 (9) 
C66—C59—C60—O7 −14.6 (10) C39—C34—C35—C36 2.4 (14) 
N7—C59—C60—N8 46.4 (9) S2—C34—C35—C36 −173.4 (8) 
C58—C59—C60—N8 −72.9 (9) C39—C34—C35—C40 175.3 (10) 
C66—C59—C60—N8 163.8 (7) S2—C34—C35—C40 −0.6 (15) 
N8—C61—C62—C63 −36.1 (8) C34—C35—C36—C37 −4.1 (16) 
C61—C62—C63—C64 41.7 (8) C40—C35—C36—C37 −177.9 (11) 
C62—C63—C64—N8 −28.8 (8) C35—C36—C37—C38 −0.4 (18) 
C62—C63—C64—C65 −146.9 (7) C35—C36—C37—C43 −177.6 (11) 
N8—C64—C65—O8 −144.9 (8) C36—C37—C38—C39 7.2 (17) 
C63—C64—C65—O8 −30.9 (12) C43—C37—C38—C39 −175.8 (11) 
N8—C64—C65—N7 37.2 (9) C37—C38—C39—C34 −8.8 (16) 
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C63—C64—C65—N7 151.2 (7) C37—C38—C39—C46 172.1 (10) 
C18—C25—N2—C24 −0.7 (9) C35—C34—C39—C38 3.9 (14) 
C26—C25—N2—C24 177.6 (6) S2—C34—C39—C38 179.9 (7) 
C23—C24—N2—C25 −179.3 (9) C35—C34—C39—C46 −177.2 (9) 
C19—C24—N2—C25 −1.1 (9) S2—C34—C39—C46 −1.2 (12) 
O4—C32—N3—C26 −163.2 (7) C34—C35—C40—C41 127.5 (11) 
C31—C32—N3—C26 12.6 (10) C36—C35—C40—C41 −59.5 (13) 
C25—C26—N3—C32 75.5 (8) C34—C35—C40—C42 −112.4 (13) 
C27—C26—N3—C32 −48.8 (8) C36—C35—C40—C42 60.6 (14) 
C33—C26—N3—C32 −165.2 (7) C36—C37—C43—C45 −135.3 (18) 
O3—C27—N4—C31 −178.7 (7) C38—C37—C43—C45 48 (2) 
C26—C27—N4—C31 2.2 (10) C36—C37—C43—C44 91.4 (14) 
O3—C27—N4—C28 8.7 (12) C38—C37—C43—C44 −85.6 (13) 
C26—C27—N4—C28 −170.4 (7) C38—C39—C46—C48 −55.7 (11) 
C32—C31—N4—C27 −39.8 (10) C34—C39—C46—C48 125.4 (9) 
C30—C31—N4—C27 −165.0 (7) C38—C39—C46—C47 67.1 (12) 
C32—C31—N4—C28 133.6 (7) C34—C39—C46—C47 −111.9 (10) 
C30—C31—N4—C28 8.4 (8) C35—C34—S2—O6 118.9 (8) 
C29—C28—N4—C27 −171.8 (7) C39—C34—S2—O6 −57.2 (8) 
C29—C28—N4—C31 14.9 (8) C35—C34—S2—O5 −12.0 (9) 
C52—C57—N6—C58 0.7 (12) C39—C34—S2—O5 171.9 (7) 
C56—C57—N6—C58 179.4 (12) C35—C34—S2—N5 −128.9 (8) 
C51—C58—N6—C57 −0.1 (11) C39—C34—S2—N5 55.0 (8) 
C59—C58—N6—C57 176.8 (8) O6—S2—N5—C49 172.8 (9) 
O8—C65—N7—C59 −167.4 (8) O5—S2—N5—C49 −56.9 (10) 
C64—C65—N7—C59 10.5 (10) C34—S2—N5—C49 59.3 (9) 
C58—C59—N7—C65 69.2 (9) S2—N5—C49—C50 101.7 (10) 
C66—C59—N7—C65 −170.8 (7) N5—C49—C50—C51 −169.2 (8) 
C60—C59—N7—C65 −54.0 (9) N6—C58—C51—C52 −0.5 (12) 
O7—C60—N8—C64 178.1 (8) C59—C58—C51—C52 −176.8 (9) 
C59—C60—N8—C64 −0.3 (10) N6—C58—C51—C50 −160.6 (11) 
O7—C60—N8—C61 6.4 (13) C59—C58—C51—C50 23 (2) 
C59—C60—N8—C61 −172.0 (7) C57—C52—C51—C58 0.9 (14) 
C65—C64—N8—C60 −44.2 (10) C53—C52—C51—C58 −179.2 (15) 
C63—C64—N8—C60 −166.4 (7) C57—C52—C51—C50 163.1 (11) 
C65—C64—N8—C61 128.4 (7) C53—C52—C51—C50 −17 (2) 
C63—C64—N8—C61 6.2 (8) C49—C50—C51—C58 −95.4 (15) 
C62—C61—N8—C60 −167.9 (8) C49—C50—C51—C52 106.8 (13) 
Hydrogen-bond geometry (Å, º) 
D—H···A D—H H···A D···A D—H···A 
N5—H5A···O3
i
 0.88 1.95 2.819 (9) 169 
N1—H1···O7
ii
 0.88 1.98 2.850 (8) 171 
N7—H7A···O6
iii
 0.88 2.21 2.849 (10) 129 
N6—H6···O6
iii
 0.88 2.41 3.195 (12) 150 
N3—H3A···O1
iv
 0.88 2.35 3.002 (8) 131 
N2—H2···O1
iv
 0.88 2.17 3.010 (8) 160 
Symmetry codes: (i) x+1/2, y−1/2, z; (ii) x−1/2, y+1/2, z; (iii) x, y+1, z; (iv) x, y−1, z 
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Appendix 4: Crystallographic data for (3.37) 
 
 
 
 
Data obtained at School of Chemistry, The University of Manchester, Oxford Road, Manchester, 
M13 9PL, UK. 
Refinement 
The structure was solved by direct methods. The non-hydrogen atoms were refined anisotropically. 
H atoms were included in calculated positions with C—H lengths of 0.95(CH), 0.99(CH2) & 
0.98(CH3)Å; Uiso(H) values were fixed at 1.2Ueq(C) except for CH3 where it was 1.5Ueq(C). 
Experimental: 
Crystal data 
C18H20ClN3O2 Z = 3 
Mr = 345.82 Mo Kα radiation, λ = 0.71073 Å 
Trigonal, P31 µ = 0.24 mm
−1
 
a = 10.1517 (5) Å T = 100 K 
c = 14.5792 (15) Å 0.40 × 0.25 × 0.20 mm 
V = 1301.19 (16) Å
3
  
Data collection 
CCD area detector  
diffractometer 
3596 reflections with I > 2σ(I) 
11175 measured reflections Rint = 0.052 
4061 independent reflections  
Refinement 
R[F
2
 > 2σ(F
2
)] = 0.051 
H atoms treated by a mixture of 
independent and constrained 
refinement 
wR(F
2
) = 0.096 Δρmax = 0.39 e Å
−3
 
S = 1.06 Δρmin = −0.23 e Å
−3
 
4061 reflections 
Absolute structure: Flack H D (1983), 
Acta Cryst. A39, 876-881 
226 parameters Flack parameter: 0.04 (6) 
1 restraint  
Table 1 
Hydrogen-bond geometry (Å, º) 
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D—H···A D—H H···A D···A D—H···A 
N1—H1···O2
i
 0.83 (3) 1.97 (3) 2.744 (3) 154 (3) 
N3—H2···O1
ii
 0.86 (3) 2.09 (3) 2.920 (3) 164 (2) 
  
Data collection: Bruker SMART; cell refinement: Bruker SMART; data reduction: Bruker SAINT; 
program(s) used to solve structure: SHELXS97 (Sheldrick, 1990); program(s) used to refine 
structure: SHELXL97 (Sheldrick, 1997); molecular graphics: Bruker SHELXTL; software used to 
prepare material for publication: Bruker SHELXTL. 
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Supplementary materials 
Crystal data 
C18H20ClN3O2 Dx = 1.324 Mg m
−3
 
Mr = 345.82 Mo Kα radiation, λ = 0.71073 Å 
Trigonal, P31 Cell parameters from 3357 reflections 
a = 10.1517 (5) Å θ = 2.3–26.7° 
c = 14.5792 (15) Å µ = 0.24 mm
−1
 
V = 1301.19 (16) Å
3
 T = 100 K 
Z = 3 Block, White 
F(000) = 546 0.40 × 0.25 × 0.20 mm 
Data collection 
CCD area detector  
diffractometer 
3596 reflections with I > 2σ(I) 
Radiation source: fine-focus sealed 
tube 
Rint = 0.052 
graphite θmax = 28.3°, θmin = 2.3° 
phi and ω scans h = −13→13 
11175 measured reflections k = −13→13 
4061 independent reflections l = −19→19 
Refinement 
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Refinement on F
2
 
Secondary atom site location: 
Difference Fourier map 
Least-squares matrix: Full 
Hydrogen site location: Inferred from 
neighbouring sites 
R[F
2
 > 2σ(F
2
)] = 0.051 
H atoms treated by a mixture of 
independent and constrained 
refinement 
wR(F
2
) = 0.096 
w = 1/[σ
2
(Fo
2
) + (0.0402P)
2
]  
where P = (Fo
2
 + 2Fc
2
)/3 
S = 1.06 (Δ/σ)max < 0.001 
4061 reflections Δρmax = 0.39 e Å
−3
 
226 parameters Δρmin = −0.23 e Å
−3
 
1 restraint 
Absolute structure: Flack H D (1983), 
Acta Cryst. A39, 876-881 
Primary atom site location: Structure-
invariant direct methods 
Flack parameter: 0.04 (6) 
Special details 
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated 
using the full covariance matrix. The cell esds are taken into account individually in the estimation 
of esds in distances, angles and torsion angles; correlations between esds in cell parameters are 
only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell 
esds is used for estimating esds involving l.s. planes. 
Refinement. Refinement of F
2
 against ALL reflections. The weighted R-factor wR and goodness of 
fit S are based on F
2
, conventional R-factors R are based on F, with F set to zero for negative F
2
. 
The threshold expression of F
2
 > 2sigma(F
2
) is used only for calculating R-factors(gt) etc. and is 
not relevant to the choice of reflections for refinement. R-factors based on F
2
 are statistically about 
twice as large as those based on F, and R- factors based on ALL data will be even larger. 
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å
2
) 
 x y z Uiso*/Ueq 
C1 0.5339 (3) 0.7628 (3) 0.39334 (16) 0.0168 (5) 
C2 0.5516 (3) 0.5470 (3) 0.32764 (16) 0.0179 (5) 
C3 0.6388 (3) 0.5557 (3) 0.41355 (16) 0.0202 (5) 
H3 0.7473 0.6375 0.4061 0.024* 
C4 0.6333 (4) 0.4093 (3) 0.44363 (18) 0.0304 (6) 
H4A 0.7178 0.4005 0.4162 0.036* 
H4B 0.5355 0.3189 0.4264 0.036* 
C5 0.6500 (4) 0.4268 (3) 0.54839 (18) 0.0329 (7) 
H5A 0.6119 0.3269 0.5786 0.040* 
H5B 0.7575 0.4946 0.5662 0.040* 
C6 0.5530 (3) 0.4968 (3) 0.57324 (17) 0.0282 (6) 
H6A 0.4452 0.4175 0.5819 0.034* 
H6B 0.5905 0.5587 0.6298 0.034* 
C7 0.5087 (3) 0.6796 (3) 0.48629 (16) 0.0177 (5) 
C8 0.4124 (3) 0.8098 (3) 0.38109 (18) 0.0228 (5) 
H8A 0.4294 0.8644 0.3229 0.034* 
H8B 0.4192 0.8763 0.4319 0.034* 
H8C 0.3111 0.7188 0.3807 0.034* 
C9 0.6903 (3) 0.9020 (3) 0.39466 (15) 0.0153 (5) 
C10 0.8648 (3) 1.1252 (3) 0.45559 (16) 0.0179 (5) 
C11 0.9446 (3) 1.2547 (3) 0.51007 (17) 0.0250 (6) 
H11 0.8986 1.2733 0.5614 0.030* 
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C12 1.0935 (3) 1.3543 (3) 0.48574 (19) 0.0324 (7) 
H12 1.1516 1.4439 0.5210 0.039* 
C13 1.1608 (3) 1.3257 (3) 0.4098 (2) 0.0306 (6) 
H13 1.2639 1.3960 0.3954 0.037* 
C14 1.0816 (3) 1.1993 (3) 0.35627 (19) 0.0271 (6) 
H14 1.1285 1.1819 0.3049 0.032* 
C15 0.9301 (3) 1.0961 (3) 0.37880 (16) 0.0189 (5) 
C16 0.8171 (3) 0.9526 (3) 0.34033 (16) 0.0180 (5) 
C17 0.8446 (3) 0.8879 (3) 0.25419 (17) 0.0217 (5) 
H17A 0.7646 0.7798 0.2483 0.026* 
H17B 0.9438 0.8919 0.2592 0.026* 
C18 0.8447 (3) 0.9732 (3) 0.16861 (18) 0.0306 (6) 
H18A 0.8754 0.9344 0.1153 0.037* 
H18B 0.9205 1.0824 0.1759 0.037* 
Cl1 0.66151 (8) 0.95295 (8) 0.14665 (5) 0.0393 (2) 
N1 0.5136 (2) 0.6550 (2) 0.32064 (14) 0.0171 (4) 
N2 0.5718 (2) 0.5929 (2) 0.49233 (13) 0.0198 (4) 
N3 0.7196 (2) 1.0053 (2) 0.46458 (14) 0.0184 (4) 
O1 0.51990 (19) 0.44961 (19) 0.26851 (11) 0.0230 (4) 
O2 0.4367 (2) 0.69384 (19) 0.54976 (12) 0.0241 (4) 
H1 0.456 (3) 0.648 (3) 0.2778 (19) 0.023 (7)* 
H2 0.656 (3) 1.006 (3) 0.5031 (18) 0.018 (7)* 
Atomic displacement parameters (Å
2
) 
 U
11
 U
22
 U
33
 U
12
 U
13
 U
23
 
C1 0.0145 (12) 0.0160 (11) 0.0190 (12) 0.0070 (10) −0.0011 (9) −0.0027 (9) 
C2 0.0130 (11) 0.0168 (12) 0.0195 (12) 0.0043 (10) 0.0028 (9) 0.0017 (10) 
C3 0.0250 (13) 0.0191 (12) 0.0195 (12) 0.0133 (11) 0.0018 (10) 0.0006 (10) 
C4 0.0518 (18) 0.0277 (15) 0.0230 (13) 0.0283 (14) −0.0002 (13) −0.0017 (11) 
C5 0.059 (2) 0.0275 (15) 0.0221 (14) 0.0285 (15) 0.0017 (13) 0.0046 (11) 
C6 0.0465 (18) 0.0236 (14) 0.0157 (12) 0.0183 (13) 0.0063 (12) 0.0063 (10) 
C7 0.0159 (12) 0.0122 (12) 0.0203 (12) 0.0035 (10) 0.0018 (10) −0.0027 (9) 
C8 0.0182 (13) 0.0244 (13) 0.0287 (14) 0.0128 (11) −0.0004 (11) −0.0043 (11) 
C9 0.0184 (12) 0.0153 (11) 0.0135 (11) 0.0094 (10) −0.0003 (9) 0.0021 (9) 
C10 0.0141 (11) 0.0164 (12) 0.0195 (11) 0.0048 (10) 0.0012 (9) 0.0023 (9) 
C11 0.0257 (14) 0.0183 (13) 0.0253 (14) 0.0067 (11) −0.0012 (11) −0.0047 (10) 
C12 0.0295 (15) 0.0222 (14) 0.0355 (16) 0.0055 (12) −0.0027 (12) −0.0071 (12) 
C13 0.0176 (13) 0.0227 (14) 0.0389 (15) 0.0006 (11) 0.0067 (12) −0.0014 (12) 
C14 0.0235 (14) 0.0262 (14) 0.0293 (14) 0.0107 (12) 0.0064 (11) 0.0015 (11) 
C15 0.0213 (13) 0.0178 (12) 0.0192 (12) 0.0111 (10) −0.0006 (10) 0.0000 (9) 
C16 0.0190 (12) 0.0144 (12) 0.0201 (12) 0.0081 (10) 0.0007 (10) 0.0033 (9) 
C17 0.0183 (12) 0.0195 (12) 0.0232 (13) 0.0063 (11) 0.0052 (10) −0.0015 (10) 
C18 0.0269 (15) 0.0286 (15) 0.0256 (15) 0.0058 (12) 0.0059 (11) 0.0008 (11) 
Cl1 0.0339 (4) 0.0356 (4) 0.0306 (4) 0.0040 (3) −0.0094 (3) 0.0053 (3) 
N1 0.0181 (10) 0.0177 (10) 0.0157 (10) 0.0091 (9) −0.0042 (9) −0.0015 (8) 
N2 0.0256 (11) 0.0206 (11) 0.0153 (10) 0.0131 (10) 0.0053 (9) 0.0022 (8) 
N3 0.0160 (10) 0.0189 (11) 0.0186 (10) 0.0075 (9) 0.0034 (9) −0.0005 (8) 
O1 0.0243 (9) 0.0237 (10) 0.0243 (9) 0.0144 (8) −0.0055 (8) −0.0085 (7) 
O2 0.0269 (10) 0.0193 (9) 0.0235 (9) 0.0096 (8) 0.0078 (8) 0.0002 (7) 
Geometric parameters (Å, º) 
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C1—N1 1.462 (3) C9—C16 1.373 (3) 
C1—C9 1.508 (3) C9—N3 1.384 (3) 
C1—C8 1.539 (3) C10—N3 1.370 (3) 
C1—C7 1.549 (3) C10—C11 1.397 (3) 
C2—O1 1.227 (3) C10—C15 1.405 (3) 
C2—N1 1.336 (3) C11—C12 1.380 (4) 
C2—C3 1.511 (3) C11—H11 0.9500 
C3—N2 1.477 (3) C12—C13 1.405 (4) 
C3—C4 1.524 (3) C12—H12 0.9500 
C3—H3 1.0000 C13—C14 1.368 (4) 
C4—C5 1.537 (4) C13—H13 0.9500 
C4—H4A 0.9900 C14—C15 1.400 (4) 
C4—H4B 0.9900 C14—H14 0.9500 
C5—C6 1.518 (4) C15—C16 1.443 (3) 
C5—H5A 0.9900 C16—C17 1.507 (3) 
C5—H5B 0.9900 C17—C18 1.519 (4) 
C6—N2 1.482 (3) C17—H17A 0.9900 
C6—H6A 0.9900 C17—H17B 0.9900 
C6—H6B 0.9900 C18—Cl1 1.795 (3) 
C7—O2 1.232 (3) C18—H18A 0.9900 
C7—N2 1.325 (3) C18—H18B 0.9900 
C8—H8A 0.9800 N1—H1 0.83 (3) 
C8—H8B 0.9800 N3—H2 0.86 (3) 
C8—H8C 0.9800   
    
N1—C1—C9 113.49 (19) N3—C9—C1 116.5 (2) 
N1—C1—C8 108.25 (19) N3—C10—C11 129.9 (2) 
C9—C1—C8 110.06 (19) N3—C10—C15 107.5 (2) 
N1—C1—C7 107.61 (18) C11—C10—C15 122.5 (2) 
C9—C1—C7 108.00 (18) C12—C11—C10 116.8 (2) 
C8—C1—C7 109.35 (19) C12—C11—H11 121.6 
O1—C2—N1 122.7 (2) C10—C11—H11 121.6 
O1—C2—C3 122.6 (2) C11—C12—C13 121.2 (2) 
N1—C2—C3 114.6 (2) C11—C12—H12 119.4 
N2—C3—C2 109.16 (19) C13—C12—H12 119.4 
N2—C3—C4 103.23 (19) C14—C13—C12 121.7 (2) 
C2—C3—C4 116.6 (2) C14—C13—H13 119.2 
N2—C3—H3 109.2 C12—C13—H13 119.2 
C2—C3—H3 109.2 C13—C14—C15 118.6 (2) 
C4—C3—H3 109.2 C13—C14—H14 120.7 
C3—C4—C5 103.0 (2) C15—C14—H14 120.7 
C3—C4—H4A 111.2 C14—C15—C10 119.1 (2) 
C5—C4—H4A 111.2 C14—C15—C16 133.3 (2) 
C3—C4—H4B 111.2 C10—C15—C16 107.5 (2) 
C5—C4—H4B 111.2 C9—C16—C15 106.1 (2) 
H4A—C4—H4B 109.1 C9—C16—C17 131.4 (2) 
C6—C5—C4 103.4 (2) C15—C16—C17 122.5 (2) 
C6—C5—H5A 111.1 C16—C17—C18 112.5 (2) 
C4—C5—H5A 111.1 C16—C17—H17A 109.1 
C6—C5—H5B 111.1 C18—C17—H17A 109.1 
C4—C5—H5B 111.1 C16—C17—H17B 109.1 
H5A—C5—H5B 109.1 C18—C17—H17B 109.1 
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N2—C6—C5 102.61 (19) H17A—C17—H17B 107.8 
N2—C6—H6A 111.2 C17—C18—Cl1 112.11 (18) 
C5—C6—H6A 111.2 C17—C18—H18A 109.2 
N2—C6—H6B 111.2 Cl1—C18—H18A 109.2 
C5—C6—H6B 111.2 C17—C18—H18B 109.2 
H6A—C6—H6B 109.2 Cl1—C18—H18B 109.2 
O2—C7—N2 122.7 (2) H18A—C18—H18B 107.9 
O2—C7—C1 122.6 (2) C2—N1—C1 124.7 (2) 
N2—C7—C1 114.69 (19) C2—N1—H1 117.5 (19) 
C1—C8—H8A 109.5 C1—N1—H1 116.2 (19) 
C1—C8—H8B 109.5 C7—N2—C3 123.75 (19) 
H8A—C8—H8B 109.5 C7—N2—C6 123.0 (2) 
C1—C8—H8C 109.5 C3—N2—C6 112.00 (19) 
H8A—C8—H8C 109.5 C10—N3—C9 109.3 (2) 
H8B—C8—H8C 109.5 C10—N3—H2 122.5 (17) 
C16—C9—N3 109.6 (2) C9—N3—H2 127.5 (18) 
C16—C9—C1 134.0 (2)   
    
O1—C2—C3—N2 −139.7 (2) N3—C9—C16—C15 −0.6 (3) 
N1—C2—C3—N2 41.2 (3) C1—C9—C16—C15 179.7 (2) 
O1—C2—C3—C4 −23.3 (3) N3—C9—C16—C17 −177.4 (2) 
N1—C2—C3—C4 157.6 (2) C1—C9—C16—C17 2.9 (4) 
N2—C3—C4—C5 −30.7 (3) C14—C15—C16—C9 177.7 (3) 
C2—C3—C4—C5 −150.4 (2) C10—C15—C16—C9 0.0 (3) 
C3—C4—C5—C6 40.2 (3) C14—C15—C16—C17 −5.1 (4) 
C4—C5—C6—N2 −33.1 (3) C10—C15—C16—C17 177.2 (2) 
N1—C1—C7—O2 −138.3 (2) C9—C16—C17—C18 104.0 (3) 
C9—C1—C7—O2 98.8 (3) C15—C16—C17—C18 −72.4 (3) 
C8—C1—C7—O2 −20.9 (3) C16—C17—C18—Cl1 −65.6 (2) 
N1—C1—C7—N2 42.2 (2) O1—C2—N1—C1 173.0 (2) 
C9—C1—C7—N2 −80.7 (2) C3—C2—N1—C1 −7.9 (3) 
C8—C1—C7—N2 159.6 (2) C9—C1—N1—C2 85.5 (3) 
N1—C1—C9—C16 2.7 (4) C8—C1—N1—C2 −152.1 (2) 
C8—C1—C9—C16 −118.7 (3) C7—C1—N1—C2 −34.0 (3) 
C7—C1—C9—C16 122.0 (3) O2—C7—N2—C3 170.6 (2) 
N1—C1—C9—N3 −177.0 (2) C1—C7—N2—C3 −9.9 (3) 
C8—C1—C9—N3 61.6 (3) O2—C7—N2—C6 4.4 (4) 
C7—C1—C9—N3 −57.7 (3) C1—C7—N2—C6 −176.2 (2) 
N3—C10—C11—C12 177.5 (3) C2—C3—N2—C7 −32.5 (3) 
C15—C10—C11—C12 −0.6 (4) C4—C3—N2—C7 −157.1 (2) 
C10—C11—C12—C13 −0.2 (4) C2—C3—N2—C6 135.1 (2) 
C11—C12—C13—C14 0.8 (5) C4—C3—N2—C6 10.5 (3) 
C12—C13—C14—C15 −0.5 (4) C5—C6—N2—C7 −177.9 (2) 
C13—C14—C15—C10 −0.3 (4) C5—C6—N2—C3 14.4 (3) 
C13—C14—C15—C16 −177.8 (3) C11—C10—N3—C9 −179.2 (3) 
N3—C10—C15—C14 −177.6 (2) C15—C10—N3—C9 −0.9 (3) 
C11—C10—C15—C14 0.9 (4) C16—C9—N3—C10 0.9 (3) 
N3—C10—C15—C16 0.5 (3) C1—C9—N3—C10 −179.3 (2) 
C11—C10—C15—C16 179.0 (2)   
Hydrogen-bond geometry (Å, º) 
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D—H···A D—H H···A D···A D—H···A 
N1—H1···O2
i
 0.83 (3) 1.97 (3) 2.744 (3) 154 (3) 
N3—H2···O1
ii
 0.86 (3) 2.09 (3) 2.920 (3) 164 (2) 
Symmetry codes: (i) −x+y, −x+1, z−1/3; (ii) −y+1, x−y+1, z+1/3. 
  Appendix 5 
204 
Appendix 5: Crystallographic data for (3.48) 
 
 
 
Data obtained at School of Chemistry, The University of Manchester, Oxford Road, Manchester, 
M13 9PL, UK. 
Refinement 
The structure was solved by direct methods. The non-hydrogen atoms were refined anisotropically. 
H atoms were included in calculated positions with C—H lengths of 0.95(CH), 0.99(CH2) & 
0.98(CH3)Å; Uiso(H) values were fixed at 1.2Ueq(C) except for CH3 where it was 1.5Ueq(C). 
Experimental: 
Crystal data 
C18H19N3S2 V = 815.9 (2) Å
3
 
Mr = 341.48 Z = 2 
Monoclinic, P21 Mo Kα radiation, λ = 0.71073 Å 
a = 8.8373 (14) Å µ = 0.33 mm
−1
 
b = 10.6736 (17) Å T = 100 K 
c = 9.0407 (14) Å 0.30 × 0.20 × 0.04 mm 
β = 106.912 (3)°  
Data collection  
CCD area detector  
diffractometer 
2190 reflections with I > 2σ(I) 
7109 measured reflections Rint = 0.050 
3709 independent reflections  
Refinement 
R[F
2
 > 2σ(F
2
)] = 0.041 
H atoms treated by a mixture of 
independent and constrained 
refinement 
wR(F
2
) = 0.054 Δρmax = 0.42 e Å
−3
 
S = 0.66 Δρmin = −0.27 e Å
−3
 
3709 reflections 
Absolute structure: Flack H D (1983), 
Acta Cryst. A39, 876-881 
213 parameters Flack parameter: −0.03 (6) 
1 restraint  
Table 1 
Hydrogen-bond geometry (Å, º) 
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D—H···A D—H H···A D···A D—H···A 
N3—H3···S1
i
 0.97 (2) 2.61 (3) 3.438 (3) 143 (2) 
N3—H3···S2 0.97 (2) 2.51 (3) 3.069 (3) 116.4 (19) 
  
Data collection: Bruker SMART; cell refinement: Bruker SMART; data reduction: Bruker SAINT; 
program(s) used to solve structure: SHELXS97 (Sheldrick, 1990); program(s) used to refine 
structure: SHELXL97 (Sheldrick, 1997); molecular graphics: Bruker SHELXTL; software used to 
prepare material for publication: Bruker SHELXTL. 
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Supplementary materials 
Crystal data 
C18H19N3S2 F(000) = 360 
Mr = 341.48 Dx = 1.390 Mg m
−3
 
Monoclinic, P21 Mo Kα radiation, λ = 0.71073 Å 
a = 8.8373 (14) Å Cell parameters from 1031 reflections 
b = 10.6736 (17) Å θ = 2.4–21.3° 
c = 9.0407 (14) Å µ = 0.33 mm
−1
 
β = 106.912 (3)° T = 100 K 
V = 815.9 (2) Å
3
 Plate, White 
Z = 2 0.30 × 0.20 × 0.04 mm 
Data collection 
CCD area detector  
diffractometer 
2190 reflections with I > 2σ(I) 
Radiation source: fine-focus sealed 
tube 
Rint = 0.050 
graphite θmax = 28.3°, θmin = 2.4° 
phi and ω scans h = −11→11 
7109 measured reflections k = −14→14 
3709 independent reflections l = −11→11 
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Refinement 
Refinement on F
2
 
Secondary atom site location: 
Difference Fourier map 
Least-squares matrix: Full 
Hydrogen site location: Inferred from 
neighbouring sites 
R[F
2
 > 2σ(F
2
)] = 0.041 
H atoms treated by a mixture of 
independent and constrained 
refinement 
wR(F
2
) = 0.054 
w = 1/[σ
2
(Fo
2
) + (0.P)
2
]  
where P = (Fo
2
 + 2Fc
2
)/3 
S = 0.66 (Δ/σ)max < 0.001 
3709 reflections Δρmax = 0.42 e Å
−3
 
213 parameters Δρmin = −0.27 e Å
−3
 
1 restraint 
Absolute structure: Flack H D (1983), 
Acta Cryst. A39, 876-881 
Primary atom site location: Structure-
invariant direct methods 
Flack parameter: −0.03 (6) 
Special details 
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated 
using the full covariance matrix. The cell esds are taken into account individually in the estimation 
of esds in distances, angles and torsion angles; correlations between esds in cell parameters are 
only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell 
esds is used for estimating esds involving l.s. planes. 
Refinement. Refinement of F
2
 against ALL reflections. The weighted R-factor wR and goodness of 
fit S are based on F
2
, conventional R-factors R are based on F, with F set to zero for negative F
2
. 
The threshold expression of F
2
 > 2sigma(F
2
) is used only for calculating R-factors(gt) etc. and is 
not relevant to the choice of reflections for refinement. R-factors based on F
2
 are statistically about 
twice as large as those based on F, and R- factors based on ALL data will be even larger. 
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å
2
) 
 x y z Uiso*/Ueq 
C1 0.4095 (3) 1.2172 (2) 0.8080 (3) 0.0263 (8) 
H1A 0.4735 1.2707 0.7598 0.032* 
H1B 0.4671 1.2063 0.9189 0.032* 
C2 0.2466 (3) 1.2753 (3) 0.7885 (3) 0.0366 (8) 
H2A 0.2231 1.3400 0.7066 0.044* 
H2B 0.2411 1.3139 0.8863 0.044* 
C3 0.1298 (3) 1.1649 (3) 0.7429 (3) 0.0300 (8) 
H3A 0.1193 1.1202 0.8353 0.036* 
H3B 0.0241 1.1938 0.6803 0.036* 
C4 0.2070 (3) 1.0818 (3) 0.6479 (3) 0.0253 (8) 
H4 0.1863 1.1193 0.5425 0.030* 
C5 0.1533 (3) 0.9476 (3) 0.6302 (3) 0.0209 (7) 
C6 0.2186 (3) 0.7259 (2) 0.6265 (3) 0.0238 (8) 
H6A 0.2393 0.6934 0.5317 0.029* 
H6B 0.1041 0.7171 0.6144 0.029* 
C7 0.3121 (3) 0.6501 (2) 0.7650 (3) 0.0213 (7) 
H7A 0.2842 0.6759 0.8589 0.026* 
H7B 0.2885 0.5597 0.7472 0.026* 
C8 0.4836 (3) 0.6745 (3) 0.7845 (3) 0.0183 (7) 
C9 0.6181 (3) 0.5953 (3) 0.8394 (3) 0.0193 (7) 
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C10 0.6439 (3) 0.4783 (2) 0.9123 (3) 0.0215 (7) 
H10 0.5606 0.4368 0.9394 0.026* 
C11 0.7913 (3) 0.4236 (3) 0.9445 (3) 0.0265 (7) 
H11 0.8086 0.3434 0.9920 0.032* 
C12 0.9155 (3) 0.4848 (3) 0.9082 (3) 0.0306 (8) 
H12 1.0159 0.4451 0.9310 0.037* 
C13 0.8957 (3) 0.6023 (3) 0.8396 (3) 0.0313 (8) 
H13 0.9808 0.6448 0.8170 0.038* 
C14 0.7455 (3) 0.6550 (3) 0.8052 (3) 0.0233 (7) 
C15 0.5320 (3) 0.7786 (3) 0.7243 (3) 0.0194 (7) 
C16 0.4328 (3) 0.8890 (3) 0.6487 (3) 0.0198 (7) 
C17 0.4897 (3) 1.0114 (3) 0.7353 (3) 0.0204 (7) 
C18 0.4350 (3) 0.9059 (3) 0.4796 (3) 0.0265 (7) 
H18A 0.5430 0.9248 0.4777 0.040* 
H18B 0.3647 0.9750 0.4320 0.040* 
H18C 0.3987 0.8285 0.4218 0.040* 
N1 0.3773 (3) 1.0953 (2) 0.7297 (2) 0.0218 (6) 
N2 0.2635 (3) 0.8598 (2) 0.6465 (2) 0.0197 (6) 
N3 0.6894 (3) 0.7671 (2) 0.7290 (3) 0.0242 (6) 
S1 −0.04099 (8) 0.92311 (7) 0.58844 (9) 0.0299 (2) 
S2 0.67853 (9) 1.04361 (8) 0.81851 (9) 0.0359 (2) 
H3 0.756 (3) 0.839 (2) 0.725 (3) 0.046 (10)* 
Atomic displacement parameters (Å
2
) 
 U
11
 U
22
 U
33
 U
12
 U
13
 U
23
 
C1 0.037 (2) 0.0223 (18) 0.0189 (18) −0.0107 (16) 0.0064 (16) −0.0035 (14) 
C2 0.044 (2) 0.027 (2) 0.0308 (19) 0.0047 (17) −0.0020 (17) 0.0005 (16) 
C3 0.0287 (18) 0.0282 (18) 0.0295 (19) 0.0072 (15) 0.0030 (15) 0.0022 (15) 
C4 0.0318 (19) 0.0226 (19) 0.0184 (17) 0.0015 (14) 0.0021 (15) 0.0071 (14) 
C5 0.0279 (18) 0.024 (2) 0.0109 (14) 0.0019 (14) 0.0053 (13) 0.0016 (14) 
C6 0.0203 (18) 0.0239 (19) 0.025 (2) −0.0112 (14) 0.0027 (15) −0.0060 (15) 
C7 0.0240 (17) 0.0142 (16) 0.0244 (18) 0.0004 (13) 0.0049 (14) 0.0000 (14) 
C8 0.0190 (17) 0.0226 (17) 0.0146 (16) −0.0052 (14) 0.0070 (13) −0.0073 (14) 
C9 0.0228 (17) 0.0229 (17) 0.0122 (15) −0.0006 (14) 0.0053 (13) −0.0057 (14) 
C10 0.0234 (17) 0.0250 (18) 0.0163 (16) −0.0051 (14) 0.0060 (13) −0.0085 (14) 
C11 0.0354 (18) 0.0198 (16) 0.0222 (17) 0.0025 (17) 0.0052 (14) −0.0033 (15) 
C12 0.0250 (19) 0.035 (2) 0.0302 (19) 0.0078 (16) 0.0061 (15) −0.0030 (16) 
C13 0.0246 (19) 0.042 (2) 0.0290 (19) −0.0021 (16) 0.0108 (15) −0.0035 (17) 
C14 0.0176 (17) 0.034 (2) 0.0163 (17) −0.0022 (15) 0.0027 (14) −0.0020 (15) 
C15 0.0187 (17) 0.0244 (18) 0.0151 (16) 0.0000 (15) 0.0049 (13) −0.0029 (14) 
C16 0.0170 (16) 0.0242 (18) 0.0180 (16) −0.0040 (13) 0.0051 (13) −0.0001 (14) 
C17 0.0253 (17) 0.023 (2) 0.0174 (16) −0.0069 (15) 0.0131 (14) −0.0010 (14) 
C18 0.0354 (17) 0.0244 (18) 0.0222 (16) −0.0040 (16) 0.0125 (14) 0.0006 (14) 
N1 0.0281 (15) 0.0183 (14) 0.0179 (14) −0.0071 (12) 0.0049 (12) 0.0019 (12) 
N2 0.0205 (14) 0.0228 (15) 0.0151 (13) −0.0039 (11) 0.0044 (11) −0.0012 (11) 
N3 0.0191 (15) 0.0288 (16) 0.0268 (15) −0.0036 (13) 0.0098 (12) 0.0034 (13) 
S1 0.0212 (4) 0.0355 (5) 0.0325 (5) 0.0000 (4) 0.0071 (4) 0.0037 (4) 
S2 0.0244 (5) 0.0378 (5) 0.0462 (5) −0.0088 (4) 0.0115 (4) −0.0158 (5) 
Geometric parameters (Å, º) 
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C1—N1 1.469 (3) C8—C9 1.424 (3) 
C1—C2 1.529 (3) C9—C10 1.400 (3) 
C1—H1A 0.9900 C9—C14 1.404 (3) 
C1—H1B 0.9900 C10—C11 1.379 (3) 
C2—C3 1.541 (4) C10—H10 0.9500 
C2—H2A 0.9900 C11—C12 1.396 (4) 
C2—H2B 0.9900 C11—H11 0.9500 
C3—C4 1.527 (4) C12—C13 1.387 (4) 
C3—H3A 0.9900 C12—H12 0.9500 
C3—H3B 0.9900 C13—C14 1.391 (4) 
C4—N1 1.478 (3) C13—H13 0.9500 
C4—C5 1.503 (3) C14—N3 1.398 (3) 
C4—H4 1.0000 C15—N3 1.385 (3) 
C5—N2 1.328 (3) C15—C16 1.509 (3) 
C5—S1 1.668 (3) C16—N2 1.523 (3) 
C6—N2 1.480 (3) C16—C17 1.531 (4) 
C6—C7 1.518 (3) C16—C18 1.545 (3) 
C6—H6A 0.9900 C17—N1 1.327 (3) 
C6—H6B 0.9900 C17—S2 1.655 (3) 
C7—C8 1.497 (3) C18—H18A 0.9800 
C7—H7A 0.9900 C18—H18B 0.9800 
C7—H7B 0.9900 C18—H18C 0.9800 
C8—C15 1.360 (3) N3—H3 0.97 (2) 
    
N1—C1—C2 105.1 (2) C14—C9—C8 107.2 (3) 
N1—C1—H1A 110.7 C11—C10—C9 119.5 (3) 
C2—C1—H1A 110.7 C11—C10—H10 120.3 
N1—C1—H1B 110.7 C9—C10—H10 120.3 
C2—C1—H1B 110.7 C10—C11—C12 120.7 (3) 
H1A—C1—H1B 108.8 C10—C11—H11 119.6 
C1—C2—C3 104.8 (2) C12—C11—H11 119.6 
C1—C2—H2A 110.8 C13—C12—C11 121.5 (3) 
C3—C2—H2A 110.8 C13—C12—H12 119.2 
C1—C2—H2B 110.8 C11—C12—H12 119.2 
C3—C2—H2B 110.8 C12—C13—C14 117.0 (3) 
H2A—C2—H2B 108.9 C12—C13—H13 121.5 
C4—C3—C2 102.7 (2) C14—C13—H13 121.5 
C4—C3—H3A 111.2 C13—C14—N3 129.4 (3) 
C2—C3—H3A 111.2 C13—C14—C9 122.8 (3) 
C4—C3—H3B 111.2 N3—C14—C9 107.7 (2) 
C2—C3—H3B 111.2 C8—C15—N3 110.3 (2) 
H3A—C3—H3B 109.1 C8—C15—C16 127.6 (2) 
N1—C4—C5 113.0 (2) N3—C15—C16 121.9 (2) 
N1—C4—C3 102.6 (2) C15—C16—N2 106.6 (2) 
C5—C4—C3 115.8 (2) C15—C16—C17 112.0 (2) 
N1—C4—H4 108.4 N2—C16—C17 110.9 (2) 
C5—C4—H4 108.4 C15—C16—C18 111.5 (2) 
C3—C4—H4 108.4 N2—C16—C18 107.8 (2) 
N2—C5—C4 117.5 (2) C17—C16—C18 108.1 (2) 
N2—C5—S1 126.0 (2) N1—C17—C16 115.2 (2) 
C4—C5—S1 116.5 (2) N1—C17—S2 121.4 (2) 
N2—C6—C7 110.6 (2) C16—C17—S2 123.2 (2) 
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N2—C6—H6A 109.5 C16—C18—H18A 109.5 
C7—C6—H6A 109.5 C16—C18—H18B 109.5 
N2—C6—H6B 109.5 H18A—C18—H18B 109.5 
C7—C6—H6B 109.5 C16—C18—H18C 109.5 
H6A—C6—H6B 108.1 H18A—C18—H18C 109.5 
C8—C7—C6 107.1 (2) H18B—C18—H18C 109.5 
C8—C7—H7A 110.3 C17—N1—C1 122.8 (2) 
C6—C7—H7A 110.3 C17—N1—C4 126.5 (2) 
C8—C7—H7B 110.3 C1—N1—C4 110.7 (2) 
C6—C7—H7B 110.3 C5—N2—C6 120.4 (2) 
H7A—C7—H7B 108.6 C5—N2—C16 122.9 (2) 
C15—C8—C9 107.2 (2) C6—N2—C16 115.3 (2) 
C15—C8—C7 121.4 (2) C15—N3—C14 107.4 (2) 
C9—C8—C7 130.6 (2) C15—N3—H3 122.9 (16) 
C10—C9—C14 118.5 (3) C14—N3—H3 124.1 (15) 
C10—C9—C8 134.3 (3)   
    
N1—C1—C2—C3 17.0 (3) C8—C15—C16—C18 −119.6 (3) 
C1—C2—C3—C4 −33.5 (3) N3—C15—C16—C18 54.8 (3) 
C2—C3—C4—N1 36.8 (3) C15—C16—C17—N1 −148.4 (2) 
C2—C3—C4—C5 160.3 (2) N2—C16—C17—N1 −29.5 (3) 
N1—C4—C5—N2 −18.7 (3) C18—C16—C17—N1 88.4 (3) 
C3—C4—C5—N2 −136.6 (2) C15—C16—C17—S2 36.4 (3) 
N1—C4—C5—S1 162.46 (18) N2—C16—C17—S2 155.30 (18) 
C3—C4—C5—S1 44.5 (3) C18—C16—C17—S2 −86.7 (3) 
N2—C6—C7—C8 −55.1 (3) C16—C17—N1—C1 179.0 (2) 
C6—C7—C8—C15 21.3 (3) S2—C17—N1—C1 −5.7 (3) 
C6—C7—C8—C9 −147.4 (3) C16—C17—N1—C4 −0.7 (4) 
C15—C8—C9—C10 179.6 (3) S2—C17—N1—C4 174.5 (2) 
C7—C8—C9—C10 −10.5 (5) C2—C1—N1—C17 −173.0 (2) 
C15—C8—C9—C14 −1.6 (3) C2—C1—N1—C4 6.8 (3) 
C7—C8—C9—C14 168.3 (3) C5—C4—N1—C17 26.6 (4) 
C14—C9—C10—C11 −1.8 (4) C3—C4—N1—C17 152.0 (2) 
C8—C9—C10—C11 176.9 (3) C5—C4—N1—C1 −153.1 (2) 
C9—C10—C11—C12 1.4 (4) C3—C4—N1—C1 −27.8 (3) 
C10—C11—C12—C13 0.3 (4) C4—C5—N2—C6 −178.4 (2) 
C11—C12—C13—C14 −1.5 (4) S1—C5—N2—C6 0.4 (4) 
C12—C13—C14—N3 −175.9 (3) C4—C5—N2—C16 −12.9 (4) 
C12—C13—C14—C9 1.0 (4) S1—C5—N2—C16 165.8 (2) 
C10—C9—C14—C13 0.6 (4) C7—C6—N2—C5 −127.8 (3) 
C8—C9—C14—C13 −178.4 (3) C7—C6—N2—C16 65.7 (3) 
C10—C9—C14—N3 178.1 (2) C15—C16—N2—C5 160.1 (2) 
C8—C9—C14—N3 −0.9 (3) C17—C16—N2—C5 38.0 (3) 
C9—C8—C15—N3 3.6 (3) C18—C16—N2—C5 −80.1 (3) 
C7—C8—C15—N3 −167.4 (2) C15—C16—N2—C6 −33.7 (3) 
C9—C8—C15—C16 178.6 (2) C17—C16—N2—C6 −155.8 (2) 
C7—C8—C15—C16 7.5 (4) C18—C16—N2—C6 86.1 (3) 
C8—C15—C16—N2 −2.2 (4) C8—C15—N3—C14 −4.2 (3) 
N3—C15—C16—N2 172.3 (2) C16—C15—N3—C14 −179.5 (2) 
C8—C15—C16—C17 119.2 (3) C13—C14—N3—C15 −179.6 (3) 
N3—C15—C16—C17 −66.3 (3) C9—C14—N3—C15 3.1 (3) 
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Hydrogen-bond geometry (Å, º) 
D—H···A D—H H···A D···A D—H···A 
N3—H3···S1
i
 0.97 (2) 2.61 (3) 3.438 (3) 143 (2) 
N3—H3···S2 0.97 (2) 2.51 (3) 3.069 (3) 116.4 (19) 
Symmetry code: (i) x+1, y, z. 
  Appendix 6 
211 
Appendix 6: Crystallographic data for (4.164) 
 
 
 
 
Data obtained Chemistry Research Laboratory, 12 Mansfield Road, Oxford, OX1 3TA 
Experimental: 
Crystal data 
C18H19BrN2O V = 1591.39 (8) Å
3
 
Mr = 359.27 Z = 4 
Monoclinic, C2 Mo Kα radiation, λ = 0.71073 Å 
a = 18.7232 (4) Å µ = 2.59 mm
−1
 
b = 6.9539 (2) Å T = 150 K 
c = 14.1450 (4) Å 0.17 × 0.06 × 0.05 mm 
β = 120.2197 (13)°  
Data collection 
Area  
diffractometer 
3391 independent reflections 
Absorption correction: Multi-scan  
DENZO/SCALEPACK (Otwinowski & 
Minor, 1997) 
2808 reflections with I > 2.0σ(I) 
Tmin = 0.80, Tmax = 0.89 Rint = 0.068 
7601 measured reflections  
Refinement 
R[F
2
 > 2σ(F
2
)] = 0.039 No H atoms present 
wR(F
2
) = 0.081 Δρmax = 0.70 e Å
−3
 
S = 0.93 Δρmin = −1.07 e Å
−3
 
3391 reflections 
Absolute structure: Flack (1983), 0 
Friedel-pairs 
200 parameters Flack parameter: −0.030 (11) 
1 restraint  
Table 1 
Selected geometric parameters (Å, º) 
Br1—C2 1.907 (3) C11—C12 1.532 (5) 
C2—C3 1.405 (5) C12—N13 1.455 (4) 
C2—C10 1.368 (5) N13—C14 1.484 (4) 
C3—C4 1.383 (5) N13—C17 1.364 (5) 
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C4—C5 1.395 (5) C14—C15 1.566 (5) 
C5—N6 1.383 (5) C14—C19 1.530 (5) 
C5—C9 1.408 (5) C15—C16 1.525 (5) 
N6—C7 1.377 (4) C15—C1 1.543 (5) 
C7—C8 1.377 (5) C16—C17 1.518 (5) 
C7—C14 1.506 (5) C17—O18 1.230 (4) 
C8—C9 1.445 (5) C19—C20 1.530 (4) 
C8—C11 1.500 (5) C20—C21 1.519 (5) 
C9—C10 1.401 (5) C21—C1 1.521 (5) 
    
Br1—C2—C3 117.8 (3) C12—N13—C14 117.5 (3) 
Br1—C2—C10 119.1 (3) C12—N13—C17 119.3 (3) 
C3—C2—C10 123.1 (3) C14—N13—C17 111.1 (3) 
C2—C3—C4 119.7 (3) C7—C14—N13 104.5 (3) 
C3—C4—C5 118.0 (3) C7—C14—C15 113.7 (3) 
C4—C5—N6 130.1 (3) N13—C14—C15 101.1 (3) 
C4—C5—C9 121.8 (3) C7—C14—C19 109.6 (3) 
N6—C5—C9 108.1 (3) N13—C14—C19 113.6 (3) 
C5—N6—C7 108.4 (3) C15—C14—C19 113.8 (3) 
N6—C7—C8 110.4 (3) C14—C15—C16 101.6 (3) 
N6—C7—C14 125.3 (3) C14—C15—C1 111.8 (3) 
C8—C7—C14 124.3 (3) C16—C15—C1 109.6 (3) 
C7—C8—C9 106.1 (3) C15—C16—C17 104.1 (3) 
C7—C8—C11 124.1 (3) C16—C17—N13 108.6 (3) 
C9—C8—C11 129.9 (3) C16—C17—O18 126.1 (4) 
C8—C9—C5 107.0 (3) N13—C17—O18 125.2 (4) 
C8—C9—C10 133.2 (3) C14—C19—C20 114.7 (3) 
C5—C9—C10 119.7 (3) C19—C20—C21 109.8 (3) 
C9—C10—C2 117.7 (3) C20—C21—C1 110.2 (3) 
C8—C11—C12 110.3 (3) C15—C1—C21 114.3 (3) 
C11—C12—N13 111.0 (3)   
Table 2 
Hydrogen-bond geometry (Å, º) 
D—H···A D—H H···A D···A D—H···A 
N6—H61···O18
i
 0.87 1.98 2.838 (6) 171 
Symmetry code: (i) x, y+1, z. 
  
Data collection: COLLECT (Nonius, 2001).; cell refinement: DENZO/SCALEPACK (Otwinowski & 
Minor, 1997); data reduction: DENZO/SCALEPACK (Otwinowski & Minor, 1997); program(s) used 
to solve structure: SIR92 (Altomare et al., 1994); program(s) used to refine structure: CRYSTALS 
(Betteridge et al., 2003); molecular graphics: CAMERON (Watkin et al., 1996); software used to 
prepare material for publication: CRYSTALS (Betteridge et al., 2003). 
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Supplementary materials 
(7t) 
Crystal data 
C18H19BrN2O F(000) = 736 
Mr = 359.27 Dx = 1.499 Mg m
−3
 
Monoclinic, C2 Mo Kα radiation, λ = 0.71073 Å 
Hall symbol: C 2y Cell parameters from 1825 reflections 
a = 18.7232 (4) Å θ = 5–27° 
b = 6.9539 (2) Å µ = 2.59 mm
−1
 
c = 14.1450 (4) Å T = 150 K 
β = 120.2197 (13)° Plate, Colourless 
V = 1591.39 (8) Å
3
 0.17 × 0.06 × 0.05 mm 
Z = 4  
Data collection 
Area  
diffractometer 
2808 reflections with I > 2.0σ(I) 
graphite Rint = 0.068 
ω scans θmax = 27.5°, θmin = 5.4° 
Absorption correction: Multi-scan  
DENZO/SCALEPACK (Otwinowski & 
Minor, 1997) 
h = −23→24 
Tmin = 0.80, Tmax = 0.89 k = −9→8 
7601 measured reflections l = −18→18 
3391 independent reflections  
Refinement 
Refinement on F
2
 
Hydrogen site location: Inferred from 
neighbouring sites 
Least-squares matrix: Full No H atoms present 
R[F
2
 > 2σ(F
2
)] = 0.039 
Method = Modified Sheldrick w = 
1/[σ
2
(F
2
) + ( 0.02P)
2
 + 2.8P] ,  
where P = (max(Fo
2
,0) + 2Fc
2
)/3 
wR(F
2
) = 0.081 (Δ/σ)max = 0.002 
S = 0.93 Δρmax = 0.70 e Å
−3
 
3391 reflections Δρmin = −1.07 e Å
−3
 
200 parameters 
Absolute structure: Flack (1983), 0 
Friedel-pairs 
1 restraint Flack parameter: −0.030 (11) 
Primary atom site location: Structure-
invariant direct methods 
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Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å
2
) 
H-atom positions were not refined or were subject to contraints(Warning: 
_refine_ls_hydrogen_treatment reports none) 
The following H sites were not refined or were subject to constraints: 
H61, H12, H11, H212, H211, H202, H201, H192, H191, H162, H161, H151, H122, H121, H112, 
H111, H101, H41, H31 
 x y z Uiso*/Ueq 
Br1 0.54156 (2) 0.17418 (13) 0.90615 (3) 0.0346 
C2 0.49056 (19) 0.2133 (5) 0.7522 (3) 0.0225 
C3 0.5049 (2) 0.3891 (5) 0.7156 (3) 0.0263 
C4 0.4657 (2) 0.4278 (5) 0.6047 (3) 0.0262 
C5 0.4124 (2) 0.2886 (5) 0.5327 (3) 0.0212 
N6 0.36376 (19) 0.2918 (4) 0.4200 (3) 0.0223 
C7 0.3211 (2) 0.1207 (5) 0.3862 (3) 0.0191 
C8 0.3403 (2) 0.0051 (5) 0.4749 (3) 0.0187 
C9 0.3998 (2) 0.1112 (5) 0.5702 (3) 0.0183 
C10 0.4400 (2) 0.0734 (5) 0.6827 (3) 0.0219 
C11 0.3018 (2) −0.1877 (5) 0.4672 (3) 0.0237 
C12 0.2318 (2) −0.2248 (5) 0.3499 (3) 0.0235 
N13 0.25123 (18) −0.1432 (4) 0.2708 (2) 0.0184 
C14 0.2592 (2) 0.0691 (5) 0.2696 (3) 0.0181 
C15 0.2929 (2) 0.0929 (5) 0.1890 (3) 0.0212 
C16 0.3487 (2) −0.0830 (5) 0.2168 (3) 0.0231 
C17 0.3079 (3) −0.2327 (6) 0.2523 (4) 0.0215 
O18 0.3257 (2) −0.4046 (4) 0.2678 (3) 0.0311 
C19 0.17817 (17) 0.1764 (8) 0.2337 (2) 0.0238 
C20 0.1126 (2) 0.1505 (8) 0.1131 (3) 0.0317 
C21 0.1482 (2) 0.2061 (7) 0.0413 (3) 0.0328 
C1 0.2230 (2) 0.0820 (5) 0.0684 (3) 0.0258 
H31 0.5404 0.4772 0.7662 0.0318* 
H41 0.4741 0.5425 0.5790 0.0313* 
H101 0.4328 −0.0424 0.7095 0.0251* 
H111 0.3447 −0.2846 0.4879 0.0291* 
H112 0.2801 −0.1916 0.5165 0.0289* 
H121 0.2247 −0.3644 0.3409 0.0291* 
H122 0.1810 −0.1646 0.3384 0.0285* 
H151 0.3235 0.2133 0.2032 0.0254* 
H161 0.4030 −0.0511 0.2794 0.0285* 
H162 0.3538 −0.1269 0.1559 0.0283* 
H191 0.1917 0.3125 0.2449 0.0285* 
H192 0.1552 0.1372 0.2792 0.0282* 
H201 0.0653 0.2300 0.0964 0.0384* 
H202 0.0960 0.0153 0.1014 0.0379* 
H211 0.1632 0.3441 0.0514 0.0402* 
H212 0.1091 0.1870 −0.0337 0.0398* 
H11 0.2479 0.1208 0.0239 0.0316* 
H12 0.2047 −0.0520 0.0528 0.0304* 
H61 0.3580 0.3881 0.3778 0.0288* 
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Atomic displacement parameters (Å
2
) 
 U
11
 U
22
 U
33
 U
12
 U
13
 U
23
 
Br1 0.0356 (2) 0.0425 (2) 0.01935 (16) 0.0064 (3) 0.00907 (13) 0.0002 (2) 
C2 0.0151 (15) 0.032 (3) 0.0172 (15) 0.0063 (15) 0.0059 (13) −0.0006 (15) 
C3 0.0196 (18) 0.030 (2) 0.0248 (19) −0.0037 (16) 0.0080 (16) −0.0085 (16) 
C4 0.028 (2) 0.0220 (19) 0.030 (2) −0.0043 (15) 0.0156 (18) −0.0019 (16) 
C5 0.0197 (19) 0.023 (2) 0.0187 (19) −0.0031 (15) 0.0075 (16) −0.0015 (15) 
N6 0.0235 (17) 0.0188 (16) 0.0240 (16) −0.0024 (13) 0.0116 (14) 0.0031 (13) 
C7 0.0195 (17) 0.019 (2) 0.0210 (17) 0.0011 (13) 0.0114 (15) −0.0010 (13) 
C8 0.0202 (18) 0.0135 (17) 0.0211 (17) −0.0011 (14) 0.0094 (15) −0.0008 (14) 
C9 0.0180 (16) 0.0167 (18) 0.0212 (18) 0.0032 (12) 0.0107 (15) −0.0015 (13) 
C10 0.0216 (18) 0.0260 (19) 0.0222 (18) 0.0065 (15) 0.0140 (16) 0.0042 (15) 
C11 0.030 (2) 0.0200 (19) 0.0248 (19) −0.0041 (15) 0.0164 (17) 0.0038 (15) 
C12 0.0240 (19) 0.0215 (19) 0.029 (2) −0.0028 (15) 0.0169 (17) 0.0009 (16) 
N13 0.0246 (15) 0.0129 (14) 0.0223 (15) −0.0022 (12) 0.0153 (13) 0.0006 (12) 
C14 0.0160 (16) 0.0185 (18) 0.0182 (17) −0.0020 (14) 0.0075 (14) −0.0024 (14) 
C15 0.0306 (19) 0.0162 (16) 0.0238 (18) −0.0007 (14) 0.0190 (16) 0.0047 (14) 
C16 0.0233 (19) 0.0218 (19) 0.0271 (19) 0.0034 (15) 0.0149 (16) 0.0036 (16) 
C17 0.024 (2) 0.021 (2) 0.020 (2) 0.0033 (16) 0.0119 (17) 0.0037 (16) 
O18 0.0460 (19) 0.0197 (15) 0.0359 (18) 0.0087 (13) 0.0267 (16) 0.0076 (13) 
C19 0.0212 (15) 0.0242 (16) 0.0240 (15) 0.002 (2) 0.0099 (12) 0.002 (2) 
C20 0.0196 (16) 0.039 (3) 0.0285 (18) 0.008 (2) 0.0062 (14) 0.000 (2) 
C21 0.037 (2) 0.032 (3) 0.0207 (16) 0.0038 (18) 0.0087 (15) 0.0040 (18) 
C1 0.028 (2) 0.0254 (19) 0.0218 (19) −0.0007 (16) 0.0112 (16) 0.0005 (15) 
Geometric parameters (Å, º) 
Br1—C2 1.907 (3) N13—C14 1.484 (4) 
C2—C3 1.405 (5) N13—C17 1.364 (5) 
C2—C10 1.368 (5) C14—C15 1.566 (5) 
C3—C4 1.383 (5) C14—C19 1.530 (5) 
C3—H31 0.922 C15—C16 1.525 (5) 
C4—C5 1.395 (5) C15—C1 1.543 (5) 
C4—H41 0.923 C15—H151 0.977 
C5—N6 1.383 (5) C16—C17 1.518 (5) 
C5—C9 1.408 (5) C16—H161 0.981 
N6—C7 1.377 (4) C16—H162 0.964 
N6—H61 0.867 C17—O18 1.230 (4) 
C7—C8 1.377 (5) C19—C20 1.530 (4) 
C7—C14 1.506 (5) C19—H191 0.972 
C8—C9 1.445 (5) C19—H192 0.976 
C8—C11 1.500 (5) C20—C21 1.519 (5) 
C9—C10 1.401 (5) C20—H201 0.966 
C10—H101 0.929 C20—H202 0.978 
C11—C12 1.532 (5) C21—C1 1.521 (5) 
C11—H111 0.974 C21—H211 0.990 
C11—H112 0.969 C21—H212 0.947 
C12—N13 1.455 (4) C1—H11 0.992 
C12—H121 0.979 C1—H12 0.978 
C12—H122 0.975   
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Br1—C2—C3 117.8 (3) N13—C14—C15 101.1 (3) 
Br1—C2—C10 119.1 (3) C7—C14—C19 109.6 (3) 
C3—C2—C10 123.1 (3) N13—C14—C19 113.6 (3) 
C2—C3—C4 119.7 (3) C15—C14—C19 113.8 (3) 
C2—C3—H31 119.3 C14—C15—C16 101.6 (3) 
C4—C3—H31 121.0 C14—C15—C1 111.8 (3) 
C3—C4—C5 118.0 (3) C16—C15—C1 109.6 (3) 
C3—C4—H41 121.1 C14—C15—H151 110.5 
C5—C4—H41 120.9 C16—C15—H151 112.3 
C4—C5—N6 130.1 (3) C1—C15—H151 110.7 
C4—C5—C9 121.8 (3) C15—C16—C17 104.1 (3) 
N6—C5—C9 108.1 (3) C15—C16—H161 108.4 
C5—N6—C7 108.4 (3) C17—C16—H161 108.8 
C5—N6—H61 126.0 C15—C16—H162 112.7 
C7—N6—H61 125.4 C17—C16—H162 111.8 
N6—C7—C8 110.4 (3) H161—C16—H162 110.7 
N6—C7—C14 125.3 (3) C16—C17—N13 108.6 (3) 
C8—C7—C14 124.3 (3) C16—C17—O18 126.1 (4) 
C7—C8—C9 106.1 (3) N13—C17—O18 125.2 (4) 
C7—C8—C11 124.1 (3) C14—C19—C20 114.7 (3) 
C9—C8—C11 129.9 (3) C14—C19—H191 106.7 
C8—C9—C5 107.0 (3) C20—C19—H191 107.0 
C8—C9—C10 133.2 (3) C14—C19—H192 109.7 
C5—C9—C10 119.7 (3) C20—C19—H192 109.3 
C9—C10—C2 117.7 (3) H191—C19—H192 109.3 
C9—C10—H101 121.4 C19—C20—C21 109.8 (3) 
C2—C10—H101 120.9 C19—C20—H201 109.1 
C8—C11—C12 110.3 (3) C21—C20—H201 110.3 
C8—C11—H111 107.7 C19—C20—H202 108.1 
C12—C11—H111 109.6 C21—C20—H202 109.9 
C8—C11—H112 109.4 H201—C20—H202 109.5 
C12—C11—H112 109.5 C20—C21—C1 110.2 (3) 
H111—C11—H112 110.3 C20—C21—H211 109.8 
C11—C12—N13 111.0 (3) C1—C21—H211 110.9 
C11—C12—H121 107.1 C20—C21—H212 111.2 
N13—C12—H121 110.9 C1—C21—H212 107.3 
C11—C12—H122 109.9 H211—C21—H212 107.5 
N13—C12—H122 107.8 C15—C1—C21 114.3 (3) 
H121—C12—H122 110.2 C15—C1—H11 106.3 
C12—N13—C14 117.5 (3) C21—C1—H11 110.7 
C12—N13—C17 119.3 (3) C15—C1—H12 107.6 
C14—N13—C17 111.1 (3) C21—C1—H12 108.1 
C7—C14—N13 104.5 (3) H11—C1—H12 109.8 
C7—C14—C15 113.7 (3)   
Hydrogen-bond geometry (Å, º) 
D—H···A D—H H···A D···A D—H···A 
N6—H61···O18
i
 0.87 1.98 2.838 (6) 171 
Symmetry code: (i) x, y+1, z. 
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Appendix 7: Crystallographic data for (4.167) 
 
 
Data obtained at Chemistry Research Laboratory, 12 Mansfield Road, Oxford, OX1 3TA 
Experimental: 
Crystal data 
C17H20N2O V = 1448.31 (5) Å
3
 
Mr = 268.36 Z = 4 
Monoclinic, P21/n Mo Kα radiation, λ = 0.71073 Å 
a = 5.7927 (1) Å µ = 0.08 mm
−1
 
b = 12.1783 (2) Å T = 150 K 
c = 20.5935 (5) Å 0.20 × 0.18 × 0.05 mm 
β = 94.4916 (8)°  
Data collection 
Area  
diffractometer 
3315 independent reflections 
Absorption correction: Multi-scan  
DENZO/SCALEPACK (Otwinowski & 
Minor, 1997) 
2036 reflections with I > 2.0σ(I) 
Tmin = 0.94, Tmax = 1.00 Rint = 0.041 
24984 measured reflections  
Refinement 
R[F
2
 > 2σ(F
2
)] = 0.055 0 restraints 
wR(F
2
) = 0.189 No H atoms present 
S = 0.99 Δρmax = 0.45 e Å
−3
 
3315 reflections Δρmin = −0.43 e Å
−3
 
181 parameters  
Table 1 
Selected geometric parameters (Å, º) 
O1—C2 1.240 (3) C8—C10 1.559 (3) 
C2—N3 1.340 (3) C10—C11 1.532 (3) 
C2—C11 1.504 (3) C10—C12 1.519 (3) 
N3—C4 1.462 (3) N13—C14 1.385 (3) 
N3—C8 1.480 (3) C14—C15 1.416 (3) 
C4—C5 1.525 (4) C14—C19 1.398 (3) 
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C5—C6 1.502 (3) C15—C16 1.407 (4) 
C6—C7 1.365 (3) C16—C17 1.384 (4) 
C6—C15 1.430 (3) C17—C18 1.402 (4) 
C7—C8 1.505 (3) C18—C19 1.388 (4) 
C7—N13 1.385 (3) C19—C20 1.498 (4) 
C8—C9 1.530 (3)   
    
O1—C2—N3 125.3 (2) C9—C8—C10 112.2 (2) 
O1—C2—C11 126.8 (2) C8—C10—C11 102.08 (18) 
N3—C2—C11 107.9 (2) C8—C10—C12 117.0 (2) 
C2—N3—C4 124.1 (2) C11—C10—C12 114.1 (2) 
C2—N3—C8 113.82 (19) C10—C11—C2 104.04 (19) 
C4—N3—C8 122.08 (19) C7—N13—C14 108.31 (19) 
N3—C4—C5 109.7 (2) N13—C14—C15 107.3 (2) 
C4—C5—C6 108.6 (2) N13—C14—C19 129.6 (2) 
C5—C6—C7 123.6 (2) C15—C14—C19 123.0 (2) 
C5—C6—C15 129.5 (2) C6—C15—C14 107.4 (2) 
C7—C6—C15 106.7 (2) C6—C15—C16 133.5 (2) 
C6—C7—C8 125.5 (2) C14—C15—C16 119.1 (2) 
C6—C7—N13 110.2 (2) C15—C16—C17 118.5 (3) 
C8—C7—N13 124.3 (2) C16—C17—C18 120.9 (3) 
C7—C8—N3 106.45 (18) C17—C18—C19 122.8 (3) 
C7—C8—C9 111.31 (19) C14—C19—C18 115.7 (2) 
N3—C8—C9 110.32 (18) C14—C19—C20 122.7 (2) 
C7—C8—C10 115.39 (19) C18—C19—C20 121.5 (2) 
N3—C8—C10 100.42 (18)   
Table 2 
Hydrogen-bond geometry (Å, º) 
D—H···A D—H H···A D···A D—H···A 
C4—H41···C14
i
 0.99 2.57 3.521 (4) 161 
C12—H122···O1
ii
 0.97 2.55 3.395 (4) 146 
N13—H131···O1
ii
 0.88 1.97 2.851 (4) 178 
Symmetry codes: (i) x+1, y, z; (ii) −x+3/2, y+1/2, −z+1/2. 
  
Data collection: COLLECT (Nonius, 2001).; cell refinement: DENZO/SCALEPACK (Otwinowski & 
Minor, 1997); data reduction: DENZO/SCALEPACK (Otwinowski & Minor, 1997); program(s) used 
to solve structure: SIR92 (Altomare et al., 1994); program(s) used to refine structure: CRYSTALS 
(Betteridge et al., 2003); molecular graphics: CAMERON (Watkin et al., 1996); software used to 
prepare material for publication: CRYSTALS (Betteridge et al., 2003). 
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Supplementary materials 
(7t) 
Crystal data 
C17H20N2O F(000) = 576 
Mr = 268.36 Dx = 1.231 Mg m
−3
 
Monoclinic, P21/n Mo Kα radiation, λ = 0.71073 Å 
Hall symbol: -P 2yn Cell parameters from 3455 reflections 
a = 5.7927 (1) Å θ = 5–27° 
b = 12.1783 (2) Å µ = 0.08 mm
−1
 
c = 20.5935 (5) Å T = 150 K 
β = 94.4916 (8)° Plate, Colourless 
V = 1448.31 (5) Å
3
 0.20 × 0.18 × 0.05 mm 
Z = 4  
Data collection 
Area  
diffractometer 
2036 reflections with I > 2.0σ(I) 
graphite Rint = 0.041 
ω scans θmax = 27.5°, θmin = 5.1° 
Absorption correction: Multi-scan  
DENZO/SCALEPACK (Otwinowski & 
Minor, 1997) 
h = −7→7 
Tmin = 0.94, Tmax = 1.00 k = −15→15 
24984 measured reflections l = −26→26 
3315 independent reflections  
Refinement 
Refinement on F
2
 
Primary atom site location: Structure-
invariant direct methods 
Least-squares matrix: Full 
Hydrogen site location: Inferred from 
neighbouring sites 
R[F
2
 > 2σ(F
2
)] = 0.055 No H atoms present 
wR(F
2
) = 0.189 
Method, part 1, Chebychev polynomial, 
(Watkin, 1994, Prince, 1982) [weight] = 
1.0/[A0*T0(x) + A1*T1(x) ··· + An-1]*Tn-
1(x)]  
where Ai are the Chebychev 
coefficients listed below and x = F 
/Fmax Method = Robust Weighting 
(Prince, 1982) W = [weight] * [1-
(deltaF/6*sigmaF)
2
]
2
 Ai are: 16.1 25.4 
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14.0 5.09 0.777 
S = 0.99 (Δ/σ)max = 0.0002 
3315 reflections Δρmax = 0.45 e Å
−3
 
181 parameters Δρmin = −0.43 e Å
−3
 
0 restraints  
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å
2
) 
H-atom positions were not refined or were subject to contraints(Warning: 
_refine_ls_hydrogen_treatment reports none) 
The following H sites were not refined or were subject to constraints: 
H131, H201, H203, H202, H181, H171, H161, H121, H122, H123, H112, H111, H101, H93, H92, 
H91, H52, H51, H42, H41 
 x y z Uiso*/Ueq 
O1 1.1138 (3) 0.45198 (14) 0.23180 (9) 0.0345 
C2 0.9784 (4) 0.52985 (19) 0.23688 (12) 0.0289 
N3 0.9728 (3) 0.59531 (16) 0.28904 (10) 0.0281 
C4 1.1118 (4) 0.5776 (2) 0.35052 (12) 0.0325 
C5 0.9529 (5) 0.5593 (2) 0.40517 (13) 0.0372 
C6 0.7670 (4) 0.6455 (2) 0.40027 (12) 0.0307 
C7 0.7077 (4) 0.70408 (18) 0.34494 (11) 0.0267 
C8 0.8047 (4) 0.68664 (19) 0.28007 (11) 0.0265 
C9 0.9248 (4) 0.7902 (2) 0.25753 (13) 0.0327 
C10 0.6324 (4) 0.6378 (2) 0.22569 (11) 0.0286 
C11 0.7922 (4) 0.5675 (2) 0.18683 (12) 0.0313 
C12 0.4848 (4) 0.7187 (2) 0.18452 (13) 0.0381 
N13 0.5468 (3) 0.78416 (17) 0.35712 (9) 0.0279 
C14 0.4964 (4) 0.7754 (2) 0.42158 (11) 0.0293 
C15 0.6315 (4) 0.6881 (2) 0.44966 (12) 0.0323 
C16 0.6077 (5) 0.6590 (3) 0.51490 (13) 0.0440 
C17 0.4493 (5) 0.7158 (3) 0.54896 (13) 0.0484 
C18 0.3179 (5) 0.8016 (3) 0.51951 (13) 0.0456 
C19 0.3379 (5) 0.8344 (2) 0.45567 (12) 0.0356 
C20 0.1948 (6) 0.9264 (3) 0.42557 (14) 0.0510 
H41 1.2116 0.6425 0.3605 0.0388* 
H42 1.2087 0.5125 0.3457 0.0386* 
H51 1.0435 0.5652 0.4480 0.0452* 
H52 0.8857 0.4854 0.4009 0.0451* 
H91 0.8125 0.8501 0.2533 0.0488* 
H92 1.0527 0.8103 0.2894 0.0485* 
H93 0.9871 0.7777 0.2152 0.0478* 
H101 0.5275 0.5877 0.2471 0.0337* 
H111 0.8605 0.6134 0.1538 0.0381* 
H112 0.7113 0.5049 0.1653 0.0383* 
H123 0.3744 0.6779 0.1548 0.0570* 
H122 0.3988 0.7663 0.2115 0.0564* 
H121 0.5827 0.7638 0.1584 0.0567* 
H161 0.6976 0.6006 0.5354 0.0532* 
H171 0.4297 0.6965 0.5929 0.0583* 
H181 0.2085 0.8388 0.5440 0.0552* 
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H202 0.1089 0.9642 0.4563 0.0782* 
H203 0.2890 0.9783 0.4062 0.0789* 
H201 0.0915 0.8999 0.3911 0.0788* 
H131 0.4945 0.8356 0.3296 0.0346* 
Atomic displacement parameters (Å
2
) 
 U
11
 U
22
 U
33
 U
12
 U
13
 U
23
 
O1 0.0344 (9) 0.0303 (9) 0.0388 (10) 0.0032 (7) 0.0028 (7) −0.0067 (7) 
C2 0.0281 (11) 0.0273 (11) 0.0315 (12) −0.0020 (9) 0.0046 (9) −0.0033 (9) 
N3 0.0258 (9) 0.0287 (10) 0.0296 (10) 0.0018 (8) 0.0009 (7) −0.0019 (8) 
C4 0.0281 (11) 0.0387 (13) 0.0302 (12) 0.0041 (10) −0.0008 (9) −0.0032 (10) 
C5 0.0402 (14) 0.0407 (14) 0.0309 (13) 0.0102 (11) 0.0033 (10) 0.0024 (11) 
C6 0.0311 (12) 0.0334 (12) 0.0280 (11) 0.0049 (10) 0.0041 (9) 0.0007 (9) 
C7 0.0271 (10) 0.0258 (11) 0.0274 (11) 0.0023 (9) 0.0028 (8) −0.0016 (9) 
C8 0.0240 (10) 0.0294 (11) 0.0261 (11) 0.0017 (9) 0.0029 (8) −0.0007 (9) 
C9 0.0302 (12) 0.0311 (12) 0.0375 (13) −0.0018 (10) 0.0080 (10) −0.0009 (10) 
C10 0.0258 (11) 0.0328 (12) 0.0271 (11) −0.0012 (9) 0.0024 (8) −0.0012 (9) 
C11 0.0313 (12) 0.0317 (12) 0.0307 (12) −0.0007 (10) 0.0015 (9) −0.0033 (10) 
C12 0.0325 (13) 0.0470 (15) 0.0342 (13) 0.0079 (11) −0.0007 (10) −0.0012 (12) 
N13 0.0294 (10) 0.0291 (10) 0.0256 (10) 0.0027 (8) 0.0037 (7) 0.0016 (8) 
C14 0.0306 (11) 0.0310 (12) 0.0262 (11) 0.0004 (10) 0.0016 (9) −0.0035 (9) 
C15 0.0336 (12) 0.0375 (13) 0.0259 (12) 0.0033 (10) 0.0028 (9) 0.0001 (10) 
C16 0.0530 (17) 0.0540 (17) 0.0255 (12) 0.0138 (14) 0.0052 (11) 0.0048 (12) 
C17 0.0567 (17) 0.0648 (19) 0.0250 (12) 0.0160 (15) 0.0099 (12) 0.0028 (13) 
C18 0.0466 (15) 0.0613 (19) 0.0298 (13) 0.0153 (14) 0.0083 (11) −0.0047 (12) 
C19 0.0361 (13) 0.0420 (14) 0.0292 (12) 0.0073 (11) 0.0046 (10) −0.0037 (11) 
C20 0.0604 (19) 0.0584 (19) 0.0349 (14) 0.0274 (16) 0.0086 (13) −0.0007 (13) 
Geometric parameters (Å, º) 
O1—C2 1.240 (3) C10—H101 0.988 
C2—N3 1.340 (3) C11—H111 0.986 
C2—C11 1.504 (3) C11—H112 0.982 
N3—C4 1.462 (3) C12—H123 0.984 
N3—C8 1.480 (3) C12—H122 0.968 
C4—C5 1.525 (4) C12—H121 0.980 
C4—H41 0.991 N13—C14 1.385 (3) 
C4—H42 0.981 N13—H131 0.882 
C5—C6 1.502 (3) C14—C15 1.416 (3) 
C5—H51 0.993 C14—C19 1.398 (3) 
C5—H52 0.981 C15—C16 1.407 (4) 
C6—C7 1.365 (3) C16—C17 1.384 (4) 
C6—C15 1.430 (3) C16—H161 0.959 
C7—C8 1.505 (3) C17—C18 1.402 (4) 
C7—N13 1.385 (3) C17—H171 0.951 
C8—C9 1.530 (3) C18—C19 1.388 (4) 
C8—C10 1.559 (3) C18—H181 0.954 
C9—H91 0.977 C19—C20 1.498 (4) 
C9—H92 0.981 C20—H202 0.953 
C9—H93 0.981 C20—H203 0.944 
C10—C11 1.532 (3) C20—H201 0.949 
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C10—C12 1.519 (3)   
    
O1—C2—N3 125.3 (2) C12—C10—H101 108.1 
O1—C2—C11 126.8 (2) C10—C11—C2 104.04 (19) 
N3—C2—C11 107.9 (2) C10—C11—H111 109.6 
C2—N3—C4 124.1 (2) C2—C11—H111 109.9 
C2—N3—C8 113.82 (19) C10—C11—H112 112.5 
C4—N3—C8 122.08 (19) C2—C11—H112 111.3 
N3—C4—C5 109.7 (2) H111—C11—H112 109.4 
N3—C4—H41 109.6 C10—C12—H123 109.2 
C5—C4—H41 109.8 C10—C12—H122 111.2 
N3—C4—H42 108.2 H123—C12—H122 108.7 
C5—C4—H42 109.9 C10—C12—H121 110.2 
H41—C4—H42 109.7 H123—C12—H121 108.5 
C4—C5—C6 108.6 (2) H122—C12—H121 109.0 
C4—C5—H51 109.7 C7—N13—C14 108.31 (19) 
C6—C5—H51 109.6 C7—N13—H131 125.8 
C4—C5—H52 109.1 C14—N13—H131 125.7 
C6—C5—H52 110.9 N13—C14—C15 107.3 (2) 
H51—C5—H52 108.9 N13—C14—C19 129.6 (2) 
C5—C6—C7 123.6 (2) C15—C14—C19 123.0 (2) 
C5—C6—C15 129.5 (2) C6—C15—C14 107.4 (2) 
C7—C6—C15 106.7 (2) C6—C15—C16 133.5 (2) 
C6—C7—C8 125.5 (2) C14—C15—C16 119.1 (2) 
C6—C7—N13 110.2 (2) C15—C16—C17 118.5 (3) 
C8—C7—N13 124.3 (2) C15—C16—H161 121.0 
C7—C8—N3 106.45 (18) C17—C16—H161 120.5 
C7—C8—C9 111.31 (19) C16—C17—C18 120.9 (3) 
N3—C8—C9 110.32 (18) C16—C17—H171 119.5 
C7—C8—C10 115.39 (19) C18—C17—H171 119.7 
N3—C8—C10 100.42 (18) C17—C18—C19 122.8 (3) 
C9—C8—C10 112.2 (2) C17—C18—H181 119.1 
C8—C9—H91 109.1 C19—C18—H181 118.1 
C8—C9—H92 109.8 C14—C19—C18 115.7 (2) 
H91—C9—H92 109.6 C14—C19—C20 122.7 (2) 
C8—C9—H93 110.4 C18—C19—C20 121.5 (2) 
H91—C9—H93 109.1 C19—C20—H202 112.8 
H92—C9—H93 108.8 C19—C20—H203 110.9 
C8—C10—C11 102.08 (18) H202—C20—H203 107.8 
C8—C10—C12 117.0 (2) C19—C20—H201 110.6 
C11—C10—C12 114.1 (2) H202—C20—H201 109.3 
C8—C10—H101 107.3 H203—C20—H201 105.2 
C11—C10—H101 107.8   
Hydrogen-bond geometry (Å, º) 
D—H···A D—H H···A D···A D—H···A 
C4—H41···C14
i
 0.99 2.57 3.521 (4) 161 
C12—H122···O1
ii
 0.97 2.55 3.395 (4) 146 
N13—H131···O1
ii
 0.88 1.97 2.851 (4) 178 
Symmetry codes: (i) x+1, y, z; (ii) −x+3/2, y+1/2, −z+1/2. 
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Appendix 8: NOE data for (4.121) 
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